{"title":"Psychiatry","description":"","products":[{"product_id":"harvard-principles-of-medical-education-maximizing-your-teaching-skills-march-edition-2026","title":"Harvard Principles of Medical Education Maximizing Your Teaching Skills March Edition 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: medical educators and clinical faculty who want updates on instructional strategies, curriculum design, and trainee mentorship\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eThe Harvard Principles of Medical Education Maximizing Your Teaching Skills March Edition 2026 course provides a comprehensive update on modern instructional strategies and curriculum development for clinical faculty. The program focuses on leveraging the science of learning, improving bedside and small group teaching, addressing implicit bias, and navigating emerging technologies like artificial intelligence in the educational landscape.\u003c\/p\u003e\n\u003cp\u003eCourse Date: March 2026\u003c\/p\u003e\n\u003cp\u003eImprove the effectiveness of your teaching and mentoring with best practices, new principles of adult learning, and the latest educational technology. This comprehensive exploration of medical education will help you inspire students, residents, fellows, and colleagues at the bedside, in ambulatory settings, and in the classroom.\u003c\/p\u003e\n\u003cp\u003eThe Techniques and Strategies That Significantly Improve Student Engagement, and Teaching and Mentoring Effectiveness\u003c\/p\u003e\n\u003ch3\u003eThe 2026 curriculum helps medical educators to:\u003c\/h3\u003e\n\u003cp\u003eLeverage artificial intelligence in your teaching\u003c\/p\u003e\n\u003cp\u003eProvide more effective feedback that motivates change\u003c\/p\u003e\n\u003cp\u003eUtilize active learning strategies in small and large group teaching settings\u003c\/p\u003e\n\u003cp\u003eDeliver more impactful and engaging lectures\u003c\/p\u003e\n\u003cp\u003eCharacterize best practices for mentor-mentee relationships and identify ways to leverage mentorship opportunities to help you thrive at work\u003c\/p\u003e\n\u003cp\u003eOptimize evaluation of trainee competencies\u003c\/p\u003e\n\u003cp\u003eImprove engagement and interactivity for in-person and virtual teaching sessions\u003c\/p\u003e\n\u003cp\u003eEnhance critical thinking and self-directed learning among students\u003c\/p\u003e\n\u003cp\u003eDescribe real-time strategies to address unprofessional behavior\u003c\/p\u003e\n\u003cp\u003eIdentify strengths and weaknesses of various assessment tools\u003c\/p\u003e\n\u003cp\u003eIncorporate various forms of technology, including digital media and artificial intelligence, into your teaching\u003c\/p\u003e\n\u003cp\u003eCreate an action plan for implementing and sustaining effective change as leaders in medical education\u003c\/p\u003e\n\u003cp\u003eIdentify strategies to recognize and mitigate bias\u003c\/p\u003e\n\u003cp\u003eDescribe personal and organizational strategies to improve the well-being of yourself and your trainees\u003c\/p\u003e\n\u003cp\u003eCase-based and hands-on learning are a hallmark of this course, with significant participant interaction and active modeling of instruction techniques. Whether you are newer to teaching or a seasoned educator and mentor, this course will give you modern tools and practices to optimize skills transfer and learner success.\u003c\/p\u003e\n\u003cp\u003eSKILLS DEVELOPMENT\u003c\/p\u003e\n\u003ch3\u003eAreas of focus in which attendees will deepen their skills include:\u003c\/h3\u003e\n\u003cp\u003eInteractive Lecturing\u003c\/p\u003e\n\u003cp\u003eBedside Teaching\u003c\/p\u003e\n\u003cp\u003eEffective Mentoring\u003c\/p\u003e\n\u003cp\u003eImpactful Feedback\u003c\/p\u003e\n\u003cp\u003eDeveloping Curricula\u003c\/p\u003e\n\u003cp\u003eAssessing Learners\u003c\/p\u003e\n\u003cp\u003eLearner Engagement\u003c\/p\u003e\n\u003cp\u003eTeaching Critical Thinking\u003c\/p\u003e\n\u003cp\u003eTeaching and Maintaining Wellness\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this course, participants will be able to:\u003c\/h3\u003e\n\u003ch3\u003eIdentify principles of adult learning in order to:\u003c\/h3\u003e\n\u003cp\u003eAssess their learners’ needs,\u003c\/p\u003e\n\u003cp\u003eDesign an educational intervention\u003c\/p\u003e\n\u003cp\u003eEstablish learner-centered learning environments\u003c\/p\u003e\n\u003ch3\u003eEmploy venue-specific teaching skills for:\u003c\/h3\u003e\n\u003cp\u003eAmbulatory teaching\u003c\/p\u003e\n\u003cp\u003eBedside teaching\u003c\/p\u003e\n\u003cp\u003eLarge-group presentations\u003c\/p\u003e\n\u003cp\u003eSmall-group\/case-based teaching\u003c\/p\u003e\n\u003cp\u003eRecognize effective learner assessment strategies and provide effective feedback in order to set educational expectations\u003c\/p\u003e\n\u003cp\u003eFoster critical thinking skills so learners may effectively use questions to promote clinical decision-making\u003c\/p\u003e\n\u003cp\u003eEngage in reflective practice in order to identify effective teaching techniques\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for medical educators and clinical faculty who want updates on instructional strategies, curriculum design, and trainee mentorship.\u003c\/p\u003e\n\u003cp\u003eWho Should Participate\u003c\/p\u003e\n\u003ch3\u003eMedical personnel of all specialties involved in the practice of medical education, including:\u003c\/h3\u003e\n\u003cp\u003ePhysicians\u003c\/p\u003e\n\u003cp\u003eNurse Practitioners\u003c\/p\u003e\n\u003cp\u003ePhysician Assistants\u003c\/p\u003e\n\u003cp\u003eNurses\u003c\/p\u003e\n\u003cp\u003ePharmacists\u003c\/p\u003e\n\u003cp\u003ePsychologists\u003c\/p\u003e\n\u003cp\u003eVeterinarians\u003c\/p\u003e\n\u003cp\u003eDentists\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e01 Effective Teaching Setting the Stage\u003c\/p\u003e\n\u003cp\u003e02 Teaching in the 21st Century Leveraging the Science of Learning\u003c\/p\u003e\n\u003cp\u003e03 Clinical Bedside Teaching Effective Techniques and Overcoming Barriers\u003c\/p\u003e\n\u003cp\u003e04 Teaching Professionalism in 2025 Strategies for the Frontline\u003c\/p\u003e\n\u003cp\u003e05 Defining, Teaching, and Assessing Critical Thinking and Clinical Reasoning\u003c\/p\u003e\n\u003cp\u003e06 Skills and Strategies to Improve Small Group Teaching\u003c\/p\u003e\n\u003cp\u003e07 Strategies to Reduce Implicit Bias\u003c\/p\u003e\n\u003cp\u003e08 Teaching in the Brave New World- Medical Education in the World of AI \u0026amp; other Emerging Technologies\u003c\/p\u003e\n\u003cp\u003e09 Designing and Delivering More Effective Lectures Techniques for Better Learner Engagement\u003c\/p\u003e\n\u003cp\u003e10 Mentoring for the Future Mentoring to Combat Burnout and Attrition\u003c\/p\u003e\n\u003cp\u003e11 Interprofessional Teaching From Parallel Practice to Partnership\u003c\/p\u003e\n\u003cp\u003e12 Assessment of Learning Determining Competence\u003c\/p\u003e\n\u003cp\u003e13 Meeting learners where they practice Bringing simulation to the clinical environment\u003c\/p\u003e\n\u003cp\u003e14 Coaching for Success Supporting Trainee Well-Being and Your Own\u003c\/p\u003e\n\u003cp\u003e15 Curriculum Design Best Practices for Creation, Implementation and Evaluation\u003c\/p\u003e\n\u003cp\u003e16 Feedback Making it Powerful, Effective, and Efficient\u003c\/p\u003e\n\u003cp\u003e17 Leading Effective Change in Medical Education\u003c\/p\u003e\n\u003cp\u003e18 TANGIBLE TAKE HOME – SNAPPS Daniel Ricotta, MD\u003c\/p\u003e\n\u003cp\u003e19 Tangible Take Home Series – Concept Mapping – Practice Jeremy Richards, MD\u003c\/p\u003e\n\u003cp\u003eFaculty Introduction Videos\u003c\/p\u003e\n\u003cp\u003eParticipants Introduction Videos\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405719785668,"sku":null,"price":195.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Principles-of-Medical-Education-Maximizing-Your-Teaching-Skills-March-Edition-2026.jpg?v=1784215321"},{"product_id":"american-psychiatric-association-annual-meeting-on-demand-2026","title":"American Psychiatric Association Annual Meeting On Demand 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: psychiatrists, psychiatrists in training, and other clinicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAmerican Psychiatric Association 2026 Annual Meeting on Demand\u003c\/p\u003e\n\u003cp\u003eProgram Release Date: May 17, 2025\u003c\/p\u003e\n\u003cp\u003eProgram Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completing this educational activity, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eDescribe new research findings in psychiatry and neuroscience and how they may impact practice\u003c\/p\u003e\n\u003cp\u003eApply quality improvement strategies to improve clinical care\u003c\/p\u003e\n\u003cp\u003eProvide culturally competent care for diverse populations\u003c\/p\u003e\n\u003cp\u003eDescribe the utility of psychotherapeutic and pharmacological treatment options\u003c\/p\u003e\n\u003cp\u003eIntegrate knowledge of current psychiatry into discussions with patients\u003c\/p\u003e\n\u003cp\u003eIdentify barriers to care, including health service delivery issues\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003ePsychiatrists, psychiatrists in training, and other clinicians\u003c\/p\u003e\n\u003cp\u003eBest for psychiatrists, psychologists, and mental health clinicians who want updates on psychopharmacology, clinical practices, and research.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSaturday (5\/16)\u003c\/p\u003e\n\u003cp\u003e“In This Economy?!”: Taking Control of Psychiatric Practice with Resource-Smart Lifestyle Psychiatry Interventions\u003c\/p\u003e\n\u003cp\u003eAdvancing Quality Improvement in Psychiatry: Case Examples in Education Informatics and Innovation\u003c\/p\u003e\n\u003cp\u003eApplying APA Practice Guidelines to the Real World: Benefits and Barriers to Evidence-Based Care\u003c\/p\u003e\n\u003cp\u003eArtificial Intelligence: Highway to Heaven or Road to Hell?\u003c\/p\u003e\n\u003cp\u003eASD Assessment, Diagnosis, and Treatment Planning Across the Lifespan from Childhood through Adulthood for the Clinician\u003c\/p\u003e\n\u003cp\u003eAutism Meets Obsessive-Compulsive Disorder: A Psychiatrist’s Guide to Differentiating and Empowering the Diagnostic and Treatment Gray Zone\u003c\/p\u003e\n\u003cp\u003eBeyond Burden, Toward Value: Psychiatry at the Crossroads of Value-Based Care\u003c\/p\u003e\n\u003cp\u003eBeyond the Familiar: Deep Brain Stimulation, Ketamine, Stellate Ganglion Block, and Vagus Nerve Stimulation in Interventional Psychiatry\u003c\/p\u003e\n\u003cp\u003eClinical Relevance of Big Data Studies – What Can Clinicians Learn From Them?\u003c\/p\u003e\n\u003cp\u003eCurrent Perspectives on Treatment Resistant Depression\u003c\/p\u003e\n\u003cp\u003eEmergency Department or Crisis Response Center? Where Do I Belong?\u003c\/p\u003e\n\u003cp\u003eExpanding Knowledge and Optimizing Safety: Best Practices for Psychiatrists Working with Advanced Practice Providers in Diverse Settings\u003c\/p\u003e\n\u003cp\u003eFrom Molecular Mechanisms to Global Health Equity: The New Frontier in Psychiatric Genomics Research\u003c\/p\u003e\n\u003cp\u003eInvoluntary Commitment in Psychiatry: What We Know, What We Don’t, and What’s at Stake\u003c\/p\u003e\n\u003cp\u003eMind Over Matter: Resilience, Risk, and Recovery in Military and Sports Settings\u003c\/p\u003e\n\u003cp\u003ePsychodynamic Psychopharmacology: Using Practical Psychodynamics to Understand and Address Pharmacologic Treatment-Resistance\u003c\/p\u003e\n\u003cp\u003eSafeguarding Patients, Supporting Clinicians: How Do We Address Cognitive Concerns in Aging Colleagues?\u003c\/p\u003e\n\u003cp\u003eThe Last of Us: Surviving AI through Resilient Policies in Medical Education\u003c\/p\u003e\n\u003cp\u003eThe Missing Face of Catatonia: An Overview of Catatonia in the Context of Addiction\u003c\/p\u003e\n\u003cp\u003eThe New DSM Z Code for Moral Problems: What Does It Add?\u003c\/p\u003e\n\u003cp\u003eThe Road After Residency: Scopes and Barriers and Immigration Impacts for IMGs\u003c\/p\u003e\n\u003cp\u003eThe Startup Psychiatrist: Building Mental Health Ventures That Heal\u003c\/p\u003e\n\u003cp\u003eTranslating Psychiatric Genetics Into Better Clinical Care\u003c\/p\u003e\n\u003cp\u003eTraining the Next Generation: Building the Field of Academic Sports Psychiatry Education\u003c\/p\u003e\n\u003cp\u003eWhat Can NIDA Research on Collaborative Care Models Teach Us About Improving Substance Use Care?\u003c\/p\u003e\n\u003cp\u003eSunday (5\/17)\u003c\/p\u003e\n\u003cp\u003eA Role for AI to Expand Mental Health Care Assessment and Treatment in an Under-Resourced Community Setting\u003c\/p\u003e\n\u003cp\u003eApplying to Psychiatry Residency? This Program Directors Panel Has Answers!\u003c\/p\u003e\n\u003cp\u003eBalancing Minds and Organs on Lithium: Navigating Bipolar Disorder with Thyroid and Kidney Challenges\u003c\/p\u003e\n\u003cp\u003eBasics of Psychodermatology: The Overlap Between Psychiatry and Dermatology Presents Opportunities for a Rewarding Psychiatric Practice\u003c\/p\u003e\n\u003cp\u003eBeyond Psychopharmacology, Empowering Psychiatrists to Build an Interventional Practice\u003c\/p\u003e\n\u003cp\u003eBipolar Illness: An Update on Recent Research\u003c\/p\u003e\n\u003cp\u003eCarving Meaningful, Fulfilling Career Paths in Psychiatry: Association of Women Psychiatrists’ Presidential Session\u003c\/p\u003e\n\u003cp\u003eCatching Faking: Malingering Detection for the General Psychiatrist\u003c\/p\u003e\n\u003cp\u003eChildbirth-Related PTSD: Recognizing and Treating a Unique Subtype of PTSD\u003c\/p\u003e\n\u003cp\u003eClinical Insights From Neuroimaging of Substance Use Disorders\u003c\/p\u003e\n\u003cp\u003eDecoding OCD: Diagnostic Dilemmas and Emerging Treatments in OCD\u003c\/p\u003e\n\u003cp\u003eDiagnosing Dementia: An Updated Roadmap for Clinical Practice\u003c\/p\u003e\n\u003cp\u003eDesigning a Safer Workplace: Addressing Violence in Inpatient Psychiatry\u003c\/p\u003e\n\u003cp\u003eEmpowering Practice Through Telepsychiatry: Practical Logistics Across Psychiatric Subspecialties\u003c\/p\u003e\n\u003cp\u003eEmpowering Psychiatric Residents in Quality Improvement and Patient Safety Education and Practice\u003c\/p\u003e\n\u003cp\u003eEmpowering Psychiatrists in Supporting Student Mental Health\u003c\/p\u003e\n\u003cp\u003eEssential Management Skills for Psychiatric Medical Directors and Executive Leaders\u003c\/p\u003e\n\u003cp\u003eEmpowering the Psychiatric Workforce: Advocacy for Our Patients and Practices\u003c\/p\u003e\n\u003cp\u003eEmpowering the Psychiatric Workforce: Taking Control of our Time to Optimize Professional and Personal Wellbeing\u003c\/p\u003e\n\u003cp\u003eFood, Nutrition, and Mental Health: Practical Approaches for Nutrition Counseling with Patients\u003c\/p\u003e\n\u003cp\u003eFrom Brain to Blood: Mechanism-Based Biomarkers for Psychosis Prediction and Personalized Early Intervention\u003c\/p\u003e\n\u003cp\u003eFrom Clinical to Capitol! Understanding advocacy and policy through psychiatric integration at local, state, and national levels\u003c\/p\u003e\n\u003cp\u003eFrom School to the Emergency Room: The Threat Continuum\u003c\/p\u003e\n\u003cp\u003eGuns ‘n Roses: Intimate Partner Violence, Red Flags, and the Law\u003c\/p\u003e\n\u003cp\u003eHippocrates Revisited: Psychiatric Ethics in Modern Clinical Practice\u003c\/p\u003e\n\u003cp\u003eThe NIH Adolescent Brain Cognitive Development (ABCD)? Study Reaches its own Developmental Milestone\u003c\/p\u003e\n\u003cp\u003eLifestyle Interventions for Depression: Expert Consensus\u003c\/p\u003e\n\u003cp\u003eMixed Features in Persons with Depressive and Bipolar Disorder: Historical, Conceptual, Nosological and Clinical Implications\u003c\/p\u003e\n\u003cp\u003eMoving the Needle in Combating the Opioid Epidemic: Leveraging Partnerships to Expand the Capabilities of the Psychiatrist\u003c\/p\u003e\n\u003cp\u003eMedications Development for Cannabis and Alcohol Use Disorders\u003c\/p\u003e\n\u003cp\u003ePrecision Psychiatry: Addressing Unmet Needs in Clinical Practice\u003c\/p\u003e\n\u003cp\u003eOne Patient, Multiple Needs: Treating AUD, PTSD plus\u003c\/p\u003e\n\u003cp\u003ePrivacy vs Publicity in the Digital Age-Tales From Four Psychiatrists\u003c\/p\u003e\n\u003cp\u003ePrognostic Molecular Markers in PTSD: From Vulnerability to Recovery\u003c\/p\u003e\n\u003cp\u003ePsych on the Mic: Podcasting in Psychiatric Education and Continuing Professional Development\u003c\/p\u003e\n\u003cp\u003eReaching Across Party Lines- Managing Functional Neurological Disorder in the Inpatient Medical Setting\u003c\/p\u003e\n\u003cp\u003eSimon Bolivar Award: Reimagining Academic Medicine to Ensure That All Faculty Thrive: A Focus on Policies to Support Caregivers\u003c\/p\u003e\n\u003cp\u003eReconceptualizing Placebo and Nocebo Effects in Psychiatry\u003c\/p\u003e\n\u003cp\u003eStand and Deliver: Testifying with Authority as a Clinical Psychiatrist\u003c\/p\u003e\n\u003cp\u003eStrategies to Advance Clinical, Academic, and Public Health Excellence in the Face of Global Mental Health Challenges\u003c\/p\u003e\n\u003cp\u003eDeprescribing 1: Benzodiazepines and Z-Drugs\u003c\/p\u003e\n\u003cp\u003eDeprescribing Antipsychotics: Why, When, How\u003c\/p\u003e\n\u003cp\u003eThe Global Economic Case for Investment in Mental Health\u003c\/p\u003e\n\u003cp\u003eTwo Sides of a Scale: Balancing Lifestyle and Pharmacology for Weight Management\u003c\/p\u003e\n\u003cp\u003eWhat Comes Next? Co-Creating the Future of Psychiatric Training and Practice\u003c\/p\u003e\n\u003cp\u003eWhen Disaster Hits Home: How Every Psychiatrist Can Engage in Disaster Preparedness and Response\u003c\/p\u003e\n\u003cp\u003eMonday (5\/18)\u003c\/p\u003e\n\u003cp\u003eAI and Large Language Models Beyond Therapy: Clinical Evidence, Regulatory Consideration, and Next Generation Features\u003c\/p\u003e\n\u003cp\u003eBehind the Mask: When Trauma Looks Like Depression, Anxiety, ADHD or Psychosis\u003c\/p\u003e\n\u003cp\u003eBipolar Disorders Treating Comorbid Conditions: Substance Use Disorders\u003c\/p\u003e\n\u003cp\u003eCapacity Building for Mental Health Care, Research, and Education: From America to the World and Back\u003c\/p\u003e\n\u003cp\u003eClozapine Monitoring – Life After REMS\u003c\/p\u003e\n\u003cp\u003eCollaborative Care: Leveraging Psychiatry to Improve Mental Health at the Population Level\u003c\/p\u003e\n\u003cp\u003eDeath Anxiety in Serious Illness: Clinical Insights for Psychiatry\u003c\/p\u003e\n\u003cp\u003eDecoding “Pregnancy Brain”: Neuroendocrine Shifts and Psychiatric Presentations\u003c\/p\u003e\n\u003cp\u003eDigital Therapeutics to Treat Comorbid Substance Use and Psychiatric Disorders\u003c\/p\u003e\n\u003cp\u003eEco-Medicine and the Mind: Redefining Psychiatric Practice in a Changing Climate\u003c\/p\u003e\n\u003cp\u003eEmpowering Women in Psychiatry: Development and Advancement Strategies for Early Career Psychiatrists\u003c\/p\u003e\n\u003cp\u003eEmpowerment and Inspiration: Equipping Psychiatrists To Integrate Spirituality and Religion in Child and Adolescent Practice\u003c\/p\u003e\n\u003cp\u003eFrom Obstacles to Opportunities: IMG Struggles and Success in Residency Match and Beyond – Program Director’s Views\u003c\/p\u003e\n\u003cp\u003eFrom Practice to Purpose: Cultivating Leadership in Psychiatry\u003c\/p\u003e\n\u003cp\u003eFrom Research to Practice: Issues Arising in Psychiatric Patients Who Use Cannabis\u003c\/p\u003e\n\u003cp\u003eFrom Trainee to Changemaker: Experiential Leadership Skills for Psychiatry’s Next Generation\u003c\/p\u003e\n\u003cp\u003eFuture of the DSM – A Strategic Vision\u003c\/p\u003e\n\u003cp\u003eFuture-Proofing Psychiatry: Why Measurement-Based Care Is No Longer Optional\u003c\/p\u003e\n\u003cp\u003eGLP-1 Receptor Agonists for Alcohol Use Disorder: Converging Evidence Across Multiple Human Trials\u003c\/p\u003e\n\u003cp\u003eGuiding patients through the wilderness of mobile health applications, an update to APA’s App Advisor tool\u003c\/p\u003e\n\u003cp\u003eHerbs, Nutrients, and more for Disorders of Mood, Anxiety, Trauma, Cognitive Function, ADHD, and Sexual Function\u003c\/p\u003e\n\u003cp\u003eInflammation in the Brain and the Body\u003c\/p\u003e\n\u003cp\u003eKetamine Assisted Psychotherapy for Trauma and Depression\u003c\/p\u003e\n\u003cp\u003eLeading From Every Seat: Five Leadership Skills for Psychiatrists\u003c\/p\u003e\n\u003cp\u003eMaking the Treatment of Trauma Enjoyable with Accelerated Resolution Therapy\u003c\/p\u003e\n\u003cp\u003eManagement of Severe Mental Illness During Pregnancy and the Postpartum Period\u003c\/p\u003e\n\u003cp\u003eManfred S. Guttmacher Award: Critical Issues in Forensic Addiction Psychiatry\u003c\/p\u003e\n\u003cp\u003eMicrobiome Gut Brain Axis: Innovative Interventions for Patient Care\u003c\/p\u003e\n\u003cp\u003eNew Program Development and Expansion of Programs: A Resource Toolkit\u003c\/p\u003e\n\u003cp\u003ePractical Management with “Scary” Meds: How to Impress Your Attending After APA\u003c\/p\u003e\n\u003cp\u003ePsychiatric Malpractice – A Primer for the General Psychiatrist\u003c\/p\u003e\n\u003cp\u003ePsychiatrists as Co-Designers of Safe AI: A Practicum in Evaluating LLM-Based Chatbots\u003c\/p\u003e\n\u003cp\u003ePsychiatry, Law, and APA: Mental Health Policy In and Out of the Courts\u003c\/p\u003e\n\u003cp\u003eRevitalizing community psychiatry Part II: Present challenges that impact our future capacity to disrupt, include, engage and innovat\u003c\/p\u003e\n\u003cp\u003eSex, Drugs, and Mental Health: A Psychiatrist’s Guide to Desire and Dysfunction\u003c\/p\u003e\n\u003cp\u003eThe Biopsychosocial Impact of Gambling Disorder\u003c\/p\u003e\n\u003cp\u003eThe PNEI Nexus: Multidirectional Interactions Between Alimentary, Humoral, Immunological, Dermatological, and Psychiatric Systems.\u003c\/p\u003e\n\u003cp\u003eVestermark Award: Preserving the Art of Medical Lecturing\u003c\/p\u003e\n\u003cp\u003eYes, You Can Treat Substance Use Disorders in Your Psychiatric Practice\u003c\/p\u003e\n\u003cp\u003eTuesday (5\/19)\u003c\/p\u003e\n\u003cp\u003eAdolf Meyer Award: Psychotherapy Must Remain an Integral Part of Psychiatry\u003c\/p\u003e\n\u003cp\u003eBorderline, Bipolar, or Both: The Diagnostic Dilemma\u003c\/p\u003e\n\u003cp\u003eBreaking Barriers: Expanding Psychiatric Access in America\u003c\/p\u003e\n\u003cp\u003eBrief Educational Interventions to Empower the Psychiatric Workforce to Decrease Addiction Stigma\u003c\/p\u003e\n\u003cp\u003eFeeling stuck, unsure, bored or worried with patients? Jump start effective care with mentalizing!\u003c\/p\u003e\n\u003cp\u003eFrom Tantrums to Triggers: The Diagnostic Puzzle of Irritability in Children and Adolescents\u003c\/p\u003e\n\u003cp\u003eFlourishing as a Woman Physician Leader: Strategies Across the Career Continuum\u003c\/p\u003e\n\u003cp\u003eGraying with Complexity: Addressing Psychiatric Care and Needs of Older Adults with Neurodevelopmental Disorders\u003c\/p\u003e\n\u003cp\u003eHigh Suicide Risk in Autism: Pathways to Hope and Prevention\u003c\/p\u003e\n\u003cp\u003eInnovation for Impact in Child and Adolescent Psychiatry\u003c\/p\u003e\n\u003cp\u003eHumor and Balance as Therapeutic Resources: Tools and Techniques in Positive and Transcultural Psychotherapy\u003c\/p\u003e\n\u003cp\u003eLessons in Resilience and Building a Sustainable Career for Clinicians and Researchers: A Distinguished Psychiatrist Lecture\u003c\/p\u003e\n\u003cp\u003eMilitary Cultural Competency: A primer for psychiatrists\u003c\/p\u003e\n\u003cp\u003eMission Ready Sleep: Adapting CBT-I to Military Challenges\u003c\/p\u003e\n\u003cp\u003eMonetizing the Social Impact of Psychiatry: Flipping the Dialouge\u003c\/p\u003e\n\u003cp\u003eMock Trial on Testamentary Capacity and Undue Influence\u003c\/p\u003e\n\u003cp\u003eMonoamines and so Much More: How Lifestyle Interventions Target Novel Hypotheses of Depression\u003c\/p\u003e\n\u003cp\u003eNavigating Misconceptions Around the Use of Psychotropics in Pregnancy\u003c\/p\u003e\n\u003cp\u003eNew Developments in the Diagnosis of Personality Disorders and Their Clinical Importance\u003c\/p\u003e\n\u003cp\u003eNext-Gen Psychiatry: Pathways to Interventional Psychiatry Training\u003c\/p\u003e\n\u003cp\u003eParasomnia and the Sleepwalker Defense: When Sleep Becomes a Crime\u003c\/p\u003e\n\u003cp\u003ePills, Performance, and Permission: Management of Elite Athletes with Attention-Deficit Hyperactivity Disorder (ADHD)\u003c\/p\u003e\n\u003cp\u003ePositive Psychiatry and Global Empowerment: Strengthening Well-Being Across Borders\u003c\/p\u003e\n\u003cp\u003ePreparing the Psychiatric Workforce: Recognizing and Treating Cannabis Use Disorder in Older Adults\u003c\/p\u003e\n\u003cp\u003ePsychedelics as Psychiatric Treatment: Hope or Hype?\u003c\/p\u003e\n\u003cp\u003ePsychiatric Chronification: When the Patient’s Use of Medications Does Not Promote Mental Health\u003c\/p\u003e\n\u003cp\u003ePsychiatry at a Crossroads: Empowering Canada’s Workforce\u003c\/p\u003e\n\u003cp\u003ePsychiatry at the Crossroads: Weight Stigma, Mental Health, and the New Era of Obesity Treatments\u003c\/p\u003e\n\u003cp\u003eReimagining Psychiatry’s Career Ladder: Lessons From Big 4 Consulting for Sustainable Growth\u003c\/p\u003e\n\u003cp\u003eRethinking the Inpatient Psychiatric Unit Experience – The Impact of Architectural Design\u003c\/p\u003e\n\u003cp\u003eSharing Our Expertise: Teaching Psychological Skills to Palliative Care Clinicians\u003c\/p\u003e\n\u003cp\u003eSecret Levels: Video Game Personas and Dual Virtual Lives\u003c\/p\u003e\n\u003cp\u003eSetting the Record Straight on Physician Health Programs in the United States\u003c\/p\u003e\n\u003cp\u003eSSRIs: Efficacy and Safety From Childhood to Young Adulthood\u003c\/p\u003e\n\u003cp\u003eShifting Landscapes: Epidemiology of Ketamine, LSD, and Psilocybin Use Amid Psychiatry’s Psychedelic Renaissance\u003c\/p\u003e\n\u003cp\u003eStimulants for ADHD: Did We Get It Wrong? Questioning the Sustainability of Stimulants for Life\u003c\/p\u003e\n\u003cp\u003eThe Evolution of Sports Psychiatry at International and National Levels\u003c\/p\u003e\n\u003cp\u003eThe Future of Psychiatric Classification: Strategic Work on A New Diagnostic and Scientific Manual (DSM)\u003c\/p\u003e\n\u003cp\u003eThe Most Recent US Data on Medical Aid in Dying: Vulnerability, Protection, Access, and Justice\u003c\/p\u003e\n\u003cp\u003eThe Much Too Medicated Patient: Rational and Irrational Polypharmacy\u003c\/p\u003e\n\u003cp\u003eToward Precision Psychiatry in PTSD: Subtype Discovery From Molecular and Neural Signatures\u003c\/p\u003e\n\u003cp\u003eWhat’s Your Dosha? Ayurvedic Phenotypes for Targeted Treatment in Major Depression\u003c\/p\u003e\n\u003cp\u003eWhat Every Psychiatrist Needs To Know About TMS\u003c\/p\u003e\n\u003cp\u003eYes, You Can! Empowering the Psychiatric Workforce through Teaching and Bolstering Psychotherapy Skills for Substance Use Disorders\u003c\/p\u003e\n\u003cp\u003eUnhoused, Unseen, Untreated, America’s Housing Crisis: What does the evidence say about housing, homelessness, and mental health?\u003c\/p\u003e\n\u003cp\u003eWednesday (5\/20)\u003c\/p\u003e\n\u003cp\u003eA Psychiatrist’s Guide to Digital Interventions and Augmented Intelligence for Mental Health\u003c\/p\u003e\n\u003cp\u003eBeyond the Individual: Cultivating Community, Forging Alliances, and Leveraging Professional Organizations for Women Hispanic Psychiatrists\u003c\/p\u003e\n\u003cp\u003eBipolar Disorder: Diagnose Like an Expert\u003c\/p\u003e\n\u003cp\u003eECP Panic Relief: When Patients Ask If You Do Psychotherapy, Here is Where to Start\u003c\/p\u003e\n\u003cp\u003eEmpowering Your Practice: Home Neuromodulation Implementation One Device at a Time\u003c\/p\u003e\n\u003cp\u003eFrom Promise to Practice: Psychedelic Research for Everyday Psychiatry\u003c\/p\u003e\n\u003cp\u003ePediatric Neuromodulation: Stepwise Innovations in Empowering Child and Adolescent Psychiatrist\u003c\/p\u003e\n\u003cp\u003ePsychiatric Care – Wellness Therapies\u003c\/p\u003e\n\u003cp\u003eSaving Lives of Older Adults on Lithium for Bipolar Disorder: A Global Quality Improvement Initiative to Implement Change in Laboratory Reporting\u003c\/p\u003e\n\u003cp\u003eShots Fired and Shots Poured: How Neural Pathways in Post-Traumatic Stess Disorder and Alcohol Use Disorder Inform Effective Dual Diagnosis Treatment\u003c\/p\u003e\n\u003cp\u003eSpecial Considerations for Providing Comprehensive Mental Health Support to Youth Involved in Hostage Taking and Wrongful Detention\u003c\/p\u003e\n\u003cp\u003eTaking Action Together: Leveraging the Organized Medicine Policy Process to Protect Patients and Empower the Psychiatric Workforce\u003c\/p\u003e\n\u003cp\u003eTaking Care of the Eating Disorder Patient Across the Lifespan\u003c\/p\u003e\n\u003cp\u003eThe Clock Within: The Impact of Circadian Rhythm on Health and Implications for Psychiatric Practice\u003c\/p\u003e\n\u003cp\u003eThe NNDC Revisiting Contrasting Dopamine Antagonist \/ Agonist Mechanism of Actions in Clinical Practice of Mood Disorders\u003c\/p\u003e\n\u003cp\u003eThe Role of AI and Humane Intelligence in Advancing Healthy Aging in Psychiatry\u003c\/p\u003e\n\u003cp\u003eUnderstanding and Preventing Targeted Violence Against Psychiatrists\u003c\/p\u003e\n\u003cp\u003eUpdates in the Assessment and Management of Clozapine Induced Myocarditis\u003c\/p\u003e\n\u003cp\u003eUsing Artificial Intelligence for Suicide Risk Stratification: The National Resident Policy Debate\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405720572100,"sku":null,"price":78.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Psychiatric-Association-Annual-Meeting-On-Demand-2026.jpg?v=1784215333"},{"product_id":"meetings-by-mail-cleveland-clinic-s-18th-annual-obesity-summit-2025","title":"Meetings By Mail Cleveland Clinic’s 18th Annual Obesity Summit 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude: 33 videos, size: 4.15 GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: endocrinologists, psychologists, pharmacists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAll New!  Cleveland Clinic’s 18th Annual Obesity Summit is designed for a diverse mix of health care practitioners interested in innovative solutions and new strategies to care for patients with obesity. Causes of obesity and diabetes, preventive strategies, and therapeutic management approaches are discussed throughout this activity, with special focus place on health disparities, lifestyle, diet \u0026amp; exercise, surgical treatment, medication, patient-centered treatment, complications and weight recurrence.\u003c\/p\u003e\n\u003cp\u003eThis activity is essential for all physicians, nurses, physician assistants, social workers, psychologists, pharmacists and dieticians involved in the care of patients with obesity.  ANCC, AAPA, ASWB, APA, ACPE and CDR accreditation also provided with NO POST TEST.  Additionally, physicians can earn up to 13 points for ABIM, ABP and ABS Maintenance of Certification (MOC).\u003c\/p\u003e\n\u003cp\u003eTopics include: Obesity as a chronic disease, metabolism, the impact of bias on patient care, ketogenic diets, physical activity as a modulator, negative body image, cardiovascular impact, pediatric and elder obesity, metabolic and bariatric surgical solutions, treatment innovations and much more!\u003c\/p\u003e\n\u003ch3\u003eThe Cleveland Clinic’s 18th Annual Obesity Summit 2025 is designed for a diverse mix of healthcare practitioners interested in innovative solutions and new strategies for caring for patients with obesity. The target audience includes:\u003c\/h3\u003e\n\u003cp\u003ePhysicians\u003c\/p\u003e\n\u003cp\u003eNurse practitioners\u003c\/p\u003e\n\u003cp\u003eNurses\u003c\/p\u003e\n\u003cp\u003ePhysician assistants\u003c\/p\u003e\n\u003cp\u003eDietitians\u003c\/p\u003e\n\u003cp\u003eSocial workers\u003c\/p\u003e\n\u003cp\u003ePsychologists\u003c\/p\u003e\n\u003cp\u003ePharmacists\u003c\/p\u003e\n\u003cp\u003eResearchers\u003c\/p\u003e\n\u003cp\u003eHospital and corporate administrators\u003c\/p\u003e\n\u003cp\u003eThe summit covers a wide range of topics, including the causes of obesity and diabetes, preventive strategies, therapeutic management approaches, health disparities, lifestyle, diet and exercise, surgical treatment, medical treatment, patient-centered treatment, obesity types and complications, and weight recurrence.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSession 1 Obesity Care Setting the Stage Are All Patients the Same How Does Race and Ethnicity Change Your Approach to Obesity Treatment.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Obesity Care Setting the Stage Obesity as a Chronic Disease Understanding the Metabolic Adaptation of Obesity.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Obesity Care Setting the Stage Obesity in Primary Care setting.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Obesity Care Setting the Stage Panel Discussion.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Obesity Care Setting the Stage Unconscious Bias and the Impact on Patient Care.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Obesity Through Ages and Specific Complications Cardiovascular Kidney Metabolic Syndrome What Is It.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Obesity Through Ages and Specific Complications Gender Diverse Population and Obesity Understanding the Intersection.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Obesity Through Ages and Specific Complications Management of Childhood Obesity.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Obesity Through Ages and Specific Complications Mediterranean Diet, Exercise and Sleep Apnea.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Obesity Through Ages and Specific Complications Obesity in the Elderly Population.mp4\u003c\/p\u003e\n\u003cp\u003eSession 4 The Present and Future of Obesity Care Gaps in Care When Treating Patients With Obesity.mp4\u003c\/p\u003e\n\u003cp\u003eSession 4 The Present and Future of Obesity Care Panel Discussion and Patient Narratives.mp4\u003c\/p\u003e\n\u003cp\u003eSession 5 Surgical Management Adjuvant Obesity Pharmacotherapy in the Bariatric Surgical Patient.mp4\u003c\/p\u003e\n\u003cp\u003eSession 5 Surgical Management AI, Digital Surgery and Simulation in Metabolic and Bariatric Surgery.mp4\u003c\/p\u003e\n\u003cp\u003eSession 5 Surgical Management Metabolic Pathways in MAFLD The Role of Metabolic Surgery.mp4\u003c\/p\u003e\n\u003cp\u003eSession 5 Surgical Management Panel Discussion.mp4\u003c\/p\u003e\n\u003cp\u003eSession 6 Innovations and Treatment Bariatric and Metabolic Endoscopy.mp4\u003c\/p\u003e\n\u003cp\u003eSession 6 Innovations and Treatment Digital Innovation at the Cleveland Clinic.mp4\u003c\/p\u003e\n\u003cp\u003eSession 6 Innovations and Treatment Obesity Innovations in Europe.mp4\u003c\/p\u003e\n\u003cp\u003eSession 6 Innovations and Treatment Panel Discussion.mp4\u003c\/p\u003e\n\u003cp\u003eSession 6 Innovations and Treatment The New Kids on the Block Emerging Therapies.mp4\u003c\/p\u003e\n\u003cp\u003eSession 7 Workshops Challenging Clinical Cases 1.mp4\u003c\/p\u003e\n\u003cp\u003eSession 7 Workshops Challenging Clinical Cases 2.mp4\u003c\/p\u003e\n\u003cp\u003eSession 7 Workshops Treating Negative Body Image.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405722013892,"sku":null,"price":32.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Meetings-By-Mail-Cleveland-Clinics-18th-Annual-Obesity-Summit-2025.jpg?v=1784215351"},{"product_id":"oakstone-neurology-for-non-neurologists-2025","title":"Oakstone Neurology for Non-Neurologists 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: internists, family physicians, emergency physicians, psychiatrists, physical medicine and rehabilitation physicians, obstetricians\/gynecologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eThis online continuing medical education program will improve your ability to positively impact the care of patients with neurological symptoms and help bring about the best possible outcomes. Along with lectures discussing innovations, disparities, and inclusivity of neurological care, highlighted topics include:\u003c\/h3\u003e\n\u003cp\u003eHolistic care of the Parkinson’s patient\u003c\/p\u003e\n\u003cp\u003eStroke recovery\u003c\/p\u003e\n\u003cp\u003eCGRP inhibitors and migraine treatment\u003c\/p\u003e\n\u003cp\u003eElectrolyte disorders\u003c\/p\u003e\n\u003cp\u003eNeuro-palliative care\u003c\/p\u003e\n\u003cp\u003eTBI diagnosis and treatment\u003c\/p\u003e\n\u003cp\u003eand more…\u003c\/p\u003e\n\u003cp\u003eDate of Original Release: January 31, 2025\u003c\/p\u003e\n\u003cp\u003eDate Credits Expire: January 30, 2028\u003c\/p\u003e\n\u003cp\u003eEstimated Time to Complete: 36.5 hours to complete the activity\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eAt the completion of this course, you should be able to:\u003c\/h3\u003e\n\u003cp\u003eExplain the principles surrounding the localization and differential diagnosis in behavioral abnormalities\u003c\/p\u003e\n\u003cp\u003eRecognize the persistence of ADHD symptoms and functional impairment across the lifespan\u003c\/p\u003e\n\u003cp\u003eDifferentiate between primary Parkinsonian disorders and secondary Parkinsonism\u003c\/p\u003e\n\u003cp\u003eSummarize when to start and when to stop antiepileptic drug therapy\u003c\/p\u003e\n\u003cp\u003eOutline the approach to a patient with a suspected neuropathy\u003c\/p\u003e\n\u003cp\u003eList the common causes of ischemic stroke\u003c\/p\u003e\n\u003cp\u003eDescribe the neurological complications of metastases to the nervous system and their management\u003c\/p\u003e\n\u003cp\u003eDefine integrative medicine\u003c\/p\u003e\n\u003cp\u003eDistinguish between primary headache and secondary headache\u003c\/p\u003e\n\u003cp\u003eSummarize the screening for obstructive sleep apnea\u003c\/p\u003e\n\u003cp\u003eDefine sex-specific neurologic disease concerns\u003c\/p\u003e\n\u003cp\u003eList the four types of dizziness\u003c\/p\u003e\n\u003cp\u003eIntended Audience\u003c\/p\u003e\n\u003cp\u003eThe activity was designed for internists, family physicians, emergency physicians, psychiatrists, physical medicine and rehabilitation physicians, obstetricians\/gynecologists (who act as primary care physicians), adolescent medicine physicians, geriatricians, resident and fellows in the above specialties and nurse practitioners and physician assistants in the above specialties.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eQuestions.pdf\u003c\/p\u003e\n\u003cp\u003eSyllabus.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405722472644,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Oakstone-Neurology-for-Non-Neurologists-2025.jpg?v=1784215360"},{"product_id":"international-online-conference-on-adhd-2025","title":"International Online Conference on ADHD 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: psychiatrists and primary care providers, including pediatricians, general and family practitioners\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eACO, ADDA, and CHADD—the leaders in ADHD support for individuals and families—welcome the ADHD community to the online 2025 International Online Conference on ADHD. These organizations collaborate to bring together the best minds in current research and treatment options and professionals offering best practice guidelines for their fields. #ADHD2025ONLINE will offer dynamic sessions and events featuring practical support and guidance for adults and families.\u003c\/p\u003e\n\u003cp\u003eThe theme of the International Online Conference on ADHD is to Connect, Learn \u0026amp; Thrive. It is through the connections we make along with the new skills and approaches we learn from one another that our ADHD community can thrive. At #ADHD2025ONLINE, we will Connect, Learn \u0026amp; Thrive. by gathering as adults and partners, parents of children in all stages of life, clinicians of all kinds, coaches, organizers, educators, and advocates, to inspire one another and enhance all our lives.\u003c\/p\u003e\n\u003cp\u003eThis conference will feed not only your mind but also your soul as you meet other like-minded individuals. We will welcome some of the most well-known speakers and authors to share their wisdom and research. You will also benefit from conversations with fellow attendees sitting next to you in sessions, during the coffee breaks, and wandering the exhibit hall.\u003c\/p\u003e\n\u003cp\u003eACO, ADDA, and CHADD are ready to welcome you to join the largest international conference on ADHD. We hope you will find the experience enriching, inspiring, and restorative. We cannot wait to see you!\u003c\/p\u003e\n\u003cp\u003eWho Should Attend The Online Conference?\u003c\/p\u003e\n\u003cp\u003eIf you are a member of one or more of the following interest groups, then you should attend.\u003c\/p\u003e\n\u003cp\u003eAdults: Practical and science-based information for adults with ADHD\u003c\/p\u003e\n\u003cp\u003eADHD Coaches \u0026amp; Professional Organizers: Skills and practical strategies for working with teens, adults, and families with ADHD\u003c\/p\u003e\n\u003cp\u003eEducator\/School Professional: Practical information on curriculum, instruction, and classroom management strategies to assist students with ADHD; of particular interest to teachers, administrators and guidance counselors\u003c\/p\u003e\n\u003cp\u003eParents \u0026amp; Caregivers: Research-based information on ADHD, including treatment issues and practical strategies for managing behavior at home and at school\u003c\/p\u003e\n\u003cp\u003eMedical: The latest research and information regarding the medical assessment and treatment of ADHD; of particular interest to psychiatrists and primary care providers, including pediatricians, general and family practitioners, physician assistants, and nurse practitioners\u003c\/p\u003e\n\u003cp\u003eTherapists: The latest research and information regarding the assessment and treatment of ADHD; of particular interest to psychologists, psychiatrists, counselors, social workers, therapists, occupational \u0026amp; physical therapists\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFriday, March 7, 2025\u003c\/p\u003e\n\u003cp\u003eOwn Your ADHD: What a Relief!\u003c\/p\u003e\n\u003cp\u003eSmall Talk 101 for Adults with ADHD\u003c\/p\u003e\n\u003cp\u003eVR Classroom for Attention Process Assessment in Children with ADHD\u003c\/p\u003e\n\u003cp\u003eBook Discussion: Unapologetically ADHD: A Step-By-Step Framework For Everyday Planning On Your Terms\u003c\/p\u003e\n\u003cp\u003eDoes My ADHD Retire with Me? Strategies Fulfilling Post-Career Life\u003c\/p\u003e\n\u003cp\u003eNurturing Grit and Resilience: The Art of Perseverance\u003c\/p\u003e\n\u003cp\u003eUntangling Anxiety’s Knot: Overcoming Self-sabotage, Overwhelm and Toxic Shame\u003c\/p\u003e\n\u003cp\u003eADHD and Sleep: The Missing Link\u003c\/p\u003e\n\u003cp\u003eBook Discussion: ADHD\u0026amp;Me, ADHD and the Focused Mind, Winning with ADHD\u003c\/p\u003e\n\u003cp\u003eFrom Meltdowns to Calm: Helping Youth Build Emotional Regulation (1)\u003c\/p\u003e\n\u003cp\u003eTesting Green Room\u003c\/p\u003e\n\u003cp\u003eWhy Can’t They Just…? Navigating Parent Frustration with ADHD Kids\u003c\/p\u003e\n\u003cp\u003eMaximizing ADHD Talent: Why Employers Want to Hire You\u003c\/p\u003e\n\u003cp\u003eTeaching Executive Function Strategies to build Self-directed Learners\u003c\/p\u003e\n\u003cp\u003eLET. IT. BE. ~ The Choice Lies Within You\u003c\/p\u003e\n\u003cp\u003eCollege Transitions: 10 Strategies for Parents \u0026amp; Teens with ADHD\u003c\/p\u003e\n\u003cp\u003eFrom Idealized to Realized: Reframing Consistency and Productivity\u003c\/p\u003e\n\u003cp\u003eHormonal Waves and ADHD: Adapting and Thriving Through Life’s Changes\u003c\/p\u003e\n\u003cp\u003e“Serene Green” State Of Mind: Cultivating ADHD Self-Regulation through Ecopsychology\u003c\/p\u003e\n\u003cp\u003eBook Discussion: Decoding Doing: ADHD Solutions for Procrastination\u003c\/p\u003e\n\u003cp\u003eDon’t Sacrifice Accuracy for Speed: Streamlining Comprehensive ADHD Assessments\u003c\/p\u003e\n\u003cp\u003eFamily Therapy Interventions for Adolescents with ADHD and RSD.\u003c\/p\u003e\n\u003cp\u003eNavigating the Unknown: Overcoming Ambiguous Tasks\u003c\/p\u003e\n\u003cp\u003eExploring Social Motivation in Individuals with ADHD:Insights from Clinical Practice\u003c\/p\u003e\n\u003cp\u003eSchool Support and Legal Advocacy Strategies for ADHD Teens\u003c\/p\u003e\n\u003cp\u003eQuiet Your To-Do List: Discover Your Priorities Amidst the Noise\u003c\/p\u003e\n\u003cp\u003eRe-connecting Couples – Finding new relationship foundations with ADHD\u003c\/p\u003e\n\u003cp\u003eWhat to do when Clients Disclose Suicidal Thoughts and Behaviors\u003c\/p\u003e\n\u003cp\u003eADHD Therapists Peer Support Group\u003c\/p\u003e\n\u003cp\u003eEducators Peer Support Group\u003c\/p\u003e\n\u003cp\u003eEntrepreneurship \u0026amp; ADHD: Support, Strategies, Real Talk Peer Support Group\u003c\/p\u003e\n\u003cp\u003eFrom Info to Action: Processing \u0026amp; Connection Lounge\u003c\/p\u003e\n\u003cp\u003eTriggered in Session: Coach Peer Support Group\u003c\/p\u003e\n\u003cp\u003eSaturday, March 8, 2025\u003c\/p\u003e\n\u003cp\u003eKeep Your (Aging) ADHD Brain Young \u0026amp; Vibrant\u003c\/p\u003e\n\u003cp\u003eMulti-Sensory Approach Helps Students with ADHD Develop Stronger Writing Skills\u003c\/p\u003e\n\u003cp\u003eWe Want To Pump You Up!: ADHD, Exercise \u0026amp; Strength-Training\u003c\/p\u003e\n\u003cp\u003eWomen living with ADHD Peer Support Group\u003c\/p\u003e\n\u003cp\u003eBIPOC Peer Support Group\u003c\/p\u003e\n\u003cp\u003eBook Discussion: Getting It Done With ADHD: Specialized ADHD Techniques to Expertly Handle the Overwhelm, Distraction, and Procrastination of Accomplishing Tasks\u003c\/p\u003e\n\u003cp\u003eLeveraging IEP Goals to Meet Your Child’s Needs\u003c\/p\u003e\n\u003cp\u003eMindfulness and Play Based Activities for Kids and Teens\u003c\/p\u003e\n\u003cp\u003eNavigating ADHD Medication Shortages: Key Strategies to Stay on Track\u003c\/p\u003e\n\u003cp\u003eFrom Ghosting to Glowing: Maintaining ADHD Friendships\u003c\/p\u003e\n\u003cp\u003eMen with ADHD Peer Support Group\u003c\/p\u003e\n\u003cp\u003eRegulation for Parents: Tuning into Your Unique Nervous System\u003c\/p\u003e\n\u003cp\u003eUnlock ADHD Strengths with AI: Thrive in the Future Workplace\u003c\/p\u003e\n\u003cp\u003eParenting ADHD Peer Support Group\u003c\/p\u003e\n\u003cp\u003eRebuilding Connections: A Practical Approach to Restoring and Sustaining Relationships\u003c\/p\u003e\n\u003cp\u003eStick With It: The Secret to Creating Habits That Last\u003c\/p\u003e\n\u003cp\u003eWeird-ish Strategies To Manage Executive Function Challenges\u003c\/p\u003e\n\u003cp\u003eLGBTQ Peer Support Group\u003c\/p\u003e\n\u003cp\u003eSquirrelling with Sensory Sensitivity; Succeeding with ADHD and SPD\u003c\/p\u003e\n\u003cp\u003eWhen SMART Goals Fall Short: Rethinking Goal-Setting Strategies for ADHDers\u003c\/p\u003e\n\u003cp\u003eEmotional Regulation: The Foundation in ADHD Care\u003c\/p\u003e\n\u003cp\u003eHarnessing Fidgeting to Improve Focus and Motivation\u003c\/p\u003e\n\u003cp\u003eLatine\/x ADHD Peer Support Group\u003c\/p\u003e\n\u003cp\u003eThe Complicated Mental Side of Productivity\u003c\/p\u003e\n\u003cp\u003eDecoding AuDHD: A Playbook for Understanding and Empowering\u003c\/p\u003e\n\u003cp\u003ePositive Illusory Bias and Reporter Reliability in Adolescents with ADHD\u003c\/p\u003e\n\u003cp\u003eRapid Stress Relief for Parents\u003c\/p\u003e\n\u003cp\u003eWorkplace Accommodation Overcoming Obstacles to get Accommodation You Desire\u003c\/p\u003e\n\u003cp\u003eADHD \u0026amp; Low Sexual Desire\u003c\/p\u003e\n\u003cp\u003eADHD Job Seekers’ Peer Support Group\u003c\/p\u003e\n\u003cp\u003eEpiphany! The Agony and Ecstasy of an Adult ADHD Diagnosis\u003c\/p\u003e\n\u003cp\u003eRewriting the Narrative for Adults with ADHD\u003c\/p\u003e\n\u003cp\u003eKeynote Kojo Sarfo | Embracing your ADHD Journey\u003c\/p\u003e\n\u003cp\u003eRetired Persons with ADHD Peer Support Group\u003c\/p\u003e\n\u003cp\u003eSouth Asian Peer Support Group\u003c\/p\u003e\n\u003cp\u003eSpouses of Partners with ADHD Peer Support Group\u003c\/p\u003e\n\u003cp\u003eYoung ADDults Peer Support Group\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405725716676,"sku":null,"price":78.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/International-Online-Conference-on-ADHD-2025.webp?v=1784215405"},{"product_id":"harvard-41st-annual-review-of-geriatric-medicine-2025","title":"Harvard 41st Annual Review of Geriatric Medicine 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: geriatrics, primary care physician\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e2025 Course Overview\u003c\/p\u003e\n\u003cp\u003eThis five-day course provides an authoritative update on the specialized clinical management of older adults. The focus is on common clinical problems encountered in primary care practice. The program incorporates the knowledge and skills of many disciplines needed for effective management of medical, neurological, and psychiatric illness in the older adult. Lectures are complimented by small group workshop sessions that emphasize practical approached to complex problems of a geriatric population in a variety of settings, including office practices, hospitals, and nursing homes. Target audience includes all medical professionals seeking training in the care of an older population.\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003eNurses\u003c\/p\u003e\n\u003cp\u003eNurse Practitioners\u003c\/p\u003e\n\u003cp\u003ePrimary Care Physicians\u003c\/p\u003e\n\u003cp\u003ePharmacists\u003c\/p\u003e\n\u003cp\u003eSpecialty Physicians\u003c\/p\u003e\n\u003cp\u003ePhysician Assistants\u003c\/p\u003e\n\u003cp\u003ePsychologists\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eEvaluate palliative care and its role in caring for older adults at end of life.\u003c\/p\u003e\n\u003cp\u003eIdentify opportunities to engage patients in advanced care planning.\u003c\/p\u003e\n\u003cp\u003eDetermine which patients are eligible for hospice benefits.\u003c\/p\u003e\n\u003cp\u003eDevelop appropriate strategies to manage pain in older adults.\u003c\/p\u003e\n\u003cp\u003eRecognize the altered presentation of common illnesses in older adults.\u003c\/p\u003e\n\u003cp\u003eDetermine the etiologic factors contributing to the most commonly encountered geriatric syndromes.\u003c\/p\u003e\n\u003cp\u003eDifferentiate between the effects of aging and disease.\u003c\/p\u003e\n\u003cp\u003eApply new strategies to manage common medical problems in older adults, such as COPD, pain, infection, and osteoarthritis.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003ecourse brochure.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Chronic Heart Failure in Older Adults Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Chronic Heart Failure in Older Adults.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Chronic Heart Failure in Older Adults.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Coronary Artery Disease Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Coronary Artery Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Coronary Artery Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Diabetes Management Made Simple Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Diabetes Management Made Simple.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Diabetes Management Made Simple.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Diagnosis \u0026amp; Management of Peripheral Artery Disease Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Diagnosis \u0026amp; Management of Peripheral Artery Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Diagnosis \u0026amp; Management of Peripheral Artery Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Dyslipidemia Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Dyslipidemia.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Dyslipidemia.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Evaluation \u0026amp; Management of Arrythmias Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Evaluation \u0026amp; Management of Arrythmias.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Evaluation \u0026amp; Management of Arrythmias.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Hypertension Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Hypertension.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Hypertension.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Prevention Made Ridiculously Easy Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Prevention Made Ridiculously Easy.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Prevention Made Ridiculously Easy.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Strokes and Transient Ischemic Attacks Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Strokes and Transient Ischemic Attacks.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Strokes and Transient Ischemic Attacks.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Update in Geriatrics Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Update in Geriatrics.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Update in Geriatrics.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Welcome.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1.xlsx\u003c\/p\u003e\n\u003cp\u003eDay 2 Blueprint for Smarter Antibiotic Use in the Older Adult Part 1 \u0026amp; Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Blueprint for Smarter Antibiotic Use in the Older Adult Part 1 Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Blueprint for Smarter Antibiotic Use in the Older Adult Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Blueprint for Smarter Antibiotic Use in the Older Adult Part 2 Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Blueprint for Smarter Antibiotic Use in the Older Adult Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Challenging Cases in Rheumatology Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Challenging Cases in Rheumatology.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Challenging Cases in Rheumatology.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Clinical Workshops A A. The Nuts and Bolts of Treatment for Diabetes in the Older Adults Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Clinical Workshops A A. The Nuts and Bolts of Treatment for Diabetes in the Older Adults.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Clinical Workshops A A. The Nuts and Bolts of Treatment for Diabetes in the Older Adults.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Clinical Workshops A B. Blood Pressure Management in Older Adults.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Clinical Workshops A B. Blood Pressure Management in Older Adults.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Clinical Workshops A C. Managing Older Drivers Addressing Clinical, Ethical and Legal Issues Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Clinical Workshops A C. Managing Older Drivers Addressing Clinical, Ethical and Legal Issues.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Clinical Workshops A C. Managing Older Drivers Addressing Clinical, Ethical and Legal Issues.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Clinical Workshops A D. Defying Gravity Exercise as a Vital Component of Successful Aging.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Clinical Workshops A D. Defying Gravity Exercise as a Vital Component of Successful Aging.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Clinical Workshops A E. Hearing Loss \u0026amp; Aging When to Refer and How to Manage.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Clinical Workshops A E. Hearing Loss \u0026amp; Aging When to Refer and How to Manage.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Clinical Workshops A F. Frailty in Older Adults From Assessment to Action.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Clinical Workshops A F. Frailty in Older Adults From Assessment to Action.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 COPD Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 COPD.doc\u003c\/p\u003e\n\u003cp\u003eDay 2 COPD.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 COPD.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Management of Spinal Stenosis Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Management of Spinal Stenosis.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Management of Spinal Stenosis.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Osteoarthritis – Recognition and Management.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Osteoporosis Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Osteoporosis.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Osteoporosis.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Sleep Problems in the Older Adult Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Sleep Problems in the Older Adult.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Sleep Problems in the Older Adult.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Welcome.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2.xlsx\u003c\/p\u003e\n\u003cp\u003eDay 3 Aging Skin Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Aging Skin.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Aging Skin.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Common Thyroid Problems Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Common Thyroid Problems.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Common Thyroid Problems.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Drug Therapy Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Drug Therapy.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Drug Therapy.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Falls Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Falls.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Falls.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 GI Issues in Older Adults Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 GI Issues in Older Adults.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 GI Issues in Older Adults.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Health Screening Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Health Screening.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Health Screening.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Kidney Disease Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Kidney Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Kidney Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Perioperative Assessment and Treatment of the Older Adult Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Perioperative Assessment and Treatment of the Older Adult.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Perioperative Assessment and Treatment of the Older Adult.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Pressure Ulcers Evidence-Based Prevention and Management.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Prostate Cancer \u0026amp; Benign Prostatic Hypertrophy.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Prostate Cancer \u0026amp; Benign Prostatic Hypertrophy.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Urinary Incontinence Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Urinary Incontinence.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Urinary Incontinence.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3.xlsx\u003c\/p\u003e\n\u003cp\u003eDay 4 CLINICAL WORKSHOPS A. Advanced Care Planning for the Older Adult How to Have the Conversation.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 CLINICAL WORKSHOPS A. Advanced Care Planning for the Older Adult How to Have the Conversation.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 CLINICAL WORKSHOPS B. Problems in Geriatric Psychiatry Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 CLINICAL WORKSHOPS B. Problems in Geriatric Psychiatry.docx\u003c\/p\u003e\n\u003cp\u003eDay 4 CLINICAL WORKSHOPS B. Problems in Geriatric Psychiatry.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 CLINICAL WORKSHOPS C. Cognitive Testing for the PCP Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 CLINICAL WORKSHOPS C. Cognitive Testing for the PCP.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 CLINICAL WORKSHOPS C. Cognitive Testing for the PCP.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 CLINICAL WORKSHOPS D. Putting It All TogetherThe Toe to head Geriatric Assessment Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 CLINICAL WORKSHOPS D. Putting It All TogetherThe Toe to head Geriatric Assessment.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 CLINICAL WORKSHOPS D. Putting It All TogetherThe Toe to head Geriatric Assessment.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 CLINICAL WORKSHOPS E. Diet and Exercise Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 CLINICAL WORKSHOPS E. Diet and Exercise.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 CLINICAL WORKSHOPS E. Diet and Exercise.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Delirium Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Delirium.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Delirium.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Depression Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Depression.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Depression.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Diagnosis of Dementia Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Diagnosis of Dementia.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Diagnosis of Dementia.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 KEYNOTE LUNCHEON LECTURE Goal Directed Care for Older Adults with Multiple Chronic Conditions Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 KEYNOTE LUNCHEON LECTURE Goal Directed Care for Older Adults with Multiple Chronic Conditions.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 KEYNOTE LUNCHEON LECTURE Goal Directed Care for Older Adults with Multiple Chronic Conditions.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Late Life Psychosis Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Late Life Psychosis.docx\u003c\/p\u003e\n\u003cp\u003eDay 4 Late Life Psychosis.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Late Life Psychosis.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Parkinson’s Disease Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Parkinson’s Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Parkinson’s Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Problems in Geriatric Psychiatry Eran Metzger, MD.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Treatment of Dementia Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Treatment of Dementia.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Treatment of Dementia.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Women’s Health Issues Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Women’s Health Issues.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Women’s Health Issues.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4.xlsx\u003c\/p\u003e\n\u003cp\u003eDay 5 Care of the Care Partner of a Person Living with Dementia A Critical Part of Dementia Care Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Care of the Care Partner of a Person Living with Dementia A Critical Part of Dementia Care.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Care of the Care Partner of a Person Living with Dementia A Critical Part of Dementia Care.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Challenges of Anti-Coagulation in Older Adults.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Common Hematological Malignancies and Novel Therapeutics in Older Adults Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Common Hematological Malignancies and Novel Therapeutics in Older Adults.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Common Hematological Malignancies and Novel Therapeutics in Older Adults.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Hematology 101 for the Geriatrician Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Hematology 101 for the Geriatrician.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Hematology 101 for the Geriatrician.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Pain Management in the Older Adult Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Pain Management in the Older Adult.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Pain Management in the Older Adult.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 The Aging Eye Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 The Aging Eye.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 The Aging Eye.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5.xlsx\u003c\/p\u003e\n\u003cp\u003eMore AD8.pdf\u003c\/p\u003e\n\u003cp\u003eMore IQCODE.pdf\u003c\/p\u003e\n\u003cp\u003eMore Mini-Cog.pdf\u003c\/p\u003e\n\u003cp\u003eMore MoCA-Administration Instructions.pdf\u003c\/p\u003e\n\u003cp\u003eMore MoCA-Basic Instructions.pdf\u003c\/p\u003e\n\u003cp\u003eMore MOCA-Basic.pdf\u003c\/p\u003e\n\u003cp\u003eMore MoCA.pdf\u003c\/p\u003e\n\u003cp\u003eMore RUDAS Administration Guide.pdf\u003c\/p\u003e\n\u003cp\u003eMore RUDAS Score Sheet.pdf\u003c\/p\u003e\n\u003cp\u003eMore Short Blessed Test.pdf\u003c\/p\u003e\n\u003cp\u003eMore short_portable_mental_health_questionnaire.pdf\u003c\/p\u003e\n\u003cp\u003eMore SLUMS.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405726896324,"sku":null,"price":91.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-41st-Annual-Review-of-Geriatric-Medicine-2025.jpg?v=1784215414"},{"product_id":"harvard-front-line-neurology-advances-and-innovations-2025","title":"Harvard Front Line Neurology Advances and Innovations 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: neurologists, neurosurgeons, psychiatrists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e2025 Course Overview\u003c\/p\u003e\n\u003cp\u003eNeurology is a rapidly advancing field of medicine with many subspecialties. It is critical for Neurologist and those in allied disciplines to remain up to date in these innovations to provide the best care for patients. This is a major public health challenge as neurologic disorders already impact one in three people world-wide and many neurologic conditions such as stroke and dementia are expected to continue to increase in prevalence in the coming decades.\u003c\/p\u003e\n\u003cp\u003eThis two-day CME course is designed to prepare clinicians to address vanguard topics in neurology including climate change and its impact on neurologic diseases, generative artificial intelligence in neurologic care, neurotherapeutics, and gene therapies.\u003c\/p\u003e\n\u003cp\u003eThe course is designed to increase accessibility for a global and neurodiverse audience of clinicians. Content will be offered with a novel format of videos which will be translated in selected languages to increase accessibility. Video presentations be followed by virtual live case-based discussions with world experts, Q\u0026amp;A sessions, and panel discussions on hot topics in Neurology. The course is accredited and taught by Harvard Medical School faculty. Speakers will include experts in vascular, cognitive, genetics, neuro-oncology, headache, movement disorders, neuro-immunology, neuromuscular disorders, epilepsy and epilepsy surgery, neuromodulation, neuro-critical care, traumatic brain injury and neurorehabilitation, global neurology, health equity, functional disorders, and climate change. Sessions will cover content in each of these disciplines including novel diagnostics and therapeutics.\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003eNeurologists\u003c\/p\u003e\n\u003cp\u003eNeurosurgeons\u003c\/p\u003e\n\u003cp\u003ePsychiatrists\u003c\/p\u003e\n\u003cp\u003eNurse Practitioners\u003c\/p\u003e\n\u003cp\u003ePhysician Assistants\u003c\/p\u003e\n\u003cp\u003eNurses\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eIntegrate Emerging Technologies and Therapies into Neurologic Practice: Evaluate and integrate cutting-edge diagnostic and therapeutic technologies, including generative AI, transcranial magnetic stimulation, and deep brain stimulation, to enhance patient care across a variety of neurological disorders including movement disorders, epilepsy, and headache.\u003c\/p\u003e\n\u003cp\u003eIdentify Global Health Dynamics and Health Disparities in Neurological Care: Identify strategies to effectively manage neurological conditions in the context of global health challenges, including the impact of climate change and health care disparities, focusing on impactful interventions that create equitable care for diverse populations.\u003c\/p\u003e\n\u003cp\u003eDemonstrate Knowledge in Neurogenetics, Neuroimmunology, and Neuro-Oncology: Demonstrate an understanding of recent advances in neurogenetics, neuroimmunology, and surgical management of neurological disorders. Participants will apply this knowledge to improve diagnostic accuracy and optimize treatment approaches for diverse neurologic disorders.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAcute Stroke Care Update Latest Research and Innovations Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eAcute Stroke Care Update Latest Research and Innovations.mp4\u003c\/p\u003e\n\u003cp\u003eAcute Stroke Care Update Latest Research and Innovations.pdf\u003c\/p\u003e\n\u003cp\u003eAgenda.pdf\u003c\/p\u003e\n\u003cp\u003eAutonomic Disorders Advances and Updates 2025.mp4\u003c\/p\u003e\n\u003cp\u003eAutonomic Disorders Advances and Updates 2025.pdf\u003c\/p\u003e\n\u003cp\u003eAvant Guard Neurology Panel Jonah Zuflacht, MD; Omar Siddiqi, MD; Alexandra Hovaguimian, MD; David Urion, MD, FAAN.mp4\u003c\/p\u003e\n\u003cp\u003eCerebral Palsy Modern Approaches to an Age-Old Disorder and Implications for the Adult Neurologist Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eCerebral Palsy Modern Approaches to an Age-Old Disorder and Implications for the Adult Neurologist.mp4\u003c\/p\u003e\n\u003cp\u003eCerebral Palsy Modern Approaches to an Age-Old Disorder and Implications for the Adult Neurologist.pdf\u003c\/p\u003e\n\u003cp\u003eClinical Approach for Diagnosis and Treatment of Functional Neurologic Disorders Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eClinical Approach for Diagnosis and Treatment of Functional Neurologic Disorders.mp4\u003c\/p\u003e\n\u003cp\u003eClinical Approach for Diagnosis and Treatment of Functional Neurologic Disorders.pdf\u003c\/p\u003e\n\u003cp\u003eConcussion Diagnosis and Management Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eConcussion Diagnosis and Management.mp4\u003c\/p\u003e\n\u003cp\u003eConcussion Diagnosis and Management.pdf\u003c\/p\u003e\n\u003cp\u003eDeep Brain Stimulation for Movement Disorders Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDeep Brain Stimulation for Movement Disorders.mp4\u003c\/p\u003e\n\u003cp\u003eDeep Brain Stimulation for Movement Disorders.pdf\u003c\/p\u003e\n\u003cp\u003eEndovascular Approaches to Unruptured Cerebral Aneurysms.mp4\u003c\/p\u003e\n\u003cp\u003eEndovascular Approaches to Unruptured Cerebral Aneurysms.pdf\u003c\/p\u003e\n\u003cp\u003eEquipping the Modern Neurologist Key AI Tools and Technologies Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eEquipping the Modern Neurologist Key AI Tools and Technologies.mp4\u003c\/p\u003e\n\u003cp\u003eEquipping the Modern Neurologist Key AI Tools and Technologies.pdf\u003c\/p\u003e\n\u003cp\u003eGlobal Health and Neurology Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eGlobal Health and Neurology.mp4\u003c\/p\u003e\n\u003cp\u003eGlobal Health and Neurology.pdf\u003c\/p\u003e\n\u003cp\u003eHealth Care Disparities- What Can We Do, How to beÿ Impactful Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eHealth Care Disparities- What Can We Do, How to beÿ Impactful.mp4\u003c\/p\u003e\n\u003cp\u003eHealth Care Disparities- What Can We Do, How to beÿ Impactful.pdf\u003c\/p\u003e\n\u003cp\u003eImmune-Mediated Central and Peripheral Disorders Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eImmune-Mediated Central and Peripheral Disorders.mp4\u003c\/p\u003e\n\u003cp\u003eImmune-Mediated Central and Peripheral Disorders.pdf\u003c\/p\u003e\n\u003cp\u003eInnovations and Applications for Noninvasive Brain Stimulation in Neurology Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eInnovations and Applications for Noninvasive Brain Stimulation in Neurology.mp4\u003c\/p\u003e\n\u003cp\u003eInnovations and Applications for Noninvasive Brain Stimulation in Neurology.pdf\u003c\/p\u003e\n\u003cp\u003eInnovations in Dementia Diagnosis and Treatment Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eInnovations in Dementia Diagnosis and Treatment.mp4\u003c\/p\u003e\n\u003cp\u003eInnovations in Dementia Diagnosis and Treatment.pdf\u003c\/p\u003e\n\u003cp\u003eInnovations in Neuro-Oncology Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eInnovations in Neuro-Oncology.mp4\u003c\/p\u003e\n\u003cp\u003eInnovations in Neuro-Oncology.pdf\u003c\/p\u003e\n\u003cp\u003eInnovations in Neuromuscular Diagnostics and Therapy Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eInnovations in Neuromuscular Diagnostics and Therapy.mp4\u003c\/p\u003e\n\u003cp\u003eInnovations in Neuromuscular Diagnostics and Therapy.pdf\u003c\/p\u003e\n\u003cp\u003eIntroduction to the Front Line Neurology- Advances and Innovations 2025.mp4\u003c\/p\u003e\n\u003cp\u003eMore 2025 FrontLine Neuro – AI – GOLDENHOLZ.pptx\u003c\/p\u003e\n\u003cp\u003eMore BIDMC CME_Neurology-Climate Change_2025_Final.pptx\u003c\/p\u003e\n\u003cp\u003eMore BIDMC Dmeentia CME 2025.pptx\u003c\/p\u003e\n\u003cp\u003eMore CME_Slides_Substance_Use_Bahou_Zuflacht.pptx\u003c\/p\u003e\n\u003cp\u003eMore FND Frontline CME talk_for upload.pptx\u003c\/p\u003e\n\u003cp\u003eMore Front Line Neurology 2025 – Vega Talk.pptx\u003c\/p\u003e\n\u003cp\u003eMore FrontLineNeuro_CME_Luo.pptx\u003c\/p\u003e\n\u003cp\u003eMore Harvard CME talk Concussion, Diagnosis and Management 1.15.25.pptx\u003c\/p\u003e\n\u003cp\u003eMore Innovations in Neurology- Stroke .pptx\u003c\/p\u003e\n\u003cp\u003eMore Luo_FrontLineNeuro_CME_Poll.pdf\u003c\/p\u003e\n\u003cp\u003eMore Nirav Barot_From Cenobamate to Surgery_Seizure Freedom in 2025.pdf\u003c\/p\u003e\n\u003cp\u003eMore Sloane – MS talk CME 2025.pdf\u003c\/p\u003e\n\u003cp\u003eMore Vega_Front Line Neurology 2025 Talk.pptx.pdf\u003c\/p\u003e\n\u003cp\u003eNeurogenetics – Recent Advances in Diagnostics and Gene Therapies Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eNeurogenetics – Recent Advances in Diagnostics and Gene Therapies.mp4\u003c\/p\u003e\n\u003cp\u003eNeurogenetics – Recent Advances in Diagnostics and Gene Therapies.pdf\u003c\/p\u003e\n\u003cp\u003eNeurologic Care of Transgender Persons and Persons Transitioning Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eNeurologic Care of Transgender Persons and Persons Transitioning.mp4\u003c\/p\u003e\n\u003cp\u003eNeurologic Care of Transgender Persons and Persons Transitioning.pdf\u003c\/p\u003e\n\u003cp\u003eNeurologic Health and Disease in the Era of Climate Change- Problems and Potential Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eNeurologic Health and Disease in the Era of Climate Change- Problems and Potential.mp4\u003c\/p\u003e\n\u003cp\u003eNeurologic Health and Disease in the Era of Climate Change- Problems and Potential.pdf\u003c\/p\u003e\n\u003cp\u003eNeurotoxicology Syndromes in Substance Use Disorders Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eNeurotoxicology Syndromes in Substance Use Disorders.mp4\u003c\/p\u003e\n\u003cp\u003eNeurotoxicology Syndromes in Substance Use Disorders.pdf\u003c\/p\u003e\n\u003cp\u003ePrognosis of Anoxic and Traumatic Brain Injuries Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003ePrognosis of Anoxic and Traumatic Brain Injuries.mp4\u003c\/p\u003e\n\u003cp\u003ePrognosis of Anoxic and Traumatic Brain Injuries.pdf\u003c\/p\u003e\n\u003cp\u003eResection to Lasers Seizure Freedom in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eResection to Lasers Seizure Freedom in 2025.pptx\u003c\/p\u003e\n\u003cp\u003eRound Table Discussion on Hot Topics in Dementia.mp4\u003c\/p\u003e\n\u003cp\u003eRoundtable on Brain Injury Alexandra Stillman, MD; Magdy Selim, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eThe Epileptic Heart Cardiac Comorbidities and Complications of Epilepsy Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eThe Epileptic Heart Cardiac Comorbidities and Complications of Epilepsy.mp4\u003c\/p\u003e\n\u003cp\u003eThe Epileptic Heart Cardiac Comorbidities and Complications of Epilepsy.pdf\u003c\/p\u003e\n\u003cp\u003eUpdates in Headache Medicine AI, CGRP, and neuromodulation Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eUpdates in Headache Medicine AI, CGRP, and neuromodulation.mp4\u003c\/p\u003e\n\u003cp\u003eUpdates in Headache Medicine AI, CGRP, and neuromodulation.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405729026244,"sku":null,"price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Front-Line-Neurology-Advances-and-Innovations-2025.jpg?v=1784215430"},{"product_id":"harvard-psychopharmacology-2025-a-master-class","title":"Harvard Psychopharmacology 2025: A Master Class","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: psychiatrists and other physicians, pharmacists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e2025 Course Overview\u003c\/p\u003e\n\u003cp\u003eWe are pleased to offer our 14th annual two-day Master Class uniquely designed for practicing clinicians, clinical researchers, and trainees in psychiatry. Presentations will focus on typical psychiatric patients with emphasis on those who are difficult to treat or are treatment resistant. Newer treatments and developing treatment strategies will be discussed including the use of genetic tests, blood level measurements, and drug combinations. New research that can inform clinical practice will be emphasized. There will be considerable opportunity for interaction with the presenters.\u003c\/p\u003e\n\u003cp\u003eThroughout the course both the establishment and importance of the therapeutic alliance when prescribing all psychotropic medications as well as new neurobiological research findings that will influence clinical practice.\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003ePsychiatrists and other Physicians\u003c\/p\u003e\n\u003cp\u003ePharmacists\u003c\/p\u003e\n\u003cp\u003eNurse Practitioners\u003c\/p\u003e\n\u003cp\u003ePhysician Assistants\u003c\/p\u003e\n\u003cp\u003eNurses\u003c\/p\u003e\n\u003cp\u003ePsychologists\u003c\/p\u003e\n\u003cp\u003eSocial Workers\u003c\/p\u003e\n\u003cp\u003eMedical students, residents and other trainees\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eEvaluate the effects of neurotransmitters, neurocircuits, and genes on psychotropic drug treatment.\u003c\/p\u003e\n\u003cp\u003eOutline the emerging theories and treatments of bipolar disorder, depression, treatment resistant depression, bipolar depression, stress, and anxiety, PTSD, and neuropsychiatric disorders.\u003c\/p\u003e\n\u003cp\u003eDiscuss the role of psychopharmacology in the management of depression and bipolar disorder in childhood and adolescence.\u003c\/p\u003e\n\u003cp\u003eIdentify the benefits and risks of ketamine and psychedelics, including use for PTSD.\u003c\/p\u003e\n\u003cp\u003eDiscuss the role of psychotropic medications in women’s mental health with an emphasis on PMS, pregnancy, nursing, and the postpartum period.\u003c\/p\u003e\n\u003cp\u003eExplain the role of psychopharmacology in the treatment of substance use disorders with particular emphasis on alcohol, opiates, and cannabis.\u003c\/p\u003e\n\u003cp\u003eGive examples of the latest advances and problems associated with treatment approaches in the geriatric populations.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFriday, March 28, 2025\u003c\/p\u003e\n\u003cp\u003eSaturday, March 29, 2025\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405729222852,"sku":null,"price":97.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Psychopharmacology-2025-A-Master-Class.jpg?v=1784215432"},{"product_id":"harvard-meditation-and-psychotherapy-learning-from-nature-2025","title":"Harvard Meditation and Psychotherapy Learning from Nature 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: psychologists, psychiatrists, primary care physician\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eResearch shows that connection to nature can have a wide range of benefits, such as improved attention, memory, mood, social interactions, happiness and wellbeing, and reduced stress, anxiety, depression, and chronic disease. Although human beings have evolved with nature, benefit from nature, and are part of nature, modern society is increasingly alienated from the natural world and our environment is in crisis. Eco-anxiety and climate distress are having a significant impact on mental health, especially among young people.\u003c\/p\u003e\n\u003cp\u003eMeditation and psychotherapy can be harnessed to improve our relationship to nature, and nature can have a positive influence on how we meditate and do clinical work. This webinar series explores the importance of nature from a variety of perspectives—scientific, therapeutic, mindfulness, and indigenous. Attendees will learn useful tools and strategies to help their patients realign with, benefit from, and support the natural world. Therapists will also have a chance to explore their own relationship to nature and environmental disruption.\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003ePrimary Care Physicians\u003c\/p\u003e\n\u003cp\u003ePsychologists\u003c\/p\u003e\n\u003cp\u003eSocial Workers\u003c\/p\u003e\n\u003cp\u003eCounselors\u003c\/p\u003e\n\u003cp\u003eFamily Therapists\u003c\/p\u003e\n\u003cp\u003eOthers\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eSummarize the research supporting the mental and physical health benefits of exposure to nature.\u003c\/p\u003e\n\u003cp\u003eTeach their patients mindfulness practices to enhance their sense of connection with nature in urban and rural settings.\u003c\/p\u003e\n\u003cp\u003eGuide patients with trauma to alleviate their distress by engaging safely and effectively with the natural world.\u003c\/p\u003e\n\u003cp\u003eEngage therapeutically with adults and youth who are experiencing eco-anxiety.\u003c\/p\u003e\n\u003cp\u003eIntegrate elements of indigenous wisdom into mindfulness practice.\u003c\/p\u003e\n\u003cp\u003eUnderstand and manage the clinician’s own emotional distress associated with climate change.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFriday, April 4, 2025\u003c\/p\u003e\n\u003cp\u003eWeek One\u003c\/p\u003e\n\u003cp\u003eMindfulness in Nature Practice – Pathways to Wonder, Wisdom, and Well-Being\u003c\/p\u003e\n\u003cp\u003eMark Coleman\u003c\/p\u003e\n\u003cp\u003eDiscussion \/ Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eChristopher Germer, PhD; Ronald D. Siegel, PsyD; Zev Schuman-Olivier, MD; Mark Coleman\u003c\/p\u003e\n\u003cp\u003eFriday, April 11, 2025\u003c\/p\u003e\n\u003cp\u003eWeek Two\u003c\/p\u003e\n\u003cp\u003eMindfully Accessing Earth for Emotion Regulation, Mental Health, and Trauma Recovery\u003c\/p\u003e\n\u003cp\u003eBarbara Hamm, PsyD; Zev Schuman-Olivier, MD\u003c\/p\u003e\n\u003cp\u003eDiscussion \/ Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eChristopher Germer, PhD; Ronald D. Siegel, PsyD; Zev Schuman-Olivier, MD; Barbara Hamm, PsyD\u003c\/p\u003e\n\u003cp\u003eFriday, April 18, 2025\u003c\/p\u003e\n\u003cp\u003eWeek Three\u003c\/p\u003e\n\u003cp\u003eHearing the Cry of the Earth: Responding Compassionately to Change, Loss, and Disruption\u003c\/p\u003e\n\u003cp\u003eKaira Jewel Lingo, MA\u003c\/p\u003e\n\u003cp\u003eDiscussion \/ Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eRonald D. Siegel, PsyD; Zev Schuman-Olivier, MD; Kaira Jewel Lingo, MA\u003c\/p\u003e\n\u003cp\u003eFriday, April 25, 2025\u003c\/p\u003e\n\u003cp\u003eWeek Four\u003c\/p\u003e\n\u003cp\u003eConnecting and Reflecting: Contemplative Practices as a Way of Addressing Eco-Anxiety and Climate Distress\u003c\/p\u003e\n\u003cp\u003eChristopher Willard, PsyD; Dekila Chungyalpa\u003c\/p\u003e\n\u003cp\u003eDiscussion \/ Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eChristopher Germer, PhD; Christopher Willard, PsyD; Dekila Chungyalpa\u003c\/p\u003e\n\u003cp\u003eFriday, May 2, 2025\u003c\/p\u003e\n\u003cp\u003eWeek Five\u003c\/p\u003e\n\u003cp\u003eIndigenous Wisdom and Integration of Mindfulness and Earth Awareness Practices and the Impact on Mental Health\u003c\/p\u003e\n\u003cp\u003eBonnie Duran, DrPH\u003c\/p\u003e\n\u003cp\u003eDiscussion \/ Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eRonald D. Siegel, PsyD; Zev Schuman-Olivier, MD; Christopher Germer, PhD; Bonnie Duran, DrPH\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405733155012,"sku":null,"price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Meditation-and-Psychotherapy-Learning-from-Nature-2025.jpg?v=1784215455"},{"product_id":"harvard-updates-in-general-internal-medicine-for-specialists-2025","title":"Harvard Updates in General Internal Medicine for Specialists 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: internists, primary care physician, psychiatrist or pathologist, cardiologist or anesthesiologist, surgeon or hospitalist\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAdvances, Updates, Guidelines, and Best Practices in General Internal Medicine—Expressly for Specialists\u003c\/p\u003e\n\u003cp\u003eOverview\u003c\/p\u003e\n\u003cp\u003eIn this unique program, Harvard Medical School’s leading clinical faculty, representing more than 30 fields of medicine and surgery, share updates and provide recommendations to ensure you are current with the recent advances in both general internal medicine and select specialties. General Internal Medicine for Specialists covers the clinical breadth of internal medicine and the working knowledge specialists need in order to understand the most important advances outside your field of expertise.\u003c\/p\u003e\n\u003cp\u003eWhether you are a psychiatrist or pathologist, cardiologist or anesthesiologist, surgeon or hospitalist, you can rely on this program for updates and advances that impact day-to-day practice, clinical decisions, and patient care.\u003c\/p\u003e\n\u003cp\u003e2025 Updates, Strategies, and Tools to Improve Patient Care\u003c\/p\u003e\n\u003cp\u003eThe program’s curriculum provides broad and inclusive content ranging from clinical controversies to specific new and innovative therapies. General Internal Medicine for Specialists was developed by experienced practitioners, and sessions are presented by Harvard faculty and select guest speakers dedicated to peer-to-peer education. They will succinctly and effectively summarize material and provide focused updates, emphasizing specific recommendations for clinical practice and improved patient care.\u003c\/p\u003e\n\u003ch3\u003eTopics covered in the 2025 program include:\u003c\/h3\u003e\n\u003ch3\u003eTopics covered in the 2025 program include:\u003c\/h3\u003e\n\u003cp\u003eIschemic heart disease\u003c\/p\u003e\n\u003cp\u003eHepatitis\u003c\/p\u003e\n\u003cp\u003eStroke\u003c\/p\u003e\n\u003cp\u003eChronic obstructive lung disease\u003c\/p\u003e\n\u003cp\u003eDiabetes management\u003c\/p\u003e\n\u003cp\u003eMenopause management\u003c\/p\u003e\n\u003cp\u003eAnticoagulation\u003c\/p\u003e\n\u003cp\u003eNon-diabetes endocrinology\u003c\/p\u003e\n\u003cp\u003eCognitive decline\u003c\/p\u003e\n\u003cp\u003eCongestive heart failure\u003c\/p\u003e\n\u003cp\u003eCommon eye problems\u003c\/p\u003e\n\u003cp\u003eManagement of GI complaints\u003c\/p\u003e\n\u003cp\u003eBreast cancer risk\u003c\/p\u003e\n\u003cp\u003eRenal medicine\u003c\/p\u003e\n\u003cp\u003eSleep disorders\u003c\/p\u003e\n\u003cp\u003eBasic orthopedics\u003c\/p\u003e\n\u003cp\u003eAtrial fibrillation\u003c\/p\u003e\n\u003cp\u003eLipid management\u003c\/p\u003e\n\u003cp\u003eDisease prevention and health promotion\u003c\/p\u003e\n\u003cp\u003eOsteoporosis management\u003c\/p\u003e\n\u003cp\u003eAsthma\u003c\/p\u003e\n\u003cp\u003eProstate cancer\u003c\/p\u003e\n\u003cp\u003eColon cancer\u003c\/p\u003e\n\u003cp\u003eGenetic testing\u003c\/p\u003e\n\u003cp\u003eManaging obesity\u003c\/p\u003e\n\u003cp\u003eHeadaches\u003c\/p\u003e\n\u003cp\u003eAllergy medicine\u003c\/p\u003e\n\u003cp\u003eThyroid disorders\u003c\/p\u003e\n\u003cp\u003eHypertension\u003c\/p\u003e\n\u003cp\u003eCancer screening\u003c\/p\u003e\n\u003cp\u003eLower back pain\u003c\/p\u003e\n\u003ch3\u003eWhatever your specialty, you can rely on General Internal Medicine for Specialists for practical updates that ensure a working knowledge of current internal medicine practices and a familiarity with critical advances across a broad range of specialties. This program is designed to provide focused updates of general medicine topics for specialists, and to cover a vast amount of information efficiently and effectively, including:\u003c\/h3\u003e\n\u003cp\u003eCurrent guidelines and management strategies for diabetes, cardiovascular disease, lipid disorders, hypertension, chronic lung disease, sleep disturbances, cognitive decline\u003c\/p\u003e\n\u003cp\u003eStrategies for assessing and managing interacting comorbidities\u003c\/p\u003e\n\u003cp\u003ePotential adverse interactions between medications you prescribe and those prescribed by others\u003c\/p\u003e\n\u003cp\u003eFocused examination techniques in basic orthopedics\u003c\/p\u003e\n\u003cp\u003eWomen’s health topics\u003c\/p\u003e\n\u003cp\u003eUp-to-date therapies in cardiology, endocrinology, gastroenterology, neurology, oncology and more\u003c\/p\u003e\n\u003cp\u003eInter-specialty clinical decision-making\u003c\/p\u003e\n\u003cp\u003eThe most current evidence-based screening and prevention practices\u003c\/p\u003e\n\u003cp\u003eBreakthrough innovations with proven patient benefit\u003c\/p\u003e\n\u003cp\u003eHow medical practices can positively address health care inequities and disparities\u003c\/p\u003e\n\u003cp\u003eHow climate changes affect health\u003c\/p\u003e\n\u003cp\u003eLearn from the Best Clinical Faculty at Harvard Medical School\u003c\/p\u003e\n\u003cp\u003eThis program is led by active expert practitioners and committed teachers, each with extensive experience in the care of patients and in peer-to-peer presentations to colleagues. The Harvard faculty and select guest speakers will cover state-of-the-art advances and recommendations. You will take home relevant, up-to-date, and evidence-based strategies and tools to improve your patient care.\u003c\/p\u003e\n\u003ch3\u003eThe Harvard Updates in General Internal Medicine for Specialists 2025 course is designed for healthcare professionals specializing in various medical fields who need updates on general internal medicine. The target audience includes:\u003c\/h3\u003e\n\u003cp\u003eSpecialists in fields such as cardiology, psychiatry, anesthesiology, surgery, and hospital medicine.\u003c\/p\u003e\n\u003cp\u003eInternists and primary care physicians looking to expand their knowledge beyond their specialty.\u003c\/p\u003e\n\u003cp\u003eMedical trainees seeking advanced education in general internal medicine.\u003c\/p\u003e\n\u003cp\u003eHealthcare providers interested in the latest guidelines, treatments, and best practices across multiple specialties.\u003c\/p\u003e\n\u003cp\u003eThis program covers clinical updates, management strategies, and innovations in areas like cardiology, endocrinology, gastroenterology, neurology, and oncology.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eDay 1 2025 Heart Failure Update for Subspecialists.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 2025 Heart Failure Update for Subspecialists.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Chronic Ischemic Heart Disease Treatment Choices in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Chronic Ischemic Heart Disease Treatment Choices in 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Course Introduction.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Diseases of the Foregut.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Diseases of the Foregut.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Frequently Asked Questions in Hematology A Case-Based Approach.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Genetic Testing.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Genetic Testing.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Ophthalmology in Primary Care.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Ophthalmology in Primary Care.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Updates in Stroke Prevention and Treatment.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Updates in Stroke Prevention and Treatment.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Asthma.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Asthma.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Colon Cancer.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Colon Cancer.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Diabetes An Update for Subspecialists.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Diabetes An Update for Subspecialists.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Hyperlipidemia 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Hyperlipidemia 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Lung Cancer Therapy.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Lung Cancer Therapy.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Overview of Sleep Medicine.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Overview of Sleep Medicine.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Update in Renal Medicine.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Update in Renal Medicine.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Update on Anticoagulants and Venous Thromboembolism.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Update on Anticoagulants and Venous Thromboembolism.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Atrial Fibrillation.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Atrial Fibrillation.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Chronic Obstructive Pulmonary Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Chronic Obstructive Pulmonary Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Common Outpatient Infections Current Treatment Recommendations.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Common Outpatient Infections Current Treatment Recommendations.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Managing Obesity.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Managing Obesity.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 New Practices for Managing Osteoporosis and Reducing Fractures.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 New Practices for Managing Osteoporosis and Reducing Fractures.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Principles of Care for the Older Adult.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Principles of Care for the Older Adult.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Prostate Cancer.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Prostate Cancer.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Updates in Addressing Headaches.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Updates in Addressing Headaches.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Breast Cancer Current Approaches to Diagnosis and Treatment.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Breast Cancer Current Approaches to Diagnosis and Treatment.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Infectious and Metabolic Liver Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Infectious and Metabolic Liver Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Memory Loss, Alzheimer’s Disease, and Dementia Update 2025 1.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Memory Loss, Alzheimer’s Disease, and Dementia Update 2025 2.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Memory Loss, Alzheimer’s Disease, and Dementia Update 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Opioid Use Disorder.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Opioid Use Disorder.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Shoulder, Elbow, Wrist, Hand Pain Diagnosis and Management.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Shoulder, Elbow, Wrist, Hand Pain Diagnosis and Management.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Treating Tobacco Use Optimizing for Enduring Outcomes.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Treating Tobacco Use Optimizing for Enduring Outcomes.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Understanding Disparities in Specialty Care.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Understanding Disparities in Specialty Care.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Updates in Allergy What to Know in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Updates in Allergy What to Know in 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Case Studies in Reproductive Endocrinology.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Case Studies in Reproductive Endocrinology.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Common Thyroid Problems.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Common Thyroid Problems.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Disease Prevention and Health Promotion.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Disease Prevention and Health Promotion.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Healthcare Delivery in the Face of Climate Change.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Healthcare Delivery in the Face of Climate Change.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Lower Back Pain Evaluation and Treatment Approaches.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Lower Back Pain Evaluation and Treatment Approaches.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Women’s Health Managing Menopause.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Women’s Health Managing Menopause.pdf\u003c\/p\u003e\n\u003cp\u003eGims Course Schedule.pdf\u003c\/p\u003e\n\u003cp\u003eMain Session.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405734105284,"sku":null,"price":84.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Updates-in-General-Internal-Medicine-for-Specialists-2025.png?v=1784215463"},{"product_id":"harvard-female-sexual-wellness-identifying-concerns-and-treatment-options-2025","title":"Harvard Female Sexual Wellness Identifying Concerns and Treatment Options 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: primary care physician, obstetricians, gynecologists, urologists, pain management specialists, psychiatrists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFemale Sexual Wellness: Identifying Concerns and Treatment Options is a one-day virtual CME course on diagnosing and treating female sexual function concerns. The course will cover disorders of desire, arousal, and orgasm, as well as sexual pain, using topical lectures, and case-based vignettes. Content will be evidence-based and directed towards clinicians and researchers in Obstetrics and Gynecology, Internal Medicine, Family Medicine, Urology, Pain Management, Psychiatry, Psychology, Nursing, and Social Work.\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003eNurse Practitioners\u003c\/p\u003e\n\u003cp\u003ePhysician Assistants\u003c\/p\u003e\n\u003cp\u003eNurses\u003c\/p\u003e\n\u003cp\u003ePsychologists\u003c\/p\u003e\n\u003cp\u003eSocial Workers\u003c\/p\u003e\n\u003cp\u003ePrimary Care Physicians\u003c\/p\u003e\n\u003cp\u003eSpecialty Physicians\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eConduct a thorough history for patients with female sexual function concerns.\u003c\/p\u003e\n\u003cp\u003eRecognize causes and interaction of desire, arousal, and orgasmic disorders and explore the range of behavioral, pharmacologic, and device-based treatment options.\u003c\/p\u003e\n\u003cp\u003eIdentify causes and treatments for female sexual pain (dyspareunia).\u003c\/p\u003e\n\u003ch3\u003eThe Harvard Female Sexual Wellness: Identifying Concerns and Treatment Options 2025 course is designed for healthcare professionals who diagnose and treat female sexual function concerns. The target audience includes:\u003c\/h3\u003e\n\u003cp\u003ePrimary care physicians managing sexual health concerns in general practice.\u003c\/p\u003e\n\u003cp\u003eObstetricians and gynecologists specializing in female reproductive health.\u003c\/p\u003e\n\u003cp\u003eUrologists addressing sexual dysfunction and pelvic health.\u003c\/p\u003e\n\u003cp\u003ePain management specialists treating conditions like dyspareunia.\u003c\/p\u003e\n\u003cp\u003ePsychiatrists and psychologists focusing on mental health aspects of sexual wellness.\u003c\/p\u003e\n\u003cp\u003eThis one-day virtual course covers disorders of desire, arousal, orgasm, and sexual pain, using evidence-based approaches and case-based discussions.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e01 Course Introduction.mp4\u003c\/p\u003e\n\u003cp\u003e02 Course Overview.mp4\u003c\/p\u003e\n\u003cp\u003e02 Course Overview.pdf\u003c\/p\u003e\n\u003cp\u003e03 Classification of Female Sexual Dysfunction.mp4\u003c\/p\u003e\n\u003cp\u003e03 Classification of Female Sexual Dysfunction.pdf\u003c\/p\u003e\n\u003cp\u003e04 Sex Counseling.mp4\u003c\/p\u003e\n\u003cp\u003e04 Sex Counseling.pdf\u003c\/p\u003e\n\u003cp\u003e05 Sex Therapy.mp4\u003c\/p\u003e\n\u003cp\u003e05 Sex Therapy.pdf\u003c\/p\u003e\n\u003cp\u003e06 Pharmacologic Treatment Options for Low Desire.mp4\u003c\/p\u003e\n\u003cp\u003e06 Pharmacologic Treatment Options for Low Desire.pdf\u003c\/p\u003e\n\u003cp\u003e07 Arousal and Orgasmic Dysfunction Sex Counseling and Vibrator Therapy.mp4\u003c\/p\u003e\n\u003cp\u003e07 Arousal and Orgasmic Dysfunction Sex Counseling and Vibrator Therapy.pdf\u003c\/p\u003e\n\u003cp\u003e08 Arousal and Orgasmic Dysfunction Medication and Medical Device Options.mp4\u003c\/p\u003e\n\u003cp\u003e08 Arousal and Orgasmic Dysfunction Medication and Medical Device Options.pdf\u003c\/p\u003e\n\u003cp\u003e09 Q\u0026amp;A 1.mp4\u003c\/p\u003e\n\u003cp\u003e10 Dyspareunia Anatomy and Differential Diagnosis.mp4\u003c\/p\u003e\n\u003cp\u003e10 Dyspareunia Anatomy and Differential Diagnosis.pdf\u003c\/p\u003e\n\u003cp\u003e11 Sexual Function in Perimenopause and Menopause.mp4\u003c\/p\u003e\n\u003cp\u003e11 Sexual Function in Perimenopause and Menopause.pdf\u003c\/p\u003e\n\u003cp\u003e12 Vulvar Dermatoses.mp4\u003c\/p\u003e\n\u003cp\u003e12 Vulvar Dermatoses.pdf\u003c\/p\u003e\n\u003cp\u003e13 Vulvodynia.mp4\u003c\/p\u003e\n\u003cp\u003e13 Vulvodynia.pdf\u003c\/p\u003e\n\u003cp\u003e14 Trauma-Informed Care.pdf\u003c\/p\u003e\n\u003cp\u003e15 Care of the Gender Diverse Patient.mp4\u003c\/p\u003e\n\u003cp\u003e15 Care of the Gender Diverse Patient.pdf\u003c\/p\u003e\n\u003cp\u003e16 Q\u0026amp;A 2.mp4\u003c\/p\u003e\n\u003cp\u003e17 Pelvic Floor Physical Therapy Focus on Pelvic Floor Muscles.mp4\u003c\/p\u003e\n\u003cp\u003e17 Pelvic Floor Physical Therapy Focus on Pelvic Floor Muscles.pdf\u003c\/p\u003e\n\u003cp\u003e18 Pain Management Options for Dyspareunia and Pelvic Pain.mp4\u003c\/p\u003e\n\u003cp\u003e18 Pain Management Options for Dyspareunia and Pelvic Pain.pdf\u003c\/p\u003e\n\u003cp\u003e19 Office-Based Gynecologic Procedures for Pain.pdf\u003c\/p\u003e\n\u003cp\u003e20 Surgical Management of Dyspareunia Vaginal Approach.mp4\u003c\/p\u003e\n\u003cp\u003e20 Surgical Management of Dyspareunia Vaginal Approach.pdf\u003c\/p\u003e\n\u003cp\u003e21 Surgical Management of Fibroids and Endometriosis Laparoscopic Approach.mp4\u003c\/p\u003e\n\u003cp\u003e21 Surgical Management of Fibroids and Endometriosis Laparoscopic Approach.pdf\u003c\/p\u003e\n\u003cp\u003e22 Vaginal Lengthening and Neovagina Creation.mp4\u003c\/p\u003e\n\u003cp\u003e22 Vaginal Lengthening and Neovagina Creation.pdf\u003c\/p\u003e\n\u003cp\u003e23 The Impact of Hysterectomy and Gynecologic Surgery on Sexual Function.mp4\u003c\/p\u003e\n\u003cp\u003e23 The Impact of Hysterectomy and Gynecologic Surgery on Sexual Function.pdf\u003c\/p\u003e\n\u003cp\u003e24 Q\u0026amp;A 3.mp4\u003c\/p\u003e\n\u003cp\u003e25 Case Studies.mp4\u003c\/p\u003e\n\u003cp\u003e25 Case Studies.pdf\u003c\/p\u003e\n\u003cp\u003eAgenda.pdf\u003c\/p\u003e\n\u003cp\u003eBIDMC break loop V2.mp4\u003c\/p\u003e\n\u003cp\u003eHMS CME Course Faculty Bios May 2025.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405734269124,"sku":null,"price":58.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Female-Sexual-Wellness-Identifying-Concerns-and-Treatment-Options-2025.jpg?v=1784215466"},{"product_id":"harvard-testosterone-therapy-and-sexual-dysfunction-2025","title":"Harvard Testosterone Therapy and Sexual Dysfunction 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: endocrinologists, urologists, family practice providers, primary care providers, geriatricians, gynecologists, psychiatrists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTestosterone therapy is one of the most controversial topics in medicine, yet multiple medical societies endorse its use, supported by level 1 evidence showing a variety of health benefits in men. This innovative and comprehensive course will focus on testosterone deficiency and its treatment in men and women and will also address several other sexual issues.\u003c\/p\u003e\n\u003cp\u003eStudies indicate that nearly 40% of men over the age of 45 have overtly low testosterone levels, yet education in this area is extremely limited. Similarly, there have been few educational opportunities to address sexual dysfunction in men and women. Approximately 40% of men and a similar percentage of women have one sexual dysfunction or another. Indeed, there have been several fascinating therapeutic advances in the treatment of sexual dysfunction in women that have received scant attention in other educational events.\u003c\/p\u003e\n\u003cp\u003eThe course is led by men’s health pioneer Abraham Morgentaler, MD, FACS whose research in the field transformed our understanding of the science of testosterone in men. Dr. Morgentaler has assembled as all-star faculty of thought leaders to address the most relevant issues and controversies, demystify the topic with science and clinical experience and provide an evidence-based approach to treatment. The course will also address management of several common sexual problems for men, including erectile dysfunction, and will also address several common sexual issues for women, including hypoactive sexual desire disorder. A clinical psychologist and sex therapist will explore non-medical strategies for managing couples with sexual complaints.\u003c\/p\u003e\n\u003cp\u003eOBJECTIVES\u003c\/p\u003e\n\u003ch3\u003eAt the end of the course, you will be able to:\u003c\/h3\u003e\n\u003cp\u003eIdentify individuals with testosterone deficiency\u003c\/p\u003e\n\u003cp\u003eIdentify risks and benefits of testosterone therapy\u003c\/p\u003e\n\u003cp\u003eDiscuss the advantages and disadvantage of each of the treatment options for management of male and female sexual dysfunctions\u003c\/p\u003e\n\u003cp\u003eProgram Highlights\u003c\/p\u003e\n\u003cp\u003eThe importance of testosterone in male health\u003c\/p\u003e\n\u003cp\u003eThe ABCs of testosterone\u003c\/p\u003e\n\u003cp\u003eCan testosterone be used in men with prostate cancer?\u003c\/p\u003e\n\u003cp\u003eTestosterone and the risk of breast cancer in women\u003c\/p\u003e\n\u003cp\u003eReducing risks, including cardiovascular disease\u003c\/p\u003e\n\u003cp\u003eEffective and safe interventions to preserve fertility\u003c\/p\u003e\n\u003cp\u003eIs it low T or natural aging?\u003c\/p\u003e\n\u003cp\u003eThe who, when and why of testosterone replacement therapy\u003c\/p\u003e\n\u003cp\u003eAdvising patients on testosterone myths and facts\u003c\/p\u003e\n\u003cp\u003eCurrent evidence regarding HRT in women\u003c\/p\u003e\n\u003cp\u003eAddressing “hormonophobia”: What’s the truth?\u003c\/p\u003e\n\u003cp\u003eEvidence-based solutions for improving male sexual problems\u003c\/p\u003e\n\u003cp\u003eThe TRAVERSE Trial results\u003c\/p\u003e\n\u003cp\u003eHypoactive sexual desire disorder and other common sexual issues for women\u003c\/p\u003e\n\u003cp\u003eReal-world evidence – who’s a candidate for T therapy? Recent updates on society guidelines and recommendations\u003c\/p\u003e\n\u003cp\u003eManagement of complex cases\u003c\/p\u003e\n\u003cp\u003eHow to handle adverse effects from treatment (i.e., erythrocytosis, rise in PSA)\u003c\/p\u003e\n\u003cp\u003eCommon female sexual issues and their treatment\u003c\/p\u003e\n\u003cp\u003eNon-medical strategies for managing couples with sexual complaints – expert advice from a clinical psychologist and sex therapist\u003c\/p\u003e\n\u003cp\u003eEvaluation of and cutting-edge treatment for ED\u003c\/p\u003e\n\u003cp\u003eMedical management of transgenderism\u003c\/p\u003e\n\u003cp\u003ePractical pearls from Dr. Morgentaler\u003c\/p\u003e\n\u003cp\u003eWHO SHOULD ATTEND?\u003c\/p\u003e\n\u003ch3\u003eThis special program provides education for:\u003c\/h3\u003e\n\u003cp\u003eEndocrinologists\u003c\/p\u003e\n\u003cp\u003eUrologists\u003c\/p\u003e\n\u003cp\u003eFamily practice providers\u003c\/p\u003e\n\u003cp\u003ePrimary care providers\u003c\/p\u003e\n\u003cp\u003eGeriatricians\u003c\/p\u003e\n\u003cp\u003eGynecologists\u003c\/p\u003e\n\u003cp\u003ePsychiatrists\u003c\/p\u003e\n\u003cp\u003ePsychologists\u003c\/p\u003e\n\u003cp\u003eNPs\u003c\/p\u003e\n\u003cp\u003ePAs\u003c\/p\u003e\n\u003cp\u003eOther clinicians who treat low testosterone and male and female sexual health issues\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eJanuary 17 Afternoon.ts\u003c\/p\u003e\n\u003cp\u003eJanuary 17 History of Testosterone Therapy Where We Have Been and Where We Are Going Traish.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 17 How to Treat Injections, Topicals, Pellets, Orals, Nasal Morgentaler.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 17 Impact of Testosterone Deficiency Health Consequences Traish.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 17 Is it Low T or Natural Aging Traish.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 17 Managing Testosterone Deficiency in Men Wishing to Preserve Fertility Effective and Safe Interventions Khera.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 17 Morning.ts\u003c\/p\u003e\n\u003cp\u003eJanuary 17 Navigating a Sea of Guidelines What You Need to Know Khera.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 17 Prostate Cancer and BPH Risks What’s the Truth Morgentaler.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 17 Testosterone Physiology and Pathophysiology Traish.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 17 The Importance of Testosterone in Men’s Health Morgentaler.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 17 The TRAVERSE Trial and Cardiovascular Risks Khera.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 17 Who is a Candidate The Marriage of Guidelines and Clinical Experience for Testosterone Therapy Morgentaler.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Afternoon.ts\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Beyond the Bedroom Sociosexual Trends in the U.S. Brandon.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Bringing it All Together Questions and Discussion Panel.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 History of Testosterone Therapy in Women Traish.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Hormone Replacement Therapy in Women Rationale and How I Do It Rubin.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 How to Evaluate and Treat Men with Erectile Dysfunction Pills, Injections, Surgery, and More Khera.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 How to Treat Trans Men in 2025 and How to Treat Trans Women in 2025 Irwig.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Hypoactive Sexual Desire Disorder Rubin.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Keynote Testosterone, Science and Human Dignity Morgentaler.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Morning.ts\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Other Female Sexual Dysfunctions Rubin.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Physiology and Pathophysiology of Women’s Sexual Function Traish.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Practical Tricks of the Trade in Treating ED and Other Male Sexual Issues An RN’s Perspective Flinn.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Premature and Delayed Ejaculation Recommendations for Optimal Care Khera.mp4\u003c\/p\u003e\n\u003cp\u003eTT-Compiled-QA.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405734596804,"sku":null,"price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Testosterone-Therapy-and-Sexual-Dysfunction-2025.jpg?v=1784215469"},{"product_id":"harvard-testosterone-therapy-and-sexual-dysfunction-2026","title":"Harvard Testosterone Therapy and Sexual Dysfunction 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: dermatologists, endocrinologists, family practice providers, geriatricians, gynecologists, PAs, primary care providers, psychiatrists, urologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eInnovative and Comprehensive Continuing Medical Education Course on Testosterone Deficiency and Sexual Issues\u003c\/p\u003e\n\u003cp\u003eTestosterone Therapy and Sexual Dysfunction – Demystifying the Hype with Science to Provide Cutting Edge Treatment for Your Patients\u003c\/p\u003e\n\u003cp\u003eUpdates, Best Practices, Tools and Optimized Strategies for Testosterone Therapy and Men’s Health\u003c\/p\u003e\n\u003cp\u003eTestosterone therapy is one of the most controversial topics in medicine, yet multiple medical societies endorse its use, supported by level 1 evidence showing a variety of health benefits in men. This innovative and comprehensive course will focus on testosterone deficiency and its treatment in men and women and will also address several other sexual issues. Studies indicate that nearly 40% of men over the age of 45 have overtly low testosterone levels, yet education in this area is extremely limited. Similarly, there have been few educational opportunities to address sexual dysfunction in men and women. Approximately 40% of men and a similar percentage of women have one sexual dysfunction or another. Indeed, there have been several fascinating therapeutic advances in the treatment of sexual dysfunction in women that have received scant attention in other educational events.\u003c\/p\u003e\n\u003ch3\u003eProgram Highlights Include:\u003c\/h3\u003e\n\u003cp\u003eNEW! Important FDA Labeling Updates\u003c\/p\u003e\n\u003cp\u003eThe importance of testosterone in male health\u003c\/p\u003e\n\u003cp\u003eCan testosterone be used in men with prostate cancer?\u003c\/p\u003e\n\u003cp\u003eCurrent evidence regarding HRT in women and how to start treatment\u003c\/p\u003e\n\u003cp\u003eThe who, when and why of testosterone therapy\u003c\/p\u003e\n\u003cp\u003eEvaluation of and cutting-edge treatment for ED\u003c\/p\u003e\n\u003cp\u003eThe TRAVERSE Trial results\u003c\/p\u003e\n\u003cp\u003eHair and hormones\u003c\/p\u003e\n\u003cp\u003eNon-medical strategies for managing couples with sexual complaints\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003eDermatologists\u003c\/p\u003e\n\u003cp\u003eEndocrinologists\u003c\/p\u003e\n\u003cp\u003eFamily practice providers\u003c\/p\u003e\n\u003cp\u003eGeriatricians\u003c\/p\u003e\n\u003cp\u003eGynecologists\u003c\/p\u003e\n\u003cp\u003ePAs\u003c\/p\u003e\n\u003cp\u003ePrimary care providers\u003c\/p\u003e\n\u003cp\u003ePsychiatrists\u003c\/p\u003e\n\u003cp\u003ePsychologists\u003c\/p\u003e\n\u003cp\u003eNPs and nurses\u003c\/p\u003e\n\u003cp\u003eUrologists\u003c\/p\u003e\n\u003cp\u003eOther clinicians who treat low testosterone and male and female sexual health issues\u003c\/p\u003e\n\u003ch3\u003eFEATURING:\u003c\/h3\u003e\n\u003cp\u003eInnovative lectures\u003c\/p\u003e\n\u003cp\u003eValuable case-based sessions\u003c\/p\u003e\n\u003cp\u003eLive demonstrations\u003c\/p\u003e\n\u003cp\u003eQuestion-and-answer panels\u003c\/p\u003e\n\u003cp\u003eInteractive discussions\u003c\/p\u003e\n\u003cp\u003eProgram Highlights\u003c\/p\u003e\n\u003cp\u003eThe importance of testosterone in male health\u003c\/p\u003e\n\u003cp\u003eThe ABCs of testosterone\u003c\/p\u003e\n\u003cp\u003eCan testosterone be used in men with prostate cancer?\u003c\/p\u003e\n\u003cp\u003eTestosterone and the risk of breast cancer in women\u003c\/p\u003e\n\u003cp\u003eManaging risks, including cardiovascular disease\u003c\/p\u003e\n\u003cp\u003eEffective and safe interventions to preserve fertility\u003c\/p\u003e\n\u003cp\u003eThe who, when and why of testosterone replacement therapy\u003c\/p\u003e\n\u003cp\u003eAdvising patients on testosterone myths and facts\u003c\/p\u003e\n\u003cp\u003eCurrent evidence regarding HRT in women and how to start treatment\u003c\/p\u003e\n\u003cp\u003eAddressing “hormonophobia”: What’s the truth?\u003c\/p\u003e\n\u003cp\u003eEvidence-based solutions for improving male sexual problems\u003c\/p\u003e\n\u003cp\u003eThe TRAVERSE Trial results\u003c\/p\u003e\n\u003cp\u003eHypoactive sexual desire disorder and other common sexual issues for women\u003c\/p\u003e\n\u003cp\u003eReal-world evidence – who’s a candidate for T therapy? Recent updates on society guidelines and recommendations\u003c\/p\u003e\n\u003cp\u003eManagement of complex cases\u003c\/p\u003e\n\u003cp\u003eHow to handle adverse effects from treatment (i.e., erythrocytosis, rise in PSA)\u003c\/p\u003e\n\u003cp\u003eCommon female sexual issues and their treatment\u003c\/p\u003e\n\u003cp\u003eNon-medical strategies for managing couples with sexual complaints – expert advice from a clinical psychologist and sex therapist\u003c\/p\u003e\n\u003cp\u003eEvaluation of and cutting-edge treatment for ED\u003c\/p\u003e\n\u003cp\u003ePractical pearls from Dr. Morgentaler\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFri. Jan. 16\u003c\/p\u003e\n\u003cp\u003e7:15 AM\u003c\/p\u003e\n\u003cp\u003e8:00 AM\u003c\/p\u003e\n\u003cp\u003eREGISTRATION AND BREAKFAST\u003c\/p\u003e\n\u003cp\u003e8:00 AM\u003c\/p\u003e\n\u003cp\u003e8:15 AM\u003c\/p\u003e\n\u003cp\u003eIntroduction and Welcome\u003c\/p\u003e\n\u003cp\u003eMorgentaler\u003c\/p\u003e\n\u003cp\u003e8:15 AM\u003c\/p\u003e\n\u003cp\u003e8:45 AM\u003c\/p\u003e\n\u003cp\u003eThe Importance of Testosterone in Men’s Health\u003c\/p\u003e\n\u003cp\u003eKhera\u003c\/p\u003e\n\u003cp\u003e8:45 AM\u003c\/p\u003e\n\u003cp\u003e9:15 AM\u003c\/p\u003e\n\u003cp\u003eHistory of Testosterone Therapy: Where Have We Been and Where Are We Going?\u003c\/p\u003e\n\u003cp\u003eMorgentaler\u003c\/p\u003e\n\u003cp\u003e9:15 AM\u003c\/p\u003e\n\u003cp\u003e9:30 AM\u003c\/p\u003e\n\u003cp\u003eMorgentaler\u003c\/p\u003e\n\u003cp\u003e9:30 AM\u003c\/p\u003e\n\u003cp\u003e10:00 AM\u003c\/p\u003e\n\u003cp\u003eTestosterone Physiology and Pathophysiology\u003c\/p\u003e\n\u003cp\u003eTraish\u003c\/p\u003e\n\u003cp\u003e10:00 AM\u003c\/p\u003e\n\u003cp\u003e10:20 AM\u003c\/p\u003e\n\u003cp\u003eREFRESHMENT BREAK\u003c\/p\u003e\n\u003cp\u003e10:20 AM\u003c\/p\u003e\n\u003cp\u003e10:50 AM\u003c\/p\u003e\n\u003cp\u003eNavigating a Sea of Guidelines: What You Need to Know\u003c\/p\u003e\n\u003cp\u003eKhera\u003c\/p\u003e\n\u003cp\u003e10:50 AM\u003c\/p\u003e\n\u003cp\u003e11:30 AM\u003c\/p\u003e\n\u003cp\u003eWho is a Candidate? The Marriage of Guidelines and Clinical Experience for Testosterone Therapy\u003c\/p\u003e\n\u003cp\u003eMorgentaler\u003c\/p\u003e\n\u003cp\u003e11:30 AM\u003c\/p\u003e\n\u003cp\u003e12:00 PM\u003c\/p\u003e\n\u003cp\u003eTestosterone and Mental Health in Men and Women*\u003c\/p\u003e\n\u003cp\u003eCampbell\u003c\/p\u003e\n\u003cp\u003e12:00 PM\u003c\/p\u003e\n\u003cp\u003e1:00 PM\u003c\/p\u003e\n\u003cp\u003eLUNCH BREAK\u003c\/p\u003e\n\u003cp\u003e1:00 PM\u003c\/p\u003e\n\u003cp\u003e1:35 PM\u003c\/p\u003e\n\u003cp\u003eCurrent Treatments for Hair Loss in 2026\u003c\/p\u003e\n\u003cp\u003eAvram\u003c\/p\u003e\n\u003cp\u003e1:35 PM\u003c\/p\u003e\n\u003cp\u003e2:10 PM\u003c\/p\u003e\n\u003cp\u003eHow to Treat: Injections, Topicals, Pellets, Orals\u003c\/p\u003e\n\u003cp\u003eMorgentaler\u003c\/p\u003e\n\u003cp\u003e2:10 PM\u003c\/p\u003e\n\u003cp\u003e2:40 PM\u003c\/p\u003e\n\u003cp\u003eThe TRAVERSE Trial and Cardiovascular Risks*\u003c\/p\u003e\n\u003cp\u003eKhera\u003c\/p\u003e\n\u003cp\u003e2:40 PM\u003c\/p\u003e\n\u003cp\u003e3:10 PM\u003c\/p\u003e\n\u003cp\u003eProstate Cancer and BPH Risks: What’s the Truth?*\u003c\/p\u003e\n\u003cp\u003eMorgentaler\u003c\/p\u003e\n\u003cp\u003e3:10 PM\u003c\/p\u003e\n\u003cp\u003e3:30 PM\u003c\/p\u003e\n\u003cp\u003eREFRESHMENT BREAK\u003c\/p\u003e\n\u003cp\u003e3:30 PM\u003c\/p\u003e\n\u003cp\u003e4:00 PM\u003c\/p\u003e\n\u003cp\u003eOther Risks and Their Management: A Case-Based Interactive Session*\u003c\/p\u003e\n\u003cp\u003eMorgentaler\u003c\/p\u003e\n\u003cp\u003e4:00 PM\u003c\/p\u003e\n\u003cp\u003e4:30 PM\u003c\/p\u003e\n\u003cp\u003eManaging Testosterone Deficiency in Men Wishing to Preserve Fertility: Effective and Safe Interventions*\u003c\/p\u003e\n\u003cp\u003eKhera\u003c\/p\u003e\n\u003cp\u003e4:30 PM\u003c\/p\u003e\n\u003cp\u003e5:00 PM\u003c\/p\u003e\n\u003cp\u003eManagement of Complex Clinical Cases: A Case-Based Session\u003c\/p\u003e\n\u003cp\u003eMorgentaler\u003c\/p\u003e\n\u003cp\u003e5:00 PM\u003c\/p\u003e\n\u003cp\u003e5:30 PM\u003c\/p\u003e\n\u003cp\u003eQuestion-and-Answer Session\u003c\/p\u003e\n\u003cp\u003ePanel\u003c\/p\u003e\n\u003cp\u003eSat. Jan. 17\u003c\/p\u003e\n\u003cp\u003e7:30 AM\u003c\/p\u003e\n\u003cp\u003e8:00 AM\u003c\/p\u003e\n\u003cp\u003eBREAKFAST\u003c\/p\u003e\n\u003cp\u003e8:00 AM\u003c\/p\u003e\n\u003cp\u003e8:30 AM\u003c\/p\u003e\n\u003cp\u003eSexual Health is the Best Barometer of Overall Health\u003c\/p\u003e\n\u003cp\u003eKhera\u003c\/p\u003e\n\u003cp\u003e8:30 AM\u003c\/p\u003e\n\u003cp\u003e9:10 AM\u003c\/p\u003e\n\u003cp\u003eHow to Evaluate and Treat Men with Erectile Dysfunction: Pills, Injections, Surgery and More\u003c\/p\u003e\n\u003cp\u003eCampbell\u003c\/p\u003e\n\u003cp\u003e9:10 AM\u003c\/p\u003e\n\u003cp\u003e9:30 AM\u003c\/p\u003e\n\u003cp\u003eNew and Cutting-Edge Treatments for ED: Low-Intensity Shock Wave Therapy, PRP, and More\u003c\/p\u003e\n\u003cp\u003eKhera\u003c\/p\u003e\n\u003cp\u003e9:30 AM\u003c\/p\u003e\n\u003cp\u003e9:50 AM\u003c\/p\u003e\n\u003cp\u003eREFRESHMENT BREAK\u003c\/p\u003e\n\u003cp\u003e9:50 AM\u003c\/p\u003e\n\u003cp\u003e10:20 AM\u003c\/p\u003e\n\u003cp\u003ePremature and Delayed Ejaculation: Recommendations for Optimal Care\u003c\/p\u003e\n\u003cp\u003eCampbell\u003c\/p\u003e\n\u003cp\u003e10:20 AM\u003c\/p\u003e\n\u003cp\u003e10:40 AM\u003c\/p\u003e\n\u003cp\u003ePractical Tricks of the Trade in Treating ED and Other Male Sexual Issues: An RN’s Perspective\u003c\/p\u003e\n\u003cp\u003eFlinn\u003c\/p\u003e\n\u003cp\u003e10:40 AM\u003c\/p\u003e\n\u003cp\u003e10:50 AM\u003c\/p\u003e\n\u003cp\u003eBringing It All Together: Questions and Discussion\u003c\/p\u003e\n\u003cp\u003ePanel\u003c\/p\u003e\n\u003cp\u003e10:50 AM\u003c\/p\u003e\n\u003cp\u003e11:20 AM\u003c\/p\u003e\n\u003cp\u003eHot Off the Press: FDA Labeling Changes and their Impact on Clinical Practice\u003c\/p\u003e\n\u003cp\u003eMorgentaler, Khera, Rubin\u003c\/p\u003e\n\u003cp\u003e11:20 AM\u003c\/p\u003e\n\u003cp\u003e12:00 PM\u003c\/p\u003e\n\u003cp\u003eKEYNOTE: Testosterone, Science and Human Dignity\u003c\/p\u003e\n\u003cp\u003eMorgentaler\u003c\/p\u003e\n\u003cp\u003e12:00 PM\u003c\/p\u003e\n\u003cp\u003e1:00 PM\u003c\/p\u003e\n\u003cp\u003eLUNCH BREAK\u003c\/p\u003e\n\u003cp\u003e1:00 PM\u003c\/p\u003e\n\u003cp\u003e1:30 PM\u003c\/p\u003e\n\u003cp\u003ePhysiology and Pathophysiology of Women’s Sexual Function\u003c\/p\u003e\n\u003cp\u003eTraish\u003c\/p\u003e\n\u003cp\u003e1:30 PM\u003c\/p\u003e\n\u003cp\u003e2:00 PM\u003c\/p\u003e\n\u003cp\u003eSociosexual Trends and Sex Therapy: Addressing Modern Intimacy*\u003c\/p\u003e\n\u003cp\u003eBrandon\u003c\/p\u003e\n\u003cp\u003e2:00 PM\u003c\/p\u003e\n\u003cp\u003e2:30 PM\u003c\/p\u003e\n\u003cp\u003eKEYNOTE: Hormone Replacement Therapy in Women: Rationale and How I Do It\u003c\/p\u003e\n\u003cp\u003eRubin\u003c\/p\u003e\n\u003cp\u003e2:30 PM\u003c\/p\u003e\n\u003cp\u003e2:50 PM\u003c\/p\u003e\n\u003cp\u003eREFRESHMENT BREAK\u003c\/p\u003e\n\u003cp\u003e2:50 PM\u003c\/p\u003e\n\u003cp\u003e3:20 PM\u003c\/p\u003e\n\u003cp\u003eHypoactive Sexual Desire Disorder\u003c\/p\u003e\n\u003cp\u003eRubin\u003c\/p\u003e\n\u003cp\u003e3:20 PM\u003c\/p\u003e\n\u003cp\u003e3:50 PM\u003c\/p\u003e\n\u003cp\u003eThe X-Factor: Partner Dynamics and Its Effect on Treatment\u003c\/p\u003e\n\u003cp\u003eBrandon\u003c\/p\u003e\n\u003cp\u003e3:50 PM\u003c\/p\u003e\n\u003cp\u003e4:20 PM\u003c\/p\u003e\n\u003cp\u003eOther Female Sexual Dysfunctions\u003c\/p\u003e\n\u003cp\u003eRubin\u003c\/p\u003e\n\u003cp\u003e4:20 PM\u003c\/p\u003e\n\u003cp\u003e4:50 PM\u003c\/p\u003e\n\u003cp\u003eSex Tech, Chatbots, and the Future of Intimacy\u003c\/p\u003e\n\u003cp\u003eBrandon\u003c\/p\u003e\n\u003cp\u003e4:50 PM\u003c\/p\u003e\n\u003cp\u003e5:30 PM\u003c\/p\u003e\n\u003cp\u003eQuestion-and-Answer Session\u003c\/p\u003e\n\u003cp\u003ePanel\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405739446468,"sku":null,"price":130.0,"currency_code":"USD","in_stock":true}]},{"product_id":"harvard-updates-in-general-internal-medicine-for-specialists-2026","title":"Harvard Updates in General Internal Medicine for Specialists 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: internists, subspecialists and primary care physicians who want updates on internal medicine, chronic disease management, and digital health tools\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eGeneral Medicine for Specialists (formerly General Internal Medicine for Specialists) is a one-of-a-kind course designed to provide specialists with the latest, evidence-based updates in general medical care. With expert-led presentations spanning core topics in medicine from over 35 medical specialties, General Medicine for Specialists provides an outstanding opportunity to refresh knowledge in areas beyond core expertise to enhance the general care of patients.\u003c\/p\u003e\n\u003cp\u003eNow in its third decade, the vibrant and well-attended General Medicine for Specialists course serves a broad national and international multispecialty audience and is available as a hybrid with both in-person in Boston, MA—a vibrant hub for medical innovation and a wonderful city to visit—and remote learning options. The live stream includes real-time closed captioning and multilingual translation, ensuring accessibility for a global audience. The concurrent session options and bonus video library empower participants to tailor their learning experience to the topics which are most relevant and interesting to each specialist in their practice. Past participants include members of nearly all specialties, with a large number of surgeons, psychiatrists, OB\/GYN, and physical medicine and rehab physicians.\u003c\/p\u003e\n\u003cp\u003eHighlights for 2026\u003c\/p\u003e\n\u003cp\u003eIschemic heart disease\u003c\/p\u003e\n\u003cp\u003eHepatitis\u003c\/p\u003e\n\u003cp\u003eStroke\u003c\/p\u003e\n\u003cp\u003eChronic obstructive lung disease\u003c\/p\u003e\n\u003cp\u003eDiabetes management\u003c\/p\u003e\n\u003cp\u003eMenopause management\u003c\/p\u003e\n\u003cp\u003eAnticoagulation\u003c\/p\u003e\n\u003cp\u003eNon-diabetes endocrinology\u003c\/p\u003e\n\u003cp\u003eCognitive decline\u003c\/p\u003e\n\u003cp\u003eCongestive heart failure\u003c\/p\u003e\n\u003cp\u003eCommon eye problems\u003c\/p\u003e\n\u003cp\u003eManagement of GI complaints\u003c\/p\u003e\n\u003cp\u003eBreast cancer risk\u003c\/p\u003e\n\u003cp\u003eBasic orthopedics\u003c\/p\u003e\n\u003cp\u003eAtrial fibrillation\u003c\/p\u003e\n\u003cp\u003eLipid management\u003c\/p\u003e\n\u003cp\u003eDisease prevention and health promotion\u003c\/p\u003e\n\u003cp\u003eOsteoporosis management\u003c\/p\u003e\n\u003cp\u003eAsthma\u003c\/p\u003e\n\u003cp\u003eRenal medicine\u003c\/p\u003e\n\u003cp\u003eSleep disorders\u003c\/p\u003e\n\u003cp\u003eGenetic Testing\u003c\/p\u003e\n\u003cp\u003eManaging obesity\u003c\/p\u003e\n\u003cp\u003eHeadaches\u003c\/p\u003e\n\u003cp\u003eAllergy medicine\u003c\/p\u003e\n\u003cp\u003eThyroid disorders\u003c\/p\u003e\n\u003cp\u003eHypertension\u003c\/p\u003e\n\u003cp\u003eLower back pain and more!\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eApply updated evidence-based guidelines to the diagnosis and management of common medical conditions including cardiovascular disease, diabetes, dyslipidemia, hypertension, chronic kidney and liver disease, sleep disorders and women’s health.\u003c\/p\u003e\n\u003cp\u003eTranslate innovative, evidence-based interventions from across specialties into effective clinical practice.\u003c\/p\u003e\n\u003cp\u003eRecognize the management strategies and clinical decision-making of colleagues, including the rationale for specific modalities and medications.\u003c\/p\u003e\n\u003cp\u003eEvaluate the current and future role of Artificial Intelligence in medicine, including its applications in diagnostics, clinical decision-making, risk prediction, and workflow efficiency.\u003c\/p\u003e\n\u003cp\u003eImplement best practices in preventive care, screening, and health promotion, with a focus on older adults and patients with multimorbidity.\u003c\/p\u003e\n\u003cp\u003eAssess the value of new diagnostic and screening tests, including changes to thresholds for established testing.\u003c\/p\u003e\n\u003cp\u003eAnticipate and manage adverse effects of therapies prescribed across specialties.\u003c\/p\u003e\n\u003cp\u003eManage complex patients by assessing comorbidities and anticipating adverse interactions between therapies prescribed across specialties.\u003c\/p\u003e\n\u003cp\u003ePerform focused examination skills in areas such as basic orthopedics.\u003c\/p\u003e\n\u003cp\u003eIncorporate breakthrough innovations with proven patient benefit into clinical care.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for subspecialists and primary care physicians who want updates on internal medicine, chronic disease management, and digital health tools.\u003c\/p\u003e\n\u003cp\u003eWho Should Participate\u003c\/p\u003e\n\u003cp\u003eMedical Sub-Specialists, Surgeons, Nurse Practitioners, Physician Assistants, Physical Medicine and Rehab Specialists, Psychiatrists, OB\/GYN Clinicians, Primary Care Physicians, Residents, Fellows, Nurses, and Allied Health Professionals\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e01 Course Introduction\u003c\/p\u003e\n\u003cp\u003e02 Chronic Ischemic Heart Disease Treatment Choices in 2026\u003c\/p\u003e\n\u003cp\u003e03 Women’s Health Hormone Therapy for Treatment and Prevention\u003c\/p\u003e\n\u003cp\u003e04 Updates in Stroke Prevention and Treatment\u003c\/p\u003e\n\u003cp\u003e05 Frequently Asked Questions in Hematology A Case-Based Approach\u003c\/p\u003e\n\u003cp\u003e06 A1 Healthcare Delivery in the Face of Climate\u003c\/p\u003e\n\u003cp\u003e07 A2 Insomnia Treatment\u003c\/p\u003e\n\u003cp\u003e08 B1 Opioid Use Disorder\u003c\/p\u003e\n\u003cp\u003e09 B2 Lyme and Tick-borne Diseases\u003c\/p\u003e\n\u003cp\u003e10 C1 Shoulder, Elbow, Wrist, Hand Pain Diagnosis and Management\u003c\/p\u003e\n\u003cp\u003e11 C2 Update in Renal Medicine\u003c\/p\u003e\n\u003cp\u003e12 D1 Diseases of the Foregut Updates from the Upper GI Tract\u003c\/p\u003e\n\u003cp\u003e13 D2 Ophthalmology in Primary Care\u003c\/p\u003e\n\u003cp\u003e14 Using Alto Optimize the EHR Experience for Clinicians\u003c\/p\u003e\n\u003cp\u003e15 Diabetes An Update forSubSpecialist\u003c\/p\u003e\n\u003cp\u003e16 Update on Anticoagulants and Venous Thromboembolism\u003c\/p\u003e\n\u003cp\u003e17 Hyperlipidemia 2026\u003c\/p\u003e\n\u003cp\u003e18 E1 Autonomic Medicine\u003c\/p\u003e\n\u003cp\u003e19 E2 The Digital Healthcare Landscape 2026\u003c\/p\u003e\n\u003cp\u003e20 F1 Asthma Updates\u003c\/p\u003e\n\u003cp\u003e21 F2 Anxiety and Depression\u003c\/p\u003e\n\u003cp\u003e22 G1 Lung CancerScreening and Strategic Approach to the Management of Pulmonary Nodules\u003c\/p\u003e\n\u003cp\u003e23 G2 New and Emerging Viruses\u003c\/p\u003e\n\u003cp\u003e24 H1 Pre and Post-Exposure Prophylaxis for HIV and STIs\u003c\/p\u003e\n\u003cp\u003e25 H2 Neuropathy What You Need to Know\u003c\/p\u003e\n\u003cp\u003e26 AI in Medicine Promises and Pitfalls\u003c\/p\u003e\n\u003cp\u003e27 Common OutpatientInfections Current Treatment Recommendations\u003c\/p\u003e\n\u003cp\u003e28 Updates in Addressing Headaches\u003c\/p\u003e\n\u003cp\u003e29 Atrial Fibrillation\u003c\/p\u003e\n\u003cp\u003e30 I1 Genetic Testing for Cancer Risk\u003c\/p\u003e\n\u003cp\u003e31 I2 Managing Obesity\u003c\/p\u003e\n\u003cp\u003e32 J1 Prostate Cancer- Screening and Beyond Disparities, Therapy, Medical Malpractice Avoidance and Advances\u003c\/p\u003e\n\u003cp\u003e33 J2 Intermittent Fasting and Circadian Rhythms Does WhenYou Eat Matter\u003c\/p\u003e\n\u003cp\u003e34 K1 Chronic Obstructive Pulmonary Disease\u003c\/p\u003e\n\u003cp\u003e36 L1 New Practices for Managing Osteoporosis and Reducing Fractures\u003c\/p\u003e\n\u003cp\u003e37 L2 Tuberculosis 2026\u003c\/p\u003e\n\u003cp\u003e38 Memory Loss, Alzheimer’s Disease, and Dementia Update 2026\u003c\/p\u003e\n\u003cp\u003e39 Infectious and Metabolic Liver Disease\u003c\/p\u003e\n\u003cp\u003e40 2026 Heart Failure Update for Subspecialists\u003c\/p\u003e\n\u003cp\u003e41 Treating Tobacco Use Optimizing forEnduring Outcomes\u003c\/p\u003e\n\u003cp\u003e42 Breast Cancer Current Approaches to Prevention, Diagnosis and Treatment\u003c\/p\u003e\n\u003cp\u003e43 Introduction to Lifestyle Medicine\u003c\/p\u003e\n\u003cp\u003e44 Updates in Allergy Whatto Know in 2026\u003c\/p\u003e\n\u003cp\u003e45 Mood Disorders in Geriatrics\u003c\/p\u003e\n\u003cp\u003e46 Putting Evidence Into Practice Lessons from Implementation Research\u003c\/p\u003e\n\u003cp\u003e47 Common Thyroid Problems\u003c\/p\u003e\n\u003cp\u003e48 Principles of Care for the Older\u003c\/p\u003e\n\u003cp\u003e49 Lower BackPain Evaluation and Treatment Approaches\u003c\/p\u003e\n\u003cp\u003e50 Case Studies in Reproductive Endocrinology\u003c\/p\u003e\n\u003cp\u003e51 Teaching in the 21st Century Leveraging the Science of Learning\u003c\/p\u003e\n\u003cp\u003e52 Special Lectures A- New and Emerging Viruses – Martin Hirsch\u003c\/p\u003e\n\u003cp\u003e53 Special Lectures B- Supplements – Pieter Cohen\u003c\/p\u003e\n\u003cp\u003e54 Special Lectures C- Hormone Therapy for Women- Clinical Cases – Dr. Deborah Gomez Kwolek\u003c\/p\u003e\n\u003cp\u003e55 Special Lectures D- Practical Tips to Address Health Insurance Challenges – Lori Tishler\u003c\/p\u003e\n\u003cp\u003e56 Special Lectures E- Practicing with Health Equity in Mind – Aisha James\u003c\/p\u003e\n\u003cp\u003eDay 1 Track 2\u003c\/p\u003e\n\u003cp\u003eDay 1\u003c\/p\u003e\n\u003cp\u003eDay 2 Track 2\u003c\/p\u003e\n\u003cp\u003eDay 2\u003c\/p\u003e\n\u003cp\u003eDay 3 Track 2\u003c\/p\u003e\n\u003cp\u003eDay 3\u003c\/p\u003e\n\u003cp\u003eDay 4\u003c\/p\u003e\n\u003cp\u003eDay 5\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405742690500,"sku":null,"price":156.0,"currency_code":"USD","in_stock":true}]},{"product_id":"banner-health-foundation-5th-annual-alzheimer-s-disease-lewy-body-and-related-disorders-symposium-2026","title":"Banner Health Foundation 5th Annual Alzheimer’s Disease, Lewy Body and Related Disorders Symposium 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: neurologists, psychiatrists, and geriatricians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eThe Banner Health Foundation 5th Annual Alzheimer’s Disease, Lewy Body and Related Disorders Symposium 2026 provides a comprehensive clinical update on the diagnosis, management, and emerging therapeutics for neurodegenerative diseases. The course explores advancements in biomarker utilization, monoclonal antibodies, neuropsychological evaluation, and specialized care strategies for complex dementia syndromes and movement disorders.\u003c\/p\u003e\n\u003cp\u003eCourse Date: 2026\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eEvaluate the role of neuropsychological testing and biomarkers in accurately diagnosing Alzheimer’s disease and distinguishing atypical presentations.\u003c\/p\u003e\n\u003cp\u003eAnalyze emerging therapeutics, including monoclonal antibodies, for the treatment of Alzheimer’s disease and their practical clinical implications.\u003c\/p\u003e\n\u003cp\u003eFormulate comprehensive management plans for Lewy Body Dementia, Frontotemporal Dementia, and atypical parkinsonian syndromes like PSP and CBS.\u003c\/p\u003e\n\u003cp\u003eImplement primary prevention strategies and address unique challenges in the cognitive evaluation of multilingual and diverse patient populations.\u003c\/p\u003e\n\u003cp\u003eAssess the cognitive impact of deep brain stimulation (DBS) in Parkinson’s disease and develop intervention models to alleviate caregiver burden.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for neurologists, psychiatrists, and geriatricians who want updates on Alzheimer’s biomarkers, monoclonal antibodies, and related dementias.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e01 Understanding the Role of Neuropsychologic Evaluation in Older Adults with Cognitive Concerns – Christine Belden, Ps…\u003c\/p\u003e\n\u003cp\u003e02 Challenges in Cognitive Evaluation of Multilingual – Juan A. Serrano-Salcedo, PsyD\u003c\/p\u003e\n\u003cp\u003e03 Primary Prevention and Risk Reduction in Dementia – Jeremy Pruzin, MD\u003c\/p\u003e\n\u003cp\u003e04 Using Biomarkers to Diagnose Alzheimer’s Disease – Don’t Miss the Atypical Ones! – Po-Heng Tsai, MD\u003c\/p\u003e\n\u003cp\u003e05 Q\u0026amp;A – Panel\u003c\/p\u003e\n\u003cp\u003e06 The Future of Neurodegenerative Diseases – Alireza Atri, MD, PhD\u003c\/p\u003e\n\u003cp\u003e07 Emerging Therapeutics in Alzheimer’s Disease- Monoclonal Antibodies to Amyloid and Beyond – Alireza Atri, MD, PhD…\u003c\/p\u003e\n\u003cp\u003e08 Case Discussion – Nicholas Ashton, PhD\u003c\/p\u003e\n\u003cp\u003e09 Diagnosis \u0026amp; Management of Lewy Body Dementia\u003c\/p\u003e\n\u003cp\u003e10 Caregiver Burden Intervention Models – Lori Nisson, MSW, LCSW\u003c\/p\u003e\n\u003cp\u003e11 Q\u0026amp;A – Panel\u003c\/p\u003e\n\u003cp\u003e12 Case Discussion – Neuropsychiatric Symptoms in Alzheimer’s Disease and Related Disorders- Recognition and Treatme…\u003c\/p\u003e\n\u003cp\u003e13 PSP and CBS. – Holly Laub-Brown, DO\u003c\/p\u003e\n\u003cp\u003e14 E\u0026amp;M of Hyperkinetic and Drug-Induced Movement Disorders- State of the Art\u003c\/p\u003e\n\u003cp\u003e15 Frontotemporal Dementia Syndromes – Andrew Ho, DO\u003c\/p\u003e\n\u003cp\u003e16 Cognitive Impact of DBS in Parkinson’s Disease\u003c\/p\u003e\n\u003cp\u003e17 Q\u0026amp;A – Panel\u003c\/p\u003e\n\u003cp\u003e51th Annual Alzheimers Disease\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405743182020,"sku":null,"price":52.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Banner-Health-Foundation-5th-Annual-Alzheimers-Disease-Lewy-Body-and-Related-Disorders-Symposium-2026.png?v=1784215528"},{"product_id":"harvard-brain-medicine-integrating-the-clinical-neurosciences-2026","title":"Harvard Brain Medicine Integrating the Clinical Neurosciences 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: neurologists, psychiatrists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eThe concept of brain medicine aims to integrate clinical and neuroscientific perspectives across the various non-surgical specialties (e.g., neurology, psychiatry, neurorehabilitation, allied medical, and mental health services) that care for and conduct research in people with biopsychosocially-complex brain disorders. This one-day activity accredited by Harvard Medical School will include pre-recorded lectures with a virtual live Q\u0026amp;A format. Speakers will include experts in behavioral neurology \u0026amp; neuropsychiatry, consultation liaison psychiatry, biological psychiatry, cognitive-affective neuroscience, brain medicine, and brain health, speaking on a broad array of assessment and management principles for individuals with brain disorders that negatively impact cognition, behavior, emotion, perception, social cognition, and sensorimotor functions. Content for this 2nd annual course will specifically include topics such as: brain medicine in 2026, social networks, digital phenotyping, neuropsychological testing, personalizing neuromodulation interventions, and primary and secondary psychotic spectrum disorders.\u003c\/p\u003e\n\u003cp\u003eCourse Date: February 6, 2026\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eEvaluate the historical evolution and future clinical applications of integrated brain medicine.\u003c\/p\u003e\n\u003cp\u003eImplement insights from integrated inpatient medicine-psychiatry services and outpatient brain medicine models.\u003c\/p\u003e\n\u003cp\u003eAnalyze the role of social networks and digital phenotyping in advancing the clinical neurosciences.\u003c\/p\u003e\n\u003cp\u003eApply updated strategies for neuropsychological testing and the psychopharmacological management of neuropsychiatric symptoms.\u003c\/p\u003e\n\u003cp\u003eAssess customized approaches to both noninvasive and deep brain stimulation for treating complex brain disorders.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for neurologists and psychiatrists who want updates on personalized neurostimulation, digital phenotyping, and psychotic disorders.\u003c\/p\u003e\n\u003cp\u003eWho Should Participate\u003c\/p\u003e\n\u003cp\u003eSpecialty Physicians, Primary Care Physicians, Psychologists, Nurse Practitioners, Physician Assistants, Nurses, and Other Allied Health Professionals.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003ch3\u003eTopics (16 Lectures):\u003c\/h3\u003e\n\u003cp\u003e01 Brain Medicine Past, Present \u0026amp; Future\u003c\/p\u003e\n\u003cp\u003e02 Lessons Learned from Integrated Inpatient Medicine-Psychiatry Services\u003c\/p\u003e\n\u003cp\u003e03 Spotlight Outpatient Brain Medicine atthe University of Toronto\u003c\/p\u003e\n\u003cp\u003e04 Q\u0026amp;A David Perez; Amy Newhouse; Sara Mitchell\u003c\/p\u003e\n\u003cp\u003e05 Social Networks in the Clinical Neurosciences\u003c\/p\u003e\n\u003cp\u003e06 Digital Phenotyping in the Clinical Neurosciences\u003c\/p\u003e\n\u003cp\u003e07 Neuropsychological Testing in 2026 Where are We\u003c\/p\u003e\n\u003cp\u003e08 Q\u0026amp;A Dorene Rentz; Caitlin Adams\u003c\/p\u003e\n\u003cp\u003e09 Psychopharmacological Management of Neuropsychiatric Symptoms\u003c\/p\u003e\n\u003cp\u003e10 Towards Personalized Noninvasive NeuroStimulation for Brain Disorders\u003c\/p\u003e\n\u003cp\u003e11 Towards Personalized Deep Brain Stimulation for Brain Disorders\u003c\/p\u003e\n\u003cp\u003e12 Q\u0026amp;A Caitlin Adams; Michael Fox; Joan Camprodon; David Perez\u003c\/p\u003e\n\u003cp\u003e13 The Pathophysiology of Idiopathic Psychotic Spectrum Disorders\u003c\/p\u003e\n\u003cp\u003e14 Case Based Discussion of Autoimmune Encephalitis w Psychosis\u003c\/p\u003e\n\u003cp\u003e15 Psychotherapy forPsychosis in 2026 – Where are We\u003c\/p\u003e\n\u003cp\u003e16 Q\u0026amp;A Matcheri Keshavan; Kim Mueser; Caitlin Adams\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405745606852,"sku":null,"price":58.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Brain-Medicine-Integrating-the-Clinical-Neurosciences-2026.jpg?v=1784215546"},{"product_id":"carle-health-system-brain-injury-symposium-2026","title":"Carle Health System Brain Injury Symposium 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: rehab specialists, physiatrists, and neurologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eThe Carle Health System Brain Injury Symposium is a professional clinical conference focused on the latest advancements in the multidisciplinary treatment and management of brain injuries. Taking place on February 21, 2026, the symposium brings together medical experts to discuss critical topics ranging from visual deficits and cognitive rehabilitation to autonomic nervous system symptoms and posture care, aiming to improve patient outcomes throughout the rehabilitation process.\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eUnderstand the causes and characteristics of acquired brain injury visual deficits and their multidisciplinary treatment approaches.\u003c\/p\u003e\n\u003cp\u003eExplore cognitive rehabilitation therapy (CRT) and develop tools to empower individuals with traumatic brain injuries (TBI) throughout their recovery.\u003c\/p\u003e\n\u003cp\u003eRecognize the role of lying balance and posture care management as a foundation for rehabilitation.\u003c\/p\u003e\n\u003cp\u003eExamine acute brain injury management strategies with a specific focus on disorders of consciousness.\u003c\/p\u003e\n\u003cp\u003eIdentify the autonomic nervous system’s role in PTSD, dizziness, and other lingering symptoms following a TBI.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for rehab specialists, physiatrists, and neurologists who want key updates on multidisciplinary traumatic brain injury management.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003eSaturday, February 21st, 2026.mp4 Full Live\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405746524356,"sku":null,"price":13.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Carle-Health-System-Brain-Injury-Symposium-2026.jpg?v=1784215551"},{"product_id":"university-of-miami-thinking-through-alzheimer-s-exploring-cognition-psychopharmacology-and-geriatric-psychiatry-2026","title":"University of Miami Thinking Through Alzheimer’s Exploring Cognition, Psychopharmacology and Geriatric Psychiatry 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: psychiatrists and neurologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eThe University of Miami Thinking Through Alzheimer’s Exploring Cognition, Psychopharmacology and Geriatric Psychiatry 2026 course provides a comprehensive clinical update on dementia care and geriatric mental health. The program covers the spectrum from normal cognitive aging to early Alzheimer’s diagnosis, highlighting new breakthroughs in neuropsychological assessments, emerging biomarkers, and the latest pharmacological and non-pharmacological management strategies.\u003c\/p\u003e\n\u003cp\u003eAnxiety, depression and other mental health condition in later life can reduce longevity, increase the risk of medical and cognitive disorders and lead to poorer outcomes. Most concerning is the fact that the prevalence of cognitive disorders is increasing rapidly as people live longer. Reducing the risk of cognitive disorders such as Alzheimer’s Disease and Related Dementias (ADRD) is as essential to the clinician as reducing hypertension and diabetes in reducing cardiovascular disease.\u003c\/p\u003e\n\u003cp\u003eThis seminar is designed to educate the practitioners and equip them with essential knowledge and state-of-the-art scientific methods to diagnose Alzheimer’s Disease and Related Dementias (ADRD) at its earliest stages and assist patients and their loved ones. Understanding normal cognitive neurology and stradegies to reduce the risk of developing Alzheimer’s disease will also be discussed. Drawing on the presenters’ vast scientific and clinical expertise, the participants will be able to differentiate different cognitive syndromes and the etiological underpinnings of various clinical presentations. In addition, the participant will be familiarized with state-of-the-art neuropsychological and novel neuroimaging and plasma-based biomarkers methods to detect the earliest stages of Alzheimer’s Disease.\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eDescribe the promotion of brain health and longevity through evidence-based prevention.\u003c\/p\u003e\n\u003cp\u003eDifferentiate between normal cognitive neurology, mild cognitive impairment (MCI), and clinical dementia.\u003c\/p\u003e\n\u003cp\u003eDemonstrate how to identify the underlying brain disorders causing clinical cognitive impairment in older adults.\u003c\/p\u003e\n\u003cp\u003eIdentify the evidence-based, emerging brain biomarkers in cognitive disorders that help to diagnose at-risk older individuals for Alzheimer’s Disease and Related Dementias (ADRD).\u003c\/p\u003e\n\u003cp\u003eIdentify the role of traditional and novel cognitive neuropsychological testing in early diagnosis of cognitive disorders in older individuals.\u003c\/p\u003e\n\u003cp\u003eDifferentiate Alzheimer’s Disease from non- Alzheimer’s Disease pathology\u003c\/p\u003e\n\u003cp\u003eDescribe current pharmacological and nonpharmacological approaches to the treatment of Alzheimer’s Disease and Related Dementias (ADRD).\u003c\/p\u003e\n\u003cp\u003eIdentify the emerging and promising agents in the treatment and management of early Alzheimer’s disease (AD).\u003c\/p\u003e\n\u003cp\u003eRecognize geriatric psychopharmacology and how to optimally treat the more challenging geriatric mental health conditions.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for psychiatrists and neurologists who want updates on Alzheimer’s biomarkers, cognitive assessments, and geriatric psychopharmacology.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e01 Normal Cognitive Aging with Philip Harvey, PhD\u003c\/p\u003e\n\u003cp\u003e02 Delaying or Preventing Alzheimer’s Evidence-Based Risk Reduction With Kirsten CrenshaW, PsyD\u003c\/p\u003e\n\u003cp\u003e03 Clinical Overview of Common Neurodegenerative Disorders in Older Adults With Alexandra Ortega, PsyD\u003c\/p\u003e\n\u003cp\u003e04 New Breakthroughs in cognitive Neuropsychological Assessment With David Loewenstein, PhD\u003c\/p\u003e\n\u003cp\u003e05 Guiding Practitioners in Identifying Individuals Who Are Most at Risk for Amnestic MCI with Rosie Curiel-Cid, PsyD\u003c\/p\u003e\n\u003cp\u003e06 Emerging Biomarkers in Diagnosing Early Alzheimer’s Disease with Rosie Curiel-Cid, PsyD\u003c\/p\u003e\n\u003cp\u003e07 Treating the Family Constellation in Geriatric Psychiatry and Dementia with Elizabeth Crocco, MD\u003c\/p\u003e\n\u003cp\u003e08 The Most Common Treatment Challenges in Geriatric Psychopharmacology with Elizabeth Crocco, MD\u003c\/p\u003e\n\u003cp\u003e09 Pharmacological and Non-Pharmacological Management of Alzheimer’s and Related Dementias with Elizabeth Crocco, MD\u003c\/p\u003e\n\u003cp\u003e10 The New Emerging Pharmacological Agents for Alzheimer’s Disease with Elizabeth Crocco, MD\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405748719812,"sku":null,"price":32.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/University-of-Miami-Thinking-Through-Alzheimers-Exploring-Cognition-Psychopharmacology-and-Geriatric-Psychiatry-2026.jpg?v=1784215574"},{"product_id":"harvard-psychopharmacology-a-master-class-2026","title":"Harvard Psychopharmacology A Master Class 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: psychiatrists, nurse practitioners, and primary care physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eUnderstand the underlying neurobiology of psychiatric disorders to inform targeted psychopharmacological interventions.\u003c\/p\u003e\n\u003cp\u003eEvaluate and implement advanced therapeutic strategies for difficult-to-treat conditions, including refractory depression and complex bipolar disorder.\u003c\/p\u003e\n\u003cp\u003eAssess emerging treatments, such as neuromodulation approaches, psychedelics for PTSD, and the role of Apps\/AI in psychiatric care.\u003c\/p\u003e\n\u003cp\u003eTailor psychopharmacologic treatments for specific populations, including geriatric, pediatric, perinatal, and substance use disorder patients.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for psychiatrists, nurse practitioners, and primary care physicians who want key updates on advanced psychopharmacology and novel therapeutics.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003eUpdate on the Neurobiology for the Practicing Clinician Understanding Brain Function and its Clinical Relevance\u003c\/p\u003e\n\u003cp\u003eUpdate on the Development of Antidepressant for Refractory Depression\u003c\/p\u003e\n\u003cp\u003eTreatment of Bipolar Disorders Rational Polypharmacy and Bipolar Depression\u003c\/p\u003e\n\u003cp\u003ePsychopharmacology in Perinatal Mood and Anxiety Disorders\u003c\/p\u003e\n\u003cp\u003ePsychopharmacologic Approaches in Childhood and Adolescents Affective Disorders\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 1\u003c\/p\u003e\n\u003cp\u003eCurrent and Emerging Neuromodulation Approaches Update for Prescribers\u003c\/p\u003e\n\u003cp\u003ePsychopharmacology in Geriatrics and Neuropsychiatry Population\u003c\/p\u003e\n\u003cp\u003eTherapeutic Approaches to the Difficult Patient Difficult-to-Treat Depression\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 2\u003c\/p\u003e\n\u003cp\u003eNeurobiology and treatment of Sleep in Psychiatric Disorders\u003c\/p\u003e\n\u003cp\u003eApps and AI as Therapeutics\u003c\/p\u003e\n\u003cp\u003eMechanisms of Psychedelics and Their Potential Treatment for PTSD\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 3\u003c\/p\u003e\n\u003cp\u003eEffective Treatment of Substance Use Disorders\u003c\/p\u003e\n\u003cp\u003eAnxiety Mechanisms, Treatment of Anxiety Spectrum Disorders \u0026amp; New Benzodiazepine Data\u003c\/p\u003e\n\u003cp\u003eThe Status of Laboratory Testing to Predict Antidepressant Response Problems and Promises\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405749276868,"sku":null,"price":117.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Psychopharmacology-A-Master-Class-2026.png?v=1784215592"},{"product_id":"cleveland-clinic-sleep-matters-unlocking-the-mysteries-of-sleep-brain-health-for-neurology-practitioners-2026","title":"Cleveland Clinic Sleep Matters Unlocking the Mysteries of Sleep \u0026 Brain Health for Neurology Practitioners 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: neurologists and sleep medicine practitioners\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eThe Cleveland Clinic Sleep Matters: Unlocking the Mysteries of Sleep \u0026amp; Brain Health for Neurology Practitioners 2026 course provides a comprehensive exploration of the critical intersection between sleep disorders and neurological health. The program covers diagnostic strategies, emerging therapies, artificial intelligence applications, and the clinical management of conditions such as sleep apnea, insomnia, hypersomnolence, and restless legs syndrome.\u003c\/p\u003e\n\u003cp\u003eCourse Date: 2026\u003c\/p\u003e\n\u003cp\u003ePlease join us for an intriguing, interactive program that promises to stimulate interest in the underappreciated subspecialty of sleep neurology.\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003ch3\u003eAt the completion of this activity, the participant should be able to:\u003c\/h3\u003e\n\u003cp\u003eExplain how sleep and sleep disorders impact neurologic health, cognition, and disease progression.\u003c\/p\u003e\n\u003cp\u003eRecognize key clinical features of sleep disorders commonly seen in neurologic practice.\u003c\/p\u003e\n\u003cp\u003eApply current diagnostic and treatment strategies for sleep disorders in neurologic populations.\u003c\/p\u003e\n\u003cp\u003eSummarize advances in neurobiology, pathophysiology, diagnosis, and management of hypersomnolence disorders, restless legs syndrome, parasomnias, insomnias, sleep disordered breathing and circadian rhythm disorders.\u003c\/p\u003e\n\u003cp\u003eIncorporate the sleep evaluation into routine neurologic care for adults and children.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for neurologists and sleep medicine practitioners who want updates on diagnosing and treating sleep disorders to optimize brain health.\u003c\/p\u003e\n\u003cp\u003eThis educational activity is directed towards neurologists, advanced practice providers including PAs and APRNs, nurses and others involved in the care of patients with neurological disorders.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e01 The Case for a Good Night’s Sleep Role of Sleep on Neurologic Outcomes\u003c\/p\u003e\n\u003cp\u003e02 Your Brain Without Sleep Diagnosing and Treating Sleep Disorders to Optimize Brain Health\u003c\/p\u003e\n\u003cp\u003e03 Sleep Apnea Diagnosis, Treatment and Clinical Implications in Neurologic Populations\u003c\/p\u003e\n\u003cp\u003e04 Q\u0026amp;A Faculty Panel Discussion\u003c\/p\u003e\n\u003cp\u003e05 REM Behavior Disorder Diagnosis, Treatment and Clinical Implication on Brain Health\u003c\/p\u003e\n\u003cp\u003e06 Advances in Understanding and Treatment of Restless Legs Syndrome\u003c\/p\u003e\n\u003cp\u003e07 Crossing Paths The Clinical Convergence of Sleep and Headache Disorders\u003c\/p\u003e\n\u003cp\u003e08 Q\u0026amp;A Faculty Panel Discussion\u003c\/p\u003e\n\u003cp\u003e09 Evolution in Phenotyping and Diagnostic Testing of Central Disorders of Hypersomnolence\u003c\/p\u003e\n\u003cp\u003e10 Wake Me Up New and Emerging Therapies for Central Disorders of Hypersomnolence\u003c\/p\u003e\n\u003cp\u003e11 Leveraging Artificial Intelligence to Enhance Diagnosis and Treatment Outcomes in Hypersomnolence Disorders\u003c\/p\u003e\n\u003cp\u003e12 Q\u0026amp;A Faculty Panel Discussion\u003c\/p\u003e\n\u003cp\u003e13 Insomnia in Neurologic and Psychiatric Populations Diagnosis, Treatment and Outcomes\u003c\/p\u003e\n\u003cp\u003e14 What’s in a Sleep Study Understanding Indications for Sleep Testing and Tailoring Evaluations to Optimize Outcomes\u003c\/p\u003e\n\u003cp\u003e15 Sleep Considerations in Pediatric Neurology Common Case Presentations\u003c\/p\u003e\n\u003cp\u003e16 SLEEP by Cleveland Clinic A Mobile Application for Sleep Disorder Screening\u003c\/p\u003e\n\u003cp\u003e17 Q\u0026amp;A Faculty Panel Discussion\u003c\/p\u003e\n\u003cp\u003e18 Wrap Up\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405749866692,"sku":null,"price":19.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Cleveland-Clinic-Sleep-Matters-Unlocking-the-Mysteries-of-Sleep-Brain-Health-for-Neurology-Practitioners-2026.jpg?v=1784215604"},{"product_id":"cleveland-clinic-cultivating-joy-and-purpose-in-healthcare-2026","title":"Cleveland Clinic Cultivating Joy and Purpose in Healthcare 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: healthcare professionals and clinical leaders who want strategies for resilience\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eThe Cleveland Clinic Cultivating Joy and Purpose in Healthcare 2026 course is designed to enhance clinician well-being, foster resilient leadership, and build inclusive workplace environments. The program offers a blend of personal development strategies, communication skills for conflict and feedback, and practical clinical updates to help healthcare professionals thrive both personally and professionally.\u003c\/p\u003e\n\u003cp\u003eCourse Date: 2026\u003c\/p\u003e\n\u003cp\u003eAs we face increasing demands and systemic challenges, this conference serves as a reminder that joy and purpose are not luxuries. They are vital to quality care, resilience, and human-centered practice. Through interactive presentations and meaningful dialogue, we hope to equip you with practical tools, renewed inspiration, and a strengthened network of peers committed to elevating healthcare systems.\u003c\/p\u003e\n\u003cp\u003eTopics include resilient leadership, strategy, navigating changes, conflict management, and growing your joyful career. This session will also provide a concise overview of key clinical updates to enhance professional development and healthcare practice.\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, the participant will be able to:\u003c\/h3\u003e\n\u003cp\u003eAssess and implement career planning, networking, and leadership skills to enhance the professional development of healthcare professionals.\u003c\/p\u003e\n\u003cp\u003eIdentify strategies to achieve and maintain optimal work-life control, wellbeing, professional satisfaction, and belonging.\u003c\/p\u003e\n\u003cp\u003eAssemble a strong and meaningful network of professionals in healthcare by facilitating hands-on sessions and networking events to encourage collaboration, knowledge sharing, and mutual, authentic support.\u003c\/p\u003e\n\u003cp\u003eApply skills and knowledge necessary to strengthen professional growth in leadership roles.\u003c\/p\u003e\n\u003cp\u003eDescribe evidence-based clinical pearls that enhance diagnostic accuracy, improve patient management, and support informed decision-making in everyday practice.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for healthcare professionals and clinical leaders who want strategies for resilience, well-being, and inclusive leadership in medicine.\u003c\/p\u003e\n\u003cp\u003eIntended for physicians from various specialties, physician assistants, nurse practitioners, nurses, pharmacists, psychologists, social workers and other healthcare practitioners and professionals who are focused on enhancing and developing their careers.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e01 Resilient Leadership\u003c\/p\u003e\n\u003cp\u003e02 From Snouts to Souls – How Palliative Pigs Cultivate Resilience, Joy and Purpose in Healthcare\u003c\/p\u003e\n\u003cp\u003e03 Joy and Purpose – Realizing That Nobody Else Can Be the Best You\u003c\/p\u003e\n\u003cp\u003e04 Our Relationship With Change\u003c\/p\u003e\n\u003cp\u003e05 Allyship From the (Fe)Male Perspective – He for She\u003c\/p\u003e\n\u003cp\u003e06 Belonging at the Office – The Heart of Inclusive Leadership\u003c\/p\u003e\n\u003cp\u003e07 Managing Mood Disorders from a Pharmacologic Perspective\u003c\/p\u003e\n\u003cp\u003e08 Womens Preventative Brain Health\u003c\/p\u003e\n\u003cp\u003e09 Gender-Based Differences in Atrial Fibrillation\u003c\/p\u003e\n\u003cp\u003e10 Lets Talk About Infertility\u003c\/p\u003e\n\u003cp\u003e11 Sleep Pearls\u003c\/p\u003e\n\u003cp\u003e12 Non-Pharmacologic Mood Management – Treating State Before Symptoms\u003c\/p\u003e\n\u003cp\u003e13 Career Transitions – Giving Yourself Permission to Change\u003c\/p\u003e\n\u003cp\u003e14 Conflict Management and Handling Bad News\u003c\/p\u003e\n\u003cp\u003e15 How to Get and Handle the Feedback You Need and Deserve\u003c\/p\u003e\n\u003cp\u003e16 Hot Topics in Pharma – Whats New in Medicine\u003c\/p\u003e\n\u003cp\u003e17 Driving Success With Self-Leadership and Team Self-Leadership\u003c\/p\u003e\n\u003cp\u003e18 Ambient AI Scribe and its Impact on Clinicians Wellbeing\u003c\/p\u003e\n\u003cp\u003e19 Thriving in Your Career – Personal Triumphs and Tumbles Along the Way\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405749899460,"sku":null,"price":26.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Cleveland-Clinic-Cultivating-Joy-and-Purpose-in-Healthcare-2026.jpg?v=1784215606"},{"product_id":"cleveland-clinic-14th-annual-comprehensive-neurotoxin-course-for-neurological-conditions-2026","title":"Cleveland Clinic 14th Annual Comprehensive Neurotoxin Course for Neurological Conditions 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: neurologists and pain specialists, physiatrists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eThe Cleveland Clinic 14th Annual Comprehensive Neurotoxin Course for Neurological Conditions provides an in-depth, practical exploration of botulinum toxin applications. The program covers foundational principles, anatomical considerations, and the clinical management of various neurological disorders, including dystonias, spasticity, and facial pain, across both adult and pediatric populations.\u003c\/p\u003e\n\u003cp\u003eCourse Date: 2026\u003c\/p\u003e\n\u003cp\u003eWith the ever-growing therapeutic indications for toxin treatment, increasing numbers of available toxins, and the potential dangers and pitfalls if toxin injections are performed sub-optimally, there is a clear need for a comprehensive training of toxin injection. The clear educational need is for a thorough and intensive training that incorporates balanced and comprehensive didactic lectures, the opportunity to ask questions on uncertain areas, patient demonstrations, and true assessment of understanding of concepts and readiness for injection.\u003c\/p\u003e\n\u003cp\u003eThis comprehensive course will provide the practicing clinician or clinician-in-training the necessary knowledge needed to competently utilize all types of botulinum toxins, including the use of EMG and ultrasound, all adult and pediatric neurological indications. The course also features toxin injection demonstrations on patients and the opportunity to interact with North American thought-leaders in dystonia and toxin injections with reputations for being exemplary educators.\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eDescribe the fundamental pharmacology of botulinum toxin therapies, their mechanisms of action, duration and onset, potential side effects, and clinical indications.\u003c\/p\u003e\n\u003cp\u003eList the FDA-approved botulinum toxin products and summarize their clinical indications, efficacy, side effects, dosing and administration, and role in clinical practice.\u003c\/p\u003e\n\u003cp\u003eDiscuss the advantages and disadvantages of neurotoxin injections, including ultrasound-guided injections, and describe their best use in clinical practice.\u003c\/p\u003e\n\u003cp\u003eDescribe the evidence-based practices for neurotoxin use in the pediatric population, including indications and dosing considerations.\u003c\/p\u003e\n\u003cp\u003eDemonstrate proper techniques for administering botulinum toxins including anatomic localization, target and muscle selection, use of ultrasound guidance, and injection techniques.\u003c\/p\u003e\n\u003cp\u003eSummarize the proper and ethical process of consent, preauthorization, billing, and coding for botulinum toxin use.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for neurologists and pain specialists who want updates on neurotoxin applications, dystonia management, and injection techniques.\u003c\/p\u003e\n\u003cp\u003eThis educational activity is intended for neurologists, physiatrists, residents and fellows.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e1 Introduction to Botulinum Toxins\u003c\/p\u003e\n\u003cp\u003e2 Headache and Facial Pain\u003c\/p\u003e\n\u003cp\u003e3 Lingual Dystonia and Spasmodic Dysphonia\u003c\/p\u003e\n\u003cp\u003e4 Blepharospasms, Hemifacial Spasms and Oromandibular Dystonia\u003c\/p\u003e\n\u003cp\u003e5 Cervical Dystonia\u003c\/p\u003e\n\u003cp\u003e6 Limb Dystonia and Spasticity\u003c\/p\u003e\n\u003cp\u003e7 Other Neurological Uses of Neurotoxin\u003c\/p\u003e\n\u003cp\u003e8 Neurotoxin Indications in the Pediatric Population\u003c\/p\u003e\n\u003cp\u003e9 Proper Billing and Coding Practices\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405749932228,"sku":null,"price":19.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Cleveland-Clinic-14th-Annual-Comprehensive-Neurotoxin-Course-for-Neurological-Conditions-2026.jpg?v=1784215607"},{"product_id":"harvard-psychedelic-assisted-psychotherapy-neglected-clinical-complexities-2026","title":"Harvard Psychedelic-Assisted Psychotherapy Neglected Clinical Complexities 2026","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  file sub vtt +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: psychiatrists, psychologists, and psychotherapists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eClinicians encounter a wide range of complex clinical challenges in psychedelic-assisted psychotherapy (PAP). While many of these arise in other forms of treatment, longer sessions with dramatically lowered defenses and the frequent arising of transpersonal, spiritual, and other novel experiences require clinicians to broaden their skillsets and relational capacities.\u003c\/p\u003e\n\u003cp\u003eIn addition to providing an update to progress in the field, our 5th conference will explore a wide range of these challenges, including potential adverse effects of PAP, how to identify and work with our own metaphysical assumptions, and how to understand and respond to novel experiences.\u003c\/p\u003e\n\u003cp\u003eThe program will include multiple case studies and clinical vignettes designed to illuminate the nuances of PAP for both newcomers and veteran therapists alike. If you would like to join the exploration and gain confidence in addressing these and other often neglected facets of the work, please join us in February 2026, either in person or online. We look forward to meeting you or seeing you again!\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eArticulate the basic structure and core principles of psychedelic-assisted psychotherapy (PAP).\u003c\/p\u003e\n\u003cp\u003eList the most commonly used medicines in PAP and their current applications.\u003c\/p\u003e\n\u003cp\u003eExplain how clinicians can improve the patient experience by fully exploring the emotions of grief and awe in PAP sessions.\u003c\/p\u003e\n\u003cp\u003eSummarize common metaphysical interpretations of the PAP experience, and techniques to respectfully acknowledge these in client sessions.\u003c\/p\u003e\n\u003cp\u003eIdentify opportunities to effectively integrate spiritual, existential, religious, and theological domains in PAP.\u003c\/p\u003e\n\u003cp\u003eDescribe Western vs. Indigenous approaches to understanding and working with non-ordinary states of consciousness.\u003c\/p\u003e\n\u003cp\u003eList several potential harms that can occur with PAP, and how therapists can minimize them.\u003c\/p\u003e\n\u003cp\u003eDiscuss benefits and challenges of working within a multidisciplinary PAP team.\u003c\/p\u003e\n\u003cp\u003eDescribe the foundations and aspects of the non-directive approach as a framework for working with participants through psilocybin sessions, and pragmatic advantages of this approach when working with OCD.\u003c\/p\u003e\n\u003cp\u003eArticulate effective ways that clinicians can address neglected complexities of the clinical encounter in PAP.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for psychiatrists, psychologists, and psychotherapists who want updates on clinical challenges and ethical nuances in psychedelic therapies.\u003c\/p\u003e\n\u003cp\u003eWho Should Participate\u003c\/p\u003e\n\u003cp\u003eSpecialty Physicians, Primary Care Physicians, Social workers, Counselors, Psychologists, Nurses, and Others\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003ch3\u003eKey sessions include:\u003c\/h3\u003e\n\u003cp\u003eBack to Basics: The Method and the Medicines of PAP\u003c\/p\u003e\n\u003cp\u003eClinical Outcomes of Psychedelic Therapy\u003c\/p\u003e\n\u003cp\u003eNeglected Considerations for Set \u0026amp; Settings\u003c\/p\u003e\n\u003cp\u003eSomatic Experiences in Psychedelic Therapy\u003c\/p\u003e\n\u003cp\u003eReligious and Spiritual Perspectives in PAP\u003c\/p\u003e\n\u003cp\u003ePanel discussions and case-based learning\u003c\/p\u003e\n\u003ch3\u003eHighlights include:\u003c\/h3\u003e\n\u003cp\u003eWestern vs Indigenous Approaches to Psychedelic Experiences\u003c\/p\u003e\n\u003cp\u003eEgo Dissolution Case Studies\u003c\/p\u003e\n\u003cp\u003eManaging Difficult or Adverse Psychedelic Experiences\u003c\/p\u003e\n\u003cp\u003ePsychedelic-Boosted Behavioral Therapy for OCD\u003c\/p\u003e\n\u003cp\u003eInterdisciplinary Collaboration in PAP\u003c\/p\u003e\n\u003cp\u003eClinical Complexities in Psychedelic Therapy\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405749964996,"sku":null,"price":97.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Psychedelic-Assisted-Psychotherapy-Neglected-Clinical-Complexities-2026.jpg?v=1784215609"},{"product_id":"university-of-miami-clinical-psychopharmacology-beyond-conventional-wisdom-2026","title":"University of Miami Clinical Psychopharmacology Beyond Conventional Wisdom 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: psychiatrists and mental health clinicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eThe presentation places a strong emphasis on diagnostic accuracy and the application of research-driven clinical practices, prioritizing efficacy and safety as demonstrated in clinical trials over speculative biological mechanisms. In-depth analysis and treatment strategies will be provided for schizophrenia, bipolar disorder, depression, and anxiety disorders, with additional focus on mixed states, bipolar depression, and the nuanced role of psychopharmacology in optimizing treatment outcomes.\u003c\/p\u003e\n\u003cp\u003eThe seminar will incorporate the latest research findings, including recent advancements in clinical psychopharmacology, to ensure participants are equipped with up-to-date knowledge and skills. Special attention will be given to the application of these strategies in diverse patient populations, including children, the elderly, and those with comorbid medical conditions, to promote holistic and effective patient care.\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eDescribe the historical background on the major themes to be covered during the course.\u003c\/p\u003e\n\u003cp\u003eExamine the biological mechanisms of major psychotropic drug classes.\u003c\/p\u003e\n\u003cp\u003eGrasp the basic neuroanatomy relevant to clinical psychopharmacology.\u003c\/p\u003e\n\u003cp\u003eRecognize and apply key clinical trials of drug classes for various diagnoses.\u003c\/p\u003e\n\u003cp\u003eExamine the validity of DSM diagnoses and learn how to use non-DSM approaches to diagnosis and drug treatment.\u003c\/p\u003e\n\u003cp\u003eDiscuss practices with antipsychotics, mood stabilizers, and antidepressants.\u003c\/p\u003e\n\u003cp\u003eExplain the risks and side effects of major drug classes.\u003c\/p\u003e\n\u003cp\u003eEmploy medications with an understanding of pharmacokinetic interactions.\u003c\/p\u003e\n\u003cp\u003eIdentify factors in medication use for those with comorbid medical conditions.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for psychiatrists and mental health clinicians who want updates on psychopharmacology, drug safety, and mood disorder management.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e01 Bipolar Depression and Mixed States – Why Antidepressants Fail and Dopamine Blockers Work\u003c\/p\u003e\n\u003cp\u003e02 Mood Stabilizers in Bipolar Disorder – Limitations of Anticonvulsants vs Lithium\u003c\/p\u003e\n\u003cp\u003e03 How Mood Temperaments Drive Misdiagnosis in Psychiatry\u003c\/p\u003e\n\u003cp\u003e04 Treating Mood Temperaments to Improve Mental Health Outcomes\u003c\/p\u003e\n\u003cp\u003e05 Antipsychotic Safety – Neurotoxicity, Akathisia, and Tardive Dyskinesia Risks\u003c\/p\u003e\n\u003cp\u003e06 Lithium in Mood Disorders – Is It the Safest Mood Stabilizer\u003c\/p\u003e\n\u003cp\u003e07 Lithium Safety and Renal Effects – Interpreting eGFR and True Kidney Risk\u003c\/p\u003e\n\u003cp\u003e08 Antipsychotics in Schizophrenia – Short-Term Symptom Control vs Long-Term Outcomes\u003c\/p\u003e\n\u003cp\u003e09 Antipsychotic-Induced Akathisia and EPS – Clinical Risks and Management\u003c\/p\u003e\n\u003cp\u003e10 Antipsychotics and Metabolic Risk – Insulin Resistance, Weight Gain, \u0026amp; More\u003c\/p\u003e\n\u003cp\u003e11 Bipolar Mania Management With Antipsychotics – Acute Efficacy vs Maintenance Limitations\u003c\/p\u003e\n\u003cp\u003e12 ADHD – Clinical Efficacy and Safety of Amphetamine-Based Therapies\u003c\/p\u003e\n\u003cp\u003e13 Antidepressant Safety Risks – Suicidality, Cardiovascular Effects, and Withdrawal Syndromes\u003c\/p\u003e\n\u003cp\u003e14 MDD Maintenance Treatment – Do Antidepressants Sustain Remission\u003c\/p\u003e\n\u003cp\u003e15 Acute Treatment of Major Depressive Disorder – Interpreting Effect Size, Placebo Response, and Clinical Meaningfulness\u003c\/p\u003e\n\u003cp\u003e16 Do Antidepressants Work in Bipolar Depression or Worsen Outcomes\u003c\/p\u003e\n\u003cp\u003e17 Basic Concepts of Psychopharmacology for the Clinician\u003c\/p\u003e\n\u003cp\u003e18 Neurobiology in Psychopharmacology – Why Mechanisms Matter Less Than Clinical Outcomes\u003c\/p\u003e\n\u003cp\u003e19 Antipsychotic Psychopharmacology – Receptor Affinity, Dosing, and Adverse Effects\u003c\/p\u003e\n\u003cp\u003e20 Mood Stabilizer Neurobiology – Lithium and Antiepileptics Mechanisms\u003c\/p\u003e\n\u003cp\u003e21 Psychopharmacology of Monoamine Agonists From Chemical Structure to Clinical Effect\u003c\/p\u003e\n\u003cp\u003e22 Benzodiazepines \u0026amp; Alternatives for Sleep and Anxiety Disorders – Pharmacology \u0026amp; Adverse Effects\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405750194372,"sku":null,"price":19.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/University-of-Miami-Clinical-Psychopharmacology-Beyond-Conventional-Wisdom-2026.jpg?v=1784215619"},{"product_id":"university-of-miami-advanced-psychopharmacology-from-neurobiology-to-personalized-treatment-2026","title":"University of Miami Advanced Psychopharmacology From Neurobiology to Personalized Treatment 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: psychiatrists, psychiatric nurses, and clinical psychologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eThe seminal role of child abuse and neglect in increased vulnerability to mood and anxiety disorders will be explored with a focus on the long-term persistent effects of early life trauma on the brain and the body. An update on the pathophysiology of the major mood and anxiety disorders will be described including new data on inflammation. The latest data on suicide will be presented including risk factors and strategies for prevention.\u003c\/p\u003e\n\u003cp\u003eThe seminar will emphasize the establishment and importance of the therapeutic alliance when prescribing all psychotropic medications.\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of the course, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eApply the latest advances in the neurobiology of psychiatric disorders and understand the potential role of pharmacogenomic testing in the selection of specific psychiatric medications.\u003c\/p\u003e\n\u003cp\u003eEvaluate treatment options for treatment-resistant bipolar and unipolar depression, including psychotherapies.\u003c\/p\u003e\n\u003cp\u003eAssess the neurobiological mechanism and evidence-based treatment of depressive and anxiety spectrum disorders, including PTSD.\u003c\/p\u003e\n\u003cp\u003eDetermine when to implement switch versus augmentation strategies for treatment-resistant depression.\u003c\/p\u003e\n\u003cp\u003eAnalyze the use of ketamine with benefits and hazards in treatment-resistant depression.\u003c\/p\u003e\n\u003cp\u003eDemonstrate when to use ECT and TMS for the treatment of depression.\u003c\/p\u003e\n\u003cp\u003eUnderstand novel treatments under development.\u003c\/p\u003e\n\u003cp\u003eAnalyze the role of psychopharmacology and psychotherapy in the treatment of PTSD.\u003c\/p\u003e\n\u003cp\u003eAssess the current database on the efficacy and side effect profile of psychedelic medications.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for psychiatrists, psychiatric nurses, and clinical psychologists who want updates on advanced psychopharmacology and targeted treatments.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e01 PTSD – How Neurobiology Guides Pharmacologic and Behavioral Therapies\u003c\/p\u003e\n\u003cp\u003e02 Managing Patients With Coexisting Medical and Psychiatric Disorders\u003c\/p\u003e\n\u003cp\u003e03 Managing Anxiety \u0026amp; Trauma Disorders – Pharmacologic and Psychotherapeutic Approaches\u003c\/p\u003e\n\u003cp\u003e04 Psychedelic Therapies in Psychiatric Disorders – Efficacy, Risks, and Clinical Integration\u003c\/p\u003e\n\u003cp\u003e05 Ketamine and Esketamine – The Amazing, The Good, The Bad, and The Ugly\u003c\/p\u003e\n\u003cp\u003e06 Predicting Antidepressant Response in Depression – Clinical Utility of Laboratory Testing\u003c\/p\u003e\n\u003cp\u003e07 Augmentation Strategies in Depression – Role of Atypical Antipsychotics in Clinical Practice\u003c\/p\u003e\n\u003cp\u003e09 Management of Treatment Resistant Depression – The Art and the Science\u003c\/p\u003e\n\u003cp\u003e10 Psychiatric Disorders – Linking Molecular Mechanisms to Clinical Symptoms\u003c\/p\u003e\n\u003cp\u003e11 Advances in Suicide Research – Risk Factors and Genetics\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405750227140,"sku":null,"price":149.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/University-of-Miami-Advanced-Psychopharmacology-From-Neurobiology-to-Personalized-Treatment-2026.jpg?v=1784215620"},{"product_id":"harvard-psychosocial-oncology-what-to-expect-when-caring-for-an-oncology-patient-2026","title":"Harvard Psychosocial Oncology What to Expect When Caring for an Oncology Patient 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: oncologists, psychiatrists, primary care physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003ePsychosocial Oncology: What to Expect When Caring for an Oncology Patient\u003c\/p\u003e\n\u003cp\u003eDeliver a comprehensive two-day, Harvard-accredited virtual conference that equips clinicians with essential skills in psychosocial oncology, from managing cancer-related mental health conditions to addressing substance use, bereavement, and supportive care needs across diverse patient populations.\u003c\/p\u003e\n\u003cp\u003eDana-Farber Cancer Institute will be offering its second annual virtual conference accredited by Harvard Medical School. This course, which has been expanded to two days based on audience feedback, will focus on the psychosocial care of patients living with cancer. With 1 out of 3 people diagnosed with cancer at some point in their life, there is an increasing need for cancer-related training among health care professionals.\u003c\/p\u003e\n\u003cp\u003eAll clinicians interested in learning more about the care of individuals living with cancer are encouraged to attend, including psychiatrists, social workers, psychologists, and primary care providers.\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003cp\u003eIdentify psychosocial stressors faced by patients living with cancer.\u003c\/p\u003e\n\u003cp\u003eRecognize skills in managing the psychosocial needs of these patients.\u003c\/p\u003e\n\u003cp\u003eUnderstand the impact of cancer and cancer treatments on patients and their support systems.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eBest for oncologists, psychiatrists, social workers, and nurses who want updates on comprehensive psychosocial care for cancer patients.\u003c\/p\u003e\n\u003cp\u003eWho Should Participate\u003c\/p\u003e\n\u003cp\u003ePrimary Care Physicians, Physician Assistants, Specialty, Social workers, Psychiatrists Physicians, Psychologists, and Others\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e01 Approaching Cancer Care for the Whole Patient\u003c\/p\u003e\n\u003cp\u003e02 Overview of Cancer Treatment and Treatment Side Effects\u003c\/p\u003e\n\u003cp\u003e03 Adjustment to Illness\u003c\/p\u003e\n\u003cp\u003e04 Couples and Families\u003c\/p\u003e\n\u003cp\u003e05 Morning Q\u0026amp;A Courtney Bitz; Eileen Joyce; Damien Miran; Cristina Pozo-Kaderman; Anna Muriel\u003c\/p\u003e\n\u003cp\u003e06 Anxiety\u003c\/p\u003e\n\u003cp\u003e07 Depression\u003c\/p\u003e\n\u003cp\u003e08 Survivorship\u003c\/p\u003e\n\u003cp\u003e09 Spiritual Care (Moderated Discussion)\u003c\/p\u003e\n\u003cp\u003e10 Afternoon Q\u0026amp;A Stephanie Tung; Timothy Steinhoff; Carrie Wu; Stephen Conway; Leora Lowenthal; John Peteet; Damien Mir\u003c\/p\u003e\n\u003cp\u003e11 Psychedelics\u003c\/p\u003e\n\u003cp\u003e12 Substance usemisuse\u003c\/p\u003e\n\u003cp\u003e13 Cannabis\u003c\/p\u003e\n\u003cp\u003e14 Navigating Challenging Patients\u003c\/p\u003e\n\u003cp\u003e15 Morning Q\u0026amp;A Roxanne Sholevar; Miryam Yusufov; Ilana Braun; Stephanie Tung; Michelle Jacobo\u003c\/p\u003e\n\u003cp\u003e16 Bereavement\u003c\/p\u003e\n\u003cp\u003e16 Sue Morris Recording 2026\u003c\/p\u003e\n\u003cp\u003e17 Facilitating Cancer Support Groups\u003c\/p\u003e\n\u003cp\u003e18 Existential Distress and End of Life Issues\u003c\/p\u003e\n\u003cp\u003e19 Pediatric Psychosocial Care (Moderated Discussion)\u003c\/p\u003e\n\u003cp\u003e20 Care of Young Adults\u003c\/p\u003e\n\u003cp\u003e21 Afternoon Q\u0026amp;A Sue Morris; Tricia Hughes; Leora Lowenthal; Amanda Moment; Kate Lally; Joan Hanania; Cristina Pozo-Kaderman\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405752914116,"sku":null,"price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Psychosocial-Oncology-What-to-Expect-When-Caring-for-an-Oncology-Patient-2026.jpg?v=1784215681"},{"product_id":"harvard-neurorehabilitation-2026","title":"Harvard NeuroRehabilitation 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: physiatrists, neurologists, geriatricians, internists, family practitioners\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eStay ahead of the rapidly expanding options to help patients with stroke, SCI, TBI, and functional and degenerative neurological diseases. In this program, neurorehabilitation experts provide updates and state-of-the-art clinical interventions that improve health, function, and quality of life for patients requiring neurological rehabilitation.\u003c\/p\u003e\n\u003cp\u003eComprehensive Neurorehabilitation Update\u003c\/p\u003e\n\u003cp\u003eCutting-edge strategies, updates, and best practices for state-of-the-art rehabilitation\u003c\/p\u003e\n\u003cp\u003eNeuroRehabilitation 2026 is a live online course, using live streaming, electronic Q\u0026amp;A, and other remote learning technologies.\u003c\/p\u003e\n\u003cp\u003eStay ahead of the rapidly expanding options to help patients with stroke, SCI, TBI, and functional and degenerative neurological diseases.\u003c\/p\u003e\n\u003cp\u003eIn this program, some of the country’s most experienced neurorehabilitation experts provide updates and state-of-the-art clinical interventions that improve health, function, and quality of life for patients requiring neurological rehabilitation.\u003c\/p\u003e\n\u003cp\u003e2026 Course Highlights Enhanced and Accelerated Recovery\u003c\/p\u003e\n\u003ch3\u003eThis program includes important updates, new best practices, and state-of-the-art approaches to enhance and accelerate recovery, including:\u003c\/h3\u003e\n\u003cp\u003eDenervation and surgical procedures for spasticity\u003c\/p\u003e\n\u003cp\u003ePharmacologic approaches to spasticity\u003c\/p\u003e\n\u003cp\u003ePharmacologic options for aggressive behavior after TBI\u003c\/p\u003e\n\u003cp\u003eTreatment of pituitary disorders after TBI\u003c\/p\u003e\n\u003cp\u003eInsight, awareness, and denial in neurorehabilitation\u003c\/p\u003e\n\u003cp\u003eCutting-edge treatment of multiple sclerosis\u003c\/p\u003e\n\u003cp\u003eAdvances in stroke rehabilitation\u003c\/p\u003e\n\u003cp\u003ePediatric TBI\u003c\/p\u003e\n\u003cp\u003eVestibular rehabilitation after TBI\u003c\/p\u003e\n\u003cp\u003eSwallowing and dysphagia management\u003c\/p\u003e\n\u003cp\u003eImproved Quality of Life\u003c\/p\u003e\n\u003ch3\u003eThis program includes strategies, best practices, and cutting-edge approaches to help foster quality of life:\u003c\/h3\u003e\n\u003cp\u003eVision rehabilitation after stroke\u003c\/p\u003e\n\u003cp\u003ePatient-caregiver dyads in the ICU to prevent chronic emotional distress\u003c\/p\u003e\n\u003cp\u003eWomen’s health in SCI\u003c\/p\u003e\n\u003cp\u003eMild TBI and PTSD in the military\u003c\/p\u003e\n\u003cp\u003eFamily and caregiver support\u003c\/p\u003e\n\u003cp\u003eApproaches to obesity in neurorehabilitation\u003c\/p\u003e\n\u003cp\u003eEvolving Treatment Options\u003c\/p\u003e\n\u003ch3\u003eThis program offers attendees the opportunity to learn about the future of treatment options and how and when they will impact patient outcomes:\u003c\/h3\u003e\n\u003cp\u003eArtificial intelligence in neurorehabilitation\u003c\/p\u003e\n\u003cp\u003eVirtual reality treatments\u003c\/p\u003e\n\u003cp\u003eForced exercise in Parkinson’s disease\u003c\/p\u003e\n\u003cp\u003eAdvances in pharmacologic treatment of depression\u003c\/p\u003e\n\u003cp\u003eAdvanced technology in the rehabilitation of SCI\u003c\/p\u003e\n\u003cp\u003eExpanded Understanding of a Wide Range of Neurological Conditions\u003c\/p\u003e\n\u003ch3\u003eThrough this program, Physicians, NPs, PAs, PTs, OTs, SLPs, and Psychologists can deepen their knowledge and optimize clinical decisions concerning the following neurorehabilitation issues:\u003c\/h3\u003e\n\u003cp\u003eAdvanced neuroimaging of TBI\u003c\/p\u003e\n\u003cp\u003eRecovery and outcome after mild TBI\u003c\/p\u003e\n\u003cp\u003eThe CBI-M framework for classifying TBI\u003c\/p\u003e\n\u003cp\u003eASIA classification of SCI\u003c\/p\u003e\n\u003cp\u003eFunctional neurologic disorders and post-concussion symptoms\u003c\/p\u003e\n\u003cp\u003eChronic traumatic encephalopathy\u003c\/p\u003e\n\u003cp\u003eThe cerebellar cognitive affective syndrome\u003c\/p\u003e\n\u003cp\u003eCovert consciousness in TBI\u003c\/p\u003e\n\u003cp\u003eAmyotrophic lateral sclerosis\u003c\/p\u003e\n\u003cp\u003eAutonomic nervous system after TBI\u003c\/p\u003e\n\u003cp\u003eWithdrawal of life-sustaining treatment\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this course, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eSummarize the research evidence base for neurorehabilitation practice.\u003c\/p\u003e\n\u003cp\u003eIntegrate state-of-the-art, evidence-based approaches to neurorehabilitation into their care of patients.\u003c\/p\u003e\n\u003cp\u003eEvaluate advances in research that will lead to future approaches to neurorehabilitation.\u003c\/p\u003e\n\u003cp\u003eDescribe the risk factors for chronic traumatic encephalopathy.\u003c\/p\u003e\n\u003cp\u003eDiscuss the treatment of adults with early childhood disorders of the central nervous system.\u003c\/p\u003e\n\u003cp\u003eDiscuss how virtual reality can be used to treat patients with neurologic disorders.\u003c\/p\u003e\n\u003cp\u003eDescribe the approach to working with patients with functional neurologic disorders.\u003c\/p\u003e\n\u003cp\u003eDiscuss factors in research studies that can lead one to a false presumption of causality.\u003c\/p\u003e\n\u003cp\u003eDiscuss appropriate treatments for spasticity after CNS injury or disease.\u003c\/p\u003e\n\u003cp\u003eSummarize the relationship between neurologic and psychological denial in people with stroke and traumatic brain injury.\u003c\/p\u003e\n\u003cp\u003eDescribe approaches to obesity and cardiometabolic disease in neurorehabilitation patients.\u003c\/p\u003e\n\u003cp\u003eDescribe three surgical approaches to neuro-orthopedic disorders of the upper limb.\u003c\/p\u003e\n\u003cp\u003eDescribe the use of antidepressants other than SSRIs and SNRIs in neurorehabilitation.\u003c\/p\u003e\n\u003cp\u003eWho Should Participate\u003c\/p\u003e\n\u003cp\u003ePhysicians: Physiatrists, Neurologists, Geriatricians, Internists, Family Practitioners\u003c\/p\u003e\n\u003cp\u003ePhysical Therapists\u003c\/p\u003e\n\u003cp\u003eOccupational Therapists\u003c\/p\u003e\n\u003cp\u003eSpeech-Language Pathologists\u003c\/p\u003e\n\u003cp\u003eNurse Practitioners\u003c\/p\u003e\n\u003cp\u003ePhysician Assistants\u003c\/p\u003e\n\u003cp\u003eNurses\u003c\/p\u003e\n\u003cp\u003ePsychologists\u003c\/p\u003e\n\u003cp\u003e…and other health professionals interested in neurological rehabilitation\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eDưới đây là danh sách tổng hợp tên các bài giảng được trích xuất từ các hình ảnh bạn đã cung cấp (đã lược bỏ các đuôi file .mp4, .pdf, .vtt để bạn dễ theo dõi):\u003c\/h3\u003e\n\u003cp\u003e01 KEYNOTE Artificial Intelligence in Neurorehabilitation The Good, the Bad, and the Ugly\u003c\/p\u003e\n\u003cp\u003e02 Insight, Awareness, and Denial in Neurorehabilitation\u003c\/p\u003e\n\u003cp\u003e03 Surgical Approaches to NeuroOrthopedic Disorders of the Upper Limb Following Stroke, SCI, and TBI\u003c\/p\u003e\n\u003cp\u003e04 1A Interventions to Support Family and Caregivers in Neurorehabilitation\u003c\/p\u003e\n\u003cp\u003e05 1B Forced Exercise for Parkinson’s Disease\u003c\/p\u003e\n\u003cp\u003e06 1C Chemo- and Cryo-Denervation Procedures for the Treatment of Spasticity\u003c\/p\u003e\n\u003cp\u003e07 2A Autonomic Nervous System and Brain Blood Flow after Traumatic Brain Injury\u003c\/p\u003e\n\u003cp\u003e08 2B Obesity and Metabolic Syndrome after TBI and Stroke\u003c\/p\u003e\n\u003cp\u003e09 2C Cutting-Edge Treatment of Multiple Sclerosis\u003c\/p\u003e\n\u003cp\u003e10 3A Vestibular Rehabilitation Dr. Katie MacDonald\u003c\/p\u003e\n\u003cp\u003e11 3B Posthospital Residential Rehabilitation Programs for Stroke and TBI\u003c\/p\u003e\n\u003cp\u003e12 3C The Use of Advanced Technology for SCI in Neurorehabilitation Clinical Practice\u003c\/p\u003e\n\u003cp\u003e13 4A Mild TBI and PTSD in the Military\u003c\/p\u003e\n\u003cp\u003e14 4B Advances in Stroke Rehabilitation and Recovery\u003c\/p\u003e\n\u003cp\u003e15 4C Pharmacologic Treatment of Spasticity\u003c\/p\u003e\n\u003cp\u003e16 KEYNOTE Virtual Reality in Neurorehabilitation\u003c\/p\u003e\n\u003cp\u003e17 Promoting Critical Analysis of Scientific Literature for Neurorehabilitation Clinicians How Scientists Fool Themselves\u003c\/p\u003e\n\u003cp\u003e18 5A Pharmacologic Approaches to Attentional Disorders After TBI\u003c\/p\u003e\n\u003cp\u003e19 5B-C Central Neuropathic Pain in CNS Trauma and Disorders\u003c\/p\u003e\n\u003cp\u003e20 6A Recovery and Outcome of Patients with Cognitive Motor Dissociation (Covert Consciousness) After Severe TBI\u003c\/p\u003e\n\u003cp\u003e21 6B Effect of Exercise Intensity on Aerobic Fitness After Stroke\u003c\/p\u003e\n\u003cp\u003e22 6C Neurorehabilitation of Adults with Childhood CNS Disorders\u003c\/p\u003e\n\u003cp\u003e23 7A Advanced Neuroimaging After TBI\u003c\/p\u003e\n\u003cp\u003e24 7B Cognitive Impairment, Capacity, and Decision-Making\u003c\/p\u003e\n\u003cp\u003e25 7C Home Modifications and Environmental Control Units (ECUs)\u003c\/p\u003e\n\u003cp\u003e26 8A The CBI-M Framework for Classifying TBI\u003c\/p\u003e\n\u003cp\u003e27 8B Vision Rehabilitation After Stroke\u003c\/p\u003e\n\u003cp\u003e28 8C Women’s Health After SCI\u003c\/p\u003e\n\u003cp\u003e29 9A Recovery and Outcome After Mild TBI\u003c\/p\u003e\n\u003cp\u003e30 9B Swallowing and Dysphagia Management\u003c\/p\u003e\n\u003cp\u003e31 9C Update on Amyotrophic Lateral Sclerosis\u003c\/p\u003e\n\u003cp\u003e32 10A Pediatric TBI Dr. Brian Wishart\u003c\/p\u003e\n\u003cp\u003e33 10B Depression Advances in Pharmacologic Approaches-Beyond SSRIs and SNRIs\u003c\/p\u003e\n\u003cp\u003e34 10C Research Trends and Innovations in SCI Rehabilitation\u003c\/p\u003e\n\u003cp\u003e35 Risk Factors and Clinical Manifestations of Chronic Traumatic Encephalopathy\u003c\/p\u003e\n\u003cp\u003e36 11A Pituitary Disorders after TBI\u003c\/p\u003e\n\u003cp\u003e37 11B The Cerebellar Cognitive Affective Syndrome\u003c\/p\u003e\n\u003cp\u003e38 11C ASIA Classification\u003c\/p\u003e\n\u003cp\u003e39 Recovering Together Patient-Caregiver Dyads in the Neuro-ICU to Prevent Chronic Emotional Distress\u003c\/p\u003e\n\u003cp\u003e40 Functional Neurologic Disorders and Post-Concussive Symptoms\u003c\/p\u003e\n\u003cp\u003e41 Panel Withdrawal of Life-Sustaining\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405753209028,"sku":null,"price":117.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-NeuroRehabilitation-2026.jpg?v=1784215690"},{"product_id":"ucsf-addiction-conference-2026","title":"UCSF Addiction Conference 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: psychiatrists, primary care physicians, and addiction specialists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe UCSF Addiction Conference 2026 provides a comprehensive, evidence-based update on the clinical management of substance use disorders. The program equips healthcare providers with the latest strategies in pharmacology, behavioral therapies, and harm reduction to effectively diagnose, treat, and support patients dealing with various forms of addiction and co-occurring mental health conditions.\u003c\/p\u003e\n\u003ch3\u003eTopics covered will include:\u003c\/h3\u003e\n\u003cp\u003eKeynote address from a person with lived experience of Substance Use Disorder (SUD)\u003c\/p\u003e\n\u003cp\u003eSUD as a brain disease\u003c\/p\u003e\n\u003cp\u003eStigma around Opioid Use Disorder, including starting buprenorphine and methadone\u003c\/p\u003e\n\u003cp\u003eAlcohol Use Disorder\u003c\/p\u003e\n\u003cp\u003eBenzodiazepine Use Disorder and withdrawal management\u003c\/p\u003e\n\u003cp\u003eStimulant Use Disorder\u003c\/p\u003e\n\u003cp\u003ePregnancy and SUDs\u003c\/p\u003e\n\u003cp\u003ePain and SUDs\u003c\/p\u003e\n\u003cp\u003eHospital based care for patients with SUDs\u003c\/p\u003e\n\u003cp\u003eCommunication and documentation in caring for patients with SUDs\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003cp\u003eApply new knowledge to better recognize substance use disorders (SUD), including through use of the DSM-5 criteria for SUD\u003c\/p\u003e\n\u003cp\u003eOffer evidence-based medical and\/or behavioral treatments for opioid, alcohol, and stimulant use disorders\u003c\/p\u003e\n\u003cp\u003eApply communication strategies for more effective individual and team care of patients with SUD\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eBest for psychiatrists, primary care physicians, and addiction specialists who want updates on substance use disorder treatments.\u003c\/p\u003e\n\u003cp\u003eTopics\u003c\/p\u003e\n\u003cp\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003c\/p\u003e\n\u003cp\u003eApr 23_Day 1 AM\u003c\/p\u003e\n\u003cp\u003eApr 23_Day 1 PM\u003c\/p\u003e\n\u003cp\u003eApr 24_Day 2 AM\u003c\/p\u003e\n\u003cp\u003eApr 24_Day 2 PM\u003c\/p\u003e\n\u003ch3\u003e* Detail:\u003c\/h3\u003e\n\u003cp\u003eApril 23, 2026\u003c\/p\u003e\n\u003cp\u003e8:00 AM\u003c\/p\u003e\n\u003cp\u003eWelcome from the Conference Chairs\u003c\/p\u003e\n\u003cp\u003e8:05 AM\u003c\/p\u003e\n\u003cp\u003eKeynote Address\u003c\/p\u003e\n\u003cp\u003e8:45 AM\u003c\/p\u003e\n\u003cp\u003eStigma and Clinical Diagnosis of Substance Use Disorders\u003c\/p\u003e\n\u003cp\u003e9:15 AM\u003c\/p\u003e\n\u003cp\u003eOUD Diagnosis and Methadone Induction\u003c\/p\u003e\n\u003cp\u003e10:15 AM\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e10:30 AM\u003c\/p\u003e\n\u003cp\u003eComplex Buprenorphine Inductions\u003c\/p\u003e\n\u003cp\u003e11:30\u003c\/p\u003e\n\u003cp\u003eTransition into Small Groups\u003c\/p\u003e\n\u003cp\u003e11:35 AM\u003c\/p\u003e\n\u003cp\u003eCase 1: Group Discussion\u003c\/p\u003e\n\u003cp\u003e12:15 PM\u003c\/p\u003e\n\u003cp\u003eLunch\u003c\/p\u003e\n\u003cp\u003e1:15 PM\u003c\/p\u003e\n\u003cp\u003e1:40 PM\u003c\/p\u003e\n\u003cp\u003eCannabis Use and Use Disorder for Adolescents and Adults\u003c\/p\u003e\n\u003cp\u003e2:40 PM\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e2:55 PM\u003c\/p\u003e\n\u003cp\u003eStimulants and Drug Involved Deaths\u003c\/p\u003e\n\u003cp\u003e3:55 PM\u003c\/p\u003e\n\u003cp\u003eAlcohol Use Disorder: Diagnosis and Treatment\u003c\/p\u003e\n\u003cp\u003e4:55 PM\u003c\/p\u003e\n\u003cp\u003eClosing Remarks\u003c\/p\u003e\n\u003cp\u003eApril 24, 2026\u003c\/p\u003e\n\u003cp\u003e8:00 AM\u003c\/p\u003e\n\u003cp\u003eWelcome from the Conference Chairs\u003c\/p\u003e\n\u003cp\u003e8:05 AM\u003c\/p\u003e\n\u003cp\u003eCommunication with Patients who use Substances\u003c\/p\u003e\n\u003cp\u003e8:55 AM\u003c\/p\u003e\n\u003cp\u003eBenzodiazpeine Use Disorder and Detoxification\u003c\/p\u003e\n\u003cp\u003e9:45 AM\u003c\/p\u003e\n\u003cp\u003ePotporri: Kratom, emerging NPS\u003c\/p\u003e\n\u003cp\u003e10:15 AM\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e10:30 AM\u003c\/p\u003e\n\u003cp\u003eHospital Based care for patients with SUD including Opioid Withdrawal Mangement\u003c\/p\u003e\n\u003cp\u003e11:30\u003c\/p\u003e\n\u003cp\u003eTransition into Small Groups\u003c\/p\u003e\n\u003cp\u003e11:35 AM\u003c\/p\u003e\n\u003cp\u003eCase 2: Group Discussion\u003c\/p\u003e\n\u003cp\u003e12:15 PM\u003c\/p\u003e\n\u003cp\u003eLunch\u003c\/p\u003e\n\u003cp\u003e1:15 PM\u003c\/p\u003e\n\u003cp\u003e1:40 PM\u003c\/p\u003e\n\u003cp\u003eTelehealth and Patient centered Documentation\u003c\/p\u003e\n\u003cp\u003e2:40 PM\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e2:55 PM\u003c\/p\u003e\n\u003cp\u003eControlled Substances and SUD\u003c\/p\u003e\n\u003cp\u003e3:55 PM\u003c\/p\u003e\n\u003cp\u003ePregnancy and SUD\u003c\/p\u003e\n\u003cp\u003e4:55 PM\u003c\/p\u003e\n\u003cp\u003eClosing Remarks\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405753536708,"sku":null,"price":78.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/UCSF-Addiction-Conference-2026.jpg?v=1784215695"},{"product_id":"harvard-dementia-a-comprehensive-update-2026","title":"Harvard Dementia A Comprehensive Update 2026","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  file sub vtt +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: neurologists, psychiatrists, and primary care physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOverview\u003c\/p\u003e\n\u003cp\u003eNew this year will be a discussion of recently approved disease-modifying therapies for AD. Lectures and programs also provide education on special topics in dementia such as managing problem behaviors, disclosure of diagnosis and risk, chronic traumatic encephalopathy, caregiving in dementia, pain, palliation, hospice care, medicolegal issues, capacity and competence, undue influence, driving, long-term\/ nursing home care, delirium and dementia, neuroethics, advanced care planning, and neuropsychology of aging.\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003cp\u003eDescribe current understanding of epidemiology, risk factors, pathobiology, societal costs, clinical differences, gaps in knowledge, and challenges in distinguishing and managing the spectra of normal cognitive aging, mild cognitive impairment (MCI), Alzheimer’s disease (AD), and other neurodegenerative dementias.\u003c\/p\u003e\n\u003cp\u003eSummarize tiered diagnostic and management approaches, including the new Clinical Practice Guidelines sponsored by the Alzheimer’s Association for the diagnostic evaluation of patients with cognitive impairment. Summarize current and future experimental therapeutics strategies under consideration for risk reduction, prevention, diagnosis and treatment of the AD spectrum.\u003c\/p\u003e\n\u003cp\u003eDifferentiate, based on neuropathology, affected neural systems, clinical criteria and biomarkers, AD and its atypical variants from other common dementias including Dementia with Lewy Bodies (DLB), Vascular Cognitive Impairment (VCI)\/Vascular-Ischemic Dementia, Frontotemporal Degeneration (FTD), Parkinson’s disease with Dementia (PDD), Parkinson’s-Plus Syndromes and less common dementias.\u003c\/p\u003e\n\u003cp\u003eIdentify and explain the importance of evidence-based and coordinated individualized approaches to the evaluation and management of MCI, AD and neurodegenerative dementias that stress combining: (i) early and accurate detection, assessment and monitoring; (ii) psycho-education and non-pharmacological interventions; (iii) pharmacological strategies; and (iv) caregiver, psychosocial\/environmental, quality of life, ethical, medico-legal and end-of-life considerations.\u003c\/p\u003e\n\u003cp\u003eApply data-supported diagnostic, behavioral, pharmacological, and environmental strategies, including appropriate and tiered use of cognitive tests\/measures, labs, and imaging studies\/biomarkers; and delineation of expectations, roles (i.e., indications and benefits), cautions (i.e., risks, side-effects, warnings) and treatment nuances in the interdisciplinary management of CI, AD and neurodegenerative dementias.\u003c\/p\u003e\n\u003cp\u003eExplain the roles of office-based screening instruments, mental status exam (MSE) and neuropsychological evaluation in the diagnosis and management of dementia; develop efficient approaches to MSE and use of screening instruments (e.g. MOCA); and interpret and compare cognitive testing\/neuropsychological performance patterns for different conditions and clinical syndromes (e.g. MCI, AD, FTD, primary progressive aphasias, posterior cortical atrophy, DLB).\u003c\/p\u003e\n\u003cp\u003eUtilize appropriate laboratory tests, imaging studies, and neuropsychological testing for the diagnosis of dementia in clinical practice; incorporate appropriate use of clinical biomarkers (e.g. CSF a-beta\/tau, MRI, FDG- and Amyloid-PET) in evaluation of neurodegenerative dementias to differentiate AD and non-AD processes; and explain clinical versus research use, and apply appropriate use criteria\/guidelines for the clinical use of biomarkers in the diagnosis of AD-like syndromes.\u003c\/p\u003e\n\u003cp\u003eApply data-supported pharmacologic management strategies including the roles (i.e., indications and benefits), cautions (i.e., risks, side-effects, warnings) and potential alternatives to using cholinesterase inhibitors, memantine, antipsychotics and antidepressants in dementia and AD.\u003c\/p\u003e\n\u003cp\u003eDiscuss the important role, and the challenges and risks caregivers face; describe strategies to help dementia caregivers cope and better care for themselves and for patients with dementia including psychosocial counseling, community support resources, and respite care.\u003c\/p\u003e\n\u003cp\u003eDevelop appropriate practices concerning medico-legal and safety issues surrounding patients with dementia, including capacity with regards to medical care, finances, contracts, independent living, and driving; and integrate medico-legal and safety practices to support and safeguard patients and families, and the public-at-large.\u003c\/p\u003e\n\u003cp\u003eDescribe issues related to dementia neuroethics, and implement effective practices in the long-term care\/nursing-home environment and in end-stage dementia regarding medical, legal, and ethical issues including recognition and treatment of delirium\/encephalopathy and pain, providing palliation and hospice care, and managing end-of-life issues related to dementia.\u003c\/p\u003e\n\u003cp\u003eDemonstrate neural processes and functional networks that support perception and cognitive systems including memory, language, attentional, frontal\/executive, visuo-spatial, and motor systems.\u003c\/p\u003e\n\u003cp\u003eDistinguish pre-clinical AD, MCI due to AD\/prodromal AD, and AD dementia phases.\u003c\/p\u003e\n\u003cp\u003eIdentify delirium\/encephalopathy and Chronic Traumatic Encephalopathy(CTE) as a dementia risks or entities.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eBest for neurologists, psychiatrists, and primary care physicians who want updates on dementia biomarkers, treatments, and patient care.\u003c\/p\u003e\n\u003cp\u003eSpecialty Physicians, Psychologists, Physician Assistants, Nurse Practitioners, Nurses, Primary Care Physicians, Social Workers, and Others.\u003c\/p\u003e\n\u003cp\u003eTopics\u003c\/p\u003e\n\u003cp\u003eIntroduction to the Course\u003c\/p\u003e\n\u003cp\u003eHuman Cognition An Overview\u003c\/p\u003e\n\u003cp\u003eMemory Systems \u0026amp; Amnesia\u003c\/p\u003e\n\u003cp\u003eNeuropathology of AD ADRD A Guide forPracticing Clinicians\u003c\/p\u003e\n\u003cp\u003eFrom Proteinopathies to Neuroimaging \u0026amp; Biomarkers in AD ADRD Primer on Practice and Advances\u003c\/p\u003e\n\u003cp\u003eAlzheimer’s Disease \u0026amp; Related Dementias Global Perspectives and Opportunities\u003c\/p\u003e\n\u003cp\u003eClinical Use of Blood Biomarkers in 2026 and Beyond\u003c\/p\u003e\n\u003cp\u003ePanel Discussion and Q\u0026amp;A Alireza Atri; Brad Dickerson\u003c\/p\u003e\n\u003cp\u003eAD Dementia Practical Evaluation \u0026amp; Managementin Clinical Practice\u003c\/p\u003e\n\u003cp\u003eMild Cognitive Impairment Prodromal AD and Beyond\u003c\/p\u003e\n\u003cp\u003eAdvances in AD Experimental Therapeutics + Panel Discussion and Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eNeuropsychology of Aging\u003c\/p\u003e\n\u003cp\u003eAttentional and Executive Systems – Don’t Leave Home without Them\u003c\/p\u003e\n\u003cp\u003eFrontotemporal Dementias Focus on Behaviorall Executive Variants\u003c\/p\u003e\n\u003cp\u003eLanguage Systems \u0026amp; Aphasia-predominant Dementia Syndromes\u003c\/p\u003e\n\u003cp\u003eUpdates on Vascular Cognitive Impairment \u0026amp; Dementia\u003c\/p\u003e\n\u003cp\u003ePanel Discussion and Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eLewy Body Disease, and Parkinsonian \u0026amp; Sensorimotorpredominant Dementias\u003c\/p\u003e\n\u003cp\u003eAssessment of Cognition in Clinical Practice\u003c\/p\u003e\n\u003cp\u003ePractical Compensatory Strategies for Cognitive Decline\u003c\/p\u003e\n\u003cp\u003eAssessment of Daily Function and Neuropsychiatric Symptoms Behavior and Staging of Dementia in Practice\u003c\/p\u003e\n\u003cp\u003eCased-based Discussion of Lecanemab and Donanemab\u003c\/p\u003e\n\u003cp\u003ePanel Discussion and Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eNon-Pharmacological Approaches to Neuropsychiatric Symptoms and Problem Behaviors in Dementia\u003c\/p\u003e\n\u003cp\u003ePharmacological Management of Behavioral Problems in Dementia\u003c\/p\u003e\n\u003cp\u003ePractical \u0026amp; Ethical Considerations for Disclosure of Demetia-Related Diagnosis and Risk\u003c\/p\u003e\n\u003cp\u003eCaregiving in Dementia Impact, Consequences \u0026amp; Opportunities\u003c\/p\u003e\n\u003cp\u003ePanel Discussion and Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eCommunity Advocacy and Activism For Dementias\u003c\/p\u003e\n\u003cp\u003eChronic Traumatic Encephalopathy (CTE) \u0026amp; Dementia\u003c\/p\u003e\n\u003cp\u003eDelirium, Encephalopathies and Uncommon Dementias\u003c\/p\u003e\n\u003cp\u003ePanel Discussion, Q\u0026amp;A and Conclusions\u003c\/p\u003e\n\u003cp\u003eDementia \u0026amp; The Law Clinical Pearls on Testamentary Capacity and Undue Influence\u003c\/p\u003e\n\u003cp\u003ePrinciples \u0026amp; Practice of Mental Capacity and Competence in Dementia From Finances to Firearms\u003c\/p\u003e\n\u003cp\u003eDriving, Home \u0026amp; Community Safety and Dementia\u003c\/p\u003e\n\u003cp\u003eAdvance Care Planning \u0026amp; Management of End-stage Dementia, Pain, Palliation \u0026amp; Hospice in Long-Term Care\u003c\/p\u003e\n\u003cp\u003ePanel Discussion, Q \u0026amp; A, and conclusions\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405754454212,"sku":null,"price":104.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Dementia-A-Comprehensive-Update-2026.jpg?v=1784215729"},{"product_id":"mer-primary-care-conferences-internal-medicine-for-primary-care-gastro-neuro-psych-mar-27-29-2026","title":"MER Primary Care Conferences Internal Medicine for Primary Care Gastro Neuro Psych Mar 27-29, 2026","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos + file sub vtt, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: internists, primary care physicians, gastroenterologists, neurologists, and psychiatrists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this program, participants should be better able to:\u003c\/h3\u003e\n\u003cp\u003eUtilize history and physical examination to distinguish weakness from non-specific symptoms.\u003c\/p\u003e\n\u003cp\u003eUtilize prevention and treatment strategies for cerebrovascular disorders.\u003c\/p\u003e\n\u003cp\u003eDiscuss the spectrum of sleep disorders and current management strategies.\u003c\/p\u003e\n\u003cp\u003eDescribe the differential diagnosis of headaches and migraines.\u003c\/p\u003e\n\u003cp\u003eList current treatment recommendations for the management of lower GI bleeding.\u003c\/p\u003e\n\u003cp\u003eDiscuss the guidelines for colonoscopic colorectal cancer screening and surveillance.\u003c\/p\u003e\n\u003cp\u003eDiscuss options to prevent recurring pancreatitis.\u003c\/p\u003e\n\u003cp\u003eIdentify patients most at risk for pancreas cancer.\u003c\/p\u003e\n\u003cp\u003eCompare the benefits and side effect profiles of pharmacologic treatment options for ADHD.\u003c\/p\u003e\n\u003cp\u003eDescribe strategies for identifying and treating substance use disorders.\u003c\/p\u003e\n\u003cp\u003eDescribe symptoms that move depression to plans for suicide.\u003c\/p\u003e\n\u003cp\u003eRecommend appropriate pharmacologic and non-pharmacologic treatment for depression.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eThis program is targeted to office-based primary care providers and other health professionals with updates in primary care medicine.\u003c\/p\u003e\n\u003cp\u003eBest for internists, primary care physicians, gastroenterologists, neurologists, and psychiatrists.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003eFriday, March 27, 2026\u003c\/p\u003e\n\u003cp\u003eNeurology – Evaluating Weakness: Using the history and physical examination to distinguish weakness from non-specific symptoms; characteristics of neurological diseases that produce weakness; presentations of representative diseases of the nervous system.\u003c\/p\u003e\n\u003cp\u003eNeurology – Cerebrovascular Disorders: Epidemiology; identifying the high-risk patient; treatment effects; transient neurological deficit: carotid, vertebrobasilar; non-specific cerebral symptoms; migraines vs. TIA; treatment options.\u003c\/p\u003e\n\u003cp\u003eNeurology – Sleep Disorders: Epidemiology; assessing sleep patterns; causes and treatment of insomnia; causes, evaluation and treatment of sleep apnea; symptoms and treatment of narcolepsy.\u003c\/p\u003e\n\u003cp\u003eGastroenterology – Management of Lower GI Bleeding- From Occult to Massive: The correct use and interpretation of tests for occult blood in the stool will be discussed in relation to lower GI bleeding; focus on the utility of different diagnostic and management approached to the spectrum of patients presenting with hematochezia.\u003c\/p\u003e\n\u003cp\u003eSaturday, March 28, 2026\u003c\/p\u003e\n\u003cp\u003eGastroenterology – Acute Pancreatitis: Etiology and Management: Recognition of acute and chronic pancreatitis; The etiology of pancreatitis and determination of next steps in management; Discussion of complications of pancreatitis and how to counsel patients on how to prevent recurrence of pancreatitis.\u003c\/p\u003e\n\u003cp\u003eGastroenterology – Pancreas Cancer Screening: Determination of who qualifies for pancreas cancer screening and how to refer for pancreas cancer screening; Discussion of the importance of the family history and genetic counseling; Discussion of how pancreas screening is accomplished.\u003c\/p\u003e\n\u003cp\u003eNeurology – Headaches \u0026amp; Migraines: Basic headache mechanisms; headache history: characteristics, precipitating factors, medical conditions; migraine: common tension, classic, treatment, complicated, cluster, sinus; trigeminal neuralgia; Giant Cell Arteritis; brain tumor; subarachnoid hemorrhage; emergency room treatment.\u003c\/p\u003e\n\u003cp\u003ePsychiatry – The Complexity of Adult ADHD: ADHD in adults with an emphasis on symptom identification; Co-occurring conditions; Psychiatric and medical differential diagnosis; evidence-based and FDA approved pharmacological treatments.\u003c\/p\u003e\n\u003cp\u003ePsychiatry – Substance Use Disorders: Substance abuse history-taking to encourage patient honesty; Accurate diagnosis; Use of screening tools; Brief intervention; Recovery and treatment options; Motivational interviewing; Family symptoms and codependency.\u003c\/p\u003e\n\u003cp\u003eSunday, March 29, 2026\u003c\/p\u003e\n\u003cp\u003ePsychiatry – Depression and Suicide: Assessment of depressive symptoms in adults; Assessment and mitigation of suicide risk; Treatment of depression.\u003c\/p\u003e\n\u003cp\u003ePsychiatry – Psychopharmacology for Major Depression: History taking, diagnosis and treatment of depression across the lifespan; pharmacologic and non-pharmacologic treatment options; rational polypharmacy.\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405754978500,"sku":null,"price":130.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/MER-Primary-Care-Conferences-Internal-Medicine-for-Primary-Care-Gastro-Neuro-Psych-Mar-27-29-2026.jpg?v=1784215746"},{"product_id":"harvard-the-blackburn-course-in-obesity-medicine-2026","title":"Harvard The Blackburn Course in Obesity Medicine 2026","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos + file sub vtt +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience:  internists, bariatric surgeons, pediatricians, dietitians, endocrinologists, gastroenterologists, psychiatrists, psychologists, and pharmacists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eEducation to Optimize Your Care of Adult, Adolescent, and Pediatric Patients with Obesity\u003c\/p\u003e\n\u003cp\u003eTreating Obesity 2026: The Blackburn Course in Obesity Medicine is an online course, using live streaming, electronic Q\u0026amp;A, and other remote learning technologies.\u003c\/p\u003e\n\u003cp\u003eThis course delivers practical strategies to optimize the management of obesity and its many complications, and provides the most up-to-date approaches to obesity prevention and treatment.\u003c\/p\u003e\n\u003ch3\u003eHighlights of the 2026 program include:\u003c\/h3\u003e\n\u003cp\u003eUpdate on using the newer GLP-1 based therapies\u003c\/p\u003e\n\u003cp\u003eComprehensive evaluation of the patient with obesity\u003c\/p\u003e\n\u003cp\u003ePrecision medicine and dietary approaches to obesity and metabolic disorders\u003c\/p\u003e\n\u003cp\u003eMedical, endoscopic, and surgical options for the treatment of obesity\u003c\/p\u003e\n\u003cp\u003eEffective counseling and motivation techniques\u003c\/p\u003e\n\u003cp\u003eMedical and surgical treatment of children and adolescents with obesity\u003c\/p\u003e\n\u003cp\u003eEmerging strategies and therapies for genetic obesity\u003c\/p\u003e\n\u003cp\u003eA guide to virtual care, group visits, private and academic practice models\u003c\/p\u003e\n\u003cp\u003eEnhancing communication about obesity with patients, referring providers, payers, and the public\u003c\/p\u003e\n\u003cp\u003eAddressing obesity bias, stigma, and disparities in care\u003c\/p\u003e\n\u003ch3\u003ePresented by experts in medicine, surgery, pediatrics, nutrition, endocrinology, gastroenterology, and psychology from the country’s leading obesity treatment centers, this course covers critical topics in the prevention and treatment of obesity and related disorders. It gives clinicians the knowledge to:\u003c\/h3\u003e\n\u003cp\u003eIdentify, evaluate and manage patients with high-risk obesity\u003c\/p\u003e\n\u003cp\u003eProvide lifestyle-based therapies for obesity, including nutritional, physical activity, and behavioral approaches\u003c\/p\u003e\n\u003cp\u003eApply effective counseling and behavioral modification techniques\u003c\/p\u003e\n\u003cp\u003eApply current pharmacological approaches to the treatment of obesity\u003c\/p\u003e\n\u003cp\u003eAssess patients for their need and appropriateness for bariatric surgery and determine surgical options\u003c\/p\u003e\n\u003cp\u003ePathophysiology of obesity\u003c\/p\u003e\n\u003cp\u003eObesity comorbidities\u003c\/p\u003e\n\u003cp\u003ePediatric patient management\u003c\/p\u003e\n\u003cp\u003eGenetic and syndromic obesity\u003c\/p\u003e\n\u003cp\u003eNutrition and exercise assessment and intervention\u003c\/p\u003e\n\u003cp\u003eIntensive lifestyle and behavioral therapy\u003c\/p\u003e\n\u003cp\u003eAnti-obesity pharmacotherapy\u003c\/p\u003e\n\u003cp\u003eBariatric surgery\u003c\/p\u003e\n\u003cp\u003e360-Degree Education\u003c\/p\u003e\n\u003cp\u003ePatient Care. Reimbursements. Challenging Cases.\u003c\/p\u003e\n\u003ch3\u003eTreating Obesity 2026 provides education about obesity, its causes and consequences, and the most effective tools and strategies for its prevention and treatment. Unique to this program is a 360-degree educational experience, where attendees:\u003c\/h3\u003e\n\u003cp\u003eHear from authorities in medicine, pediatrics, nutrition, surgery, endocrinology, gastroenterology, and mental health about strategies to optimize care for your patients with obesity\u003c\/p\u003e\n\u003cp\u003eLearn how to build and maintain a successful Obesity Medicine practice in varied clinical settings, including primary care, multidisciplinary obesity care center, and Obesity Medicine specialty private practice\u003c\/p\u003e\n\u003cp\u003eUnderstand the adverse effect of obesity on the screening, diagnosis, and treatment of diseases related to obesity\u003c\/p\u003e\n\u003cp\u003eBecome more effective at strategic communication with payers, employers, and other policymakers about the benefits and value of targeted obesity treatment\u003c\/p\u003e\n\u003cp\u003eGet feedback and guidance on your own challenging cases from experienced Obesity Medicine clinicians\u003c\/p\u003e\n\u003cp\u003eInteract directly with faculty during panel discussions and interactive question and answer sessions\u003c\/p\u003e\n\u003ch3\u003e2. Learning Objectives Upon completion of this course, participants will gain the knowledge to:\u003c\/h3\u003e\n\u003cp\u003eIdentify, evaluate, and manage patients with high-risk obesity.\u003c\/p\u003e\n\u003cp\u003eProvide lifestyle-based therapies for obesity, including nutritional, physical activity, and behavioral approaches.\u003c\/p\u003e\n\u003cp\u003eApply effective counseling and behavioral modification techniques.\u003c\/p\u003e\n\u003cp\u003eApply current pharmacological approaches to the treatment of obesity.\u003c\/p\u003e\n\u003cp\u003eAssess patients for their need and appropriateness for bariatric surgery and determine surgical options.\u003c\/p\u003e\n\u003ch3\u003e3. Target Audience Who Should Participate:\u003c\/h3\u003e\n\u003cp\u003ePhysicians\u003c\/p\u003e\n\u003cp\u003eNurse Practitioners\u003c\/p\u003e\n\u003cp\u003ePhysician Assistants\u003c\/p\u003e\n\u003cp\u003ePharmacists\u003c\/p\u003e\n\u003cp\u003eDietitians …and other health professionals who want to learn the latest approaches to the prevention and treatment of obesity and its complications.\u003c\/p\u003e\n\u003cp\u003eBest for internists, bariatric surgeons, pediatricians, dietitians, endocrinologists, gastroenterologists, psychiatrists, psychologists, and pharmacists.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003eSunday, June 7, 2026\u003c\/p\u003e\n\u003cp\u003eThis one-day program helps prepare registrants for the ABOM certification exam.\u003c\/p\u003e\n\u003cp\u003eAll times listed in Eastern Time.  Live Streaming\u003c\/p\u003e\n\u003cp\u003eWelcome and Introduction Drs. Amandeep Singh and Angela Fitch\u003c\/p\u003e\n\u003cp\u003eApproach to the Patient with Obesity Dr. Chika Anekwe\u003c\/p\u003e\n\u003cp\u003eNutritional Assessment and Therapy Dr. Gregory Curtis\u003c\/p\u003e\n\u003cp\u003eCardiorespiratory Fitness and Exercise Dr. Jennifer Mulligan\u003c\/p\u003e\n\u003cp\u003ePanel Discussion \/ Q\u0026amp;A Drs. Anekwe, Curtis, Mulligan, and Fitch\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003ePracticing Obesity Medicine with Professionalism Dr. Amanda Powell\u003c\/p\u003e\n\u003cp\u003ePediatrics 1: Patient Assessment Dr. Vibha Singhal\u003c\/p\u003e\n\u003cp\u003ePediatrics 2: Patient Management Dr. Jennifer Rosenblum\u003c\/p\u003e\n\u003cp\u003eLightning Round 1 Dr. Wesley Dutton\u003c\/p\u003e\n\u003cp\u003ePanel Discussion \/ Q\u0026amp;A Drs. Powell, Singhal, Rosenblum, Dutton, and Fitch\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003ePharmacotherapy Dr. Mehmet Burak\u003c\/p\u003e\n\u003cp\u003eBariatric Endoscopy Dr. Amandeep Singh\u003c\/p\u003e\n\u003cp\u003eBariatric Surgery Dr. Karan Chhabra\u003c\/p\u003e\n\u003cp\u003ePanel Discussion \/ Q\u0026amp;A Drs. Burak, Singh, Chhabra, and Fitch\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eBehavioral Assessment and Therapy Dr. Mark Gorman\u003c\/p\u003e\n\u003cp\u003eGenetic and Syndromic Obesity Dr. Angela Fitch\u003c\/p\u003e\n\u003cp\u003eObesity Comorbidities Dr. Wesley Dutton\u003c\/p\u003e\n\u003cp\u003eLightning Round 2 Dr. Sreevidya Bodepudi\u003c\/p\u003e\n\u003cp\u003ePanel Discussion \/ Q\u0026amp;A Drs. Gorman, Fitch, Dutton, and Bodepudi\u003c\/p\u003e\n\u003cp\u003ePathophysiology of Obesity 1 Dr. Angela Fitch\u003c\/p\u003e\n\u003cp\u003ePathophysiology of Obesity 2 Dr. Paul Copeland\u003c\/p\u003e\n\u003cp\u003ePathophysiology of Obesity 3 Dr. Angela Fitch\u003c\/p\u003e\n\u003cp\u003eMonday, June 8, 2026\u003c\/p\u003e\n\u003cp\u003eIntroduction\u003c\/p\u003e\n\u003cp\u003eWelcome and Introduction\u003c\/p\u003e\n\u003cp\u003eCourse Directors\u003c\/p\u003e\n\u003cp\u003e2026 Blackburn Lecture: State of Obesity in 2026\u003c\/p\u003e\n\u003cp\u003eDr. Robert Kushner\u003c\/p\u003e\n\u003cp\u003eRoundtable Discussion with Keynote Speaker\u003c\/p\u003e\n\u003cp\u003eDrs. Robert Kushner and Steven Heymsfeld\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eApproach to Treatment\u003c\/p\u003e\n\u003cp\u003eClinical Approach to the Patient with Obesity\u003c\/p\u003e\n\u003cp\u003eDr. Ethan Lazarus\u003c\/p\u003e\n\u003cp\u003eStandards of Care for Obesity Treatment\u003c\/p\u003e\n\u003cp\u003eDr. Kimberly Gudzune\u003c\/p\u003e\n\u003cp\u003eBody Composition\u003c\/p\u003e\n\u003cp\u003eDr. Grant Tinsley\u003c\/p\u003e\n\u003cp\u003eObesity and Mental Health: Shared Complexity, Mechanisms and Responsibilities\u003c\/p\u003e\n\u003cp\u003eDr. Robin Pashby\u003c\/p\u003e\n\u003cp\u003ePanel Discussion: Approach to Treatment\u003c\/p\u003e\n\u003cp\u003eDrs. Fitch, Tinsley, Lazarus, and Pashby\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003ePharmacotherapy\u003c\/p\u003e\n\u003cp\u003eObesity Pharmacotherapy\u003c\/p\u003e\n\u003cp\u003eDr. Leslie Golden\u003c\/p\u003e\n\u003cp\u003eCombination Treatment for Obesity Management\u003c\/p\u003e\n\u003cp\u003eDr. Sreevidya Bodepudi\u003c\/p\u003e\n\u003cp\u003ePharmacodynamics and Medication Dosing in the Patient with Obesity\u003c\/p\u003e\n\u003cp\u003eDr. Christina Chow\u003c\/p\u003e\n\u003cp\u003eA Patient’s Perspective\u003c\/p\u003e\n\u003cp\u003eDr. Angela Fitch\u003c\/p\u003e\n\u003cp\u003ePanel Discussion: Pharmacotherapy\u003c\/p\u003e\n\u003cp\u003eDrs. Golden, Bodepudi, Chow, and Fitch\u003c\/p\u003e\n\u003cp\u003eSelf-Paced Study\u003c\/p\u003e\n\u003ch3\u003eTime for self-paced study of any of the pre-recorded sessions, including the following:\u003c\/h3\u003e\n\u003cp\u003eStaging, Assessment and Treatment of Obesity\u003c\/p\u003e\n\u003cp\u003eDr. Daniel Bessesen\u003c\/p\u003e\n\u003cp\u003ePatient-Centric Treatment of Obesity\u003c\/p\u003e\n\u003cp\u003eDr. Sean Wharton\u003c\/p\u003e\n\u003cp\u003eComplex Genetic Obesity Syndromes\u003c\/p\u003e\n\u003cp\u003eDr. Sadaf Forroqi\u003c\/p\u003e\n\u003cp\u003ePatient Case Presentations Highlighting Delivery of Care 1\u003c\/p\u003e\n\u003cp\u003eDr. Jennifer Mulligan\u003c\/p\u003e\n\u003cp\u003ePatient Case Presentations Highlighting Delivery of Care 2\u003c\/p\u003e\n\u003cp\u003eDr. Jennifer Mulligan\u003c\/p\u003e\n\u003cp\u003ePatient Case Presentations Highlighting Delivery of Care 3\u003c\/p\u003e\n\u003cp\u003eDr. Sreevidya Bodepudi\u003c\/p\u003e\n\u003cp\u003eBeyond BMI: Obesity Staging and Guidelines Based on the Treatment of Obesity\u003c\/p\u003e\n\u003cp\u003eDr. Timothy Garvey\u003c\/p\u003e\n\u003cp\u003eTuesday, June 9, 2026\u003c\/p\u003e\n\u003cp\u003eIntroduction Day 2\u003c\/p\u003e\n\u003cp\u003eCourse Directors\u003c\/p\u003e\n\u003cp\u003eExercise and Dietary Considerations\u003c\/p\u003e\n\u003cp\u003eKey Exercise Recommendations for Weight Loss and Maintenance\u003c\/p\u003e\n\u003cp\u003eDr. John Jakicic\u003c\/p\u003e\n\u003cp\u003eThe Updated Dietary Guidelines for Americans\u003c\/p\u003e\n\u003cp\u003eDr. Christopher Gardner\u003c\/p\u003e\n\u003cp\u003eThis session not eligible for AAFP credits\u003c\/p\u003e\n\u003cp\u003eTime-Restricted Eating\u003c\/p\u003e\n\u003cp\u003eDr. Krista Varady\u003c\/p\u003e\n\u003cp\u003eDietary Strategies for Weight Loss\u003c\/p\u003e\n\u003cp\u003eDr. Chika Anekwe\u003c\/p\u003e\n\u003cp\u003eCulinary Medicine Programs\u003c\/p\u003e\n\u003cp\u003eDr. Michelle Hauser\u003c\/p\u003e\n\u003cp\u003ePanel Discussion: Dietary Considerations\u003c\/p\u003e\n\u003cp\u003eDrs. Jakicic, Gardner, Varady, Anekwe, and Fitch\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eIndividualization of Care\u003c\/p\u003e\n\u003cp\u003eThe New Fundamentals of Obesity Care\u003c\/p\u003e\n\u003cp\u003eDr. Carolynn Francavilla-Brown\u003c\/p\u003e\n\u003cp\u003eGenetics and the Future of Obesity Treatment\u003c\/p\u003e\n\u003cp\u003eDr. Jesse Richards\u003c\/p\u003e\n\u003cp\u003eLipodistrophy\u003c\/p\u003e\n\u003cp\u003eDr. Lindsay Fourman\u003c\/p\u003e\n\u003cp\u003ePanel Discussion: Individualization of Care\u003c\/p\u003e\n\u003cp\u003eDrs. Francavilla-Brown, Richards, Fourman, and Fitch\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003ePrecision Care\u003c\/p\u003e\n\u003cp\u003ePrecision Medical Treatment of Obesity\u003c\/p\u003e\n\u003cp\u003eDr. Andres Acosta\u003c\/p\u003e\n\u003cp\u003ePrecision Lifestyle Treatments for Obesity\u003c\/p\u003e\n\u003cp\u003eDr. Andrew Chan\u003c\/p\u003e\n\u003cp\u003eThe Future State of Obesity Care\u003c\/p\u003e\n\u003cp\u003eDr. Deborah Horn\u003c\/p\u003e\n\u003cp\u003ePatient Case Presentations Highlighting Precision Delivery of Care\u003c\/p\u003e\n\u003cp\u003eDr. Florence Porterfield\u003c\/p\u003e\n\u003cp\u003ePanel Discussion: Precision Care\u003c\/p\u003e\n\u003cp\u003eDrs. Acosta, Chan, Horn, Porterfield, and Fitch\u003c\/p\u003e\n\u003cp\u003eSelf-Paced Study\u003c\/p\u003e\n\u003ch3\u003eTime for self-paced study of any of the pre-recorded sessions, including the following:\u003c\/h3\u003e\n\u003cp\u003eCircadian Influences and Lifestyle Interventions\u003c\/p\u003e\n\u003cp\u003eDr. Frank Scheer\u003c\/p\u003e\n\u003cp\u003eA Dietitian’s Approach to a Patient with Obesity\u003c\/p\u003e\n\u003cp\u003eAbeer Bader, RD\u003c\/p\u003e\n\u003cp\u003eTailoring Obesity Care Based on Genetic Differences\u003c\/p\u003e\n\u003cp\u003eDr. Ruth Loos\u003c\/p\u003e\n\u003cp\u003eResearch into Tailoring Obesity Care\u003c\/p\u003e\n\u003cp\u003eDr. Elizabeth Speliotes\u003c\/p\u003e\n\u003cp\u003eUsing Technology to Deliver Personalized Metabolic Care\u003c\/p\u003e\n\u003cp\u003eDr. Eran Segal\u003c\/p\u003e\n\u003cp\u003eWednesday, June 10, 2026\u003c\/p\u003e\n\u003cp\u003eIntroduction Day 3\u003c\/p\u003e\n\u003cp\u003eCourse Directors\u003c\/p\u003e\n\u003cp\u003eModels of Delivering Care\u003c\/p\u003e\n\u003cp\u003eCooperative Integrated and Virtual Care Models\u003c\/p\u003e\n\u003cp\u003eDr. Florencia Halperin\u003c\/p\u003e\n\u003cp\u003eDelivering Effective Obesity Care in Private Practice\u003c\/p\u003e\n\u003cp\u003eDr. Shirly (Shalu) Ramchandani\u003c\/p\u003e\n\u003cp\u003eDr. Leigh Perreault\u003c\/p\u003e\n\u003cp\u003eOptimizing Outcomes: Success of a Pharmacist-Driven GLP-1 Program\u003c\/p\u003e\n\u003cp\u003eDr. Amanda Powell\u003c\/p\u003e\n\u003cp\u003eGroup Visit Models\u003c\/p\u003e\n\u003cp\u003eDr. Jacob Mirsky\u003c\/p\u003e\n\u003cp\u003ePanel Discussion: Models of Delivering Care\u003c\/p\u003e\n\u003cp\u003eDrs. Halperin, Ramchandani, Perreault, Mirsky, Fitch, and Singh\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003ePediatrics\u003c\/p\u003e\n\u003cp\u003eAssessment of the Pediatric Patient with Obesity\u003c\/p\u003e\n\u003cp\u003eDr. Marisa Censani\u003c\/p\u003e\n\u003cp\u003eUse of Anti-Obesity Medications in Pediatric Patients\u003c\/p\u003e\n\u003cp\u003eDr. Vibha Singhal\u003c\/p\u003e\n\u003cp\u003eBariatric Endoscopy and Surgery in the Pediatric Patient\u003c\/p\u003e\n\u003cp\u003eDr. Cornelia Griggs\u003c\/p\u003e\n\u003cp\u003ePanel Discussion: Obesity in the Pediatric Population\u003c\/p\u003e\n\u003cp\u003eDrs. Censani, Singhal, Griggs, and Fitch\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eEndoscopic and Surgical Approaches to Treating Obesity\u003c\/p\u003e\n\u003cp\u003eEndoscopic Sleeve Gastroplasty, POSE, and TORe\u003c\/p\u003e\n\u003cp\u003eDr. Barham Abu Dayyeh\u003c\/p\u003e\n\u003cp\u003eGastric Balloons and Duodenal Resurfacing\u003c\/p\u003e\n\u003cp\u003eDr. Amandeep Singh\u003c\/p\u003e\n\u003cp\u003eUpdate on Bariatric Surgery\u003c\/p\u003e\n\u003cp\u003eDr. Richard Peterson\u003c\/p\u003e\n\u003cp\u003eNonsurgical Management of the Postbariatric Surgery Patient\u003c\/p\u003e\n\u003cp\u003eDr. Angela Fitch\u003c\/p\u003e\n\u003cp\u003ePanel Discussion: Endoscopic and Surgical Approaches to Treating Obesity\u003c\/p\u003e\n\u003cp\u003eDrs. Abu Dayyeh, Singh, Peterson, and Fitch\u003c\/p\u003e\n\u003cp\u003eSelf-Paced Study\u003c\/p\u003e\n\u003ch3\u003eTime for self-paced study of any of the pre-recorded sessions, including the following:\u003c\/h3\u003e\n\u003cp\u003eProviding Virtual Obesity Care\u003c\/p\u003e\n\u003cp\u003eDrs. Katherine Saunders and Leon Igel\u003c\/p\u003e\n\u003cp\u003eOptimizing Obesity Care in Private Practice: Strategies for Success\u003c\/p\u003e\n\u003cp\u003eDr. Carolynn Francavilla-Brown\u003c\/p\u003e\n\u003cp\u003eAdvancing Obesity Care in Academic Medicine: Challenges and Opportunities\u003c\/p\u003e\n\u003cp\u003eDrs. Lauren Oshman and Dina Griauzde\u003c\/p\u003e\n\u003cp\u003eMulti-Disciplinary Weight Center Case Study: Massachusetts General Hospital\u003c\/p\u003e\n\u003cp\u003eDr. Angela Fitch\u003c\/p\u003e\n\u003cp\u003eMulti-Disciplinary Weight Center Case Study: Geisinger\u003c\/p\u003e\n\u003cp\u003eDr. Christopher Still\u003c\/p\u003e\n\u003cp\u003eMulti-Disciplinary Weight Center Case Study: University of Colorado\u003c\/p\u003e\n\u003cp\u003eDr. Adam Gilden\u003c\/p\u003e\n\u003cp\u003eImplementation Science in Cardiometabolic Health: State of the State and Future Strategies\u003c\/p\u003e\n\u003cp\u003eDr. Alexander (AJ) Blood\u003c\/p\u003e\n\u003cp\u003eThursday, June 11, 2026\u003c\/p\u003e\n\u003cp\u003eIntroduction Day 4\u003c\/p\u003e\n\u003cp\u003eCourse Directors\u003c\/p\u003e\n\u003cp\u003eDisparities and Stigma in Obesity Care\u003c\/p\u003e\n\u003cp\u003eAddressing Healthcare Disparities in Obesity Treatment\u003c\/p\u003e\n\u003cp\u003eDr. Jamy Ard\u003c\/p\u003e\n\u003cp\u003eEnsuring Equal Access to Care for All Patients: A North Carolina Story\u003c\/p\u003e\n\u003cp\u003eDr. Sarah Ro\u003c\/p\u003e\n\u003cp\u003eStigma and Bias in Treating Obesity\u003c\/p\u003e\n\u003cp\u003eJoe Nadglowski\u003c\/p\u003e\n\u003cp\u003ePanel Discussion: Disparities and Stigma\u003c\/p\u003e\n\u003cp\u003eJoe Nadglowski and Drs. Ard, Ro, and Fitch\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eConsiderations in the Patient with Obesity\u003c\/p\u003e\n\u003cp\u003eThe Unbearable Lightness of Weight and Age\u003c\/p\u003e\n\u003cp\u003eDr. Beverly Tchang\u003c\/p\u003e\n\u003cp\u003eThe Intersection of Metabolic Disease and Mental Health\u003c\/p\u003e\n\u003cp\u003eDr. Christopher Palmer\u003c\/p\u003e\n\u003cp\u003eConsiderations for the Patient with Obesity Prior to a Procedure (with Patient on GLP-1, Colonoscopy Considerations)\u003c\/p\u003e\n\u003cp\u003eDr. Rodney Voisine\u003c\/p\u003e\n\u003cp\u003ePanel Discussion: Considerations in the Patient with Obesity\u003c\/p\u003e\n\u003cp\u003eDrs. Tchang, Palmer, Voisine, Fitch, and Singh\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eDiseases in the Patient with Obesity\u003c\/p\u003e\n\u003cp\u003eObesity and Cardiovascular Disease\u003c\/p\u003e\n\u003cp\u003eDr. Harold Edward Bays\u003c\/p\u003e\n\u003cp\u003eSleep Health and Sleep Apnea\u003c\/p\u003e\n\u003cp\u003eDr. Jeremy McConnell\u003c\/p\u003e\n\u003cp\u003eObesity and Cancer\u003c\/p\u003e\n\u003cp\u003eDr. Justin Brown\u003c\/p\u003e\n\u003cp\u003eMASLD\/MASH Updates and Treatment Landscape in 2026\u003c\/p\u003e\n\u003cp\u003eDr. Nadege Gunn\u003c\/p\u003e\n\u003cp\u003eObesity and Diabetes\u003c\/p\u003e\n\u003cp\u003eDr. Paul Copeland\u003c\/p\u003e\n\u003cp\u003ePanel Discussion: Diseases\u003c\/p\u003e\n\u003cp\u003eDrs. Bays, McConnell, Gunn, Copeland, Fitch, and Singh\u003c\/p\u003e\n\u003cp\u003eSelf-Paced Study\u003c\/p\u003e\n\u003ch3\u003eTime for self-paced study of any of the pre-recorded sessions, including the following:\u003c\/h3\u003e\n\u003cp\u003eCaring for All Patients\u003c\/p\u003e\n\u003cp\u003eDr. Adjoa Anyane-Yeboa\u003c\/p\u003e\n\u003cp\u003eEquity in Obesity Care\u003c\/p\u003e\n\u003cp\u003eDr. Wesley Dutton\u003c\/p\u003e\n\u003cp\u003eDiagnosis and Staging of MAFLD\/MASH\u003c\/p\u003e\n\u003cp\u003eDr. Kathleen Corey\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405755863236,"sku":null,"price":195.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-The-Blackburn-Course-in-Obesity-Medicine-2026.jpg?v=1784215761"},{"product_id":"mer-primary-care-conferences-geriatric-medicine-for-primary-care-cardio-id-sleep-mar-13-15-2026","title":"MER Primary Care Conferences Geriatric Medicine for Primary Care Cardio ID Sleep Mar 13-15, 2026","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos + file sub vtt, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: primary care physicians, cardiologists, infectious diseases physicians, sleep medicine physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this program, participants should be better able to:\u003c\/h3\u003e\n\u003cp\u003eList pharmacologic options for stroke prevention in patients with atrial fibrillation and the benefits of each\u003c\/p\u003e\n\u003cp\u003eDiscuss best practices for reading and interpreting EKGs\u003c\/p\u003e\n\u003cp\u003ePerform a cardiovascular workup\u003c\/p\u003e\n\u003cp\u003eRecognize and manage the unique challenges of the geriatric heart failure population\u003c\/p\u003e\n\u003cp\u003eDiscuss the basic mechanisms of sleep and circadian rhythm disorders\u003c\/p\u003e\n\u003cp\u003eDevelop a therapeutic plan related to common complaints surrounding insomnia and restless legs syndrome\u003c\/p\u003e\n\u003cp\u003eDescribe medical issues surrounding RLS, parasomnias and other special sleep issues\u003c\/p\u003e\n\u003cp\u003eList common causative pathogens for various respiratory tract infections\u003c\/p\u003e\n\u003cp\u003eDiagnose and manage genitourinary infections\u003c\/p\u003e\n\u003cp\u003eEvaluate the severity of diarrhea and evaluate the need for treatment\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eThis program is targeted to office-based primary care providers and other health professionals with updates in primary care medicine.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003eCardiology\u003c\/p\u003e\n\u003cp\u003eAtrial Fibrillation: Management, Monitoring, and Stroke Prevention: New methods of detection, rate vs rhythm control, new options for stroke prevention.\u003c\/p\u003e\n\u003cp\u003eInteractive EKG Refresher: A case-based refresher including challenging EKG readings.\u003c\/p\u003e\n\u003cp\u003eCardiac Imaging for Primary Care: A Practical Case-based Update: The evaluation of a cardiac patient and appropriate use of imaging and laboratory tests to improve diagnosis and treatment.\u003c\/p\u003e\n\u003cp\u003eHeart Failure Update with a Focus on the Elderly: Diagnostic and management challenges in the geriatric population, new therapies for systolic HF, home-based management, end-of-life care for a CHF patient.\u003c\/p\u003e\n\u003cp\u003eSleep Medicine\u003c\/p\u003e\n\u003cp\u003eHow Sleep Works: The drivers of sleep and integration of how these drivers can be used to improve sleep; Basic principles of sleep drive, circadian rhythm and sleep associations will be discussed; Related to cases to highlight these principles.\u003c\/p\u003e\n\u003cp\u003eInfectious Diseases\u003c\/p\u003e\n\u003cp\u003eSkin \u0026amp; Soft Tissue Infections: Presentation on important skin and soft-tissue infections and their prompt recognition, emphasizing evaluation and management strategies.\u003c\/p\u003e\n\u003cp\u003eRespiratory Tract Infections: Discussion highlighting critical points regarding the diagnosis and management of pneumonia and bronchitis – with a focus on the impact of multidrug resistant pathogens.\u003c\/p\u003e\n\u003cp\u003eGenitourinary Infections: Presentation on a relevant and clinically practical approach to the patient with genitourinary complaints focusing on the latest guidelines for the range of urinary tract infections and highlights of selected and important sexually-transmitted disease syndromes.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal Infections \u0026amp; Clostridiodes Difficile: Presentation on important enteric pathogens and their recognition, diagnosis and management; special emphasis on clostridiodes difficile colitis and related updates from the ID and infection control literature.\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405756223684,"sku":null,"price":130.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/MER-Primary-Care-Conferences-Geriatric-Medicine-for-Primary-Care-Cardio-ID-Sleep-Mar-13-15-2026.jpg?v=1784215764"},{"product_id":"mayo-clinic-neurology-in-clinical-practice-2026","title":"Mayo Clinic Neurology in Clinical Practice 2026","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos + pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: neurologists, psychiatrists, and family medicine physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eJune 25, 2026 to June 27, 2026\u003c\/p\u003e\n\u003cp\u003eCourse Directors: Christopher J. Lamb, M.D., Maisha T. Robinson, M.D., and Devon I. Rubin, M.D\u003c\/p\u003e\n\u003cp\u003eThe annual Mayo Clinic Neurology in Clinical Practice course brings together a multidisciplinary faculty from across Mayo Clinic’s three campuses in Rochester, Minnesota; Jacksonville, Florida; and Scottsdale, Arizona.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eThis course is designed for any provider who sees patients with neurologic diseases, including neurologists, psychiatrists, and family medicine.\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, participants should be able to:\u003c\/h3\u003e\n\u003cp\u003eRecognize red flags in common neurologic disorders\u003c\/p\u003e\n\u003cp\u003eDiscuss factors influencing therapeutic decisions in migraine management\u003c\/p\u003e\n\u003cp\u003eCite the importance of palliative care in neurologic illnesses\u003c\/p\u003e\n\u003cp\u003eDescribe the impact of recent trials on standard acute ischemic stroke care\u003c\/p\u003e\n\u003cp\u003eEvaluate emerging disease-modifying therapies in Parkinson’s disease\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThursday\u003c\/p\u003e\n\u003cp\u003eJune 25, 2026\u003c\/p\u003e\n\u003cp\u003eNon-CME Product Theater (Lunch provided) Catalyst Pharma\u003c\/p\u003e\n\u003cp\u003e11:30 a.m.\u003c\/p\u003e\n\u003cp\u003eRegistration and Exhibits\u003c\/p\u003e\n\u003cp\u003e11:55 a.m.\u003c\/p\u003e\n\u003cp\u003eWelcome Moderator: Maisha Robinson, M.D.\u003c\/p\u003e\n\u003cp\u003eStroke \/ CV\u003c\/p\u003e\n\u003cp\u003e12:00 pm\u003c\/p\u003e\n\u003cp\u003eAcute Stroke Diagnosis and Management Josephine Huang, M.D.\u003c\/p\u003e\n\u003cp\u003e12:30 pm\u003c\/p\u003e\n\u003cp\u003eSecondary Prevention of Stroke Cumara O’Carroll, M.D.\u003c\/p\u003e\n\u003cp\u003e1:00 pm\u003c\/p\u003e\n\u003cp\u003eAneurysms, Cerebrovascular Malformations\u003c\/p\u003e\n\u003cp\u003eOana Dumitrascu, M.D.\u003c\/p\u003e\n\u003cp\u003e1:30 pm\u003c\/p\u003e\n\u003cp\u003ePanel \/ Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e1:45 pm\u003c\/p\u003e\n\u003cp\u003eBreak and Exhibits\u003c\/p\u003e\n\u003cp\u003eAutoimmune\/Demyelinating\u003c\/p\u003e\n\u003cp\u003e2:00 pm\u003c\/p\u003e\n\u003cp\u003eMultiple Sclerosis: Diagnosis Sebastian Lopez Chiriboga, M.D.\u003c\/p\u003e\n\u003cp\u003e2:30 pm\u003c\/p\u003e\n\u003cp\u003eMultiple Sclerosis: Treatment Vanessa Marin-Collazo, M.D.\u003c\/p\u003e\n\u003cp\u003e3:00 pm\u003c\/p\u003e\n\u003cp\u003eMOG Antibody Disease and Neuromyelitis Optica Spectrum Disorder Eoin Flanagan, M.B., B.Ch.\u003c\/p\u003e\n\u003cp\u003e3:30 pm\u003c\/p\u003e\n\u003cp\u003eUpdates in Paraneoplastic Neurologic Disorders Divyanshu Dubey, M.B.B.S.\u003c\/p\u003e\n\u003cp\u003e4:00 pm\u003c\/p\u003e\n\u003cp\u003ePanel \/ Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e4:15 pm\u003c\/p\u003e\n\u003cp\u003eBreak and Exhibits\u003c\/p\u003e\n\u003cp\u003eNeurohospitalist Topics\u003c\/p\u003e\n\u003cp\u003e4:30 pm\u003c\/p\u003e\n\u003cp\u003eAltered Mental Status Amen Yonas, M.D.\u003c\/p\u003e\n\u003cp\u003e5:00 pm\u003c\/p\u003e\n\u003cp\u003eTropical Neurologic Infections Reece Hass, D.O.\u003c\/p\u003e\n\u003cp\u003e5:30 pm\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e\n\u003cp\u003e5:45 p.m.\u003c\/p\u003e\n\u003cp\u003eNon-CME Product Theater (Food provided) Argenx\u003c\/p\u003e\n\u003cp\u003eFriday\u003c\/p\u003e\n\u003cp\u003eJune 26, 2026\u003c\/p\u003e\n\u003cp\u003eNon-CME Product Theater (Breakfast provided) Astrazeneca\u003c\/p\u003e\n\u003cp\u003e7:00 a.m.\u003c\/p\u003e\n\u003cp\u003eModerator: Chris Lamb, M.D.\u003c\/p\u003e\n\u003cp\u003eNeurodegenerative\u003c\/p\u003e\n\u003cp\u003e7:00\u003c\/p\u003e\n\u003cp\u003eEvaluation of Mild Cognitive Impairment\/Dementia Meredith Wicklund, M.D.\u003c\/p\u003e\n\u003cp\u003e7:30\u003c\/p\u003e\n\u003cp\u003eNew Treatment in Alzheimers Disease Neil Graff-Radford, M.D.\u003c\/p\u003e\n\u003cp\u003e8:00\u003c\/p\u003e\n\u003cp\u003eAutoimmune Encephalopathy and Rapidly Progressive Dementia Gregg Day. M.D.\u003c\/p\u003e\n\u003cp\u003e8:30\u003c\/p\u003e\n\u003cp\u003eParkinson’s Disease\/Parkinson-plus Syndromes Diagnosis and Treatment Shyamal Mehta, M.D., Ph.D.\u003c\/p\u003e\n\u003cp\u003e9:00\u003c\/p\u003e\n\u003cp\u003ePanel \/ Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e9:15\u003c\/p\u003e\n\u003cp\u003eBreak \u0026amp; Exhibits\u003c\/p\u003e\n\u003cp\u003eNeuromuscular\/Autonomic\u003c\/p\u003e\n\u003cp\u003e9:30\u003c\/p\u003e\n\u003cp\u003ePeripheral Neuropathy: Diagnostic Approach and Treatment Updates Chris Lamb, M.D.\u003c\/p\u003e\n\u003cp\u003e10:00\u003c\/p\u003e\n\u003cp\u003eMyasthenia Gravis and Neuromuscular Junction Disorders Treatment Updates Michael Skolka, M.D.\u003c\/p\u003e\n\u003cp\u003e10:30\u003c\/p\u003e\n\u003cp\u003eApproach to Immune-Mediated Myopathies Andre Granger, M.D.\u003c\/p\u003e\n\u003cp\u003e11:00\u003c\/p\u003e\n\u003cp\u003eOrthostatic Intolerance and Postural Orthostatic Tachycardia Syndrome POTS Forrest Sturgill, M.D.\u003c\/p\u003e\n\u003cp\u003e11:30\u003c\/p\u003e\n\u003cp\u003ePanel \/ Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e11:45\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eNon-CME Product Theater (Lunch provided) UCB\u003c\/p\u003e\n\u003cp\u003eSpine\u003c\/p\u003e\n\u003cp\u003e1:00 p.m.\u003c\/p\u003e\n\u003cp\u003eNeurologic Red Flags in Neck and Back Pain Christy Hunt, D.O.\u003c\/p\u003e\n\u003cp\u003e1:30 p.m.\u003c\/p\u003e\n\u003cp\u003eNeuropathic Pain Management Narayan Kissoon, M.D.\u003c\/p\u003e\n\u003cp\u003e2:00 p.m.\u003c\/p\u003e\n\u003cp\u003eClinical and Radiologic Pearls in Myelopathies Neeraj Kumar, M.D.\u003c\/p\u003e\n\u003cp\u003e2:45 p.m.\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e3:00 p.m.\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e\n\u003cp\u003e3:00 p.m.\u003c\/p\u003e\n\u003cp\u003eNon-CME Product Theater (Food provided) Alexion\u003c\/p\u003e\n\u003cp\u003eSaturday\u003c\/p\u003e\n\u003cp\u003eJune 27, 2026\u003c\/p\u003e\n\u003cp\u003e6:30 a.m.\u003c\/p\u003e\n\u003cp\u003eBreakfast and Exhibits\u003c\/p\u003e\n\u003cp\u003eEpilepsy\/Sleep\u003c\/p\u003e\n\u003cp\u003eModerator: Maisha Robinson, M.D.\u003c\/p\u003e\n\u003cp\u003e7:00\u003c\/p\u003e\n\u003cp\u003eDiagnosis Approach to Seizures and Spells Keith Starnes, M.D.\u003c\/p\u003e\n\u003cp\u003e7:30\u003c\/p\u003e\n\u003cp\u003ePharmacologic Treatment of Epilepsy David Burkholder, M.D.\u003c\/p\u003e\n\u003cp\u003e8:00\u003c\/p\u003e\n\u003cp\u003eDrug Resistant Epilepsy Diagnosis and Treatment Brin Freund, M.D.\u003c\/p\u003e\n\u003cp\u003e8:30\u003c\/p\u003e\n\u003cp\u003eEvaluation and Management of Common Sleep Disorders Brynn Dredla, M.D.\u003c\/p\u003e\n\u003cp\u003e9:00\u003c\/p\u003e\n\u003cp\u003ePanel \/ Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e9:15\u003c\/p\u003e\n\u003cp\u003eBreak \u0026amp; Exhibits\u003c\/p\u003e\n\u003cp\u003eHeadache \/ Neuro-ophthalmology \/ CSF Dynamics\u003c\/p\u003e\n\u003cp\u003e9:30\u003c\/p\u003e\n\u003cp\u003eHeadache: When to Worry Juliana VanderPluym, M.D.\u003c\/p\u003e\n\u003cp\u003e10:00\u003c\/p\u003e\n\u003cp\u003eNovel Migraine Treatments Beth Robertson, M.D.\u003c\/p\u003e\n\u003cp\u003e10:30\u003c\/p\u003e\n\u003cp\u003eDiplopia as a Consequence of Stroke Misha Pless, M.D.\u003c\/p\u003e\n\u003cp\u003e11:00\u003c\/p\u003e\n\u003cp\u003eCommon Treatable Disorders of CSF Dynamics Olga Fermo, M.D.\u003c\/p\u003e\n\u003cp\u003e11:30\u003c\/p\u003e\n\u003cp\u003ePanel \/ Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e11:45\u003c\/p\u003e\n\u003cp\u003ePick up lunch\u003c\/p\u003e\n\u003cp\u003eNeuro Onc\/Palliative\u003c\/p\u003e\n\u003cp\u003e12:00 p.m.\u003c\/p\u003e\n\u003cp\u003ePrimary Brain Tumors Ugur Sener, M.D.\u003c\/p\u003e\n\u003cp\u003e12:30\u003c\/p\u003e\n\u003cp\u003eNeurologic Complications of Cancer Therapies: Chemotherapy, Radiation, Checkpoint Inhibitors Julie Hammack, M.D.\u003c\/p\u003e\n\u003cp\u003e1:00\u003c\/p\u003e\n\u003cp\u003eCase Studies in Neuro-Palliative Care  Maisha Robinson, M.D.\u003c\/p\u003e\n\u003cp\u003e1:30\u003c\/p\u003e\n\u003cp\u003ePanel \/ Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e1:45 p.m.\u003c\/p\u003e\n\u003cp\u003eExhibits \/ Adjourn\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405756944580,"sku":null,"price":260.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Mayo-Clinic-Neurology-in-Clinical-Practice-2026.webp?v=1784215777"},{"product_id":"mer-primary-care-conferences-internal-medicine-for-primary-care-gastro-pain-psych-vasc-apr-09-12-2026","title":"MER Primary Care Conferences Internal Medicine for Primary Care Gastro Pain Psych Vasc Apr 09-12, 2026","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  file sub vtt, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: internists, primary care physicians, psychiatrists, gastroenterologists, pain management specialists, and vascular medicine specialists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this program, participants should be better able to:\u003c\/h3\u003e\n\u003cp\u003eCompare the benefits and side effect profiles of pharmacologic treatment options for ADHD.\u003c\/p\u003e\n\u003cp\u003eDiscuss mood stabilizing psychosocial and pharmacologic treatments of bipolar disorder as well as frequent co-morbid psychiatric disorders.\u003c\/p\u003e\n\u003cp\u003eRecommend appropriate pharmacologic and non-pharmacologic treatment for depression.\u003c\/p\u003e\n\u003cp\u003eDescribe strategies for identifying and treating substance use disorders.\u003c\/p\u003e\n\u003cp\u003eList current treatment recommendations for the management of lower GI bleeding.\u003c\/p\u003e\n\u003cp\u003eDiscuss the guidelines for colonoscopic colorectal cancer screening and surveillance.\u003c\/p\u003e\n\u003cp\u003eIdentify patients most at risk for pancreas cancer.\u003c\/p\u003e\n\u003cp\u003eList current treatment recommendations for HBV and HCV.\u003c\/p\u003e\n\u003cp\u003eDesign non-opioid pain management strategies.\u003c\/p\u003e\n\u003cp\u003eDesign opioid pain management strategies.\u003c\/p\u003e\n\u003cp\u003eDiscuss some of the controversies surrounding pain management.\u003c\/p\u003e\n\u003cp\u003eCompare the benefits and side effect profiles of pharmacologic treatment options for fibromyalgia.\u003c\/p\u003e\n\u003cp\u003eDescribe the spectrum of maladies included in peripheral vascular disease.\u003c\/p\u003e\n\u003cp\u003eDiscuss presentation and interventional treatment of stroke patients.\u003c\/p\u003e\n\u003cp\u003eList current pharmacologic options for the management of aneurysms.\u003c\/p\u003e\n\u003cp\u003eDescribe the evaluation and treatment of venous thrombosis.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eThis program is targeted to office-based primary care providers and other health professionals with updates in primary care medicine.\u003c\/p\u003e\n\u003cp\u003eBest for internists, primary care physicians, psychiatrists, gastroenterologists, pain management specialists, and vascular medicine specialists.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003eThursday, April 9, 2026\u003c\/p\u003e\n\u003cp\u003ePsychiatry – The Complexity of Adult ADHD: ADHD in adults with an emphasis on symptom identification; Co-occurring conditions; Psychiatric and medical differential diagnosis; evidence-based and FDA approved pharmacological treatments.\u003c\/p\u003e\n\u003cp\u003ePsychiatry – Bipolar Spectrum Disorders: Bipolar spectrum disorders in adults as compared to youth; Comprehensive history-taking; Differential diagnosis; Co-occurring psychiatric and medical conditions; Phase specific treatment considerations and interventions.\u003c\/p\u003e\n\u003cp\u003ePsychiatry – Depressive Disorders: History taking, diagnosis and treatment of depression across the lifespan; pharmacologic and non-pharmacologic treatment options; rational polypharmacy.\u003c\/p\u003e\n\u003cp\u003eGastroenterology – Management of Lower GI Bleeding- From Occult to Massive: The correct use and interpretation of tests for occult blood in the stool will be discussed in relation to lower GI bleeding; focus on the utility of different diagnostic and management approached to the spectrum of patients presenting with hematochezia.\u003c\/p\u003e\n\u003cp\u003eFriday, April 10, 2026\u003c\/p\u003e\n\u003cp\u003eGastroenterology – Understanding and Treating Chronic Diarrhea: Guidelines on the diagnosis and management of acute diarrhea as well as the evaluation of persistent and chronic diarrhea.\u003c\/p\u003e\n\u003cp\u003eGastroenterology – Hepatitis B and C Management: HBV screening: whom to screen, whom to vaccinate; management of patients with decompensated hepatitis B related liver disease; treatment in special populations.\u003c\/p\u003e\n\u003cp\u003ePsychiatry – Substance Use Disorders: Substance abuse history-taking to encourage patient honesty; Accurate diagnosis; Use of screening tools; Brief intervention; Recovery and treatment options; Motivational interviewing; Family symptoms and codependency.\u003c\/p\u003e\n\u003cp\u003ePain – Non-Opioid Pharmacologic Options in Pain Management: NSAID’s; Acetaminophen; Topicals; Injections; Antidepressants; Anticonvulsants; Medical marijuana.\u003c\/p\u003e\n\u003cp\u003ePain – Opioid Pharmacologic Options in Pain Management: Overall safety and efficacy; Selecting and monitoring patients; Pain contracts; Regulatory issues; Urine drug testing.\u003c\/p\u003e\n\u003cp\u003eSaturday, April 11, 2026\u003c\/p\u003e\n\u003cp\u003ePain – Controversies in Pain Management: Urine drug testing, cannabinoids.\u003c\/p\u003e\n\u003cp\u003ePain – Fibromyalgia: Differential diagnosis and treatment of this difficult-to-manage pain syndrome; Treatment options of anti-epileptics and SNRI’s.\u003c\/p\u003e\n\u003cp\u003eVascular Medicine – Peripheral Vascular Disease and Medical Therapy: Defining the spectrum of maladies under the umbrella of Peripheral Vascular Disease including the pathophysiology of atherosclerosis and treatments highlighting lipid lowering agents and antiplatelet therapy.\u003c\/p\u003e\n\u003cp\u003eVascular Medicine – Stroke: Initial Presentation to Medical and Surgical Treatment: An overview of embolic stroke including diagnosis and medical, surgical, and interventional therapy.\u003c\/p\u003e\n\u003cp\u003eSunday, April 12, 2026\u003c\/p\u003e\n\u003cp\u003eVascular Medicine – Aortic and Peripheral Aneurysms: A guide for primary care outlining diagnosis, management, and therapeutic options.\u003c\/p\u003e\n\u003cp\u003eVascular Medicine – Management of Venous Thrombosis: A discussion focusing on the variety of venous thrombotic diagnoses and the multiple available treatment options.\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405757731012,"sku":null,"price":156.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/MER-Primary-Care-Conferences-Internal-Medicine-for-Primary-Care-Gastro-Pain-Psych-Vasc-Apr-09-12-2026.jpg?v=1784215797"},{"product_id":"harvard-ai-in-clinical-medicine-2026","title":"Harvard AI in Clinical Medicine 2026","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos + file sub vtt +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: pathologists, endocrinologists, ophthalmologists, nurses, gastroenterologists, intensivists, radiologists, surgeons, anesthesiologists, oncologists, pulmonologists, cardiologists, and psychiatrists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eNew technologies are available now to help you impact your practice. AI medical scribes, new research tools and diagnostic tests, and personalized treatment options are just a few applications of AI that are beginning to have a direct impact on clinicians and the patients they serve.\u003c\/p\u003e\n\u003cp\u003eUp until now, most health care providers have not received formal training in artificial intelligence. Now is the time for physicians, nurses, advanced practice providers, and all allied health professionals to prepare for how AI is changing medical care.\u003c\/p\u003e\n\u003cp\u003eThis live online course focuses on cutting edge and exciting new applications of AI, including foundational principles and lessons learned that you will be able to take directly back to your practice. Over three days, you will hear from medical society leaders, academic leaders, and innovators from academia and industry.\u003c\/p\u003e\n\u003ch3\u003e2. Learning Objectives Upon completion of this course, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eDiscuss the ethical considerations and potential biases in AI algorithms, especially in decision-making processes related to patient care, diagnosis, and treatment planning.\u003c\/p\u003e\n\u003cp\u003eAssess the long-term quality and accuracy of AI technologies and their impact on patient care.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eWho Should Participate: Clinicians treating patients in any type of setting including, physicians, nurses, nurse practitioners, and clinical leaders.\u003c\/p\u003e\n\u003cp\u003eBest for pathologists, endocrinologists, ophthalmologists, nurses, gastroenterologists, intensivists, radiologists, surgeons, anesthesiologists, oncologists, pulmonologists, cardiologists, and psychiatrists.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003eKeynote: Paging Dr. A.I.: How AI is Changing the Face of Clinical Care\u003c\/p\u003e\n\u003cp\u003eLearning the AI Lingo: Machine Learning, Deep Learning, and Large Language Models\u003c\/p\u003e\n\u003cp\u003eA Look Into the Black Box: Technical Background for Clinicians\u003c\/p\u003e\n\u003cp\u003eMedical Data as the Backbone of AI\u003c\/p\u003e\n\u003cp\u003eChatbots in Health Care: A Historical Expedition\u003c\/p\u003e\n\u003cp\u003eAI Learning Revolution: Transforming Medical Education\u003c\/p\u003e\n\u003cp\u003eAmbient Scribes\u003c\/p\u003e\n\u003cp\u003eAn AI designed drug for IPF: from preclinical development to phase II in under 3 years\u003c\/p\u003e\n\u003cp\u003ePrecision Medicine: AI and Personalized Treatment in Oncology\u003c\/p\u003e\n\u003cp\u003eKeynote: Ethics and AI in Healthcare\u003c\/p\u003e\n\u003cp\u003eAI for Pioneering Leadership in the Digital Era\u003c\/p\u003e\n\u003cp\u003eLaw and Regulation in AI\u003c\/p\u003e\n\u003cp\u003eTelemetry\/Mhealth for early detection of heart failure exacerbation\u003c\/p\u003e\n\u003cp\u003eBrain computer interfaces and decoding speech\u003c\/p\u003e\n\u003cp\u003eCan Chat bots improve mental health?\u003c\/p\u003e\n\u003cp\u003eBias in Risk Stratification for allocation and policy\u003c\/p\u003e\n\u003cp\u003eRobust, Fair and private AI\u003c\/p\u003e\n\u003cp\u003eAlgorithmic bias in clinical scores and implications for AI\u003c\/p\u003e\n\u003cp\u003eBut I Want it Now!: Barriers to Clinical AI Implementation\u003c\/p\u003e\n\u003cp\u003eHow Can I Help You? Clinical Decision Support in the EHR\u003c\/p\u003e\n\u003cp\u003eImplementing AI in your small practice\u003c\/p\u003e\n\u003cp\u003eHidden risks of AI in your practice\u003c\/p\u003e\n\u003cp\u003eMoney Talks: How AI Can Help You Improve Your Bottom Line\u003c\/p\u003e\n\u003cp\u003eAI and Reducing Healthcare Provider Burnout\u003c\/p\u003e\n\u003cp\u003eWhy AI may be good for our health but hurt our wallets\u003c\/p\u003e\n\u003cp\u003eStudy Hall – Clinical Applications: Pathology\u003c\/p\u003e\n\u003cp\u003eStudy Hall – Clinical Applications: Endocrinology\u003c\/p\u003e\n\u003cp\u003eStudy Hall – Clinical Applications: Ophthalmology\u003c\/p\u003e\n\u003cp\u003eStudy Hall – Clinical Applications: Nursing\u003c\/p\u003e\n\u003cp\u003eStudy Hall – Clinical Applications: Gastroenterology\u003c\/p\u003e\n\u003cp\u003eStudy Hall – Clinical Applications: Critical Care\u003c\/p\u003e\n\u003cp\u003eStudy Hall – Clinical Applications: Radiology\u003c\/p\u003e\n\u003cp\u003eStudy Hall – Clinical Applications: Surgery or Anesthesia\u003c\/p\u003e\n\u003cp\u003eVirtual demonstrations: Ambient Scribe from Abridge\u003c\/p\u003e\n\u003cp\u003eVirtual demonstrations: Leveraging clinician’s expertise with Agentic AI\u003c\/p\u003e\n\u003cp\u003eVirtual demonstrations: Evidence search using OpenEvidence\u003c\/p\u003e\n\u003cp\u003eVirtual demonstrations: Doctronic\u003c\/p\u003e\n\u003cp\u003eVirtual demonstrations: Uptodate Expert AI\u003c\/p\u003e\n\u003cp\u003eVirtual demonstrations: Glasshealth’s clinical decision support platform\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405757862084,"sku":null,"price":390.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-AI-in-Clinical-Medicine-2026.jpg?v=1784215801"},{"product_id":"harvard-heat-emergencies-prevention-diagnosis-and-management-2026","title":"Harvard Heat Emergencies Prevention, Diagnosis, and Management 2026","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos + file sub vtt +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: Emergency Physicians, Nephrologists, Psychiatrists, Pediatricians, Internal Medicine Specialists, and Family Medicine Physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe Heat Emergencies Clinical Education CME Course is a virtual, lecture-based four half-day course to educate clinicians about how to diagnose, treat, and prevent heat-related illness. The course will describe the current evidence around all heat-related emergencies, including heat stroke, heat exhaustion, and heat syncope. The course will provide a background on the changing epidemiology of heat-related illness, varying definitions of heat, basics of thermal physiology, and individual and population based approaches to prevention of heat-related illness.\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003cp\u003eExplain the epidemiology of heat related illness and associated disease processes.\u003c\/p\u003e\n\u003cp\u003eRecognize the thermal physiology underlying clinical presentations of heat related illness.\u003c\/p\u003e\n\u003cp\u003eCreate a differential diagnosis and develop comprehensive, evidence-based management plans for all forms of heat related illness, including heat exhaustion, heat syncope, and heat stroke.\u003c\/p\u003e\n\u003cp\u003eDescribe groups at increased risk for heat related illness and develop anticipatory guidance and prevention plans.\u003c\/p\u003e\n\u003cp\u003eDiscuss the pharmacological interactions with heat-related illness and develop plans for protecting patients.\u003c\/p\u003e\n\u003cp\u003eIdentify the resources needed and best steps to take for preparedness, diagnosis and treatment of heat related illness during event medicine and in low-resources settings.\u003c\/p\u003e\n\u003cp\u003eExplain the impacts of heat across organ systems, including impacts on mental health and behavioral health and kidney disease.\u003c\/p\u003e\n\u003cp\u003eApply preventive solutions for heat related illness including from a community based, public health, and health systems approach.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eGeneral Physicians, Specialty Physicians, Physician Assistants, Nurse Practitioners, Nurses, Pharmacists, Primary Care Physicians, and Others.\u003c\/p\u003e\n\u003cp\u003eBest for Emergency Physicians, Nephrologists, Psychiatrists, Pediatricians, Clinical Pharmacologists, Occupational Medicine Physicians, Public Health Specialists, Internal Medicine Specialists, and Family Medicine Physicians.\u003c\/p\u003e\n\u003cp\u003eTopics\u003c\/p\u003e\n\u003cp\u003eDay 1: Monday, June 15, 2026\u003c\/p\u003e\n\u003cp\u003eWelcome, Overview, and Importance of Heat Clinical Education\u003c\/p\u003e\n\u003cp\u003eDefining Heat\u003c\/p\u003e\n\u003cp\u003eHeat Physiology\u003c\/p\u003e\n\u003cp\u003eEpidemiological Impacts of Heat\u003c\/p\u003e\n\u003cp\u003eFluids, Electrolytes and Perspiration\u003c\/p\u003e\n\u003cp\u003eClosing Remarks and Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eDay 2: Wednesday, June 17, 2026\u003c\/p\u003e\n\u003cp\u003eWelcome and Recap\u003c\/p\u003e\n\u003cp\u003eEvent Medicine and Heat Related Illness\u003c\/p\u003e\n\u003cp\u003eCurrent Evidence on Heat Related Illness\u003c\/p\u003e\n\u003cp\u003eDiagnosis of Heat Related Illness\u003c\/p\u003e\n\u003cp\u003eManagement of Heat Related Illness\u003c\/p\u003e\n\u003cp\u003eClosing Remarks and Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eDay 3: Monday, June 22, 2026\u003c\/p\u003e\n\u003cp\u003eWelcome and Recap\u003c\/p\u003e\n\u003cp\u003eHeat, Kidney Disease, and Outdoor Work\u003c\/p\u003e\n\u003cp\u003ePharmaceutical Considerations in Hot Weather\u003c\/p\u003e\n\u003cp\u003eSmall Group Discussions: What Special Populations Are You Worried About in Your Practice, and What can be Done to Meet Their Needs?\u003c\/p\u003e\n\u003cp\u003eHeat-Related Illness in Special Populations\u003c\/p\u003e\n\u003cp\u003eHeat and Behavioral Health\u003c\/p\u003e\n\u003cp\u003eClosing Remarks and Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eDay 4: Wednesday, June 24, 2026\u003c\/p\u003e\n\u003cp\u003eWelcome and Recap\u003c\/p\u003e\n\u003cp\u003ePrevention and Management of Heat Related Illness in Low Resource Settings\u003c\/p\u003e\n\u003cp\u003ePractical Resources for the Busy Clinician\u003c\/p\u003e\n\u003cp\u003eHealth System Impacts and Preparedness for Extreme Heat\u003c\/p\u003e\n\u003cp\u003ePreventive Solutions Through Public Health and Public Policy\u003c\/p\u003e\n\u003cp\u003eClosing Remarks and Q\u0026amp;A\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405758025924,"sku":null,"price":117.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Heat-Emergencies-Prevention-Diagnosis-and-Management-2026.jpg?v=1784215805"},{"product_id":"oakstone-comprehensive-review-of-pain-medicine-2025","title":"Oakstone Comprehensive Review of Pain Medicine 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: anesthesiologists, neurologists, psychiatrists, emergency physicians, physical medicine and rehabilitation physicians, dentists, oral surgeons, internists, and family physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003ePain Medicine CME: Expert Guidelines and More\u003c\/p\u003e\n\u003ch3\u003eClinically active, multidisciplinary faculty share guidelines for assessment of a patient’s unique situation and their experienced perspectives regarding the links between pain treatment and disease mechanisms. Along with clinical updates in musculoskeletal pain, neuroaugmentation, and cancer-related pain, featured continuing medical education topic areas include:\u003c\/h3\u003e\n\u003cp\u003eManaging the medical-legal risks of chronic opioid prescribing\u003c\/p\u003e\n\u003cp\u003eHealthcare disparities and underserved patients in pain medicine\u003c\/p\u003e\n\u003cp\u003ePain practice management\u003c\/p\u003e\n\u003cp\u003eAdvances in pain physiology and treatment\u003c\/p\u003e\n\u003cp\u003eInterventional pain procedures\u003c\/p\u003e\n\u003cp\u003eDate of Original Release: March 31, 2025\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eAt the completion of this course, you should be able to:\u003c\/h3\u003e\n\u003cp\u003eDifferentiate between shoulder pain and cervical pain\u003c\/p\u003e\n\u003cp\u003eDescribe the importance of diversity, equity, and inclusion to successful management of patients with pain\u003c\/p\u003e\n\u003cp\u003eExplain the difference between nociplastic pain and nociceptive pain\u003c\/p\u003e\n\u003cp\u003eDescribe a comprehensive and holistic interdisciplinary approach to managing chronic pain\u003c\/p\u003e\n\u003cp\u003eRecognize the overlap of pain and mood when treating suffering and emotional distress\u003c\/p\u003e\n\u003cp\u003eList the etiologies of orofacial pain\u003c\/p\u003e\n\u003cp\u003eSummarize the neurophysiology of DRG stimulation\u003c\/p\u003e\n\u003cp\u003eRecognize the comorbidity of chronic pain, PTSD, and traumatic brain injury in veterans\u003c\/p\u003e\n\u003cp\u003eList the interdisciplinary tools available to treat thoracic back pain\u003c\/p\u003e\n\u003cp\u003eIdentify bony, vascular, nerve, and muscular anatomy of the hip\u003c\/p\u003e\n\u003cp\u003eExplain how spinal cord stimulation effectively treats refractory visceral pain syndromes\u003c\/p\u003e\n\u003cp\u003eDescribe the importance of careful patient selection and knowledge of limitations and risks when deciding on an interventional therapy\u003c\/p\u003e\n\u003cp\u003eList the types of Parkinson’s disease-related pain\u003c\/p\u003e\n\u003cp\u003eIntended Audience\u003c\/p\u003e\n\u003cp\u003eThis educational activity was designed for anesthesiologists, neurologists, psychiatrists, emergency physicians, physical medicine and rehabilitation physicians, dentists, oral surgeons, internists, and family physicians.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eQuestions.pdf\u003c\/p\u003e\n\u003cp\u003eSyllabus.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405758156996,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Oakstone-Comprehensive-Review-of-Pain-Medicine-2025.jpg?v=1784215812"},{"product_id":"oakstone-addiction-medicine-for-non-specialists-2025","title":"Oakstone Addiction Medicine for Non-Specialists 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: internists, family physicians, psychiatrists, emergency physicians, PM\u0026amp;R physicians, and neurologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOnline CME Focus: Substance Use Disorders\u003c\/p\u003e\n\u003cp\u003eAddiction Medicine for Non-Specialists is a comprehensive video CME program geared toward clinicians who see patients with substance use disorders, whether substance use is the primary complaint or not. This collection of thorough and expertly informed lectures will help you more effectively screen, treat, refer, and follow up with these patients.\u003c\/p\u003e\n\u003ch3\u003eLed by Antoine Douaihy, MD, experienced practitioners address the need to integrate, prioritize, and personalize care while avoiding harmful stigmas and racial and ethnic disparities. Featured continuing medical education topics include:\u003c\/h3\u003e\n\u003cp\u003eThe Pharmacology of Substances of Use\u003c\/p\u003e\n\u003cp\u003eGambling Disorders\u003c\/p\u003e\n\u003cp\u003eTechnology Addiction\u003c\/p\u003e\n\u003cp\u003eHelping Family Members Affected by Substance Use Disorders\u003c\/p\u003e\n\u003cp\u003eMindfulness-Based Treatment of Substance Use Disorders\u003c\/p\u003e\n\u003cp\u003eGood to Know: This activity meets the Drug Enforcement Administration (DEA) and Substance Abuse and Mental Health Services Administration (SAMHSA) requirement that as of June 27, 2023, new or renewing DEA registrants must complete a minimum of 8 hours of accredited continuing education (CE) on the treatment and management of patients with opioid or other substance use disorders before renewing their license.\u003c\/p\u003e\n\u003cp\u003eDate of Original Release: April 30, 2025\u003c\/p\u003e\n\u003cp\u003eEstimated Time to Complete: 24.75 hours\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eAt the completion of this course, you should be able to:\u003c\/h3\u003e\n\u003cp\u003eSummarize the three main stages of the addiction cycle\u003c\/p\u003e\n\u003cp\u003eList the signs and symptoms of alcohol withdrawal\u003c\/p\u003e\n\u003cp\u003eDiscuss the epidemiology of opioid use disorder and the medical complications of this disorder\u003c\/p\u003e\n\u003cp\u003eSummarize the risk factors for benzodiazepine use disorder\/misuse\u003c\/p\u003e\n\u003cp\u003eExplain the toxic effects of cannabis and CBD\u003c\/p\u003e\n\u003cp\u003eRecognize why and how pain and substance use disorder can co-occur\u003c\/p\u003e\n\u003cp\u003eOutline the management of acute pain in patients who are prescribed buprenorphine or methadone for opioid use disorder\u003c\/p\u003e\n\u003cp\u003eDescribe culturally, racially, and ethnically informed healthcare\u003c\/p\u003e\n\u003cp\u003eList the brief interventions skills found in OARS\u003c\/p\u003e\n\u003cp\u003eIntended Audience\u003c\/p\u003e\n\u003cp\u003eThis educational activity was designed for internists, family physicians, psychiatrists, emergency physicians, PM\u0026amp;R physicians, and neurologists.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eQuestions.pdf\u003c\/p\u003e\n\u003cp\u003eSyllabus.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405758517444,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Oakstone-Addiction-Medicine-for-Non-Specialists-2025.jpg?v=1784215821"},{"product_id":"memorial-sloan-kettering-cancer-center-psychopharmacology-in-cancer-care-2025","title":"Memorial Sloan Kettering Cancer Center Psychopharmacology in Cancer Care 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: oncologists, hematologists, psychiatrists, palliative care physicians, neurologists, pain medicine specialists, internists, family medicine physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSpecialties – Behavioral Care, Critical Care, General and Family Practice, Geriatric Medicine, Hematology, Integrative Medicine, Internal Medicine, Medical Oncology, Neurology, Nurse Anesthetist, Nurse Practitioner, Nursing, Pain Medicine, Psychiatry, Psychology, Social Work\u003c\/p\u003e\n\u003cp\u003eOverview\u003c\/p\u003e\n\u003cp\u003eClinicians have numerous tools at their disposal to help adult cancer patients dealing with symptoms of depression, anxiety, and other cancer sequelae. Psychiatric medications are most frequently prescribed to cancer patients by oncologists and general practitioners, however psychiatric syndromes are often underdiagnosed and undertreated. Few oncology practices have dedicated psychiatric consultants familiar with the nuances of Psycho-Oncology. Even when patients receive psychotropic medications appropriately, they may have problems that arise before their next oncology visit or before they see the person who prescribed their psychiatric medications. Psychologists, nurses, and social workers play an essential role in identifying psychological and physical symptoms as well as both beneficial and problematic medication effects as they provide frontline psychosocial interventions and support for cancer patients.\u003c\/p\u003e\n\u003cp\u003eThis highly regarded annual course, co-sponsored by the MSK Psycho-Oncology Education and Training Institute (POETI), is designed to support non-prescribing psycho-oncology clinicians and psychiatrists new to Psycho-pharmaco-oncology. Oncologists, palliative care providers, advanced practice nurses, and oncology nurses will also find it invaluable.\u003c\/p\u003e\n\u003cp\u003eThe program emphasizes effective psychopharmacological interventions for key disorders and symptoms, including anxiety, depression, delirium, sleep dsisturbances, pain, fatigue, and changes in weight or appetite. Expert faculty will provide updates on the use of novel interventions including ketamine, medical marijuana, and psilocybin for depression, anxiety, and pain. Additionally, the vital role of clinical social work in delivering psychosocial support will be examined.\u003c\/p\u003e\n\u003cp\u003eAttendees will receive access to an online syllabus after the course, which will include select PDFs of the faculty presentations (slides) and recorded videos.\u003c\/p\u003e\n\u003cp\u003eObjectives\u003c\/p\u003e\n\u003ch3\u003eBy attending this program, learners will be able to:\u003c\/h3\u003e\n\u003cp\u003eDescribe basic psycho-pharmaco-oncology principles for understanding and treating anxiety, depression and delirium in people with cancer.\u003c\/p\u003e\n\u003cp\u003eIdentify the use of novel interventions including ketamine, medical marijuana, and psilocybin for depression, anxiety, and pain in people with cancer.\u003c\/p\u003e\n\u003cp\u003eDiscuss basic psycho-pharmaco-oncology principles for understanding and improving quality of life and psychiatric palliative care in people with cancer, including managing cognitive changes, insomnia, fatigue, poor appetite and weight loss, and pain.\u003c\/p\u003e\n\u003cp\u003eThe 2025 Psychopharmacology in Cancer Care course by Memorial Sloan Kettering Cancer Center (MSKCC) is designed for physicians and healthcare professionals involved in oncology, psychiatry, palliative care, and psycho-oncology.\u003c\/p\u003e\n\u003ch3\u003eThis course is particularly beneficial for:\u003c\/h3\u003e\n\u003cp\u003eOncologists \u0026amp; Hematologists managing psychiatric symptoms in cancer patients.\u003c\/p\u003e\n\u003cp\u003ePsychiatrists \u0026amp; Psychologists specializing in psycho-oncology.\u003c\/p\u003e\n\u003cp\u003ePalliative Care Physicians addressing depression, anxiety, and delirium in cancer care.\u003c\/p\u003e\n\u003cp\u003eInternal Medicine \u0026amp; Family Medicine Physicians prescribing psychiatric medications for cancer patients.\u003c\/p\u003e\n\u003cp\u003eNeurologists \u0026amp; Pain Medicine Specialists focusing on psychiatric aspects of pain management.\u003c\/p\u003e\n\u003cp\u003eAdvanced Practice Nurses \u0026amp; Nurse Practitioners supporting psycho-oncology care.\u003c\/p\u003e\n\u003cp\u003eSocial Workers \u0026amp; Psychosocial Professionals involved in psychiatric palliative care.\u003c\/p\u003e\n\u003cp\u003eThe course covers depression, anxiety, delirium, sleep disturbances, fatigue, pain, weight changes, and emerging treatments like ketamine, medical marijuana, and psilocybin\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAnxiety Disorders.mp4\u003c\/p\u003e\n\u003cp\u003eAnxiety Disorders.pdf\u003c\/p\u003e\n\u003cp\u003eCancer and Cancer-Treatment Related Cognitive Changes.mp4\u003c\/p\u003e\n\u003cp\u003eCancer and Cancer-Treatment Related Cognitive Changes.pdf\u003c\/p\u003e\n\u003cp\u003eCancer-Related Fatigue.mp4\u003c\/p\u003e\n\u003cp\u003eCancer-Related Fatigue.pdf\u003c\/p\u003e\n\u003cp\u003eCaring for the Whole Patient- The Role of Clinical Social Work in Psychosocial Support.mp4\u003c\/p\u003e\n\u003cp\u003eCaring for the Whole Patient- The Role of Clinical Social Work in Psychosocial Support.pdf\u003c\/p\u003e\n\u003cp\u003eDelirium.mp4\u003c\/p\u003e\n\u003cp\u003eDelirium.pdf\u003c\/p\u003e\n\u003cp\u003eDepressive Disorders.mp4\u003c\/p\u003e\n\u003cp\u003eDepressive Disorders.pdf\u003c\/p\u003e\n\u003cp\u003eHandouts.pdf\u003c\/p\u003e\n\u003cp\u003eKetamine and Esketamine for Depression.mp4\u003c\/p\u003e\n\u003cp\u003eKetamine and Esketamine for Depression.pdf\u003c\/p\u003e\n\u003cp\u003eNovel Psychopharmacologic Interventions in Oncology.mp4\u003c\/p\u003e\n\u003cp\u003eNovel Psychopharmacologic Interventions in Oncology.pdf\u003c\/p\u003e\n\u003cp\u003ePain.mp4\u003c\/p\u003e\n\u003cp\u003ePain.pdf\u003c\/p\u003e\n\u003cp\u003ePsychopharm2025_Brochure.pdf\u003c\/p\u003e\n\u003cp\u003eSleep Disorders.mp4\u003c\/p\u003e\n\u003cp\u003eSleep Disorders.pdf\u003c\/p\u003e\n\u003cp\u003eWeight and Appetite Loss.mp4\u003c\/p\u003e\n\u003cp\u003eWeight and Appetite Loss.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405758812356,"sku":null,"price":26.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Memorial-Sloan-Kettering-Cancer-Center-Psychopharmacology-in-Cancer-Care-2025.jpg?v=1784215825"},{"product_id":"harvard-neurorehabilitation-2025","title":"Harvard NeuroRehabilitation 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: physiatrists, neurologists, geriatricians, internists, family practitioners\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eComprehensive Neurorehabilitation Update Cutting-edge strategies, updates, and best practices for state-of-the-art rehabilitation\u003c\/p\u003e\n\u003cp\u003eNeuroRehabilitation 2025 will be held online this year, using live streaming, electronic Q\u0026amp;A, and other remote learning technologies.\u003c\/p\u003e\n\u003cp\u003eOverview\u003c\/p\u003e\n\u003cp\u003ePatients with stroke, SCI, TBI, and functional and degenerative neurological diseases face significant disruption to so many facets of their lives, and clinicians are left with so many treatment dimensions to consider, that rehabilitation is never simple. These challenges are compounded by the fact that rehabilitation approaches are now in a period of rapid expansion. It’s difficult to stay current with, choose, and use the best options for neurorehabilitation—yet this is key to optimizing patient outcomes.\u003c\/p\u003e\n\u003ch3\u003eIt’s with these challenges in mind that we present NeuroRehabilitation 2025. Many of the country’s most experienced and committed neurorehabilitation experts provide updates and strategies for state-of-the-art clinical interventions. Education is comprehensive and practical. As a participant in the distance learning program, you can rely on this course for:\u003c\/h3\u003e\n\u003cp\u003eComprehensive updates\u003c\/p\u003e\n\u003cp\u003eEducation to further your expertise in guiding patients to their maximum level of function\u003c\/p\u003e\n\u003cp\u003eEvidence-based approaches to challenging and complex cases\u003c\/p\u003e\n\u003cp\u003eCase studies\u003c\/p\u003e\n\u003cp\u003eTake-home tools\u003c\/p\u003e\n\u003cp\u003eA learning experience to heighten your success in effectively and efficiently helping your patients gain the skills that will improve their health, function, and quality of life\u003c\/p\u003e\n\u003cp\u003eEnhanced and Accelerated Recovery\u003c\/p\u003e\n\u003ch3\u003eThis program includes important updates, new best practices, and state-of-the-art approaches to enhance and accelerate recovery, including:\u003c\/h3\u003e\n\u003cp\u003eRehabilitation of memory and executive skills after stroke and TBI\u003c\/p\u003e\n\u003cp\u003eSpasticity management\u003c\/p\u003e\n\u003cp\u003ePharmacologic options for aggressive behavior after TBI\u003c\/p\u003e\n\u003cp\u003eTreatment of pressure ulcers\u003c\/p\u003e\n\u003cp\u003eFunctional neuroimaging in disorders of consciousness\u003c\/p\u003e\n\u003cp\u003eEarly mobilization in the ICU\u003c\/p\u003e\n\u003cp\u003eLife Participation Approach to Aphasia\u003c\/p\u003e\n\u003cp\u003eMusic therapy\u003c\/p\u003e\n\u003cp\u003eThe shoulder post-stroke\u003c\/p\u003e\n\u003cp\u003eLower extremity orthotics after stroke\u003c\/p\u003e\n\u003cp\u003eMusculoskeletal overuse after SCI\u003c\/p\u003e\n\u003cp\u003ePediatric TBI\u003c\/p\u003e\n\u003cp\u003eImproved Quality of Life\u003c\/p\u003e\n\u003ch3\u003eThis program includes strategies, best practices, and cutting-edge approaches to help foster quality of life:\u003c\/h3\u003e\n\u003cp\u003eWellness groups for stroke survivors\u003c\/p\u003e\n\u003cp\u003eThe SCI consumer perspective\u003c\/p\u003e\n\u003cp\u003eVision rehabilitation after stroke\u003c\/p\u003e\n\u003cp\u003eWomen’s health in SCI\u003c\/p\u003e\n\u003cp\u003eResilience and adjustment after SCI\u003c\/p\u003e\n\u003cp\u003ePharmacologic treatment of dementia\u003c\/p\u003e\n\u003cp\u003eApproaches to obesity in neurorehabilitation\u003c\/p\u003e\n\u003cp\u003eEvolving Treatment Options\u003c\/p\u003e\n\u003ch3\u003eThis program offers attendees the opportunity to learn about the future of treatment options and how and when they will impact patient outcomes:\u003c\/h3\u003e\n\u003cp\u003eArtificial intelligence in neurorehabilitation\u003c\/p\u003e\n\u003cp\u003eGamified neurorehabilitation treatments\u003c\/p\u003e\n\u003cp\u003eForced exercise in Parkinson’s disease\u003c\/p\u003e\n\u003cp\u003eCryoneurolysis for spasticity\u003c\/p\u003e\n\u003cp\u003ePsycho-pharmacogenomics\u003c\/p\u003e\n\u003cp\u003eBrain-computer and brain-spinal interfaces\u003c\/p\u003e\n\u003cp\u003eExpanded Understanding of a Wide Range of Neurological Conditions\u003c\/p\u003e\n\u003ch3\u003eThrough this program, Physicians, NPs, PAs, PTs, OTs, SLPs, and Psychologists can deepen their knowledge and optimize clinical decisions concerning the following neurorehabilitation issues:\u003c\/h3\u003e\n\u003cp\u003eStroke recovery\u003c\/p\u003e\n\u003cp\u003eFunctional neurologic disorders\u003c\/p\u003e\n\u003cp\u003eMild TBI and PTSD in the military\u003c\/p\u003e\n\u003cp\u003eChronic traumatic encephalopathy\u003c\/p\u003e\n\u003cp\u003eSevere TBI and disorders of consciousness\u003c\/p\u003e\n\u003cp\u003eChronic TBI\u003c\/p\u003e\n\u003cp\u003eEmotional dysregulation and affective processing after TBI\u003c\/p\u003e\n\u003cp\u003eDomestic violence and TBI\u003c\/p\u003e\n\u003cp\u003eAmyotrophic lateral sclerosis\u003c\/p\u003e\n\u003cp\u003eAutonomic dysfunction after SCI\u003c\/p\u003e\n\u003cp\u003eVisual dysfunction after stroke\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003ePhysicians\u003c\/p\u003e\n\u003cp\u003e– Physiatrists\u003c\/p\u003e\n\u003cp\u003e– Neurologists\u003c\/p\u003e\n\u003cp\u003e– Geriatricians\u003c\/p\u003e\n\u003cp\u003e– Internists\u003c\/p\u003e\n\u003cp\u003e– Family Practitioners\u003c\/p\u003e\n\u003cp\u003ePhysical Therapists\u003c\/p\u003e\n\u003cp\u003eOccupational Therapists\u003c\/p\u003e\n\u003cp\u003eSpeech-Language Pathologists\u003c\/p\u003e\n\u003cp\u003eNurse Practitioners\u003c\/p\u003e\n\u003cp\u003ePhysician Assistants\u003c\/p\u003e\n\u003cp\u003eNurses\u003c\/p\u003e\n\u003cp\u003ePsychologists\u003c\/p\u003e\n\u003cp\u003e…and other health professionals interested in neurological rehabilitation\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCEU Sign in and out links.pdf\u003c\/p\u003e\n\u003cp\u003eMay 14 Artificial Intelligence and Machine Learning in Neurorehabilitation – Paolo Bonato, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 14 Interactive Breakout Sessions 1A- Common Causes of Diagnostic Error in Patients with Severe Brain Injury (and Strategies to Avoid Them) – Joseph Giacino, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 14 Interactive Breakout Sessions 1B- Lower Extremity Orthotics After Stroke – Dawn Lucier, PT.pdf\u003c\/p\u003e\n\u003cp\u003eMay 14 Interactive Breakout Sessions 1C- The Perspective of People Living with SCI – Kimberly Anderson, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 14 Interactive Breakout Sessions 2A- Pediatric TBI – Brian Wishart, DO.pdf\u003c\/p\u003e\n\u003cp\u003eMay 14 Interactive Breakout Sessions 2B- Vision Rehabilitation After Stroke – Samira Mortazavi, OD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 14 Interactive Breakout Sessions 2C- Sports and Exercise for People with SCI Kathleen Salas, PT, MHA.pdf\u003c\/p\u003e\n\u003cp\u003eMay 14 Interactive Breakout Sessions 3A- New Diagnostic Criteria for Mild TBI – Grant Iverson, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 14 Interactive Breakout Sessions 3B- Forced Exercise for Parkinson’s Disease – Jay Alberts, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 14 Interactive Breakout Sessions 3C- Brain-Computer and Brain-Spinal Cord Interfaces – Leigh Hochberg, MD, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 14 Interactive Breakout Sessions 4A-B- Rehabilitation of Memory Disorders After TBI and Stroke – Therese O’Neil-Pirozzi, ScD, CCC-SLP.pdf\u003c\/p\u003e\n\u003cp\u003eMay 14 Interactive Breakout Sessions 4C- Update on ASIA Classification – Marika Hess, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 14 KEYNOTE- Early Mobilization of Patients in the ICU – Nicole Mazwi, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 14 KEYNOTE- The Management of Spasticity – Monica Verduzco-Gutierrez, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 15 Gamified Neurorehabilitation Strategies – Jenna Tosto-Mancuso, PT, DPT.pdf\u003c\/p\u003e\n\u003cp\u003eMay 15 Interactive Breakout Sessions 10A – Covert Consciousness in Severe TBI – Brian Edlow, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 15 Interactive Breakout Sessions 10B – Music Therapy in Stroke and Parkinson’s Disease – Brian Harris, MA, MT-BC, NMT-F.pdf\u003c\/p\u003e\n\u003cp\u003eMay 15 Interactive Breakout Sessions 10C – Women’s Health After SCI – Chloe Slocum, MD, MPH.pdf\u003c\/p\u003e\n\u003cp\u003eMay 15 Interactive Breakout Sessions 5A – Recovery and Outcome After Severe TBI and Disorders of Consciousness – Yelena Bodien, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 15 Interactive Breakout Sessions 5B – Pharmacologic Treatment of Dementia – Scott McGinnis, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 15 Interactive Breakout Sessions 5C – Resilience and Adjustment During Rehabilitation After SCI – Ann Marie Warren, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 15 Interactive Breakout Sessions 6A – Chronic TBI – Mel Glenn, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 15 Interactive Breakout Sessions 6B – Models of Stroke Neurorecovery- The Cutting Edge – David Lin, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 15 Interactive Breakout Sessions 6C – Aging with SCI – Sunil Sabharwal, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 15 Interactive Breakout Sessions 7A-B – Rehabilitation of Executive Dysfunction After TBI and Stroke – Olivia Gampel, SLP and Emmaleigh Loyer, SLP.pdf\u003c\/p\u003e\n\u003cp\u003eMay 15 Interactive Breakout Sessions 7C – Update on Amyotrophic Lateral Sclerosis – Sabrina Paganoni, MD, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 15 Interactive Breakout Sessions 8A – Domestic Violence and TBI – Eve Valera, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 15 Interactive Breakout Sessions 8B – Life Participation Approach to Aphasia – Esther Herring, MS, CCC-SLP.pdf\u003c\/p\u003e\n\u003cp\u003eMay 15 Interactive Breakout Sessions 8C – Endocrine Issues After SCI – Shalender Bhasin, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 15 Interactive Breakout Sessions 9A – Mild TBI and Post-Traumatic Stress Disorder in the Military – Lauren Brenner, PhD and Johnny Jarnagin, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 15 Interactive Breakout Sessions 9B-C- Cryoneurolysis for Spasticity – Paul Winston, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 16 Interactive Breakout Sessions 11A- Improving Psychological Health After Mild Traumatic Brain Injury with Building Emotional Self-Awareness Teletherapy (BEST).pdf\u003c\/p\u003e\n\u003cp\u003eMay 16 Interactive Breakout Sessions 11B- Wellness Groups for Stroke Survivors – Elizabeth Frates, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 16 Interactive Breakout Sessions 11C- Assessment and Treatment of Pressure Ulcers After SCI – Jennifer Godfrey, RN, CWCN.pdf\u003c\/p\u003e\n\u003cp\u003eMay 16 Interactive Breakout Sessions 12A- Pharmacologic Approaches to Emotional and Behavioral Dyscontrol After TBI – Hannah Steere, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 16 Interactive Breakout Sessions 12B- Neglect-Inattention After Stroke – Priyanca Shah, DO, MBA.pdf\u003c\/p\u003e\n\u003cp\u003eMay 16 Interactive Breakout Sessions 12C- Musculoskeletal Overuse in People with SCI – Dana Kotler, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 16 Interactive Breakout Sessions 13A- Risk Factors and Clinical Manifestation of Chronic Traumatic Encephalopathy – Daniel Daneshvar, MD, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 16 Interactive Breakout Sessions 13B- The Shoulder After Stroke – Craig Rovito, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 16 Interactive Breakout Sessions 13C- Autonomic Dysfunction After SCI – James Doan, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 16 KEYNOTE Obesity and Cardiometabolic Disease in TBI, Stroke, and SCI Simon Driver, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 16 KEYNOTE Obesity and Cardiometabolic Disease in TBI, Stroke, and SCI Simon Driver, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 16 Psycho-Pharmacogenomics in Neurorehabilitation Alyson Wolz, DNP.pdf\u003c\/p\u003e\n\u003cp\u003eMay 16 Rehabilitation of Functional Neurologic Disorders Ginger Polich, MD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 16 Rehabilitation of Functional Neurologic Disorders Ginger Polich, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 16.mp4\u003c\/p\u003e\n\u003cp\u003eNeuro Rehab Scheudle.pdf\u003c\/p\u003e\n\u003cp\u003eNeuroRehab 2025 Completion Requirements OT-PT-SLP.pdf\u003c\/p\u003e\n\u003cp\u003eNeuroRehabilitation 2025 Faculty Bios and Photos.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405763104964,"sku":null,"price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-NeuroRehabilitation-2025.jpg?v=1784215838"},{"product_id":"psychiatric-society-of-virginia-spring-meeting-2025","title":"Psychiatric Society of Virginia Spring Meeting 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: psychiatrists, psychiatry residents\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis year’s theme is “Artificial Intelligence in Psychiatry: Opportunities, Challenges, and the Future of Mental Health Care.” The meeting will explore how AI is transforming psychiatric practice—from diagnosis and treatment planning to education and administrative tasks. With the growing shortage of psychiatrists, the event will also highlight how technologies like telepsychiatry and virtual therapists can extend care beyond traditional one-on-one models.\u003c\/p\u003e\n\u003ch3\u003eThe meeting includes:\u003c\/h3\u003e\n\u003cp\u003eExpert-led sessions on AI integration in mental health\u003c\/p\u003e\n\u003cp\u003eDiscussions on ethical and clinical implications\u003c\/p\u003e\n\u003cp\u003eNetworking opportunities with peers and thought leaders\u003c\/p\u003e\n\u003ch3\u003eThe target audience for the Psychiatric Society of Virginia (PSV) Spring Meeting 2025 includes a broad spectrum of mental health professionals, particularly:\u003c\/h3\u003e\n\u003cp\u003ePsychiatrists and psychiatry residents\u003c\/p\u003e\n\u003cp\u003ePsychologists and therapists\u003c\/p\u003e\n\u003cp\u003eMedical students and trainees\u003c\/p\u003e\n\u003cp\u003eNurse practitioners and physician assistants in behavioral health\u003c\/p\u003e\n\u003cp\u003eResearchers and educators in psychiatry and neuroscience\u003c\/p\u003e\n\u003cp\u003eHealthcare administrators interested in mental health innovation\u003c\/p\u003e\n\u003cp\u003eGiven the 2025 theme—“Artificial Intelligence in Psychiatry: Opportunities, Challenges, and the Future of Mental Health Care”—the meeting is especially relevant for clinicians and academics exploring how AI is reshaping psychiatric diagnosis, treatment, and education\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003c\/p\u003e\n\u003cp\u003e2025 PSV Spring Meeting – Printable Program.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 15, 2025.mp4\u003c\/p\u003e\n\u003ch3\u003e* Detail:\u003c\/h3\u003e\n\u003cp\u003eSaturday, March 15, 2025\u003c\/p\u003e\n\u003cp\u003eRegistration | Check In\u003c\/p\u003e\n\u003cp\u003eLocation: North Entry Foyer\u003c\/p\u003e\n\u003cp\u003eBreakfast with Committee Meetings and Exhibits – Open to all attendees\u003c\/p\u003e\n\u003cp\u003eLocation: Crystal Ballroom\u003c\/p\u003e\n\u003cp\u003eWelcome and Introductions\u003c\/p\u003e\n\u003cp\u003eLocation: Crystal Ballroom\u003c\/p\u003e\n\u003cp\u003eResident Mind Games\u003c\/p\u003e\n\u003cp\u003eLocation: Crystal Ballroom\u003c\/p\u003e\n\u003cp\u003eYour Online Identity: Privacy and Professional Implications\u003c\/p\u003e\n\u003cp\u003eJohn Luo, MD\u003c\/p\u003e\n\u003ch3\u003eObjectives:\u003c\/h3\u003e\n\u003cp\u003eWith the vast amount of information on the Internet, it is not a surprise that there is content available about anyone regardless of whether uploaded or generated by that person. For psychiatrists, that information may prejudice potential employers from hiring or patients with regards to considering engaging in mental health services. It is important to canvas a variety of information sources to ascertain what impact this information has on one’s professional reputation. In addition, taking action to identify such information will ensure privacy and security of personal information online.\u003c\/p\u003e\n\u003cp\u003eLocation: Roanoke CD\u003c\/p\u003e\n\u003cp\u003eDigital Addiction: The Impact on Mental Health\u003c\/p\u003e\n\u003cp\u003eSachinder Vasudeva, MD\u003c\/p\u003e\n\u003ch3\u003eObjectives:\u003c\/h3\u003e\n\u003cp\u003e1. Discuss effects of excessive use of digital media on the brain and discuss possible treatments.\u003c\/p\u003e\n\u003cp\u003eLocation: Roanoke CD\u003c\/p\u003e\n\u003cp\u003eBREAK WITH EXHIBITS\u003c\/p\u003e\n\u003cp\u003eLocation: Crystal Ballroom\u003c\/p\u003e\n\u003cp\u003eThe Potential Use of Artificial Intelligence in Differential Diagnosis in Psychiatry\u003c\/p\u003e\n\u003cp\u003eDelmar Short, MD\u003c\/p\u003e\n\u003ch3\u003eObjectives:\u003c\/h3\u003e\n\u003cp\u003eLocation: Roanoke CD\u003c\/p\u003e\n\u003cp\u003eAI in Residency\u003c\/p\u003e\n\u003cp\u003eJanie Lozovski, DO; Brian E. Wood, DO, DFAPA\u003c\/p\u003e\n\u003ch3\u003eObjectives:\u003c\/h3\u003e\n\u003cp\u003e2. Determine the role of personal statements and letters of recommendation in the residency application.\u003c\/p\u003e\n\u003cp\u003eLocation: Roanoke CD\u003c\/p\u003e\n\u003cp\u003eLUNCH WITH EXHIBITS AND BUSINESS MEETING\u003c\/p\u003e\n\u003cp\u003eLocation: Crystal Ballroom\u003c\/p\u003e\n\u003cp\u003eHeadache: A Meeting Place\u003c\/p\u003e\n\u003cp\u003eGary Harpold, MD\u003c\/p\u003e\n\u003ch3\u003eObjectives:\u003c\/h3\u003e\n\u003cp\u003e1. Show the need for more Neurologists and Psychiatrists,\u003c\/p\u003e\n\u003cp\u003e2. Discuss the impact of migraine in the general population and the links to mental illness\u003c\/p\u003e\n\u003cp\u003e3. Update the audience on the current effective treatments available for migraine.\u003c\/p\u003e\n\u003cp\u003eLocation: Roanoke CD\u003c\/p\u003e\n\u003cp\u003eResident Breakout Session: Life After Residency – Starting a Practice and Insurance Considerations\u003c\/p\u003e\n\u003cp\u003eGloria Umali, RN BSN MS MPA CPHRM\u003c\/p\u003e\n\u003cp\u003eLocation: Roanoke GH\u003c\/p\u003e\n\u003cp\u003eMental Illness Patient Diversion to an Empath Unit\u003c\/p\u003e\n\u003cp\u003ePeter Betz, MD\u003c\/p\u003e\n\u003ch3\u003eObjectives:\u003c\/h3\u003e\n\u003cp\u003e1. Empath provides early intervention and care for psychiatric patients in the ED\u003c\/p\u003e\n\u003cp\u003e2. Empath reduces LOS of psychiatric patients in the ED\u003c\/p\u003e\n\u003cp\u003e3. Empath allows a substantial majority of patients to return to the community rather than requiring inpatient hospitalization\u003c\/p\u003e\n\u003cp\u003eLocation: Roanoke CD\u003c\/p\u003e\n\u003cp\u003eTechno Stress and Physician Well Being\u003c\/p\u003e\n\u003cp\u003eBadr Ratnakaran, MBBS\u003c\/p\u003e\n\u003ch3\u003eObjectives:\u003c\/h3\u003e\n\u003cp\u003e1. Define technostress and appraise the creators of technostress\u003c\/p\u003e\n\u003cp\u003e2. Identify common sources of technostress in healthcare settings\u003c\/p\u003e\n\u003cp\u003e3. Discuss strategies to mitigate technostress and enhance physician well-being\u003c\/p\u003e\n\u003cp\u003eLocation: Roanoke CD\u003c\/p\u003e\n\u003cp\u003ePanel Discussion: The Rise of Artificial Intelligence in Psychiatry\u003c\/p\u003e\n\u003cp\u003eModerator: Karl W. Northwall, MD, DLFAPA\u003c\/p\u003e\n\u003cp\u003ePeter Betz, MD; Gary Harpold, MD; Janie Lozovski, DO; John Luo, MD; Badr Ratnakaran, MBBS; Delmar Short, MD; Sachinder Vasudeva, MD; Brian E. Wood, DO, DFAPA\u003c\/p\u003e\n\u003cp\u003eLocation: Roanoke CD\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405767889092,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Psychiatric-Society-of-Virginia-Spring-Meeting-2025.jpg?v=1784215873"},{"product_id":"harvard-dementia-a-comprehensive-update-2025","title":"Harvard Dementia A Comprehensive Update 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: primary care physicians, psychologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003eNurses\u003c\/p\u003e\n\u003cp\u003ePrimary Care Physicians\u003c\/p\u003e\n\u003cp\u003eSpecialty Physicians\u003c\/p\u003e\n\u003cp\u003ePsychologists\u003c\/p\u003e\n\u003cp\u003ePhysician Assistants\u003c\/p\u003e\n\u003cp\u003eNurse Practitioners\u003c\/p\u003e\n\u003cp\u003eSocial Workers\u003c\/p\u003e\n\u003cp\u003eOther\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eDescribe current understanding of epidemiology, risk factors, pathobiology, societal costs, clinical differences, gaps in knowledge, and challenges in distinguishing and managing the spectra of normal cognitive aging, mild cognitive impairment (MCI), Alzheimer’s disease (AD), and other neurodegenerative dementias.\u003c\/p\u003e\n\u003cp\u003eDistinguish pre-clinical AD, MCI due to AD\/prodromal AD, and AD dementia phases.\u003c\/p\u003e\n\u003cp\u003eSummarize tiered diagnostic and management approaches, and future experimental therapeutics strategies under consideration for risk reduction, prevention, diagnosis, and treatment of the AD spectrum.\u003c\/p\u003e\n\u003cp\u003eDifferentiate, based on neuropathology, affected neural systems, clinical criteria and biomarkers, AD and its atypical variants from other common dementias including Dementia with Lewy Bodies (DLB), Vascular Cognitive Impairment (VCI)\/Vascular-Ischemic Dementia, Frontotemporal Degeneration (FTD), Parkinson’s disease with Dementia (PDD), Parkinson’s-Plus Syndromes and less common dementias.\u003c\/p\u003e\n\u003cp\u003eIdentify and explain the importance of evidence-based and coordinated individualized approaches to the evaluation and management of MCI, AD, and neurodegenerative dementias that stress combining: (i) early and accurate detection, assessment, and monitoring; (ii) psycho-education and non-pharmacological interventions; (iii) pharmacological strategies; and (iv) caregiver, psychosocial\/environmental, quality of life, ethical, medico-legal and end-of-life considerations.\u003c\/p\u003e\n\u003cp\u003eApply data-supported diagnostic, behavioral, pharmacological, and environmental strategies, including appropriate and tiered use of cognitive tests\/measures, labs, and imaging studies\/biomarkers; and delineation of expectations, roles (i.e., indications and benefits), cautions (i.e., risks, side-effects, warnings) and treatment nuances in the interdisciplinary management of CI, AD, and neurodegenerative dementias.\u003c\/p\u003e\n\u003cp\u003eDemonstrate neural processes and functional networks that support perception and cognitive systems including memory, language, attentional, frontal\/executive, visuospatial, and motor systems.\u003c\/p\u003e\n\u003cp\u003eExplain the roles of office-based screening instruments, mental status exam (MSE), and neuropsychological evaluation in the diagnosis and management of dementia; develop efficient approaches to MSE and use of screening instruments (e.g. MOCA); and interpret and compare cognitive testing\/neuropsychological performance patterns for different conditions and clinical syndromes (e.g. MCI, AD, FTD, primary progressive aphasias, posterior cortical atrophy, DLB).\u003c\/p\u003e\n\u003cp\u003eUtilize appropriate laboratory tests, imaging studies, and neuropsychological testing for the diagnosis of dementia in clinical practice; incorporate appropriate use of clinical biomarkers (e.g. CSF a-beta\/tau, MRI, FDG- and Amyloid-PET) in evaluation of neurodegenerative dementias to differentiate AD and non-AD processes; and explain clinical versus research use, and apply appropriate use criteria\/guidelines to the clinical use of amyloid PET imaging in the diagnosis of AD-like syndromes.\u003c\/p\u003e\n\u003cp\u003eApply data-supported pharmacologic management strategies including the roles (i.e., indications and benefits), cautions (i.e., risks, side-effects, warnings), and potential alternatives to cholinesterase inhibitors, memantine, antipsychotics, and antidepressants in dementia and AD.\u003c\/p\u003e\n\u003cp\u003eDiscuss the important role and the challenges and risks caregivers face; describe strategies to help dementia caregivers cope and better care for themselves and patients with dementia including psychosocial counseling, community support resources, and respite care.\u003c\/p\u003e\n\u003cp\u003eIdentify delirium\/encephalopathy and Chronic Traumatic Encephalopathy (CTE) as dementia risks or entities.\u003c\/p\u003e\n\u003cp\u003eDevelop appropriate practices concerning medico-legal and safety issues surrounding patients with dementia, including capacity with regards to medical care, finances, contracts, independent living, and driving; and integrate medico-legal and safety practices to support and safeguard patients and families, and the public-at-large.\u003c\/p\u003e\n\u003cp\u003eDescribe issues related to dementia neuroethics, and implement effective practices in the long-term care\/nursing-home environment and in end-stage dementia regarding medical, legal, and ethical issues including recognition and treatment of delirium\/encephalopathy and pain, providing palliation and hospice care, and managing end-of-life issues related to dementia.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAgenda.pdf\u003c\/p\u003e\n\u003cp\u003eMay 28 AD Dementia Practical Evaluation \u0026amp; Management in Clinical Practice Alireza Atri, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 28 AD Dementia Practical Evaluation \u0026amp; Management in Clinical Practice Alireza Atri, MD, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 28 Advances in AD Experimental Therapeutics Alireza Atri, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 28 Advances in AD Experimental Therapeutics Alireza Atri, MD, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 28 Alzheimer’s Disease \u0026amp; Related Dementias Global Perspectives and Opportunities Heather Snyder, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 28 Alzheimer’s Disease \u0026amp; Related Dementias Global Perspectives and Opportunities Heather Snyder, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 28 Alzheimer’s Disease Pathobiological Definitions \u0026amp; Prevention Strategies Suzanne Schindler, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 28 Alzheimer’s Disease Pathobiological Definitions \u0026amp; Prevention Strategies Suzanne Schindler, MD, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 28 From Proteinopathies to Neuroimaging \u0026amp; Biomarkers in AD ADRD Primer on Practice and Advances David Wolk, MD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 28 From Proteinopathies to Neuroimaging \u0026amp; Biomarkers in AD ADRD Primer on Practice and Advances David Wolk, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 28 Full Live.mp4\u003c\/p\u003e\n\u003cp\u003eMay 28 Human Cognition An Overview Brad Dickerson, MD, MMSc.mp4\u003c\/p\u003e\n\u003cp\u003eMay 28 Human Cognition An Overview Brad Dickerson, MD, MMSc.pdf\u003c\/p\u003e\n\u003cp\u003eMay 28 Introduction to the Course Alireza Atri, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 28 Memory Systems \u0026amp; Amnesia Andrew Budson, MD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 28 Memory Systems \u0026amp; Amnesia Andrew Budson, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 28 Mild Cognitive Impairment Prodromal AD and Beyond Ronald Petersen, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 28 Mild Cognitive Impairment Prodromal AD and Beyond Ronald Petersen, MD, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 28 Neuropathology of AD ADRD A Guide for Practicing Clinicians Matthew P. Frosch, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 28 Neuropathology of AD ADRD A Guide for Practicing Clinicians Matthew P. Frosch, MD, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 28 Panel Discussion and Q\u0026amp;A Alireza Atri, MD, PhD; Brad Dickerson, MD, MMSc 1.mp4\u003c\/p\u003e\n\u003cp\u003eMay 28 Panel Discussion and Q\u0026amp;A Alireza Atri, MD, PhD; Brad Dickerson, MD, MMSc 2.mp4\u003c\/p\u003e\n\u003cp\u003eMay 29 Assessment of Cognition in Clinical Practice Alireza Atri, MD, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 29 Assessment of Daily Function and Neuropsychiatric Symptoms Behavior and Staging of Dementia in Practice Brad Dickerson, MD, MMSc.mp4\u003c\/p\u003e\n\u003cp\u003eMay 29 Assessment of Daily Function and Neuropsychiatric Symptoms Behavior and Staging of Dementia in Practice Brad Dickerson, MD, MMSc.pdf\u003c\/p\u003e\n\u003cp\u003eMay 29 Attentional and Executive Systems – Don’t Leave Home without Them Kirk Daffner, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 29 Frontotemporal Dementias Focus on Behaviorall Executive Variants Bruce Miller, MD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 29 Frontotemporal Dementias Focus on Behaviorall Executive Variants Bruce Miller, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 29 Full Live.mp4\u003c\/p\u003e\n\u003cp\u003eMay 29 Language Systems \u0026amp; Aphasia-Predominant Dementia Syndromes M. Marsel Mesulam, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 29 Lewy Body Disease, and Parkinsonian \u0026amp; Sensorimotor-predominant Dementias James Galvin, MD, MPH.pdf\u003c\/p\u003e\n\u003cp\u003eMay 29 Neuropsychology of Aging Sandra Weintraub, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 29 Neuropsychology of Aging Sandra Weintraub, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 29 Panel Discussion and Q\u0026amp;A Alireza Atri, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 29 Panel Discussion and Q\u0026amp;A Alireza Atri, MD, PhD; Brad Dickerson, MD, MMSc.mp4\u003c\/p\u003e\n\u003cp\u003eMay 29 Practical Compensatory Strategies for Cognitive Decline Lynn Shaughnessy, PsyD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 29 Practical Compensatory Strategies for Cognitive Decline Lynn Shaughnessy, PsyD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 29 Updates on Vascular Cognitive Impairment \u0026amp; Dementia Charles DeCarli, MD, FAAN, FAHA.mp4\u003c\/p\u003e\n\u003cp\u003eMay 29 Updates on Vascular Cognitive Impairment \u0026amp; Dementia Charles DeCarli, MD, FAAN, FAHA.pdf\u003c\/p\u003e\n\u003cp\u003eMay 30 Caregiving in Dementia Impact, Consequences \u0026amp; Opportunities Mary Mittelman, DrPH.pdf\u003c\/p\u003e\n\u003cp\u003eMay 30 Chronic Traumatic Encephalopathy (CTE) \u0026amp; Dementia Robert Stern, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 30 Chronic Traumatic Encephalopathy (CTE) \u0026amp; Dementia Robert Stern, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 30 Community Advocacy and Activism For Dementias Katie Brandt, MM.mp4\u003c\/p\u003e\n\u003cp\u003eMay 30 Community Advocacy and Activism For Dementias Katie Brandt, MM.pdf\u003c\/p\u003e\n\u003cp\u003eMay 30 Delirium, Encephalopathies and Uncommon Dementias Jeremy Schmahmann, MD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 30 Delirium, Encephalopathies and Uncommon Dementias Jeremy Schmahmann, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 30 Full Live.mp4\u003c\/p\u003e\n\u003cp\u003eMay 30 Morning Introductions Alireza Atri, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 30 Non-Pharmacological Approaches to Neuropsychiatric Symptoms and Problem Behaviors in Dementia Helen Kales, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 30 Panel Discussion and Q\u0026amp;A Alireza Atri, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 30 Panel Discussion, Q\u0026amp;A and Conclusions Alireza Atri, MD, PhD; Brad Dickerson, MD, MMSc.mp4\u003c\/p\u003e\n\u003cp\u003eMay 30 Pharmacological Management of Behavioral Problems in Dementia Clive Ballard, MDB ChB, MRC Psych, MD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 30 Pharmacological Management of Behavioral Problems in Dementia Clive Ballard, MDB ChB, MRC Psych, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 30 Practical \u0026amp; Ethical Considerations for Disclosure of Dementia-Related Diagnosis and Risk Jason Karlawish, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 31 Advance Care Planning \u0026amp; Management of End-stage Dementia, Pain, Palliation \u0026amp; Hospice in Long-Term Care Mary Norman, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 31 Dementia \u0026amp; The Law- Clinical Pearls on Testamentary Capacity and Undue Influence – Bruce H. Price, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 31 Dementia \u0026amp; The Law- Clinical Pearls on Testamentary Capacity and Undue Influence – Judith G. Edersheim, JD, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMay 31 Driving, Home \u0026amp; Community Safety and Dementia Margaret O’Connor, PhD, ABPP CN.mp4\u003c\/p\u003e\n\u003cp\u003eMay 31 Driving, Home \u0026amp; Community Safety and Dementia Margaret O’Connor, PhD, ABPP CN.pdf\u003c\/p\u003e\n\u003cp\u003eMay 31 Full Live.mp4\u003c\/p\u003e\n\u003cp\u003eMay 31 Morning Introductions Alireza Atri, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 31 Panel Discussion, Q\u0026amp;A and Conclusions Alireza Atri, MD, PhD; Brad Dickerson, MD, MMSc.mp4\u003c\/p\u003e\n\u003cp\u003eMay 31 Principles \u0026amp; Practice of Mental Capacity and Competence in Dementia From Finances to Firearms Barry S. Fogel, MD.mp4\u003c\/p\u003e\n\u003cp\u003eMay 31 Principles \u0026amp; Practice of Mental Capacity and Competence in Dementia From Finances to Firearms Barry S. Fogel, MD.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405768642756,"sku":null,"price":97.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Dementia-A-Comprehensive-Update-2025.jpg?v=1784215881"},{"product_id":"harvard-39th-annual-evaluation-and-treatment-of-pain-conference-2025","title":"Harvard 39th Annual Evaluation and Treatment of Pain Conference 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: anesthesiologists, pain specialists, psychiatrists and psychologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eA significant amount of research has indicated that many, if not all, types of pain are undertreated. Some data indicate that only 25% of patients treated for pain receive adequate relief. In addition, several studies have shown that various pain-relieving techniques may be used inappropriately, which can result in patient harm.\u003c\/p\u003e\n\u003ch3\u003eThis course will help participants:\u003c\/h3\u003e\n\u003cp\u003eDiagnose and treat common pain problems\u003c\/p\u003e\n\u003cp\u003eExplore a variety of treatment options for chronic pain, acute pain, and cancer-related pain\u003c\/p\u003e\n\u003cp\u003eUnderstand the role of opioids and their appropriate use in pain management\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003cp\u003eAssess methods for managing end-of-life pain\u003c\/p\u003e\n\u003cp\u003eCompare various pain-relieving techniques\u003c\/p\u003e\n\u003cp\u003eApply current guidelines for pediatric pain management\u003c\/p\u003e\n\u003cp\u003eDiscuss the benefits and use of non-pharmacologic treatments like yoga\u003c\/p\u003e\n\u003ch3\u003eThe target audience for the Harvard 39th Annual Evaluation and Treatment of Pain Conference in 2025 includes a wide range of healthcare professionals who specialize in or are involved with pain management:\u003c\/h3\u003e\n\u003cp\u003eAnesthesiologists\u003c\/p\u003e\n\u003cp\u003ePain specialists\u003c\/p\u003e\n\u003cp\u003ePsychiatrists and psychologists\u003c\/p\u003e\n\u003cp\u003ePhysiatrists (physical medicine and rehabilitation)\u003c\/p\u003e\n\u003cp\u003eFamily physicians and internists\u003c\/p\u003e\n\u003cp\u003ePalliative care physicians\u003c\/p\u003e\n\u003cp\u003eNeurologists and neurosurgeons\u003c\/p\u003e\n\u003cp\u003eOrthopedic surgeons\u003c\/p\u003e\n\u003cp\u003eOncologists\u003c\/p\u003e\n\u003cp\u003eEmergency medicine specialists\u003c\/p\u003e\n\u003cp\u003eNurse practitioners and nurse anesthetists\u003c\/p\u003e\n\u003cp\u003ePhysician assistants\u003c\/p\u003e\n\u003cp\u003eDentists and pharmacists\u003c\/p\u003e\n\u003cp\u003eOther professionals interested in alleviating pain across diverse patient populations2\u003c\/p\u003e\n\u003cp\u003eThe conference is designed to provide cutting-edge updates on pharmacologic, behavioral, and interventional therapies for chronic, acute, and cancer-related pain, with practical tools and techniques for diagnosis and treatment.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eJune 27 Full Live Evaluation and Treatment of Pain Conference.mp4\u003c\/p\u003e\n\u003cp\u003eJune 27 Full Live Evaluation and Treatment of Pain Conference.vtt\u003c\/p\u003e\n\u003cp\u003eSchedule – 39th Annual Evaluation and Treatment of Pain Conference.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405772574916,"sku":null,"price":91.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-39th-Annual-Evaluation-and-Treatment-of-Pain-Conference-2025.jpg?v=1784215931"},{"product_id":"harvard-neurology-for-the-non-neurologist-2025","title":"Harvard Neurology for the Non-Neurologist 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: primary care physicians, general practice providers (primary care, family medicine), internists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAdditional In-Person Live Workshop: June 12, 2025 | Mass General Brigham, Assembly Row, Somerville, MA\u003c\/p\u003e\n\u003cp\u003eNeurology for the Non-Neurologist was founded by Dr. Marty Samuels 30+ years ago and we are hoping to continue his legacy for years to come! This is a comprehensive live CME course that will provide attendees with the opportunity to improve knowledge, competence, and performance in the major sub-specialty areas of modern clinical neurology. The activity will incorporate presentations, Q\u0026amp;A, multiple-choice questions, and opportunities for the learners to interact with experts in the field. The course will provide updates on the rapidly changing field of clinical neurology. With the knowledge and competence gained, the learner will improve their ability to skillfully diagnose and manage those patients who present with neurological symptoms and disorders.\u003c\/p\u003e\n\u003cp\u003eTarget audience\u003c\/p\u003e\n\u003cp\u003eThis activity is intended for Specialty Physicians, Primary Care Physicians, APPs (PA and NP), General Practice Providers (primary care, family medicine), Internal Medicine, Emergency Medicine, Oncology, Geriatrics, Psychiatry, and Neurosurgery.\u003c\/p\u003e\n\u003cp\u003eLearning objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of the activity, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eRecognize how to diagnose common neurological problems such as headache, Parkinson’s disease, ischemic stroke, and dementia.\u003c\/p\u003e\n\u003cp\u003eCite an approach to the most common neurological symptoms including headache, vision changes, weakness, dizziness, and cognitive changes.\u003c\/p\u003e\n\u003cp\u003eApply optimal care to patients with neurological problems who do not require referral to a neurologist.\u003c\/p\u003e\n\u003cp\u003eIdentify ways to provide self-management support to patients with chronic neurological conditions such as multiple sclerosis, Parkinson’s disease, or dementia.\u003c\/p\u003e\n\u003cp\u003eRecognize and manage neurological emergencies such as ischemic stroke and meningitis\/encephalitis.\u003c\/p\u003e\n\u003cp\u003eDiscuss the roles of members of a multi-disciplinary team, and how each contributes to optimizing outcomes for neurology patients, especially those undergoing rehabilitation or living with chronic disease (e.g. PT, OT, SLP, PM\u0026amp;R, etc).\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eJune 9 Agenda.pdf\u003c\/p\u003e\n\u003cp\u003eJune 9 Approach to the Dizzy Patient Manali Sheth, MD Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eJune 9 Approach to the Dizzy Patient Manali Sheth, MD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 9 Approach to the Dizzy Patient Manali Sheth, MD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 9 Clinical Neuroanatomy for the Non-Neurologist Galina Gheihman, MD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 9 Headache Angeliki Vgontzas, MD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 9 Headache Angeliki Vgontzas, MD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 9 Introduction to Neuropathies and Radiculopathies Meabh O’Hare, MD Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eJune 9 Introduction to Neuropathies and Radiculopathies Meabh O’Hare, MD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 9 Introduction to Neuropathies and Radiculopathies Meabh O’Hare, MD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 9 Neuroimaging for the Non-Neurologist What to Order and When Joshua P. Klein, MD, PhD.pptx\u003c\/p\u003e\n\u003cp\u003eJune 9 Optional Asynchronous Sessions Introduction to Myasthenia Gravis and Muscle Diseases (40 minutes) Joome Suh, MD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 9 Optional Asynchronous Sessions Introduction to Myasthenia Gravis and Muscle Diseases (40 minutes) Joome Suh, MD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 9 Test Your Knowledge.pdf\u003c\/p\u003e\n\u003cp\u003eJune 9 The Neurological Exam for the Non-Neurologist Tamara Kaplan, MD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 10 Agenda.pdf\u003c\/p\u003e\n\u003cp\u003eJune 10 Back and Neck Pain Shamik Bhattacharyya, MD Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eJune 10 Back and Neck Pain Shamik Bhattacharyya, MD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 10 Back and Neck Pain Shamik Bhattacharyya, MD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 10 Living With MS Supporting Quality of Life Tamara Kaplan, MD Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eJune 10 Living With MS Supporting Quality of Life Tamara Kaplan, MD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 10 Living With MS Supporting Quality of Life Tamara Kaplan, MD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 10 Optional Asynchronous Sessions Acute Stroke Management (40 minutes) Sam Snider, MD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 10 Optional Asynchronous Sessions Acute Stroke Management (40 minutes) Sam Snider, MD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 10 Optional Asynchronous Sessions Basics of Seizure Management (30 minutes) Jong Woo Lee, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 10 Optional Asynchronous Sessions Tackling Neurology Below the Belt Uroneurology \u0026amp; Sexual Dysfunction Tamara B. Kaplan MD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 10 Optional Asynchronous Sessions Tackling Neurology Below the Belt Uroneurology \u0026amp; Sexual Dysfunction Tamara B. Kaplan MD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 10 Optional Asynchronous Sessions What’s New in MS (15 minutes) Sarah B. Conway, MD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 10 Optional Asynchronous Sessions What’s New in MS (15 minutes) Sarah B. Conway, MD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 10 Recognizing and Managing Acute Stroke Simona Nedelcu, MD, PhD Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eJune 10 Recognizing and Managing Acute Stroke Simona Nedelcu, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 10 Recognizing and Managing Acute Stroke Simona Nedelcu, MD, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 10 Secondary Stroke Prevention Alexis Roy, MD Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eJune 10 Secondary Stroke Prevention Alexis Roy, MD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 10 Secondary Stroke Prevention Alexis Roy, MD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 10 Seizure Mimicks Jong Woo Lee, MD, PhD Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eJune 10 Seizure Mimicks Jong Woo Lee, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 10 Seizure Mimicks Jong Woo Lee, MD, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 10 Test Your Knowledge.pdf\u003c\/p\u003e\n\u003cp\u003eJune 10 Vision Loss Differential Diagnosis Sarah B. Conway, MD Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eJune 10 Vision Loss Differential Diagnosis Sarah B. Conway, MD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 10 Vision Loss Differential Diagnosis Sarah B. Conway, MD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 11 Agenda.pdf\u003c\/p\u003e\n\u003cp\u003eJune 11 Common Neurologic Complications of Cancer \u0026amp; Their Management Eudocia Q. Lee, MD, MPH Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eJune 11 Common Neurologic Complications of Cancer \u0026amp; Their Management Eudocia Q. Lee, MD, MPH.mp4\u003c\/p\u003e\n\u003cp\u003eJune 11 Common Neurologic Complications of Cancer \u0026amp; Their Management Eudocia Q. Lee, MD, MPH.pdf\u003c\/p\u003e\n\u003cp\u003eJune 11 Evaluating Cognitive Disorders and Dementia Seth Gale, MD Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eJune 11 Evaluating Cognitive Disorders and Dementia Seth Gale, MD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 11 Evaluating Cognitive Disorders and Dementia Seth Gale, MD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 11 Functional Neurologic Disorders Angela O’Neal, MD Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eJune 11 Functional Neurologic Disorders Angela O’Neal, MD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 11 Functional Neurologic Disorders Angela O’Neal, MD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 11 Optional Asynchronous Sessions Can’t Miss Neurological Infections (35 minutes) George K. Harrold, MD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 11 Optional Asynchronous Sessions Can’t Miss Neurological Infections (35 minutes) George K. Harrold, MD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 11 Optional Asynchronous Sessions Complications of New Alzheimer’s Disease Treatments (30 minutes) Sheena Baratono, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 11 Optional Asynchronous Sessions Complications of New Alzheimer’s Disease Treatments (30 minutes) Sheena Baratono, MD, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 11 Optional Asynchronous Sessions What You Need to Know about Women’s Neurology (35 minutes) Kenda Alhadid, MD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 11 Optional Asynchronous Sessions What You Need to Know about Women’s Neurology (35 minutes) Kenda Alhadid, MD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 11 Parkinson’s Disease and other Movement Disorders Emily A. Ferenczi, MD, PhD Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eJune 11 Parkinson’s Disease and other Movement Disorders Emily A. Ferenczi, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 11 Parkinson’s Disease and other Movement Disorders Emily A. Ferenczi, MD, PhD.pptx\u003c\/p\u003e\n\u003cp\u003eJune 11 Sports Neurology Claus Reinsberger, MD Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eJune 11 Sports Neurology Claus Reinsberger, MD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 11 Sports Neurology Claus Reinsberger, MD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 11 Test Your Knowledge.pdf\u003c\/p\u003e\n\u003cp\u003eJune 11 Three Mystery Cases Test Your Knowledge! Galina Gheihman, MD; Tamara Kaplan, MD and Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eJune 11 Three Mystery Cases Test Your Knowledge! Galina Gheihman, MD; Tamara Kaplan, MD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 11 Treatment \u0026amp; Management of Alzheimer’s Disease Sheena Baratono, MD, PhD Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eJune 11 Treatment \u0026amp; Management of Alzheimer’s Disease Sheena Baratono, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eJune 11 Treatment \u0026amp; Management of Alzheimer’s Disease Sheena Baratono, MD, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eJune 12 Agenda.pdf\u003c\/p\u003e\n\u003cp\u003eJune 12 Directions-to-Mass-General-Brigham-at-Assembly-Row.pdf\u003c\/p\u003e\n\u003cp\u003eJune 12 Naclerio-HMS NNN approach to weakness slides.pdf\u003c\/p\u003e\n\u003cp\u003eJune 12 Neurology for Non-Neurologist-Dizziness_DB.pdf\u003c\/p\u003e\n\u003cp\u003eNeurology 2025 Faculty.pdf\u003c\/p\u003e\n\u003cp\u003eNNN Agenda 2025.pdf\u003c\/p\u003e\n\u003cp\u003ePage 1 – Front Page Course Intro.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405773459652,"sku":null,"price":130.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Neurology-for-the-Non-Neurologist-2025.jpg?v=1784215939"},{"product_id":"american-psychiatric-association-annual-meeting-on-demand-2025","title":"American Psychiatric Association Annual Meeting On Demand 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: psychiatrists, psychiatric residents, psychologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe 2025 APA Annual Meeting On Demand is a comprehensive digital learning experience offering access to the American Psychiatric Association’s premier annual event anytime, anywhere. Designed for mental health professionals, this program delivers recorded plenary sessions, clinical updates, interactive case discussions, and cutting-edge research presentations. Participants will benefit from flexible, on-demand access to the latest knowledge in psychiatry while earning valuable continuing education credits.\u003c\/p\u003e\n\u003cp\u003eWhat You Will Learn\u003c\/p\u003e\n\u003cp\u003eEvidence-based updates on psychiatric disorders including mood, anxiety, psychotic, and substance use disorders\u003c\/p\u003e\n\u003cp\u003eAdvances in psychopharmacology, psychotherapy, and integrated care models\u003c\/p\u003e\n\u003cp\u003eStrategies for addressing social determinants of mental health and reducing disparities in care\u003c\/p\u003e\n\u003cp\u003eInnovations in neuroscience, genetics, and digital psychiatry\u003c\/p\u003e\n\u003cp\u003ePractical tools to improve clinical practice and enhance patient outcomes\u003c\/p\u003e\n\u003cp\u003eEvent Details\u003c\/p\u003e\n\u003cp\u003eEvent: 2025 APA Annual Meeting On Demand\u003c\/p\u003e\n\u003cp\u003eProgram Highlights: Plenary addresses, symposia, case-based sessions, poster presentations, and special tracks\u003c\/p\u003e\n\u003cp\u003eTopics Covered: Clinical psychiatry, neuroscience, public mental health, health policy, and emerging therapies\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003ePsychiatrists, psychiatric residents, psychologists, nurse practitioners, physician assistants, social workers, and all mental health professionals seeking advanced, flexible continuing education.\u003c\/p\u003e\n\u003cp\u003eWhy Attend\u003c\/p\u003e\n\u003cp\u003eThe On Demand format provides the opportunity to experience the APA’s flagship meeting without time or location constraints. Attendees will gain the same high-quality educational content as the live event, with the flexibility to learn at their own pace and revisit sessions as needed. This program ensures that busy clinicians stay up to date with the latest advancements in psychiatry while maintaining convenience and accessibility.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eA Century of Cumulative Practice Wisdom From the Leaders of Lifestyle Psychiatry\u003c\/p\u003e\n\u003cp\u003eAcademic Medicine Is Evolving: Are We Preparing Women Physicians to Lead or Leaving Them Behind?: Alexandra Symonds Award\u003c\/p\u003e\n\u003cp\u003eADHD Across the Lifespan\u003c\/p\u003e\n\u003cp\u003eAdvocating for Those Who Can’t: Emergency Psychiatric Care of Patients With Non-Verbal Autism\u003c\/p\u003e\n\u003cp\u003eAfrican and Asian Traditional Healing Practices: Relevance to Contemporary Total Health\u003c\/p\u003e\n\u003cp\u003eAgeism in the Mental Health Care of Older Adults\u003c\/p\u003e\n\u003cp\u003eAlzheimer’s Disease and Related Dementias: An Update on Diagnosis, Treatment, Prevention and Research Opportunities\u003c\/p\u003e\n\u003cp\u003eAmerican Association of Social Psychiatry Abraham Halpern Humanitarian Award Recipient: Anita Everett MD. Universal Themes in Social Psychiatry\u003c\/p\u003e\n\u003cp\u003eAmp Schizophrenia: Clinically Actionable Lessons From the Largest (and Ongoing) Study of Clinical High Risk for Psychosis\u003c\/p\u003e\n\u003cp\u003eAmplifying Trainee Voices: How to Seize Leadership Opportunities Within the APA\u003c\/p\u003e\n\u003cp\u003eAn Unselfish Satisfaction: The John Fryer Award Lecture\u003c\/p\u003e\n\u003cp\u003eAPA Council on Psychiatry and Law Workgroup on Carceral (Correctional) Psychiatry: Justice-Informed Clinical Education for the Next Generation\u003c\/p\u003e\n\u003cp\u003eApplying to Residency: Program Directors Panel\u003c\/p\u003e\n\u003cp\u003eAssisted Dying and Suicide: Apples and Oranges or the Same Fruit?\u003c\/p\u003e\n\u003cp\u003eAtypical Antipsychotics in Mood and Other Disorders: Are We Too Quick on the Draw? – A Panel Discussion\u003c\/p\u003e\n\u003cp\u003eBalancing Efficiency and Security: A Comprehensive Look at AI Scribes in Medical Documentation\u003c\/p\u003e\n\u003cp\u003eBenzodiazapines and Other Sedative-Hypnotics Help or Harm: A Panel Discussion\u003c\/p\u003e\n\u003cp\u003eBetter Care for Older Adults With Mild Impairment of Cognition or Behavior\u003c\/p\u003e\n\u003cp\u003eBeyond Barriers: Women Leading in Psychiatry\u003c\/p\u003e\n\u003cp\u003eBeyond Free Pizza: Do You Have Substantive Tools to Improve Physician Wellbeing?\u003c\/p\u003e\n\u003cp\u003eBeyond the Impasse: A Psychodynamic Perspective on the Difficult Patient\u003c\/p\u003e\n\u003cp\u003eBipolar Disorder Borderline Personality Disorder or ADHD? Diagnostic Challenges and How to Deal With Them\u003c\/p\u003e\n\u003cp\u003eBoot Camp to Facilitate the Onboarding of Psychiatry Residents\u003c\/p\u003e\n\u003cp\u003eBurnout to Balance: Residency Wellness + Healthy Strategies\u003c\/p\u003e\n\u003cp\u003eCan Psychiatry Meet the Moment for Competency-Based Medical Education? A Primer on Competency-Based Assessment\u003c\/p\u003e\n\u003cp\u003eCannabis Use: Conversations With Patients\u003c\/p\u003e\n\u003cp\u003eCatch Me If You Can: Catatonia in General Medical Settings\u003c\/p\u003e\n\u003cp\u003eCatch Me When You Can: Suboxone Screening and Induction in the Psychiatric ER\u003c\/p\u003e\n\u003cp\u003eClinical Education on the Social Determinants of Mental Health: Putting the Social Back Into the Biopsychosocial Model – Vestermark Psychiatry Education Award\u003c\/p\u003e\n\u003cp\u003eClinical Update on Artificial Intelligence and Large Language Models\u003c\/p\u003e\n\u003cp\u003eClosing the Mortality Gap in Serious Mental Illness: The Role of Reverse Integrated Primary Care in Community Mental Health Settings\u003c\/p\u003e\n\u003cp\u003eClozapine: Undervalued, Underused and Irreplaceable\u003c\/p\u003e\n\u003cp\u003eCollaborative Care Model for Improving Substance Use Disorder Management in Primary Care: NIDA’s Clinical Trials Network Studies\u003c\/p\u003e\n\u003cp\u003eComprehensive Approaches to Preventing Assessing and Treating Opioid Alcohol Stimulant and Tobacco Use Disorders in Adolescents\u003c\/p\u003e\n\u003cp\u003eContinuing Certification and Other Updates From the ABPN\u003c\/p\u003e\n\u003cp\u003eDefying My Prognosis: Focusing on Wellness Through My Recovery From TBI\u003c\/p\u003e\n\u003cp\u003eDementia and Stroke Bidirectional Relationship With Mental Health\u003c\/p\u003e\n\u003cp\u003eDetecting the Undetectable: Creating a Toolkit to Develop an Anti-Human Trafficking Task Force\u003c\/p\u003e\n\u003cp\u003eDevelopmental Challenges and Opportunities for Children and Adolescents in the Age of Technology\u003c\/p\u003e\n\u003cp\u003eDisasters and Their Consequences\u003c\/p\u003e\n\u003cp\u003eDon’t Call Us Vulnerable: Stories and Data on Resilience in Disaster\u003c\/p\u003e\n\u003cp\u003eDon’t Split It: Treating Borderline Personality Disorder in Community Mental Health Settings\u003c\/p\u003e\n\u003cp\u003eAI Will See You Now: The Opportunities Challenges and Risks of Chatgpt Gemini and Other Large Language Models in Psychiatry\u003c\/p\u003e\n\u003cp\u003eEnhancing Quality and Innovation for Vulnerable Veterans in a Learning Healthcare System\u003c\/p\u003e\n\u003cp\u003eEnhancing Workplace Safety: An Interdisciplinary 360 Approach to Preventing and Addressing Workplace Violence\u003c\/p\u003e\n\u003cp\u003eEthics Dilemmas in Psychiatric Practice\u003c\/p\u003e\n\u003cp\u003eExpanding Access to Inpatient Psychiatric Care Through Telepsychiatry: A Model for Rural Hospitals\u003c\/p\u003e\n\u003cp\u003eField-Based Mental Health Teams: Utilizing Street Psychiatry for Holistic Lifestyle Transformations\u003c\/p\u003e\n\u003cp\u003eFinancial Success 101: Paving the Way to Personal and Professional Security\u003c\/p\u003e\n\u003cp\u003eFinding Meaning in Child Psychiatry: Focusing on Mission and Quality to Avoid Burnout\u003c\/p\u003e\n\u003cp\u003eFor Want of Sleep and Friends: Identifying Patients With Developmental Trauma and Tailoring Treatment Approaches\u003c\/p\u003e\n\u003cp\u003eFostering the Mental Health of a Generation: Child and Adolescent Psychiatrists’ Role in Prevention Health Promotion and Well-Being\u003c\/p\u003e\n\u003cp\u003eFrom Girlhood to Womanhood: The Under-Recognized Challenges of Autism\u003c\/p\u003e\n\u003cp\u003eFrom Home to Healing: A Journey Into a Career\u003c\/p\u003e\n\u003cp\u003eFuture of the DSM: Revisiting Functioning and Social Determinants of Mental Health\u003c\/p\u003e\n\u003cp\u003eFuture of the DSM: Revisiting Structure Dimensionality and Biomarkers\u003c\/p\u003e\n\u003cp\u003eGlp-1 Agonists to Treat Alcohol and Substance Use Disorders\u003c\/p\u003e\n\u003cp\u003eGrowing Good Enough Psychotherapy Supervision Skills\u003c\/p\u003e\n\u003cp\u003eHIV Psychiatry – Essential Clinical Updates\u003c\/p\u003e\n\u003cp\u003eHow Can Neuroimaging Be Useful for the Clinical Psychiatrist?\u003c\/p\u003e\n\u003cp\u003eHow Psychiatrists Can Help Shape the Narrative: Working With Producers and Influencers\u003c\/p\u003e\n\u003cp\u003eHuman Brain Development and Its Relevance to Drug Use and Addiction\u003c\/p\u003e\n\u003cp\u003eIdentifying and Addressing Ethical Issues in the Use of Artificial Intelligence in Psychiatric Education\u003c\/p\u003e\n\u003cp\u003eIMG Women the Unspoken Challenges\u003c\/p\u003e\n\u003cp\u003eIndigenous Women’s Mental Health Challenges and Successful Interventions\u003c\/p\u003e\n\u003cp\u003eIndispensable Tips for Delivering CBT and Dbt: Ingredients and Recipes for Clinical Success\u003c\/p\u003e\n\u003cp\u003eInflammation in Mood Disorders: Biomarkers, Cognitive Impairment, and Treatment Implications\u003c\/p\u003e\n\u003cp\u003eInnovations in Global Brain Health\u003c\/p\u003e\n\u003cp\u003eInnovative Insights: Crafting Your Own Measures for Effective Measurement Based Care\u003c\/p\u003e\n\u003cp\u003eInnovative Strategies for Advancing Training in Mental Healthcare\u003c\/p\u003e\n\u003cp\u003eIntroduction to Nutritional Psychiatry: Evidence and Application in Practice\u003c\/p\u003e\n\u003cp\u003eInventing the Neck: Psychiatry in Whole Person Primary Health Services in Federally Qualified Health Centers\u003c\/p\u003e\n\u003cp\u003eKeeping Everyone Fulfilled: The Future of Psychiatry in Healthcare Systems\u003c\/p\u003e\n\u003cp\u003eKetamine: The Long and Winding Road\u003c\/p\u003e\n\u003cp\u003eKetamine-Assisted Psychotherapy: An Evolving Treatment for Depression and Trauma\u003c\/p\u003e\n\u003cp\u003eLessons Learned From Over Forty Years of Translational Neuroscience Research in Psychiatry: Implications for Drug Development: Nasrallah Family Award\u003c\/p\u003e\n\u003cp\u003eLifestyle for Positive Mental and Physical Health\u003c\/p\u003e\n\u003cp\u003eLifestyle Medicine: The Foundation of Healthcare and Its Integration in Personal Practice Medical Education and Value-Based Care\u003c\/p\u003e\n\u003cp\u003eLive Long and Prosper With S-Adenosylmethionine (Sam-E) Arctic Root (Rhodiola Rosea) and Kanna (Sceletium Tortuosum)\u003c\/p\u003e\n\u003cp\u003eManaging Intrafamilial Conflict: Catching the Bullet From Emotionally Focused Therapy\u003c\/p\u003e\n\u003cp\u003eMental Health Advocacy: Experiences of California Legislators and Psychiatrists\u003c\/p\u003e\n\u003cp\u003eMental Health and Faith Community Partnerships 2025: At the Quarter Mark of the 21St Century\u003c\/p\u003e\n\u003cp\u003eMentorship – Building the Foundation to a Career in Psychiatric Leadership: Administrative Psychiatry Award Lecture\u003c\/p\u003e\n\u003cp\u003eMI Oh My! Using Motivational Interviewing in Diverse Settings\u003c\/p\u003e\n\u003cp\u003eMisfiring Signals: Dopamine Dysfunction in Schizophrenia-From Neural Pathways to Behavioral Manifestations: Award for Research in Psychiatry\u003c\/p\u003e\n\u003cp\u003eNavigating Advanced Therapies for Treatment-Resistant Depression: ECT, Ketamine, MAOIs, and TMS\u003c\/p\u003e\n\u003cp\u003eNavigating Clinical and Administrative Domains in Changing Times: Fiscal Sustainability Quality of Care and Innovation-Based Leadership Strategies\u003c\/p\u003e\n\u003cp\u003eNavigating Early Career Challenges: Strategies for Success and Wellbeing\u003c\/p\u003e\n\u003cp\u003eNavigating School Mental Health in the Age of Addiction\u003c\/p\u003e\n\u003cp\u003eNavigating the Complexities of Maternal Mental Health Care in Today’s Evolving Landscape\u003c\/p\u003e\n\u003cp\u003eNavigating the Current Political and Cultural Landscape: Guidance for Young Investigators\u003c\/p\u003e\n\u003cp\u003eNavigating the Road Ahead: Career Transitions Part 1: Residency to Practice\u003c\/p\u003e\n\u003cp\u003eNavigating the Road Ahead: Career Transitions Part 2: From Early Career to Seasoned Psychiatrists\u003c\/p\u003e\n\u003cp\u003eNew Drugs, New Mechanisms, and New Uses\u003c\/p\u003e\n\u003cp\u003eNew Vistas in the Treatment of Mood and Anxiety Disorders: Psychedelics, Neuromodulation and More\u003c\/p\u003e\n\u003cp\u003eNext Chapter in Suicide Prevention: Suicide Specific Diagnoses in the DSM\u003c\/p\u003e\n\u003cp\u003eNow It Matters to Me! Billing and Coding for Beginners (or Those Who Feel Like One)\u003c\/p\u003e\n\u003cp\u003eNutrition and Its Effects on Psychiatric Health: Practical Approaches to Guide Patients\u003c\/p\u003e\n\u003cp\u003eOld Biomarker New Emphasis: The Changing Role of Structural Neuroimaging in Diagnosing Alzheimer’s Disease Dementia\u003c\/p\u003e\n\u003cp\u003eOne Size Doesn’t Fit All: A Guide for Designing and Implementing Multimodal Agitation Management Training\u003c\/p\u003e\n\u003cp\u003eOur Children and Caregivers Are Not OK, and Neither Are We: The APA Foundation Mental Health Care Works Campaign for Humanity\u003c\/p\u003e\n\u003cp\u003ePGY-AI: The Impact of Artificial Intelligence on Psychiatry Education\u003c\/p\u003e\n\u003cp\u003ePharmacologic Approaches to Suicide Prevention in Outpatient Settings\u003c\/p\u003e\n\u003cp\u003ePositive Psychiatry: A Decade of Progress Meets the Age of Artificial Intelligence\u003c\/p\u003e\n\u003cp\u003ePress Start: The Journey to Writing the Internet Gaming Disorder Playbook\u003c\/p\u003e\n\u003cp\u003ePromoting Mental and Physical Well-Being in Survivors of Male Sexual Trauma: Addressing Stigma and Institutional Barriers\u003c\/p\u003e\n\u003cp\u003ePsychiatric Chronification: When the Patient’s Use of Medications Does Not Promote Mental Health\u003c\/p\u003e\n\u003cp\u003ePsychiatry Idol: Finding the Voice of Advocacy and Leadership in Psychiatry\u003c\/p\u003e\n\u003cp\u003ePsychiatry in Europe: The European Psychiatric Association and Crossing Cultural Divides\u003c\/p\u003e\n\u003cp\u003ePsychodermatology: Interface Between Skin and the Mind May Present Opportunities for a More Rewarding Psychiatric Practice\u003c\/p\u003e\n\u003cp\u003ePsychodynamic Formulations 2.0: An Updated Tool for the Modern Psychiatrist\u003c\/p\u003e\n\u003cp\u003ePsychopharmacology Master Class: The Art of Psychopharmacology\u003c\/p\u003e\n\u003cp\u003eQuijotes De La Psiquiatria: Shaping U.S. Psychiatry Through Hispanic Leadership\u003c\/p\u003e\n\u003cp\u003eReimagining Lithium – How Practical Insights From the Dawn of Psychopharmacology Inform New Molecules for Mood and Behavioral Disorders\u003c\/p\u003e\n\u003cp\u003eResearch Advances in Cannabinoid Behavioral Pharmacology and Treatments for Cannabis Use Disorder: What Do Psychiatrists Need to Know?\u003c\/p\u003e\n\u003cp\u003eRevolutionizing Mental Health: AI-Chat Bots and Digital Interventions for Personalized and Accessible Clinical Care\u003c\/p\u003e\n\u003cp\u003eRevolutionizing Psychiatry Learning Through Virtual Reality\u003c\/p\u003e\n\u003cp\u003eRising Together: The Art of Managing Up\u003c\/p\u003e\n\u003cp\u003eScientific Exploration of the Nature of Spiritual Experiences: A Key Road to Advance the Understanding of the Mind and Its Relationship to the Brain: Oskar Pfister Award\u003c\/p\u003e\n\u003cp\u003eSerotonin Reuptake Inhibitors Through the Life Span: Past and Present\u003c\/p\u003e\n\u003cp\u003eSleep: From Childhood to Aging\u003c\/p\u003e\n\u003cp\u003eSleep’s Hidden Impact: Managing Sleep Disturbances in Psychiatric Disorders\u003c\/p\u003e\n\u003cp\u003eSmart Health and SUD Research in the Era of Artificial Intelligence and Advanced Data Science\u003c\/p\u003e\n\u003cp\u003eSo You Want a Job? Career Choices, Contracts, and Negotiations\u003c\/p\u003e\n\u003cp\u003eStreet Psychiatry: On-the-Ground Experiences and Model Comparisons to Support People Experiencing Unsheltered Homelessness\u003c\/p\u003e\n\u003cp\u003eSubstance Use and Substance Use Disorders: A Focus on Prevention\u003c\/p\u003e\n\u003cp\u003eTaking the Lead: Essential Skills and Strategies-a Workshop for Residents Fellows and Early Career Psychiatrists\u003c\/p\u003e\n\u003cp\u003eTargeted Healing: The Role of the Prescribing Doctor in TMS Therapy – Where, When, and How It Works\u003c\/p\u003e\n\u003cp\u003eTeamwork in the Gray Zone: Risky Puzzles in Geriatric Forensic Psychiatry\u003c\/p\u003e\n\u003cp\u003eTelemedicine Prescribing of Controlled Substances: Your Legal \u0026amp; Regulatory Questions Answered\u003c\/p\u003e\n\u003cp\u003eThe Art and Science of Leadership in Academic Psychiatry\u003c\/p\u003e\n\u003cp\u003eThe Art of Accelerated Resolution Therapy: Treating Trauma Rapidly Without Medications\u003c\/p\u003e\n\u003cp\u003eThe Bidirectionality Between Physical and Mental Health\u003c\/p\u003e\n\u003cp\u003eThe Constant Advocate: Advancing Your Advocacy Journey\u003c\/p\u003e\n\u003cp\u003eThe Devastating Consequences of Child Abuse and Neglect on Adult Morbidity and Mortality: Biological Mechanisms and Treatment Implications: Adolf Meyer Award\u003c\/p\u003e\n\u003cp\u003eThe Fundamental Role of the Arts and Humanities in Medical Education: Concepts, Resources, and Models\u003c\/p\u003e\n\u003cp\u003eThe Future of the Psychiatrist\u003c\/p\u003e\n\u003cp\u003eThe Hype, The Hope, The Harm\u003c\/p\u003e\n\u003cp\u003eThe Impact of Critical Illness: Psychiatrists Role in Prevention and Treatment of PTSD and Post ICU Syndrome (PICS)\u003c\/p\u003e\n\u003cp\u003eThe Importance of Forensic Training for General Psychiatrists: Isaac Ray Award \/ Manfred S. Guttmacher Award\u003c\/p\u003e\n\u003cp\u003eThe Landscape of ADHD Clinical Services on College Campuses and Beyond: Challenges, Controversies, and Approaches\u003c\/p\u003e\n\u003cp\u003eThe Neurobiology of Schizophrenia: What Do We Know and Where Are We Going\u003c\/p\u003e\n\u003cp\u003eThe Past, Present and Future of Mental Health\u003c\/p\u003e\n\u003cp\u003eThe Precision Revolution: Pharmacogenomics in Modern Psychiatry With Lifestyle Applications\u003c\/p\u003e\n\u003cp\u003eThe Role of History and the Media in Narratives Regarding Race and Violence: Chester Pierce Award Lecture\u003c\/p\u003e\n\u003cp\u003eThe Role of Psychiatry in Creating Workplace Resilience in the Face of Disaster\u003c\/p\u003e\n\u003cp\u003eThe Shame Train: How Shame Builds and Breaks Physicians and What We Can Do About It\u003c\/p\u003e\n\u003cp\u003eThe Trauma of Practicing Psychiatry: Vicarious Trauma and Compassion Fatigue\u003c\/p\u003e\n\u003cp\u003eThyroid on Trial: Uncovering Its Impact on Mood Disorders\u003c\/p\u003e\n\u003cp\u003eTop Challenges for ECPs: An APA Workgroup’s Perspective\u003c\/p\u003e\n\u003cp\u003eTransforming the Conceptualization of Intellectual and Developmental Disabilities (IDD) in Psychiatry: From Classification to Care: Frank J. Menolascino Award\u003c\/p\u003e\n\u003cp\u003eTreating the Artist Patient: Provider and Artist Perspectives on Mental Health and Creativity\u003c\/p\u003e\n\u003cp\u003eTreatment of Posttraumatic Stress Disorder: An Update for 2025\u003c\/p\u003e\n\u003cp\u003eUnderstanding and Addressing the Mental Health Impact of Wildfires and Other Natural Disasters\u003c\/p\u003e\n\u003cp\u003eVirtually Training Good Enough Psychotherapy Supervisors\u003c\/p\u003e\n\u003cp\u003eWhat Every Psychiatrist Should Know About TMS-a Clinical and Research Update\u003c\/p\u003e\n\u003cp\u003eWhy Neurodevelopmental Psychiatry (Autism\/ADHD) Is Every Psychiatrist’s Business\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405773590724,"sku":null,"price":104.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Psychiatric-Association-Annual-Meeting-2025.webp?v=1784215940"},{"product_id":"university-of-miami-neurology-update-and-stroke-intensive-review-2025","title":"University of Miami Neurology Update and Stroke Intensive Review 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: neurologists, stroke specialists, neurosurgeons, psychiatrists, neuro-oncologists, hospitalists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eSpecialties – Alzheimer’s\/Cognitive Disorders, Cardiology , Epilepsy, Family Medicine, General Neurology, Internal Medicine, Movement Disorders, Multiple Sclerosis, Neurology, Neuromuscular Diseases, Neuro-Oncology, Neuro-Oncology, Neuropsychology, Neurosurgery, Psychiatry, Sleep Medicine\u003c\/p\u003e\n\u003cp\u003eProfessions – Allied Health Care Professional, Fellow, General Neurologist, Hospitalist, Intensivist, Internist, Medical Student, Neuro Ophthalmologist, Neuro-Oncologist, Neurosurgeon, Nurse, Nurse Practitioner, Pharmacist, Physician, Physician Assistant, Psychiatrist, Researcher, Resident, Scientist, Technologist\u003c\/p\u003e\n\u003cp\u003eOverview\u003c\/p\u003e\n\u003ch3\u003eTarget Audience:\u003c\/h3\u003e\n\u003cp\u003eThe course is aimed primarily at neurologists, stroke specialists, neurosurgeons, psychiatrists, neuro-oncologists, hospitalists, intensivists, fellows, residents, nurses and allied healthcare professionals that participate in the care of neurological patients or work in stroke centers.  Internists, general practitioners and cardiologists may also find the topics timely and useful.\u003c\/p\u003e\n\u003cp\u003eObjectives\u003c\/p\u003e\n\u003ch3\u003eAt the conclusion of this activity, learners will be able to:\u003c\/h3\u003e\n\u003cp\u003eEvaluate recently approved amyloid-targeting therapies for early Alzheimer’s Disease\u003c\/p\u003e\n\u003cp\u003eAssess advances in blood-based biomarkers to diagnose Lewy Body Dementia\u003c\/p\u003e\n\u003cp\u003eDetermine when to prescribe the new anti-seizure medications (ASMs) in clinical practice\u003c\/p\u003e\n\u003cp\u003eAnticipate the potential adverse events resulting from their pharmacokinetic and pharmacodynamic interaction with other ASMs\u003c\/p\u003e\n\u003cp\u003eExamine the clinical implications of medication overuse for headache and the strategies for identification and management\u003c\/p\u003e\n\u003cp\u003eAssess the updates in headache medicine over the past year, including clinical pearls for implementation into clinical practice\u003c\/p\u003e\n\u003cp\u003ePresent the latest diagnostic criteria and treatments for Parkinson’s disease\u003c\/p\u003e\n\u003cp\u003eDescribe the motor and nonmotor fluctuations that complicate Parkinson’s disease symptoms\u003c\/p\u003e\n\u003cp\u003eImprove diagnostic accuracy based on the most current criteria for diagnosis of multiple sclerosis\u003c\/p\u003e\n\u003cp\u003eAssess the MRI criteria for diagnosis of MS using the most appropriate and current sequences\u003c\/p\u003e\n\u003cp\u003eRecognize early genetic testing as an opportunity to make an early diagnosis as a familial ALS and identify Tofersen as a promising new treatment for genetic forms of ALS and as a model for future genetic treatments\u003c\/p\u003e\n\u003cp\u003eDescribe how EDX results can influence prognostic expectations of nerve recovery and analyze the advantages of electrodiagnostic in enhancing surgical planning, as well as the limitations and pitfalls\u003c\/p\u003e\n\u003cp\u003eEvaluate the role of the general neurologist in the care of patients with primary and secondary brain tumors\u003c\/p\u003e\n\u003cp\u003eDefine the sleep processes including sleep drive and circadian rhythm\u003c\/p\u003e\n\u003cp\u003eCharacterize new technologies in diagnosis and treatment of sleep disorders\u003c\/p\u003e\n\u003cp\u003eTreat appropriate acute ischemic stroke patients with modern strategies that include the extended 24-hour treatment window with thrombolytics, endovascular approaches and antithrombotic\u003c\/p\u003e\n\u003cp\u003eEstablish appropriate management of intracerebral hemorrhage according to current guidelines for the management of hypertensive and lobar hemorrhages as well as the role of reversal strategies in coagulopathic hemorrhages\u003c\/p\u003e\n\u003cp\u003eInstitute measures to prevent a recurrent stroke based on stroke mechanism and in special populations according to the most recent guidelines and evidence\u003c\/p\u003e\n\u003cp\u003eAssess the potential long-term complications of MNM, including nerve damage, disability, and the risk of recurrence\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eA Practical Approach to Diagnosis- Movement Case Studies.mp4\u003c\/p\u003e\n\u003cp\u003eAcute Management of Patients with Ischemic Stroke and TIA- Beyond Reperfusion Therapies.mp4\u003c\/p\u003e\n\u003cp\u003eAcute Management of Patients with Ischemic Stroke and TIA- Beyond Reperfusion Therapies.pdf\u003c\/p\u003e\n\u003cp\u003eAdvances in Neurocritical Care of Stroke.mp4\u003c\/p\u003e\n\u003cp\u003eAdvances in Neurocritical Care of Stroke.pdf\u003c\/p\u003e\n\u003cp\u003eAdvances in the Diagnosis of Alzheimer’s Disease and Lewy Body Dementia.mp4\u003c\/p\u003e\n\u003cp\u003eAdvances in the Diagnosis of Alzheimer’s Disease and Lewy Body Dementia.pdf\u003c\/p\u003e\n\u003cp\u003eAdvances in the Treatment of Alzheimer’s Disease.mp4\u003c\/p\u003e\n\u003cp\u003eAdvances in the Treatment of Alzheimer’s Disease.pdf\u003c\/p\u003e\n\u003cp\u003eApproach to Coma and Management of Disorders of Consciousness in Stroke.mp4\u003c\/p\u003e\n\u003cp\u003eApproach to Coma and Management of Disorders of Consciousness in Stroke.pdf\u003c\/p\u003e\n\u003cp\u003eBruton Tyrosine Kinase (BTK) Inhibitors Phase 3 Trials Update.mp4\u003c\/p\u003e\n\u003cp\u003eBruton Tyrosine Kinase (BTK) Inhibitors Phase 3 Trials Update.pdf\u003c\/p\u003e\n\u003cp\u003eCase Studies and Panel Discussion- Multiple Sclerosis.pdf\u003c\/p\u003e\n\u003cp\u003eCo-Morbid Insomnia and Sleep Apnea (COMISA).mp4\u003c\/p\u003e\n\u003cp\u003eCo-Morbid Insomnia and Sleep Apnea (COMISA).pdf\u003c\/p\u003e\n\u003cp\u003eEmbolic Stroke of Unknown Origin- A Construct Worth Reconstructing.mp4\u003c\/p\u003e\n\u003cp\u003eEmbolic Stroke of Unknown Origin- A Construct Worth Reconstructing.pdf\u003c\/p\u003e\n\u003cp\u003eFrom Diagnosis to Recovery- The Role of Electrodiagnostics in Peripheral Nerve Surgeries.mp4\u003c\/p\u003e\n\u003cp\u003eFrom Diagnosis to Recovery- The Role of Electrodiagnostics in Peripheral Nerve Surgeries.pdf\u003c\/p\u003e\n\u003cp\u003eFunctional Movement Disorders – Diagnosis and Discussion.mp4\u003c\/p\u003e\n\u003cp\u003eFunctional Movement Disorders – Diagnosis and Discussion.pdf\u003c\/p\u003e\n\u003cp\u003eGlioma- Diagnosis and Management in the New Era.mp4\u003c\/p\u003e\n\u003cp\u003eGlioma- Diagnosis and Management in the New Era.pdf\u003c\/p\u003e\n\u003cp\u003eIf You Snooze You Never Lose- Fun Facts and Myths About Sleep.mp4\u003c\/p\u003e\n\u003cp\u003eIf You Snooze You Never Lose- Fun Facts and Myths About Sleep.pdf\u003c\/p\u003e\n\u003cp\u003eIntravenous Thrombolysis in the Era of Thrombectomy- A Bridge Too Close.mp4\u003c\/p\u003e\n\u003cp\u003eIntravenous Thrombolysis in the Era of Thrombectomy- A Bridge Too Close.pdf\u003c\/p\u003e\n\u003cp\u003eKEYNOTE ADDRESS- Anti-Thrombotic Therapies Post Intracerebral Hemorrhage.mp4\u003c\/p\u003e\n\u003cp\u003eKEYNOTE ADDRESS- Anti-Thrombotic Therapies Post Intracerebral Hemorrhage.pdf\u003c\/p\u003e\n\u003cp\u003eMeningioma- Nuances in Diagnosis and Management.mp4\u003c\/p\u003e\n\u003cp\u003eMeningioma- Nuances in Diagnosis and Management.pdf\u003c\/p\u003e\n\u003cp\u003eNeurologic Complications of Primary and Secondary CNS Tumors.mp4\u003c\/p\u003e\n\u003cp\u003eNeurologic Complications of Primary and Secondary CNS Tumors.pdf\u003c\/p\u003e\n\u003cp\u003eNew Approaches in Parkinson’s Disease- Extended Dopaminergics and Subcutaneous Pumps.mp4\u003c\/p\u003e\n\u003cp\u003eNew Approaches in Parkinson’s Disease- Extended Dopaminergics and Subcutaneous Pumps.pdf\u003c\/p\u003e\n\u003cp\u003eNew Diagnostic Criteria for MS European Committee for Treatment \u0026amp; Research in MS (ECTRIMS) Update 2024.mp4\u003c\/p\u003e\n\u003cp\u003eNew Diagnostic Criteria for MS- European Committee for Treatment \u0026amp; Research in MS (ECTRIMS) Update 2024.pdf\u003c\/p\u003e\n\u003cp\u003eNew Frontiers in Mechanical Thrombectomy- Boundaries of Infarct Size and Occlusion Location.mp4\u003c\/p\u003e\n\u003cp\u003eNew Frontiers in Mechanical Thrombectomy- Boundaries of Infarct Size and Occlusion Location.pdf\u003c\/p\u003e\n\u003cp\u003eNURSING STROKE COORDINATOR SYMPOSIUM Acute Stroke Processes of Care- From Home to Triage.pdf\u003c\/p\u003e\n\u003cp\u003eNURSING STROKE COORDINATOR SYMPOSIUM How Should it be Managed- The 2025 Updates on Treatment of Stroke-Related Symptoms.pdf\u003c\/p\u003e\n\u003cp\u003eNURSING STROKE COORDINATOR SYMPOSIUM In-Hospital Stroke Alert- Pitfalls and Problems.pdf\u003c\/p\u003e\n\u003cp\u003eNURSING STROKE COORDINATOR SYMPOSIUM Stroke in Women Pregnancy, Hormonal Therapy and Special Considerations.mp4\u003c\/p\u003e\n\u003cp\u003eNURSING STROKE COORDINATOR SYMPOSIUM- Stroke in Women- Pregnancy, Hormonal Therapy and Special Considerations.pdf\u003c\/p\u003e\n\u003cp\u003ePANEL DISCUSSION- How Should it be Managed- The 2025 Updates on Diagnosis and Treatment of Challenging Cases.mp4\u003c\/p\u003e\n\u003cp\u003eRestless Legs Syndrome- New Approaches to Treatment and Management.mp4\u003c\/p\u003e\n\u003cp\u003eRestless Legs Syndrome- New Approaches to Treatment and Management.pdf\u003c\/p\u003e\n\u003cp\u003eSleep Disruption and Cognitive Disease.mp4\u003c\/p\u003e\n\u003cp\u003eSleep Disruption and Cognitive Disease.pdf\u003c\/p\u003e\n\u003cp\u003eThe Non-Pharmacologic Treatment of Migraine and Other Headache Disorders.mp4\u003c\/p\u003e\n\u003cp\u003eThe Non-Pharmacologic Treatment of Migraine and Other Headache Disorders.pdf\u003c\/p\u003e\n\u003cp\u003eThe Nursing Management in Acute Stroke- Dos and Don’ts.pdf\u003c\/p\u003e\n\u003cp\u003eThrombolysis in Acute Ischemic Stroke- New Drugs and The Race Against the Clock.mp4\u003c\/p\u003e\n\u003cp\u003eThrombolysis in Acute Ischemic Stroke- New Drugs and The Race Against the Clock.pdf\u003c\/p\u003e\n\u003cp\u003eUpdate on ALS Treatments.mp4\u003c\/p\u003e\n\u003cp\u003eUpdate on ALS Treatments.pdf\u003c\/p\u003e\n\u003cp\u003eUpdate on Atypical Parkinsonisms- Standard of Care and Study Treatments.mp4\u003c\/p\u003e\n\u003cp\u003eUpdate on Atypical Parkinsonisms- Standard of Care and Study Treatments.pdf\u003c\/p\u003e\n\u003cp\u003eUpdate on Brain Metastases- from Devastating News to a Complete Response.mp4\u003c\/p\u003e\n\u003cp\u003eUpdate on Brain Metastases- from Devastating News to a Complete Response.pdf\u003c\/p\u003e\n\u003cp\u003eUpdates on Management of Patients with Chronic Subdural Hematoma.pdf\u003c\/p\u003e\n\u003cp\u003eUpdates on the Acute Medical Management of Intracerebral Hemorrhage.mp4\u003c\/p\u003e\n\u003cp\u003eUpdates on the Acute Medical Management of Intracerebral Hemorrhage.pdf\u003c\/p\u003e\n\u003cp\u003eUpdates on the Surgical Management of Spontaneous Intracerebral Hemorrhage.mp4\u003c\/p\u003e\n\u003cp\u003eUpdates on the Surgical Management of Spontaneous Intracerebral Hemorrhage.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405773983940,"sku":null,"price":58.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/University-of-Miami-Neurology-Update-and-Stroke-Intensive-Review-2025.jpg?v=1784215945"},{"product_id":"mayo-clinic-neurology-in-clinical-practice-2025","title":"Mayo Clinic Neurology in Clinical Practice 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: neurologists, psychiatrists, primary care physicians (including internists and family care practitioners)\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCourse Directors: Katherine H. Noe, M.D., Ph.D. and Shyamal H. Mehta, M.D., Ph.D.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eThis course is designed for any provider who sees patients with neurologic diseases, including neurologists, psychiatrists, primary care physicians (including internists and family care practitioners), nurse practitioners, physician assistants and nurses.\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, participants should be able to:\u003c\/h3\u003e\n\u003cp\u003eUtilize evidence-based guidelines to select appropriate diagnostic tests for patients presenting with seizures or unexplained episodes.\u003c\/p\u003e\n\u003cp\u003eRecognize when to refer patients with neurooncological conditions to multidisciplinary teams for advanced treatment options.\u003c\/p\u003e\n\u003cp\u003eIdentify red flags in the clinical presentation of seizures or spells that require immediate intervention.\u003c\/p\u003e\n\u003cp\u003eInterpret diagnostic tests, including nerve conduction studies and electromyography (EMG), to identify the type of peripheral neuropathy.\u003c\/p\u003e\n\u003cp\u003eIdentify the clinical presentation of common autonomic disorders, such as orthostatic hypotension, autonomic neuropathy.\u003c\/p\u003e\n\u003cp\u003eRecognize critical warning signs in CNS infection presentations that require urgent management.\u003c\/p\u003e\n\u003cp\u003eInterpret diagnostic tools such as cerebrospinal fluid (CSF) analysis to support the diagnosis of neurological disease.\u003c\/p\u003e\n\u003cp\u003eAttendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eDay 1\u003c\/p\u003e\n\u003cp\u003e12:00 PM\u003c\/p\u003e\n\u003cp\u003e1:00 PM\u003c\/p\u003e\n\u003cp\u003eRegistration, Lunch and Exhibits\u003c\/p\u003e\n\u003cp\u003e1:00 PM\u003c\/p\u003e\n\u003cp\u003e1:15 PM\u003c\/p\u003e\n\u003cp\u003eWelcome Announcements\u003c\/p\u003e\n\u003cp\u003eSession 1 – Movement Disorders\u003c\/p\u003e\n\u003cp\u003e1:15 PM\u003c\/p\u003e\n\u003cp\u003e1:45 PM\u003c\/p\u003e\n\u003cp\u003eDiagnosis of Parkinsonism: Typical and Atypical Shannon Y. Chiu, M.D.\u003c\/p\u003e\n\u003cp\u003e1:45 PM\u003c\/p\u003e\n\u003cp\u003e2:15 PM\u003c\/p\u003e\n\u003cp\u003eMedical Management of Parkinsons Disease Bryan T. Klassen, M.D.\u003c\/p\u003e\n\u003cp\u003e2:15 PM\u003c\/p\u003e\n\u003cp\u003e2:45 PM\u003c\/p\u003e\n\u003cp\u003eDystonia + Hyperkinetic Movement Disorders Erika D. Driver-Dunckley, M.D.\u003c\/p\u003e\n\u003cp\u003e2:45 PM\u003c\/p\u003e\n\u003cp\u003e3:15 PM\u003c\/p\u003e\n\u003cp\u003eNeuromodulation: What’s new Jonathan J Parker, M.D., Ph.D.\u003c\/p\u003e\n\u003cp\u003e3:15 PM\u003c\/p\u003e\n\u003cp\u003e3:30 PM\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e3:30 PM\u003c\/p\u003e\n\u003cp\u003e3:45 PM\u003c\/p\u003e\n\u003cp\u003eBreak and Exhibits\u003c\/p\u003e\n\u003cp\u003eSession 2 – Headache\u003c\/p\u003e\n\u003cp\u003e3:45 PM\u003c\/p\u003e\n\u003cp\u003e4:15 PM\u003c\/p\u003e\n\u003cp\u003eApproach to Headache: When to Worry Amaal J. Starling, M.D., FAHS, FAAN\u003c\/p\u003e\n\u003cp\u003e4:15 PM\u003c\/p\u003e\n\u003cp\u003e4:45 PM\u003c\/p\u003e\n\u003cp\u003eAcute + Prophylactic Migraine Treatments Todd J Schwedt, M.D.\u003c\/p\u003e\n\u003cp\u003e4:45 PM\u003c\/p\u003e\n\u003cp\u003e5:15 PM\u003c\/p\u003e\n\u003cp\u003eNon-migraine Headaches Chia-Chun Chiang, M.D.\u003c\/p\u003e\n\u003cp\u003e5:15 PM\u003c\/p\u003e\n\u003cp\u003e5:30 PM\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e5:30 PM\u003c\/p\u003e\n\u003cp\u003e5:30 PM\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e\n\u003cp\u003eDay 2\u003c\/p\u003e\n\u003cp\u003e6:30 AM\u003c\/p\u003e\n\u003cp\u003e7:25 AM\u003c\/p\u003e\n\u003cp\u003eBreakfast and Exhibits, Optional Non-CME Product Theatre- Axsome Therapeutics\u003c\/p\u003e\n\u003cp\u003e7:25 AM\u003c\/p\u003e\n\u003cp\u003e7:30 AM\u003c\/p\u003e\n\u003cp\u003eAnnouncements\u003c\/p\u003e\n\u003cp\u003eSession 3 – Epilepsy\u003c\/p\u003e\n\u003cp\u003e7:30 AM\u003c\/p\u003e\n\u003cp\u003e8:00 AM\u003c\/p\u003e\n\u003cp\u003eDiagnosis of Seizures and Spells Gregory D. Cascino, M.D.\u003c\/p\u003e\n\u003cp\u003e8:00 AM\u003c\/p\u003e\n\u003cp\u003e8:45 AM\u003c\/p\u003e\n\u003cp\u003eTreatment of Epilepsy: Medical + Surgical David B. Burkholder, M.D.\u003c\/p\u003e\n\u003cp\u003e8:45 AM\u003c\/p\u003e\n\u003cp\u003e9:15 AM\u003c\/p\u003e\n\u003cp\u003eEpilepsy Mimics Katherine H. Noe, M.D., Ph.D.\u003c\/p\u003e\n\u003cp\u003e9:15 AM\u003c\/p\u003e\n\u003cp\u003e9:30 AM\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e9:30 AM\u003c\/p\u003e\n\u003cp\u003e9:45 AM\u003c\/p\u003e\n\u003cp\u003eBreak and Exhibits\u003c\/p\u003e\n\u003cp\u003eSession 4 – Stroke, Neuroinfectious Disease, Hospital Neurology\u003c\/p\u003e\n\u003cp\u003e9:45 AM\u003c\/p\u003e\n\u003cp\u003e10:15 AM\u003c\/p\u003e\n\u003cp\u003eAcute Stroke: Diagnosis and Management William Dave Freeman, M.D.\u003c\/p\u003e\n\u003cp\u003e10:15 AM\u003c\/p\u003e\n\u003cp\u003e10:45 AM\u003c\/p\u003e\n\u003cp\u003eSecondary Stroke Prophylaxis Gyanendra Kumar, M.D.\u003c\/p\u003e\n\u003cp\u003e10:45 AM\u003c\/p\u003e\n\u003cp\u003e11:15 AM\u003c\/p\u003e\n\u003cp\u003eCNS Infections Marie F. Grill, M.D.\u003c\/p\u003e\n\u003cp\u003e11:15 AM\u003c\/p\u003e\n\u003cp\u003e11:45 AM\u003c\/p\u003e\n\u003cp\u003eCommon Inpatient Neurology Consults Molly G. Knox, M.D.\u003c\/p\u003e\n\u003cp\u003e11:45 AM\u003c\/p\u003e\n\u003cp\u003e12:00 PM\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e12:00 PM\u003c\/p\u003e\n\u003cp\u003e1:00 PM\u003c\/p\u003e\n\u003cp\u003eLunch and Exhibits, Optional Non-CME Product Theatre- UCB, Inc\u003c\/p\u003e\n\u003cp\u003eSession 5 – Case Based Learning\/Breakout Sessions\u003c\/p\u003e\n\u003cp\u003e1:00 PM\u003c\/p\u003e\n\u003cp\u003e1:30 PM\u003c\/p\u003e\n\u003cp\u003eMovement Disorders: Day at the Movies James H Bower, M.D.\u003c\/p\u003e\n\u003cp\u003e1:30 PM\u003c\/p\u003e\n\u003cp\u003e2:00 PM\u003c\/p\u003e\n\u003cp\u003e2:00 PM\u003c\/p\u003e\n\u003cp\u003e2:30 PM\u003c\/p\u003e\n\u003cp\u003eHeadache: Challenging Chronic Headaches A. Laine L. Green, M.D., MSc, FRCPC, FAHS\u003c\/p\u003e\n\u003cp\u003e2:30 PM\u003c\/p\u003e\n\u003cp\u003e2:45 PM\u003c\/p\u003e\n\u003cp\u003eBreak and Exhibits Main Salon\u003c\/p\u003e\n\u003cp\u003eSession 6 – Behavioral Neurology\u003c\/p\u003e\n\u003cp\u003e2:45 PM\u003c\/p\u003e\n\u003cp\u003e3:30 PM\u003c\/p\u003e\n\u003cp\u003eUpdates in Alzheimer’s Diagnosis and Treatment Meredith R. Wicklund, M.D.\u003c\/p\u003e\n\u003cp\u003e3:30 PM\u003c\/p\u003e\n\u003cp\u003e4:15 PM\u003c\/p\u003e\n\u003cp\u003eNon-Alzheimer Dementia Vijay Ramanan, M.D.\u003c\/p\u003e\n\u003cp\u003e4:15 PM\u003c\/p\u003e\n\u003cp\u003e4:30 PM\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e4:30 PM\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e\n\u003cp\u003eDay 3\u003c\/p\u003e\n\u003cp\u003e6:30 AM\u003c\/p\u003e\n\u003cp\u003e7:25 AM\u003c\/p\u003e\n\u003cp\u003eRegistration \u0026amp; Breakfast, Optional Non-CME Product Theatre – Alexion AstraZeneca Rare Diseases\u003c\/p\u003e\n\u003cp\u003e7:25 AM\u003c\/p\u003e\n\u003cp\u003e7:30 AM\u003c\/p\u003e\n\u003cp\u003eAnnouncements\u003c\/p\u003e\n\u003cp\u003eSession 7 – Neuromuscular\u003c\/p\u003e\n\u003cp\u003e7:30 AM\u003c\/p\u003e\n\u003cp\u003e8:00 AM\u003c\/p\u003e\n\u003cp\u003ePeripheral Neuropathy Stephen A. Johnson, M.D.\u003c\/p\u003e\n\u003cp\u003e8:00 AM\u003c\/p\u003e\n\u003cp\u003e8:30 AM\u003c\/p\u003e\n\u003cp\u003eNeuromuscular Junction Disorders Brian A. Crum, M.D., Ph.D.\u003c\/p\u003e\n\u003cp\u003e8:30 AM\u003c\/p\u003e\n\u003cp\u003e9:00 AM\u003c\/p\u003e\n\u003cp\u003eMotor Neuron Disease Stephen A. Johnson, M.D.\u003c\/p\u003e\n\u003cp\u003e9:00 AM\u003c\/p\u003e\n\u003cp\u003e9:30 AM\u003c\/p\u003e\n\u003cp\u003eMyopathy Julie A. Khoury, M.D.\u003c\/p\u003e\n\u003cp\u003e9:30 AM\u003c\/p\u003e\n\u003cp\u003e9:45 AM\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e9:45 AM\u003c\/p\u003e\n\u003cp\u003e10:00 AM\u003c\/p\u003e\n\u003cp\u003eBreak and Exhibits\u003c\/p\u003e\n\u003cp\u003eSession 8 – Special Neurology Topics\u003c\/p\u003e\n\u003cp\u003e10:00 AM\u003c\/p\u003e\n\u003cp\u003e10:45 AM\u003c\/p\u003e\n\u003cp\u003eAutonomic Disorders William P. Cheshire JR, M.D.\u003c\/p\u003e\n\u003cp\u003e10:45 AM\u003c\/p\u003e\n\u003cp\u003e11:15 AM\u003c\/p\u003e\n\u003cp\u003eSpine:  Approach to Neck Pain, Back Pain, Radiculopathy Neeraj Kumar, M.D.\u003c\/p\u003e\n\u003cp\u003e11:15 AM\u003c\/p\u003e\n\u003cp\u003e12:00 PM\u003c\/p\u003e\n\u003cp\u003eRole of New Tracers in Neurology Ming Yang, M.D.\u003c\/p\u003e\n\u003cp\u003e12:00 PM\u003c\/p\u003e\n\u003cp\u003e12:15 PM\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e12:15 PM\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e\n\u003cp\u003eDay 4\u003c\/p\u003e\n\u003cp\u003e6:30 AM\u003c\/p\u003e\n\u003cp\u003e7:25 AM\u003c\/p\u003e\n\u003cp\u003eRegistration \u0026amp; Breakfast\u003c\/p\u003e\n\u003cp\u003e7:25 AM\u003c\/p\u003e\n\u003cp\u003e7:30 AM\u003c\/p\u003e\n\u003cp\u003eAnnouncements\u003c\/p\u003e\n\u003cp\u003eSession 9 – Neuroimmunology\/Neuro-oncology\u003c\/p\u003e\n\u003cp\u003e7:30 AM\u003c\/p\u003e\n\u003cp\u003e8:00 AM\u003c\/p\u003e\n\u003cp\u003eMultiple Sclerosis Dean M. Wingerchuk, M.D.\u003c\/p\u003e\n\u003cp\u003e8:00 AM\u003c\/p\u003e\n\u003cp\u003e8:45 AM\u003c\/p\u003e\n\u003cp\u003eAutoimmune\/Paraneoplastic Neurologic Disorders Andrew McKeon, M.B.B.Ch., M.D.\u003c\/p\u003e\n\u003cp\u003e8:45 AM\u003c\/p\u003e\n\u003cp\u003e9:15 AM\u003c\/p\u003e\n\u003cp\u003eNeuro-Oncology Maciej M. Mrugala, M.D., Ph.D.\u003c\/p\u003e\n\u003cp\u003e9:15 AM\u003c\/p\u003e\n\u003cp\u003e9:30 AM\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e9:30 AM\u003c\/p\u003e\n\u003cp\u003e9:45 AM\u003c\/p\u003e\n\u003cp\u003eBreak and Exhibits\u003c\/p\u003e\n\u003cp\u003e9:45 AM\u003c\/p\u003e\n\u003cp\u003e10:30 AM\u003c\/p\u003e\n\u003cp\u003ePediatric Neurology Pearls for the General Neurologist Katherine C. Nickels, M.D., FAAN, FAES\u003c\/p\u003e\n\u003cp\u003e10:30 AM\u003c\/p\u003e\n\u003cp\u003e11:00 AM\u003c\/p\u003e\n\u003cp\u003eNeuro-Ophthalmology Oana M. Dumitrascu, M.D.\u003c\/p\u003e\n\u003cp\u003e11:00 AM\u003c\/p\u003e\n\u003cp\u003e11:45 AM\u003c\/p\u003e\n\u003cp\u003eCommon Sleep Disorders in the Neurology Clinic Umesh Goswami, M.B.B.S, M.D.\u003c\/p\u003e\n\u003cp\u003e11:45 AM\u003c\/p\u003e\n\u003cp\u003e12:00 PM\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e12:00 PM\u003c\/p\u003e\n\u003cp\u003e12:10 PM\u003c\/p\u003e\n\u003cp\u003eClosing comments Katherine H. Noe, M.D., Ph.D., Shyamal Mehta, M.D. Ph.D.\u003c\/p\u003e\n\u003cp\u003e12:10 PM\u003c\/p\u003e\n\u003cp\u003eOptional Independent Cultural and Linguistic Competency Video (California Requirement)\u003c\/p\u003e\n\u003cp\u003e12:10 PM\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405776638148,"sku":null,"price":117.0,"currency_code":"USD","in_stock":true}]},{"product_id":"american-college-of-chest-physicians-sleep-board-review-on-demand-2025","title":"American College of Chest Physicians Sleep Board Review On Demand 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: sleep physicians, pulmonologists, neurologists, psychiatrists, pediatric sleep specialists, hospitalists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWhat You Will Learn\u003c\/p\u003e\n\u003cp\u003eDiagnostic frameworks for OSA, CSA\/Cheyne–Stokes, hypoventilation, insomnia, parasomnias, circadian rhythm disorders, narcolepsy\/idiopathic hypersomnia, and RLS\/PLMD\u003c\/p\u003e\n\u003cp\u003eHow to interpret and score PSG, HSAT, PAP downloads, actigraphy, MSLT\/MWT, and oximetry\/capnography\u003c\/p\u003e\n\u003cp\u003ePractical PAP management: initiation, titration, troubleshooting, adherence; when to use oxygen, oral appliances, positional therapy, or hypoglossal nerve stimulation\u003c\/p\u003e\n\u003cp\u003ePediatric sleep pearls: OSA in children, parasomnias, PLMD, and developmental considerations\u003c\/p\u003e\n\u003cp\u003eComorbidity integration: cardiometabolic disease, COPD\/asthma overlap, neuromuscular disorders, pregnancy, perioperative risk, and drowsy-driving prevention\u003c\/p\u003e\n\u003cp\u003eTest-taking tactics, pattern recognition, and distractor minimization\u003c\/p\u003e\n\u003cp\u003eEvent Details\u003c\/p\u003e\n\u003cp\u003eFormat: On-demand modular video lectures with board-style Q\u0026amp;A and concise summaries\u003c\/p\u003e\n\u003cp\u003eAccess: Self-paced; organized by blueprint domains with quick-reference checklists\u003c\/p\u003e\n\u003cp\u003eStructure: Core topics, case walk-throughs, image\/signal interpretation drills\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003eSleep physicians, pulmonologists, neurologists, psychiatrists, pediatric sleep specialists, hospitalists, advanced practice providers, fellows\/trainees, and any clinician seeking a comprehensive, board-aligned sleep medicine refresher.\u003c\/p\u003e\n\u003cp\u003eWhy Attend\u003c\/p\u003e\n\u003cp\u003eConvert complex guidelines into clear, usable algorithms for clinic, lab, and inpatient consults\u003c\/p\u003e\n\u003cp\u003eSharpen interpretation of PSG\/HSAT\/MSLT\/PAP data to solve real-world cases\u003c\/p\u003e\n\u003cp\u003eBoost exam readiness while improving safety, efficiency, and patient outcomes\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eObstructive sleep apnea: screening, HSAT vs. PSG, PAP\/oral appliance\/positional therapy, HNS basics\u003c\/p\u003e\n\u003cp\u003eCentral apnea \u0026amp; hypoventilation: CHF-related CSA, opioid-related breathing, neuromuscular and obesity hypoventilation\u003c\/p\u003e\n\u003cp\u003eInsomnia \u0026amp; circadian disorders: CBT-I principles, pharmacotherapy, shift work, jet lag, DSPD\/ASPD\/irregular rhythm\u003c\/p\u003e\n\u003cp\u003eHypersomnolence: narcolepsy types 1\/2, idiopathic hypersomnia, MSLT\/MWT protocols, treatment planning\u003c\/p\u003e\n\u003cp\u003eParasomnias \u0026amp; movement disorders: NREM\/REM parasomnias, RBD and neurodegenerative links, RLS\/PLMD management\u003c\/p\u003e\n\u003cp\u003ePediatric sleep medicine: adenotonsillar hypertrophy, SDB evaluation, special populations\u003c\/p\u003e\n\u003cp\u003eTesting \u0026amp; technology: PSG\/HSAT scoring pearls, actigraphy, PAP data analytics, telemedicine workflows\u003c\/p\u003e\n\u003cp\u003eSpecial settings: perioperative screening and risk mitigation, safety counseling, documentation and DME essentials\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405783421124,"sku":null,"price":117.0,"currency_code":"USD","in_stock":true}]},{"product_id":"american-academy-of-child-and-adolescent-psychiatry-pediatric-psychopharmacology-update-institute-2025","title":"American Academy of Child and Adolescent Psychiatry Pediatric Psychopharmacology Update Institute 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: child and adolescent psychiatrists, general psychiatrists, pediatricians, psychologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe American Academy of Child and Adolescent Psychiatry (AACAP) Pediatric Psychopharmacology Update Institute 2025 is an advanced educational program delivering the latest evidence-based knowledge on the use of psychotropic medications in children and adolescents. Presented by leading experts in psychiatry and pharmacology, this course blends cutting-edge research with practical, clinically relevant guidance to enhance prescribing practices, ensure patient safety, and improve treatment outcomes for young patients.\u003c\/p\u003e\n\u003cp\u003eWhat You Will Learn\u003c\/p\u003e\n\u003cp\u003eCurrent best practices in pediatric psychopharmacology across a range of psychiatric disorders\u003c\/p\u003e\n\u003cp\u003eEvidence-based medication strategies for ADHD, mood disorders, anxiety disorders, psychotic disorders, and autism spectrum disorders\u003c\/p\u003e\n\u003cp\u003eApproaches to monitoring treatment response, managing side effects, and preventing adverse events\u003c\/p\u003e\n\u003cp\u003eGuidance on polypharmacy, special populations, and treatment-resistant cases\u003c\/p\u003e\n\u003cp\u003eUpdates on novel pharmacologic agents and emerging therapeutic trends in child and adolescent psychiatry\u003c\/p\u003e\n\u003cp\u003eEvent Details\u003c\/p\u003e\n\u003cp\u003eEvent: American Academy of Child and Adolescent Psychiatry Pediatric Psychopharmacology Update Institute 2025\u003c\/p\u003e\n\u003cp\u003eFormat: Live virtual program with interactive Q\u0026amp;A sessions and on-demand access to recorded content\u003c\/p\u003e\n\u003cp\u003eProgram Highlights: Expert-led lectures, real-world case discussions, and high-yield prescribing tips\u003c\/p\u003e\n\u003cp\u003eTopics Covered: Psychopharmacology principles, disorder-specific medication management, safety protocols, and integration with psychosocial interventions\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003eChild and adolescent psychiatrists, general psychiatrists, pediatricians, psychiatric nurse practitioners, psychologists, and other healthcare professionals involved in prescribing or managing psychiatric medications for young patients.\u003c\/p\u003e\n\u003cp\u003eWhy Attend\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eBipolar Disorder in Youth What is, What Isn’t, and how to Treat it.mp3\u003c\/p\u003e\n\u003cp\u003eBipolar Disorder in Youth What is, What Isn’t, and how to Treat it.mp4\u003c\/p\u003e\n\u003cp\u003eDepression in North America What Works in Clinical Trials Versus What Works for the Teenager in Your Office.mp3\u003c\/p\u003e\n\u003cp\u003eDepression in North America What Works in Clinical Trials Versus What Works for the Teenager in Your Office.mp4\u003c\/p\u003e\n\u003cp\u003eIs Child Psychiatry Ready for the Master Observational Trial.mp3\u003c\/p\u003e\n\u003cp\u003eIs Child Psychiatry Ready for the Master Observational Trial.mp4\u003c\/p\u003e\n\u003cp\u003ePediatric Drug Development in the United States.mp3\u003c\/p\u003e\n\u003cp\u003ePediatric Drug Development in the United States.mp4\u003c\/p\u003e\n\u003cp\u003ePsychopharmacologic and Psychosocial Interventions to Address Mental Health Challenges in Autism.mp3\u003c\/p\u003e\n\u003cp\u003ePsychopharmacologic and Psychosocial Interventions to Address Mental Health Challenges in Autism.mp4\u003c\/p\u003e\n\u003cp\u003ePsychopharmacology for ODD Treating the Horse or the Cart.mp3\u003c\/p\u003e\n\u003cp\u003ePsychopharmacology for ODD Treating the Horse or the Cart.mp4\u003c\/p\u003e\n\u003cp\u003ePsychopharmacology in (not for) Autism Spectrum Disorder An Update.mp3\u003c\/p\u003e\n\u003cp\u003ePsychopharmacology in (not for) Autism Spectrum Disorder An Update.mp4\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A Discussion.mp3\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A Discussion.mp4\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A Panel Discussion 1.mp3\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A Panel Discussion 1.mp4\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A Panel Discussion 2.mp3\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A Panel Discussion 2.mp4\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A Panel Discussion 3.mp3\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A Panel Discussion 3.mp4\u003c\/p\u003e\n\u003cp\u003eTics Tactics Navigating Pharmacotherapy in Pediatric Tourette’s Syndrome.mp3\u003c\/p\u003e\n\u003cp\u003eTics Tactics Navigating Pharmacotherapy in Pediatric Tourette’s Syndrome.mp4\u003c\/p\u003e\n\u003cp\u003eUpdates in ADHD Psychopharmacology.mp3\u003c\/p\u003e\n\u003cp\u003eUpdates in ADHD Psychopharmacology.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405783879876,"sku":null,"price":149.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Academy-of-Child-and-Adolescent-Psychiatry-Pediatric-Psychopharmacology-Update-Institute-2025.jpg?v=1784216105"},{"product_id":"harvard-global-mental-health-trauma-and-recovery-2025","title":"Harvard Global Mental Health Trauma and Recovery 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude: 16 videos +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: psychiatrists, psychologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eGLOBAL MENTAL HEALTH: Trauma and Recovery Certificate Program 2025\u003c\/p\u003e\n\u003cp\u003eThe Harvard Program in Refugee Trauma (HPRT) and the Harvard Medical School are offering an extraordinary 3‑day online certificate program, Global Mental Health: Trauma and Recovery (GMH). The program provides training for health care practitioners, humanitarian relief workers and policy planners addressing the health and mental health sequelae of traumatized patients and communities. The curriculum is adaptable for diverse populations and global environments affected by violence, natural disasters, and climate change.\u003c\/p\u003e\n\u003cp\u003eUpon successful completion of the GMH program, participants receive a certificate of completion from the Harvard Program in Refugee Trauma and a certificate of participation with continuing medical education credits from Harvard Medical School.\u003c\/p\u003e\n\u003cp\u003eMission and Learning Objectives\u003c\/p\u003e\n\u003cp\u003eMore than one billion people have been affected by violence and disasters throughout the world. Our mission is to maximize a scientific and cultural approach and methodology to reduce suffering, minimize disabilities, and increase resiliency for survivors of violence worldwide. This Program offers a transformative training experience to create a network of global leaders in mental health recovery.\u003c\/p\u003e\n\u003ch3\u003eUpon completion of the certificate program, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eIntegrate science, culture, and evidence-based knowledge and practices in policy planning, clinical care, humanitarian, and human rights activities.\u003c\/p\u003e\n\u003cp\u003eImplement and use advances in the neurosciences and cultural knowledge of the clinical care of traumatized persons, their families, and communities.\u003c\/p\u003e\n\u003cp\u003eDefine effective scientific approaches for the care of survivors of extreme violence and climate change.\u003c\/p\u003e\n\u003cp\u003eAnalyze the important historical scientific and evaluation approaches to the care of survivors of trauma.\u003c\/p\u003e\n\u003cp\u003eApply professional development and ethics in working with vulnerable populations.\u003c\/p\u003e\n\u003cp\u003eUnderstand the impact of trauma on the bio-psycho-social and spiritual state of survivors of trauma.\u003c\/p\u003e\n\u003cp\u003eLearn methods for self-care.\u003c\/p\u003e\n\u003cp\u003eLearning Approach\u003c\/p\u003e\n\u003cp\u003eThe program participants will receive an e-copy of the textbook Global Mental Health: Trauma and Recovery: A Companion Guide for Field and Clinical Care of Traumatized People Worldwide. Lectures to be presented by globally recognized leaders in their respective fields and will follow the eight dimensions of the Global Mental Health Action Plan. Participants will also receive the HPRT 11 Point Clinical Toolkit for Healing Wounds of Mass Violence and Disasters.\u003c\/p\u003e\n\u003cp\u003eTopics\u003c\/p\u003e\n\u003cp\u003eThe program’s emphasis is on learning an integrated holistic approach to policy planning and clinical care using the HPRT Global Mental Health Action Plan.\u003c\/p\u003e\n\u003ch3\u003eTopics include:\u003c\/h3\u003e\n\u003cp\u003ePhenomenological theory of trauma and recovery developed by HPRT and international colleagues over 40 years.\u003c\/p\u003e\n\u003cp\u003eEpidemiology and the neuroscience of trauma.\u003c\/p\u003e\n\u003cp\u003eThe HPRT Global Mental Health Action Plan.\u003c\/p\u003e\n\u003cp\u003eTrauma-informed Care.\u003c\/p\u003e\n\u003cp\u003eMental Health Diagnosis and Treatment of Mental Health and Medical Disorders.\u003c\/p\u003e\n\u003cp\u003eScientific (Evidence-Based) and Culturally Valid Best Clinical Practices.\u003c\/p\u003e\n\u003cp\u003eThe new H5 Model for field based psychosocial and clinical approach to recovery.\u003c\/p\u003e\n\u003cp\u003eHealth and mental health impact of health disparities.\u003c\/p\u003e\n\u003cp\u003eHuman Rights and Rebuilding Social Capital.\u003c\/p\u003e\n\u003cp\u003eWorking in Interdisciplinary Medical Teams.\u003c\/p\u003e\n\u003cp\u003eScientific and culture-based approach to leadership.\u003c\/p\u003e\n\u003cp\u003eClimate change and ecocide.\u003c\/p\u003e\n\u003cp\u003eThe importance of Self-care.\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405786534084,"sku":null,"price":169.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Global-Mental-Health-Trauma-and-Recovery-2025.webp?v=1784216145"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/collections\/Gemini_Generated_Image_18b2tl18b2tl18b2_6.png?v=1784221748","url":"https:\/\/medicalcoursespro.com\/collections\/psychiatry.oembed","provider":"Medicalcoursespro","version":"1.0","type":"link"}